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Abstract 
The work is focussed on the HIV epidemic among key populations in Latin America, a region 
that has received limited international attention due to the concentrated nature of its 
epidemic. It faces important challenges in prevention and risks missing the opportunity to 
control the epidemic. Despite the evidence available showing the disproportionate burden 
of infection among key populations, principally men who have sex with men (MSM) and to a 
lesser extent injecting drug users (IDU) and female sex workers (FSW), a small percentage of 
countries’ HIV prevention spending is allocated towards prevention interventions among 
these groups. 
In this thesis, we first estimate the distribution of new infections by type of exposure in the 
Dominican Republic, Mexico and Peru and find that MSM account for a large share of new 
infections in the three countries (over 50% in Mexico and Peru and 30% in Dominican 
Republic). This highlights that this population should be prioritised in prevention 
programmes. We then turn to interventions for MSM, and investigate whether pre-exposure 
prophylaxis (PrEP) to prevent HIV acquisition among MSM in Lima, Peru represents a cost-
effective intervention at the population level. We find PrEP to be a potentially cost-effective 
intervention although unaffordable at a large scale. We conclude it should be considered as 
an additional tool within a combination prevention approach among this population.   
Following these, we seek to understand the dynamics, causes and consequences of risk 
behaviours and HIV infection in another key population that has rarely been prioritised by 
public health programmes: prison inmates. We use data from the largest prison in Peru and 
find that HIV prevalence is 4 times higher than national prevalence and inmates engage in 
riskier sexual behaviours than in the general population. Nevertheless, there are indications 
of risk behaviours and HIV prevalence reducing in recent years.  To help direct prevention 
efforts in this setting, we characterise the risk profile of inmates who engaged in sex with 
FSW, other men and in unprotected sex with casual partners and  identify inmates who have 
sex with men as being at heightened risk of infection (due to higher levels of drug use and 
unprotected sex).  
We use those data to develop a mathematical model that represents the HIV epidemic in the 
prison. Contrary to expectations, we find that incidence is likely to be less than 1% per year 
within the prison and that the dynamics of HIV in prisons are principally driven by inmates 
infected before their incarceration. We further estimate that since the beginning of the 
epidemic, at least 5% of HIV cases identified in Lima have passed through the prison, 
suggesting that the routine screening system in place at prisons could make a substantial 
contribution to controlling the HIV epidemic across the city.  
Finally, we formulate a conceptual framework of HIV risk among prison inmates in Latin 
America focussing on the social and underlying determinants of risk and develop a 
structured questionnaire to test the hypotheses proposed through the framework and 
obtain information relevant to the design of interventions within prisons and at the 
community level. 
Together this work draws on social and quantitative science to provide new insights into key 
populations in Latin America that should contribute to stronger and responsive HIV 
prevention programmes, to the benefit of all those that remain at risk of HIV in the region. 
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Chapter 1: Introduction 
1 Summary 
HIV is probably the virus that least requires an introduction as it has so efficiently spread 
across the world, physically but also as an important topic present in the medicine 
curriculum, media coverage, political agendas and people’s minds and conversations. To this 
date over 30 million people are estimated to have died of AIDS. According to the last 
UNAIDS epidemic update 33.3 million people were living with HIV in 2009 and of these 2.6 
million had acquired it that year [1].  
Over thirty years after the onset of the epidemic, billions of dollars have been spent, 
numerous discoveries and ideas have emerged, been tested in clinical trials and 
implemented, gigabytes of data have been collected and analysed, sophisticated scientific 
methods have been developed. But above these, probably the most important collateral 
repercussion of HIV is to have exposed old and ignored problems and forced the world to 
recognise them, verbalise them and address them.   
Early in the epidemic, due to the nature of its transmission, HIV mostly affected people who 
were already marginalised such as Female Sex Workers (FSW), Men who have Sex with Men 
(MSM), Injecting Drug Users (IDU) and prison inmates. HIV was consequently associated with 
promiscuous, often illegal and to the view of many, immoral habits; further stigmatising 
these groups. However, as the epidemic progressed it became evident that if the spread of 
HIV was to be curbed, these populations and the contextual and structural factors that lead 
them to risk had to be addressed. Gender and socio-economic inequalities, homophobia, 
and the victimisation of FSW and drug users are at the heart of this pandemic. HIV is in fact 
only one of the many problems that people engaging in these behaviours are faced with, but 
it has provided an incentive to resolve them. Contributing to this effort is one of the 
motivations of this work. Although there has been great progress in the political and public 
health discourse regarding these populations, the response has failed to be in tune with the 
evidence in many places, slowing and jeopardising the potential control of the epidemic [2]. 
In Latin America, where the epidemic is largely concentrated among specific groups, 
especially MSM and IDU, prevention has been focussed on the general population [3]. The 
work in this thesis aims to provide general as well as specific guidance for the prevention 
response in the region. To do this we take a broad look at the epidemic in three countries of 
the region by using the UNAIDS Modes of Transmission (MoT) model to estimate the 
distribution of new infections by type of exposure. In this way we highlight populations at 
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greater risk of infection but also provide insight into the limitations hidden behind results 
related to data quality and method shortcomings.  We build on from this to focus on the key 
population that was found to be central to the epidemic in the three countries studied: 
MSM. We develop a model reproducing the sexual behaviours and prevalence trends 
observed in Lima, Peru to investigate the potential of a novel prevention intervention 
method, Pre-Exposure Prophylaxis (PrEP) in the context of a middle income setting. We then 
turn to a population that has had much less visibility in the region in terms of research: 
prison inmates. While data characterising prevalence and sexual behaviours among MSM 
has accumulated over the years, little is known about the epidemic among prison inmates. 
Nonetheless, this is a population that has been shown to be at greater risk of HIV infection 
across the world including Latin America and so we aimed to contribute filling this gap in 
knowledge. For this we described the inmate population of the larget prison in Peru  in 
terms of demography, prison history, sexual and drug using behaviours and HIV risk and 
undertook an epidemiological analysis of its HIV epidemic through developing a 
mathematical model of HIV transmission in this setting, Peru We then expanded our 
research in terms of geography and scope to investigate the social determinants of HIV 
infection in this population, which we synthesised in the form of a conceptual framework 
and based on this we designed a structured questionnaire to collect information on the 
issues identified. 
In the introduction we revisit the main characteristics of HIV transmission both at the 
individual and at the population levels and we give an overview of the different epidemic 
patterns observed across the world. We then briefly introduce the major data collection 
systems in place to monitor the epidemic and mathematical modelling as a tool to better 
understand HIV transmission and guide prevention, as this will be used to investigate several 
questions along the thesis. We present the Latin American epidemic and the main 
populations affected, with special focus on MSM and prison inmates, and describe the 
response.  
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2 HIV transmission and risk 
Currently, HIV is mostly transmitted through sex and sharing of injecting equipment. 
Transmission occurs through the lower genital and rectal mucosa, and through direct entry 
of the virus into the bloodstream respectively [4]. Perinatal transmission also occurs, either 
in-utero through the placenta, intrapartum through ingestion of maternal blood or genital 
secretions or postpartum through ingestion of contaminated breast milk [4]. The probability 
of transmitting and acquiring HIV has been shown to vary depending on the type of 
exposure, on the timing of contacts along the natural history of infection and on biological 
characteristics of both the infected and susceptible individuals [4,5,6,7]. In broad terms, the 
transmissibility of HIV is a function of the concentration of virus in bodily fluids and 
secretions, of the permeability of the tissue to the virus and of the immune context at the 
site of contact [4].  
To understand these processes some background on the natural history of infection is 
required. The primary targets of HIV are CD4 T cells but it also infects macrophages and 
dendritic cells which share one or more receptors with CD4 cells to glycoproteins on its 
envelope [8]. Immunodeficiency is mainly related to a dramatic decline in CD4 cells [8] but 
the process through which HIV causes this decline has proven to be very complex [9]. The 
natural history of infection mainly depends on the fluctuations in CD4 cells and this is the 
main marker used to evaluate HIV patients’ disease progression. During the first 3 months 
after infection (acute infection), viral load (i.e. the concentration of virus in the blood) is high 
and there is a drop in the count of CD4 cells [10]. Viral load is then controlled by the immune 
system and maintained at a low level for years, while CD4 cells numbers rise and 
stabilise[10]. This stage is named asymptomatic or latent infection as patients do not show 
any clinical signs of infection [10]. Between 8 to 12 years later, viral load increases again and 
there is a depletion of CD4 cells resulting in symptomatic infection (AIDS) and death [10]. 
HIV is believed to be about 26 times more infectious during acute infection as compared to 
latent infection and about 7 times more infectious during the period preceding AIDS [11]. 
Regarding the type of contacts, blood transfusions represent the highest risk of infection due 
to the direct entry of large quantities of the virus into the bloodstream [12]. Sharing of 
infected injection material is also very efficient but involves smaller quantities of virus[12]. 
Regarding sexual contacts, receptive anal sex is the riskier type of act as the rectal tissue is 
not as lubricated as the vagina and is more prone to rupture; then follow insertive anal sex, 
receptive vaginal sex, insertive vaginal sex and oral sex[7].  
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These differences are partly driven by biologic characteristics as women are believed to be 
more susceptible to infection than men due to larger surface and higher permeability of the 
vaginal mucosa to the virus as compared to that of the penis [4]. Other biological 
characteristics influence the risk of infection. Circumcision has been shown to be protective 
against acquisition of infection (there is no evidence for it affecting transmission)[13,14,15] 
and the presence of Sexually Transmitted Infections (STIs), especially ulcerative STIs, has 
been shown to increase the risk of acquisition and transmission of infection[16]. This 
increased infectiousness and susceptibility is believed to result from the increased entry of 
the virus through wounds and through the presence of immune cells at the site of infection, 
providing more targets of infection to HIV [16]. Finally, anti‐retroviral therapy suppresses 
viral load to low or even undetectable levels and therefore prevents transmission [17,18]. 
 
Ultimately, transmission can only happen if there is contact with an infected individual (or 
with infected blood in the case of transmission through transfusions or injecting equipment). 
In this sense, certain behaviours will increase the risk of exposure: having a high number of 
sexual partners or sharing injecting equipment with a high number of people will increase 
the probability of encountering an infected individual. Choosing partners (sexual or injecting) 
that themselves have many partners, will also increase the likelihood of exposure to an 
infected individual. Biological vulnerability and behaviour therefore work together to shape 
the risk of individuals.  
3 From individual risk to population spread 
3.1 Fundamental concepts of disease transmission 
Individual contacts result in the formation of networks and their characteristics together 
with those of the pathogen will give rise to specific epidemic patterns. As many other 
dynamic processes such as population growth, the spread of infection at the population 
level follows mathematical properties. Some of these were first described in 1760 by Daniel 
Bernoulli, when he investigated the impact of smallpox on life expectancy [19]. At the start 
of the 20th century, mostly through the observation of the seasonality of childhood diseases 
such as measles, came the theory of mass action. This stipulates that the spread of infection 
results from the rate of random contacts between infected and susceptible individuals and 
that incidence declines as the number of susceptible decrease [20]. In fact, measles 
outbreaks occurred during school season when sufficient contacts between individuals of 
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young age groups (susceptible) happened. This concept was further developed to obtain the 
basic theory defining transmission. The work of Ross, Lotka and McDonald on malaria 
transmission defined many of the fundamental concepts governing the dynamics between 
pathogens and hosts [21]. The magnitude of an epidemic in a totally susceptible population 
is dependent of 3 elements: the transmission probability of the pathogen (Beta), which as 
described above can vary in function of several factors, the average number of contacts in 
the population (C) and the average duration of infectiousness (D) [22]. These elements 
determine the average number of secondary infections that will result from a primary 
infected individual, a fundamental number in epidemiology known as the reproduction 
number R0 [22].  
R0=Beta.C.D 
For R0< 1 the pathogen will go extinct and for R0>1 it will cause an epidemic [22]. Once some 
individuals are infected the number of secondary infections will no longer be equal to R0 as 
some contacts will be wasted on already infected individuals. This number becomes the 
“effective R0” and the epidemic eventually ends once once saturation is reached [22]. In a 
system where new susceptibles keep entering the population, either through births or loss 
of immunity, the pathogen can persist in the population and an endemic equilibrium can be 
reached[22]. Different pathogens will require different contact patterns to establish and 
persist in a population. Pathogens that have a short duration of infectiousness require 
higher contact rates to ensure they are transmitted before extinguishing and so they are 
more likely to remain inside a particular group, while those that have a high transmission 
probability or a very long infectious period will require less rapid contact rates [22]. 
These properties also apply to STIs. A classic example is that of gonorrhoea which has a 
relatively short period of infectiousness and therefore requires relatively high partner 
change rates to be maintained in the population. However, sexual behaviours and especially 
sexual contact patterns are rarely homogeneous in a population and this has been proven to 
be crucial for the spread of STIs. In 1978 York et al showed that by implementing gonorrhoea 
screening in the U.S. an additional 10% of cases were detected among women and this 
resulted in a 20% decrease in the number of infections in the few years that followed[23,24]. 
Further analysis of this data with the use of mathematical models concluded that the 
persistence of gonorrhoea in the population was dependent on the higher sexual activity of 
a small number of individuals, giving rise to the theory of the “core group”[24]. The 
importance of the core group is also relevant to HIV, although its longer duration of 
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infectiousness makes it more resilient to slower partner change rates. Some populations 
such as MSM, IDU and FSW, who have higher partner change rates and/or exhibit higher 
vulnerability to infection, have been shown to be crucial to the establishment of HIV. These 
populations will the focus of this work as the epidemic in Latin America has mainly remained 
concentrated among them and the action taken to control its spread at this level will 
determine its impact in the future. With time the HIV jargon has evolved and they have been 
referred to as “risk groups”, “Most At Risk Populations” (MARPs), “vulnerable populations” 
and “key populations”. The use of latter term is encouraged as rather than making 
assumptions about their behaviours or conditions it simply draws on their importance to the 
epidemic.  
Further spread to the lower risk or general population will be dependent on the sexual 
mixing patterns of these groups. If sexual contact only happens within key populations, 
which is defined as “assortative” like with like mixing (as opposed to random mixing 
mentioned before), the epidemic will eventually saturate and die out [24,25,26]. However, if 
contacts are made outside these groups, the epidemic can spread further. Some individuals 
who have sex with both members of key populations and of the lower risk population, such 
as clients of FSW that might also be married or in a relationship with lower risk women, can 
facilitate the spread of infection from one group to the other [27]. These are referred to as 
“bridge groups”[27]. The reality is more complex as members from the key population often 
have direct contact with the lower risk populations and even become themselves part of the 
lower risk population after a period of higher risk behaviours [27]. For instance FSW may 
have boyfriends or husbands within the lower risk population and they often work as sex 
workers for a few years only, to then return to the so called general population. The 
establishment and persistence of HIV within the lower risk population will then depend on 
the contact patterns within and between core groups and the lower risk population and on 
their interaction with biological factors [24,25,27]. 
The diversity in sexual behaviours and possible combinations of factors has resulted in an 
equally heterogeneous distribution of infection across the world as seen in Figure 1. HIV 
prevalence varies highly between regions and countries as well as locally.  
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Figure 1. Global HIV prevalence in 2009 according to UNAIDS estimates 
 
3.2 Epidemic Typologies 
As a starting point to reaching an understanding of the different epidemics observed it was 
necessary to characterise them. These were described and classified into groups that 
corresponded to broad epidemic patterns. The typology created divides them into three 
main categories: “low level”, where the HIV prevalence is under 1% in the general 
population and under 5% among key populations, “concentrated”, where the prevalence is 
under 1% in the general population but has reached 5% or more in at least one key 
population and “generalised” where the prevalence is above 1% in the general population 
[28,29]. A forth category, describing settings where prevalence has reached over 15% in the 
general population is referred to as “hyper-endemic”[29]. This concerns countries in Sub-
Saharan Africa where HIV spread has been exceptionally efficient among the general 
population. The basis of this typology is still in use; but with time, shortcomings in this 
classification have become apparent and there has been a move from the arbitrary 
prevalence thresholds to criteria that inform on the dynamics of transmission[2]. Numerical 
thresholds can mask the underlying drivers of the epidemic and therefore mislead the 
response. For example, in countries where prevalence is above 1% in the general population, 
key populations might still account for an important proportion of new infections, either 
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directly or indirectly[2]. Focussing prevention efforts on the general population might 
consequently not result in significant changes [2].  The field is moving towards evaluating 
countries’ epidemics in a more individual manner by looking at prevalence as well as 
behaviours in different populations, including temporal trends that might indicate changes 
in the dynamics of transmission and by evaluating the contribution of each population to the 
number of new infections[30]. Depending on the geographical and socio-demographical 
situation, different populations will be affected and this can also vary over time due to 
contextual changes or prevention interventions. Currently, aside from Sub-Saharan Africa 
and other African countries, which have well established epidemics affecting up to 1 in 5 
people in Botswana, epidemics across the world remain mainly concentrated among key 
populations[1]. In developed countries such as the U.S. or most of Western Europe, the 
epidemic mostly affects MSM and IDU.This also applies to Latin American countries,although 
some countries such as Haiti, Guyana and Surinam also have heterosexual epidemics, 
classified as generalised[1]. In Russia and Eastern Europe, the epidemic is largely associated 
with IDU and the potential for transmission is considered to be high[1]. In Asia, FSWs have 
been especially affected, but MSM and mobile populations are also at heightened risk [1].  
4 Monitoring the epidemic: data sources 
Obtaining the data required to characterise the epidemic and monitor it over time is a field 
of study on its own. HIV surveillance was implemented early in the epidemic both among the 
general population through measuring prevalence among pregnant women in antenatal 
clinics (ANC) and among key populations through sentinel surveillance surveys. Although 
pregnant women may seem largely representative of the general population, certain issues 
limit this association. Firstly, being pregnant involves having unprotected sex and therefore 
potentially being exposed to HIV. Secondly, HIV has an impact on fertility and therefore HIV 
positive women might be less likely to be pregnant. While the former would result in ANC 
clinic prevalence being an over-estimate of true prevalence in the population, the latter 
would have the opposite effect. In 2001, Demographic and Health Surveys (DHS) that sample 
households to obtain information on indicators related to fertility, family planning and 
children health among others, started including HIV testing [31]. Prevalence obtained from 
these large population surveys was significantly lower than estimated in ANC clinics for the 
vast majority of countries[2]. This resulted in a revision of the UNAIDS HIV estimates in 2007 
that took the number of people living with HIV from 39.5 to 33.2 million [32]. In this way, 
HIV surveillance continues to evolve over time as information becomes available and new 
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methods are developed. The HIV surveillance system is considered the most sophisticated in 
the field of infectious diseases and has set precedent to the improvement of surveillance 
systems of other diseases. In the late 1990’s, UNAIDS and the WHO reviewed the 
surveillance guidelines and introduced second generation HIV surveillance [28]. This 
represented a shift in the role of HIV surveillance from a generally passive source of 
information that allowed knowing how widespread the infection was at a particular point in 
time to a more active player in the control of the epidemic, through collecting information 
that could provide a sense of the potential spread of infection in the future. This was done 
by incorporating the surveillance of other STIs (syphilis in particular) and of sexual risk 
behaviours into HIV surveillance[28]. STIs and HIV share the same pathways for transmission 
but the former are generally more prevalent. Having a biological indicator of sexual 
behaviours in the population allows determining whether the conditions for the spread of 
HIV are present or not [28]. Directly measuring HIV risk behaviours serves the same purpose 
but provides precise information on the potential determinants for transmission and 
therefore allows formulating prevention interventions to target them. These two types of 
indicators are complementary as while the latter provides more specific information, it 
comes with a broad range of limitations as it relies on the report of sensitive behaviours 
[28]. Biological indicators on the other hand, represent a solid fact but do not tell us about 
the timing or source of the infection. 
While it is relatively straightforward to set up HIV surveillance among the general 
population, it is much harder to do it among key populations. These are often hidden and 
hard to reach and therefore methods have been developed to recruit representative 
samples of these groups [33]. Consequently, information of the prevalence and behaviours is 
often obtained from independent studies carried out sporadically as opposed to routinely as 
in ANC clinics[33]. Several methods such as snow ball or Respondent Driven Sampling (RDS) 
have been developed to improve the representativeness of the samples[33]. In general, they 
require the use of key informants that know of gathering points or are in direct contact with 
these populations. Non-Governmental Organisations (NGOs) have been very important 
intermediaries as they have established trusting relationships with members of these 
communities. 
5 Mathematical modelling of HIV 
Mathematical models are simplified representations of reality that provide a framework in 
which to explore the functioning of dynamic systems such as that of infectious diseases. 
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Several processes occur simultaneously and influence each other: the natural progression of 
infection within host, demographic processes (birth, death and aging) and contact patterns 
through time resulting in the spread of infection. Many of these processes are non-linear 
and therefore require the use of computational methods to be investigated [34].   
Although mathematical modelling of infectious diseases had started establishing itself as a 
discipline in the early 20th century [21], it truly consolidated with the advent of the HIV 
epidemic, which coincided with great improvements in computers’ capacity. There was huge 
uncertainty around the potential scale of the HIV epidemic in the early days and 
mathematical models started being used to obtain estimates and make projections. These 
turned out to be largely wrong as the impact of some of the essential characteristics of 
sexual behaviour and epidemic dynamics were not well incorporated in the models at the 
time [35,36]. The methods are now much more sophisticated and have been evolving as 
data has become available. The UNAIDS reference group in modelling estimates and 
projections, which is responsible for developing the tools that are applied across the world 
to produce estimates of number of people living with HIV, AIDS deaths, number of orphans 
due to HIV among others, gathers epidemiologists and modellers with a varied range of 
expertise and is constantly updating, modifying and developing these tools [37,38,39,40,41].  
More importantly, modelling has helped gaining an understanding of the processes 
responsible for generating the different epidemic patterns observed [34,42]. Conversely, 
models have also been evolving as more information on the virus has emerged from other 
fields. In this way, while models have helped highlighting the importance of heterogeneity in 
sexual behaviours and mixing patterns on the distribution and magnitude of the epidemic, 
epidemiological studies showing the variation in infectiousness with time since infection 
have changed the way in which the natural history of infection is modelled. HIV models have 
therefore moved from the random mixing assumption to representing groups with different 
sexual behaviours and when appropriate represent mixing patterns according to age, or 
sexual activity and most models now differentiate stages of infection according to 
infectiousness. The partitioning of the infection period is increasing as developments in HIV 
treatment take place. For instance, studies showing that earlier initiation of treatment 
improved life expectancy prompted the development of models investigating the trade-off 
between reducing infectiousness earlier and prolonging the sexual life span of infected 
individuals which demanded a more accurate representation of treatment [43].  
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Models have also evolved with the generation of hypotheses to explain epidemic patterns. 
The timing and duration of partnerships have been proposed as potential explanatory 
variables for the speed at which epidemics grow as well as for the level at which they 
establish in the population (the endemic prevalence) [44]. Compartmental models are based 
on average contact patterns and assume these happen instantaneously. To study the 
implications of partnership duration on STI epidemics, “pair models” that represent groups 
of individuals as being single or in a couple and simulate the formation and dissolution of 
partnerships, have been developed [44,45]. These allow incorporating behaviours that will 
have an impact on the extent and efficiency of spread of an STI. For example susceptibles in 
a pair will be protected from infection for the duration of the partnership, infected 
individuals who remain single for a time longer than the duration of infectiousness will not 
infect their next partner.  
In addition to the duration of partnerships, the timing at which these form is thought to be 
one of the key answers to the much more efficient spread of HIV observed in Sub-Saharan 
Africa than elsewhere. Polygamy and extra-marital sex are common and culturally accepted 
in this region and overlapping partnerships as opposed to serial partnerships (also known as 
concurrency and monogamy respectively), have been shown to allow STIs to spread more 
efficiently as they maximise the infectious period [42]. Although this issue also requires the 
representation of partnerships, pair models are not appropriate to study concurrency simply 
because they do not allow it (as individuals are either single or in a couple). Instead, 
individual-based models have been used to investigate the implications of concurrency. As 
their name indicates, rather than modelling groups with average contact patterns, these 
simulate individuals which have a certain probability of experiencing an event (such as 
partnership formation) at each time step. This results in a varied range of potential sexual 
histories for each individual providing a much closer representation of reality, including the 
formation of sexual networks [46,47]. An important distinction between individual-based 
models and compartmental models is that the former are stochastic while the latter are 
most often deterministic. Stochastic models work with probabilities and therefore 
incorporate chance, allowing the occurrence of events such as extinction of an epidemic. 
Deterministic models will produce the same result at every simulation (as long as parameter 
values remain unchanged) and so they cannot be used to reproduce the exact range of 
plausible epidemic scenarios. However, these are easier to interpret and are useful to 
investigate mechanisms influencing the epidemic. The choice of models will depend on the 
question to be answered and simplicity should always be favoured as it implies fewer 
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parameters and allows a more straightforward interpretation of results.  In this thesis we 
use deterministic compartmental models to investigate the transmission of HIV among 
populations of MSM and prison inmates based on the questions investigated and on data 
availability. However, the use of stochastic models to model the prison would also be an 
appropriate choice. 
Moving from the use of models to test hypotheses, these are also used on more empirical 
bases, to enhance the information obtained from surveillance data, interpret prevalence 
trends or estimate the population level impact of individual changes in risk [34]. A common 
example is that of circumcision which has been shown to convey 60% protection against 
acquisition of infection. Estimates of the number of infections that could be averted through 
the mass implementation of circumcision in certain African countries and the potential cost 
effectiveness of such programmes have been obtained through mathematical modelling 
studies [48]. For any given intervention, when a clinical trial is considered unethical or the 
outcome of interest is too rare or too far away in time, mathematical models can provide an 
estimate of its potential impact [34]. In the same way, they can guide the design of the 
intervention by identifying the programmatic scenarios that will result in the highest impact. 
Programmatic variables can include coverage, time to scale up, groups to be prioritised 
according to age, gender, behaviour [34]. This type of studies is especially valuable to policy 
makers that need to decide where to invest public health budgets to obtain the maximum 
impact. Models offer the possibility to investigate the impact of an intervention in the short 
and long term (provided enough data is available) influencing the response planning [34].  
Finally, mathematical models are also helpful in evaluating the impact of interventions. 
While surveys can show a decrease in risk behaviours and in prevalence, these are most 
often cross-sectional surveys and it is therefore not possible to claim causation. Additionally, 
declines in prevalence can happen independently of changes in behaviour, simply because of 
the natural dynamics of the epidemic [34]. Models allow accounting for these dynamics and 
estimating whether the declines observed could have happened or not without changes in 
behaviour. As modelling has become an integral part of prevention planning, these analyses 
have greatly improved as interventions collect the information needed for the modelling 
analysis at baseline and at different time points during and after the intervention. An 
example is the evaluation of AVAHAN, a large scale intervention carried out among FSW in 
India [49,50].   
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6 The Latin American epidemic 
6.1 Background 
6.1.1 Geography and demography 
Latin America is a cultural term referring to the Spanish, Portuguese and French speaking 
nations of the American continent [51]. However, its use has extended to designating all 
countries of the American continent that are south of the U.S. It is in this sense that we will 
employ this term throughout the thesis. Caribbean countries are generally treated 
separately in the global political and economic contexts as well as by international 
organisations including UNAIDS, which reports statistics for the Caribbean region. The 
distinction will be made here when appropriate.  The territory can be divided in 7 main areas 
as described in Figure 2: Mexico, Central America, the Andean countries, Brazil, the Southern 
Cone and the Latin and non-Spanish speaking Caribbean. 
 
Figure 2. Latin America and the Caribbean divided in 7 sub-regions according to geographical proximity.  
Source: Caceres et al., 2002 [52]. 
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Latin America covers over 20 million km2 and has a population of nearly 600 million, mostly 
concentrated in urban areas [53]. The population is young with 50% under 25 and life 
expectancy varies between 70 and 80 years in most countries with an average of 72 for the 
region [53]. However, it is projected to age rapidly following a marked demographic 
transition that started at different points in the 20th century depending on the countries. The 
median age is expected to rise by 15 years between 2000 and 2050 and the proportion of 
people over 60 will grow from less than 10% in 2000 to nearly 25% in 2050 [53].   
The population in major cities grew rampantly in the 20th century and urban development 
happened in a rather disorganised form, resulting in the creation of mega-cities where public 
services and especially transport are suboptimal and unequally distributed. Large poverty 
pockets are a legacy of the rural migration that started in the early 20th century and did not 
happen in tandem with the economic changes necessary to provide opportunities to the 
new comers. Mexico City, Sao Paulo, Rio de Janeiro and Buenos Aires all harbour over 10 
million people. 
6.1.2 Cultural context 
Countries in the region share a common cultural background as most were colonised by 
Spain, Portugal or France and have experienced the syncretism between the native and 
European populations to a greater or lesser extent. Spanish and Portuguese are spoken by 
the vast majority of people, despite the great diversity in indigenous languages still in use. 
Catholicism is the main religion practiced and the Church has remained highly influential. In 
terms of political history, most countries have experienced long periods of governance 
under the rule of a single man or party including military dictatorships and although a 
democratic transition has been claimed rather extensively, it is still far from solid in all 
countries.  
6.1.3 Socio-economic context 
In terms of socio-economic development, Latin America is a region of contrasts both 
between and within countries. While some countries such as Chile or Argentina are 
relatively well ranked based on the Human Development Index (HID), others such as Haiti 
are way lower in the list [54]. The HID is calculated based on life expectancy, education 
(literacy and schooling) and income (GDP and purchasing power), covering the fundamental 
determinants of individual attainment [54]. However, it is subject to the law of averages, 
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hiding the abysmal inequalities that have persisted in this region[54]. The average Gini 
coefficient, a measure of inequality in income distribution, has been consistently higher in 
Latin America than in other regions in the world reflecting the huge gap between rich and 
poor [54]. An evocative example is that of Mexico, home of the richest man in the world [55] 
while over 50% of its population is estimated to live under the national poverty line [56]. The 
differences in income are based on social status (with very little mobility between classes), 
gender and ethnicity. Educational attainment is closely correlated to the parents’ level of 
education and so opportunities for improvement are scarce [54]. Similarly, an important 
proportion of women’s working hours are still unpaid reflecting the inequality in gender 
status in the professional environment. Finally, the proportion of the population living under 
1$ per day is much higher among people of indigenous ethnicity than among white people 
[54]. Poverty is in fact widespread among these communities. They have restricted access to 
education and health-care and often carry the added burden of not speaking Spanish [54].  
 
6.1.4 Latin American society and sex 
These socio-economic inequalities are intertwined with cultural and religious constructions 
of gender and together they mould sexual relationships. Machismo, almost systematically 
brought up when describing men’s sexuality in this region [57,58], has a strong influence on 
both men and women’s sexual histories. Men are expected to have an overriding sexuality 
and therefore to start experimenting early and with multiple partners including sex workers 
both before and after marriage [59]. In contrast, women are expected to be sexually 
inexperienced until marriage and to remain faithful to their husband thereafter[59]. Virginity 
is a highly valued attribute and since women’s sexuality is perceived to be restricted to the 
purposes of reproduction, men seek erotic experiences such as anal or oral sex outside their 
marriage [57,59]. This translates in women having a late initiation of sexual activity, rapidly 
followed by union and first child while men start earlier during adolescence and have a 
higher number of partners including concurrent relationships [57,60]. Because women are 
expected to be inexperienced, it is more difficult for them to be assertive and demand 
condom use or even to have access to contraceptive measures when they are young as they 
are not supposed to be having sex [61]. This is more marked among the low social classes 
[59] probably because these are often more attached to traditional and religious values and 
young women have less access to information. A delay of first childbearing age is becoming 
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apparent among women with a higher educational level [59,60]. However, building a family 
remains the primary purpose of life in the Latin American society, based on the Catholic 
Church ideology. Within the family, gender roles are again clearly defined and restricted: 
women are expected to be selfless mothers, entirely devoted to their children and husband 
(which entails fidelity) while men are the family’s providers and have the responsibility to 
ensure financial stability [58,59].  These cultural constructions not only have had an impact 
(although not necessarily negative) on the spread of HIV but have also affected the response 
to the epidemic. While extramarital sex among men has contributed to spreading the virus 
among women, the widespread practice of monogamy by women has likely hindered its 
establishment in the general population. The extent to which stable female partners of men 
who have extramarital sex are affected by the HIV epidemic, as well as the level of 
establishment of the epidemic in the low risk population will be explored in Chapter 2. 
6.2 General description of the HIV epidemic:  
North, Central and South American countries are characterised by low level or concentrated 
epidemics with a few exceptions: Panama with a country prevalence of 1% and Belize, 
Guayana and Suriname with country prevalences above 2% [1]. It is estimated that 1.4 [1.2-
1.6] million people in Central and South America and another 220, 000 [180,000-280,000] in 
Mexico were living with HIV in 2009 [1]. The epidemic in Caribbean countries is mostly 
generalised with total adult prevalence estimated a 1% [0.9%-1.1%][1]. It is considered the 
second most affected region of the world after Africa. However, this translates in a small 
absolute number of cases (240,000 [220,000–270,000] in 2009) [1]. The majority of HIV 
positive individuals live in the four largest countries in the region: Brazil, Colombia, Mexico 
and Argentina. 
While overall prevalence is low in the region it reaches high levels among specific 
subpopulations, comparable to those observed in hyper-endemic countries. The Latin 
American epidemic is in fact described as concentrated among MSM, who have been, and 
continue to be, severely affected by HIV[62]. Other populations including FSW, IDU have also 
experienced a disproportionate burden of infection [62], while migrants and prison inmates 
have been shown to be at heightened risk of infection and could potentially constitute 
important groups for further spread into the general population [62]. The prevalence of HIV 
among these key populations, their associated sexual behaviours as well as the contexts in 
which they occur are described below. The MSM and prison inmate populations were 
investigated in more detail to identify issues of potential importance to the transmission of 
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HIV that should be incorporated in the mathematical models developed in this work in 
Chapter 3 and 5. 
6.3 Men who have Sex with Men 
The quantification of homosexuality and associated sexual behaviours is relatively new and 
very tightly associated with the emergence of the HIV epidemic. The first attempt at 
measuring the prevalence of homosexuality dates back to 1903 Germany where Magnus 
Hirschfeld, a physician and active defender of homosexual people rights, applied a question 
on sexual attraction to two distinct groups of men (students and factory men) with the 
purpose of demonstrating same sex attraction was a constant and therefore natural 
occurrence among men[63]. In the late 1930’s Kinsey pioneered the design and 
implementation of sexual behaviour surveys to gain insight on questions relative to sexual 
practices across the population but also along individuals’ life courses [63]. Homosexuality 
was one of the practices investigated which was doubly advanced for the time as 
homosexuality was not a subject of research and it was considered as a condition or 
deviance that affected certain people, rather than a behaviour like any other that could be 
practiced by everyone [63]. After this, only three national surveys on sexual behaviour were 
implemented previous to the onset of the HIV epidemic: one in the U.S.in 1970 by the Kinsey 
Institute, one in France in 1970 and one in Finland in 1971 [63]. It is in Kinsey’s and the 
aforementioned surveys that definitions of sex started being developed and that the 
importance of the timing of sexual practices in the person’s life course became apparent 
[63]. Estimates of the occurrence, onset and frequency of sexual practices will depend on 
how these are defined (or interpreted in the absence of a definition) [63]. The word “sex” 
can cover many practices including kissing, masturbation, oral, vaginal and anal sex, among 
the most common descriptions [63]. Determining the timing of sexual practices is important 
because these might evolve with age and contextual factors. Adolescence for instance is 
considered a time for sexual experimentation after which certain practices will not be 
repeated for some [63]. This is relevant to the quantification of homosexuality or same-sex 
sexual behaviour as the estimate is likely to be different when asking about lifetime versus 
recent behaviours. Similarly, the estimate might be different when asking about oral sex 
versus anal sex. These issues gained importance when the purpose of the sexual behaviour 
surveys shifted from simply describing practices to informing on the potential for HIV 
spread. For the purposes of epidemiological research “sex with men” is normally defined as 
anal sex in the past year. Anal sex implies a high transmission probability (as compared to 
oral sex or other sexual practices) and asking about recent behaviours allows identifying 
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“active” homosexual men, who are currently susceptible of acquiring or transmitting 
infection via this route. However, there is variation in the definitions used in studies, making 
comparisons difficult [64].  Together with the type and timing of sexual practices, two other 
concepts are relevant to the study of homosexuality: attraction or sexual desire (also 
referred to as “sexual orientation”) and identity [59]. While the former takes us back to the 
origins of measuring homosexuality the latter is a construct that acquired importance when 
the gay communities became more vocal and visible in the 1970’s and later with information 
campaigns about HIV. These two concepts can tell us about the effect of the social and legal 
contexts in regards to homosexuality as, depending on these, the gap between desire, 
practice and identity may be more or less wide. Men who feel attracted by other men might 
restrain from seeking sexual contact from other men in an environment where same-sex sex 
is considered a crime. In the same way men who do have sex with men might not identify as 
homosexual or bisexual due to the negative connotation this might entail. It is primarily for 
this reason that the term “Men who have Sex with Men” (MSM) was introduced in the field 
of HIV research. While it informs on a sexual practice that implies particular risks for 
transmission it does not make any assumptions on the orientation or identity of individuals 
[29]. By being free of social meaning it is intended to remove the stigma associated with this 
practice. However, this term does not come without shortcomings as the word “men” alone 
can be interpret differently in some settings [65] (man versus adolescent) and in particular 
transgender women have strongly objected to being included in this group for obvious 
reasons .    
The issues introduced above are of particular relevance to the study of MSM in Latin 
America, where homosexuality is deeply entrenched [52]. The social construction of gender 
as well as the strong religious influence mentioned above impose a pre-determined lifestyle 
that revolves around building a family with little space for variation [58,66]. Additionally, an 
active aversion of homosexuality prevails. Among traditional sectors of the population, both 
rich and poor, it is still considered as an unnatural condemnable phenomenon. Embracing a 
homosexual orientation in this environment is a difficult life choice as it implies breaking 
with the social expectations and potentially damaging every aspect of one’s life. Disclosure 
to the family will almost invariably cause suffering and in more traditional families it can 
result in an active rejection generally led by the paternal figure, as a mother is expected to 
bring unconditional support and understanding to her children. In the professional 
environment, disclosure can jeopardise a position or affect career progression and it will 
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certainly result in mockery among colleagues. In a society where appearances and status are 
highly important, disclosure will also restrict social relationships and entry to certain circles.  
These socio-cultural issues have shaped the behaviours and identities of MSM in the region 
[52]. While the first are of particular relevance to studying risk and spread of infection, the 
second are especially valuable for the design of interventions. Additionally, if behaviours and 
identity match to a certain extent, the characterisation of the population, and therefore a 
better understanding of it, becomes possible.  
A typical response to these social restrictions among Latin American MSM has been the 
practice of same sex-sex without the adoption of the homosexual or bisexual identities [52]. 
In the name of an overriding sexuality associated with masculinity, men can have sex with 
other men without threatening their heterosexual identity as long as they play the insertive 
(“active”) role during anal sex [67,68]. This role is associated with masculinity based on the 
heterosexual practice of sex [57]. Following the same logic, paying for the sexual encounter 
further affirms masculinity as it replicates the man/FSW interaction that fits within the 
machista conception of gender. These men, defined by Ross as the “marital bisexual type”, 
will often have stable relationships with women, involving regular sexual encounters and will 
have sporadic encounters with other men [69]. “Defensive bisexuals”, described as men who 
have sex with women to escape from the stigma of homosexuality, might have more sex 
with other men and sporadic sex with women while still retaining their heterosexual identity 
[69]. In contrast, men who decide to openly live their homosexual orientation will often 
adopt effeminate attitudes and the receptive (“passive”) sexual role during anal sex. They 
will also be more likely to engage in sex work. At the extreme of this profile are transgender 
women, who fully adopt the female gender, its physical appearance, sexual role and most 
frequently engage in sex work; although this is to a great extent a consequence of the strong 
social rejection they experience [70]. This compartmentalisation of homosexuality into the 
feminine and masculine roles and associated practices was first described in Mexico and 
Central America and has been studied further in Latin-America and in the US among Latino 
MSM [67,68,71,72]. In between these two opposing active and passive profiles that 
reproduce the traditional male-female conceptualisation of gender, an increasingly popular 
identity has developed implying flexibility in sexual roles during anal sex. “Versatiles”, also 
known as “modernos” in Peru or “internacionales” in Mexico, are MSM who identify as 
homosexual without necessarily adopting a feminine attitude and can play both the insertive 
and receptive roles during anal sex while retaining their masculinity [73,74]. The versatile 
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identity originates from the greater visibility and influence of the western gay scene, and is 
therefore perceived as modern or international [73].  Although this is a simplified 
characterisation of the practice of homosexuality in Latin America, MSM in the region will 
often broadly conform to one of these profiles. This is relevant to the study of HIV 
epidemiology in this population and to the work carried out in Chapter 3 of this thesis in 
regards to modelling the epidemic among MSM in Lima, Peru, to estimate the impact of a 
potential prevention intervention. Different profiles may imply different risks for both the 
acquisition and transmission of HIV and STIs which would impact the success of 
interventions. 
6.3.1 Transgender women 
Although transgender women have been mentioned in the description of the MSM 
population, the high prevalence of HIV in this population and the particular risks to which 
they are exposed deserve special attention. Across the world, transgender women have 
been disproportionately affected by the HIV epidemic. A recent meta-analysis comparing 
HIV prevalence among transgender sex workers, to that among transgender women, male 
sex workers and biologically female sex workers found a pooled prevalence among the first 
group of 27.3% [75]. This study found that prevalence among Trans sex workers was 
significantly higher than among biologically female sex workers. Indeed their risks are very 
different, starting from their mode of exposure. Trans engage in anal sex and most 
frequently in receptive anal sex as this brings them closer to being a biologically female 
sexual partner [75].  Several additional risk factors come into play and contribute to their 
increased vulnerability to infection. Being a transgender woman implies, by definition, a 
strong rejection of ones’ original gender or, more rightly said, of the gender associated with 
ones’ biological sex [76]. This causes psychological distress from an early age and especially 
during puberty; affecting self-esteem and all aspects associated with self-perception [76,77]. 
Social discrimination and marginalisation further contribute to experiencing these feelings 
[76]. Low self-esteem will lead to less self-protective behaviours and more involvement in 
risky situations and practices including substance abuse [75,76]. Unprotected sex and 
exposure to risky partners is therefore common among this population [76]. An additional 
layer of risk is imposed by the very common engagement in sex work observed among 
transgender women as a result of the lack of opportunities available to this population in the 
formal professional environment but also because sex work is often considered part of a 
transgender’s lifestyle in these communities [76]. Finally, transgender women often 
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experience discrimination within health care services, discouraging them from accessing 
them and therefore obtaining appropriate treatment for STIs as well as information for 
prevention [76,77]. These high HIV prevalence levels and associated risk factors are also 
observed among transgender women in the Latin American region. Studies have reported 
prevalence estimates ranging from 17% in DR [78] to 40% in Brazil [79]. Two studies in 
Argentina found prevalences of 27.6% [80] 34.1% [81]. In Lima a recent study using RDS 
sampling and therefore aiming for better representativeness found a prevalence of 29.7% 
[70]. Even higher prevalence levels have been observed among transgender women in the 
prison context [82], going up to 78% in Brazil [83]. Likewise, STI prevalence is exceedingly 
high. As an example, 72% presented at least one STI in the multicity study carried out in 
Argentina where they tested participants for HBV, HCV, HIV, HPV, Syphilis, and Chlamydia 
[81].  Involvement in sex work is widespread as seen from the proportion of transgender 
reporting it (64% in the Lima study [70], 100% in the Argentinian study recruiting at an STI 
clinic [80]) and from the proportion of MSW identifying as transgenders (40.5% among 
Brazilian MSW vs 8% among MSM who did not report sex work) [84]. As elsewhere 
transgender women in the region suffer from poverty, marginalisation and victimisation 
[70,85,86]. This population has very specific needs that need to be addressed with equally 
specific interventions, which is why we treat them separately in this introduction and in the 
work presented in this thesis. 
6.3.2 HIV and STI prevalence among MSM in Latin America 
We carried out a literature review to describe the MSM population in the region in terms of 
their prevalence of bisexual behaviour (defined as having had sex with both men and 
women in a specified period), HIV, condom use at last sex and STIs. We present data 
collected from 2000 onwards (with a few exceptions) to provide a representative picture of 
the current situation but also because sampling methods and survey instruments have 
improved together with the understanding of the MSM population and so recent estimates 
are likely to be of better quality.  While the data are  representative of MSM irrespective of 
their sexual role and identity, we illustrate the implications of these issues on behaviour and 
prevalence of infection through presenting recent findings from a study by Clark and 
colleagues in Lima, Peru [74]. They investigated sexual role, identities and practices and their 
association with HIV and a range of STIs among a sample of MSM recruited at an STI clinic 
and its surrounding neighbourhood. Aside from being a small scale study (560 participants), 
the sample is likely to be biased towards higher risk individuals based on the recruitment 
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method. However, we intended to provide insight into the importance of considering these 
issues when studying transmission among this population and were interested in the ratios 
between groups with different sexual roles and practices rather than in the absolute values.  
6.3.2.1 Prevalence of same-sex sex 
When looking at the magnitude of male to male sex in the region, estimates varied between 
5.8 and 9.2% when referring to lifetime anal sex with a man and between 1 and 7.6% when 
using “last year” as the timescale with no particular definition of sex [64]. These estimates 
do not include studies from the Caribbean. More recent studies from Peru and Brazil have 
found the lifetime prevalence of same sex behaviours to range between 10.6 and 15% 
[87,88]. Ideally, estimates of the proportion of men practicing same sex-sex in the past year 
obtained from national surveys should provide an estimate of the size of the MSM 
population to which prevalence estimates obtained from smaller scale surveys could be 
applied. This is rarely (if ever) the case because of misreporting of this sensitive behaviour 
but also because the MSM population is heterogeneous and therefore the findings obtained 
in small surveys are only representative of a certain section of the population. However, 
these estimates provide an order of magnitude of the total prevalence of same sex 
behaviour which is useful to appraising the scale of the epidemic. 
6.3.2.2 Sex with men and women 
In terms of the prevalence of bisexual behaviour among MSM in the region, 51, 53 and 64% 
reported ever having had sex with a woman in Nicaragua, Honduras and El Salvador in the 
1999-2002 multi-centric study [89,90,91]. In Peru and DR this was 34% and 78% respectively 
according to sentinel surveillance studies [92,93]. Using the last 6 months as the time scale, 
this varied between 23% and 37% in Nicaragua, Guatemala, Honduras and El Salvador and 
was 29% in Peru but this referred to the past 3 months [89,90,91,92,94]. Finally, estimates of 
the prevalence of marriage among MSM vary more broadly, going from 1.7% in El Salvador, 
to 10.1% in Nicaragua and 41% in DR, although much lower values were obtained in a recent 
study (1.9 to 13.4%)[78,93,95]. These estimates suggest that sex with women is common 
among MSM in the region. In fact, studies on MSM in the U.S. have found that the 
proportion reporting sex with women was higher among Latino MSM than white MSM. In a 
study interviewing HIV positive MSM 26% of Latino MSM had had sex with women as 
compared to 13% of white MSM [96] and in a study reporting data from AIDS records, 31% 
and 21% of Latino and white MSM respectively, reported bisexual behaviour [97].  These 
figures are in agreement with those from Latin American studies. Bisexual behaviour has 
consequences for the transmission of HIV and STI to the female population, especially within 
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stable relationships as condom use is generally reported to be low. This is one of the 
questions investigated in Chapter 2 where the proportion of new infections resulting among 
women who are stable partners of MSM is quantified.  
6.3.2.2.1 Sexual role, sexual identity and sexual partners 
The study by Clark et al. divided men into three groups according to their self-identification 
in regards to sexual role: “activos”, “pasivos” and “modernos”, corresponding to the three 
main behaviours described above (insertive/masculine, receptive/feminine and 
versatile/masculine). When looking at bisexual behaviour within the three MSM profiles, 
nearly 70% of men who identified as “activos” reported their last sex partner to be a woman 
compared to less than 2 and 2.5% of pasivos and modernos respectively as shown in Figure 
3. The median number of female partners in the past 6 months reported by activos was 2 
and it was 0 for the two other groups [74]. When matching sexual role to sexual identity, 
among those who reported being activos the vast majority identified themselves as being 
heterosexual, while pasivos identified themselves as homosexuals or transgenders, and 
modernos were more likely to identify themselves as homosexuals as seen in Figure 3 [74]. 
Few men reported a bisexual identity independently of their sexual role identification, which 
is often observed in studies in Latin America and attributed to this term being seldom used 
and to it being associated with the passive role by heterosexually-identified MSM. Within 
each sexual role (activo/pasivo/moderno), the distribution per sexual identity 
(heterosexual/homosexual/transgender) cannot be considered as representative of the 
MSM population as the Trans population is over-represented in this study. While Trans are 
estimated to account for about 4% of the MSM population in Latin America, they accounted 
for 20% of this sample, which is likely due to participants being recruited in an STI clinic 
[74,98]. The proportion within each sexual identity group is nonetheless informative.  
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Figure 3. Gender of the last partner by sexual role identification (left) and sexual identity by sexual role 
identification (right) among MSM in Lima Peru according to [74].  
 
6.3.2.3 HIV prevalence among MSM 
HIV prevalence among MSM has been found to be above 10% in the vast majority of studies 
carried out in recent years in the region and has varied from 6% to 26% (Figure 4). A number 
of multinational collaborations are responsible for the collection of a substantial share of 
this data. Between 1999 and 2002 a study was implemented in 36 cities of 7 South American 
countries: Colombia, Ecuador, Peru, Bolivia, Argentina, Uruguay and Paraguay [99]. It 
obtained data from 13,847 participants although nearly 11,000 were recruited in Peru which 
has a long history of engagement with the MSM community. This effort was replicated in the 
6 largest cities of Central America in El Salvador, Guatemala, Honduras, Nicaragua, and 
Panama recruiting 1418 MSM between 2001 and 2002 [95].  Caribbean countries have been 
slower at implementing sentinel surveillance but some studies have started to emerge [78].  
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Figure 4. HIV prevalence among MSM in Latin America by year of data collection 
Notes: 1996,1998,2000,2002: Sentinel surveillance in Lima, Peru [92] 
1999-2002: Multi-centric study in South America [99] 
2001-2002: Multi-centric study in Central-America [95] 
2003: Peru: sentinel surveillance across the country [100], Argentina: MSM cohort study Buenos Aires [101], 
Mexico: sentinel surveillance, Guadalajara [102] 
2007-2009: RDS study Buenos Aires, Argentina [103] 
2008: Reporting to the WHO “Towards Universal access” report [104] 
 
Baral et al estimated the risk of HIV infection among MSM in the region to be 33 folds higher 
than among the general population. The pooled analysis of all the regions gave an odds ratio 
of 19 [105]. Later studies have raised that this figure might overestimate the disease burden, 
as prevalence estimates were obtained from studies representative of high risk MSM. For 
example, the estimate of HIV prevalence in Mexico used in that study is 25.6% while the HIV 
national programme reports an average prevalence of 10% based on studies carried out in 
several urban centres across the country [106]. However, this is still over 20 to 30 times 
higher than the national prevalence in Mexico. Odds ratios were higher in countries 
characterised by low or very low prevalence levels, medium income and no major IDU 
epidemic [105]. These characteristics are shared by many of the countries in the region.   
6.3.2.3.1 HIV prevalence by sexual role 
When looking at HIV prevalence by sexual role in Clark’s et al study (Figure 5), this was 
significantly higher among pasivos and modernos than among activos [74]. While caution 
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must be taken when looking at the absolute values of prevalence in this study (because 
participants were recruited at an STI clinic), the estimates among pasivos and modernos are 
in agreement with those obtained from the Ministry of Health (MoH) sentinel surveillance 
surveys in Lima until 2002 [92], while prevalence in activos is similar to that obtained in a 
study carried out in 3 coastal towns in Peru using ethnographic methods to plan the 
recruitment [107]. It is possible that the variation in prevalence obtained in these studies is 
related to different sample compositions in terms of sexual role. Pasivos and modernos are 
easier to reach as they are more likely to be part of the gay community and to frequent gay 
bars and other meeting places. 
  
Figure 5. HIV prevalence by sexual role according to self-identification among MSM in Lima according to [74]. 
 
6.3.2.4 HIV associated behaviours 
In the various studies included in a literature review spanning the years 1999 to 2004, 
between 34 and 80% of men who had sex with another man in the last year reported high 
risk sex, defined by either unprotected anal sex or sex work[64]. Condom use at last anal sex 
with another man is one of the UNGASS indicators used to monitor country progress in their 
response to HIV/AIDS. Data from the 2008 and 2010 UNAIDS epidemic updates as well as 
from the 2009 WHO/UNICEF/UNAIDS report on universal access to priority interventions are 
plotted in Figure 6. In the latter report condom use at last sex varied between 23% in 
Ecuador to 84% in El Salvador with a median of 66%, suggesting higher condom use among 
MSM in Latin America compared to the other regions [104]. There is important variability 
between countries and across years, however most estimates are above 60% and only 3 
surveys have recorded estimates below 40%. This variability is partly explained by 
differences in the sampling methods (for instance bars versus cruising areas), type of partner 
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at last sex (stable versus casual) and type of sex (insertive versus receptive). As in 
heterosexual sex, condom use among MSM has been shown to be lower with stable than 
with casual partners. In the multicentric Central American study 46.7% and 61.2% reported 
consistent condom use with regular and casual partners respectively [95]. Similarly, condom 
use with male sex workers or clients was above 67% in this study. There is still progress to be 
made to reach the levels obtained among FSW, especially considering the higher 
transmissibility of HIV during anal sex. In particular, condom use among HIV positive men 
was shown to be relatively low in a study carried out in an STI clinic in Lima with 34.2% 
reporting not using a condom during insertive anal sex with their last partner [108]. 
  
Figure 6. Reported condom use at last sex with a man among MSM in Latin American countries. Sources: 
[1,104,109] 
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6.3.2.4.1 Condom use and sexual role 
There were significant differences in the reporting of unprotected anal intercourse 
depending on sexual role in the Peruvian study. Men were asked about having had any 
unprotected sex in the last 6 months so the estimates are not directly comparable to those 
presented above, which refer to the last sex act [74]. Activos and pasivos were significantly 
less likely to report having had any unprotected receptive and insertive anal intercourse 
respectively as compared to the other groups. This is mostly related to their practice of 
receptive and insertive sex which as shown in Figure 7 is minimal in each group. When the 
outcome was any unprotected sex independently of sexual positioning modernos were 
significantly more likely than activos to report unprotected sex. This is in agreement with 
other studies carried out in the region which find lower risk behaviours among men who also 
have sex with women than among exclusive homosexuals [71]. 
   
Figure 7. Type of unprotected anal sex in the last 6 months by sexual role identification (left)  and type of anal 
sex practiced with last partner (right) by sexual role identification among MSM in Lima according to [74]. 
 
6.3.2.5 Sexually transmitted infections 
The role of STIs as a risk factor for HIV infection has been investigated quite thoroughly in 
Latin America in the context of MSM research. Syphilis (both past and recent infection) 
together with HSV-2 are often detected in HIV sentinel surveillance surveys and other 
studies looking at HIV prevalence among this population. Figure 8 presents prevalence 
estimates for different STIs in a selection of countries of Central and South America. HSV-2 is 
highly prevalent with most countries obtaining estimates between 40 and 60%. Two studies 
in Peru obtained estimates outside this range; the first is representative of men who 
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reported ever having sex with a man (MESM) in a general population survey [88]while the 
second is representative of HIV positive men recruited at an STI clinic in Lima [108]. Both 
studies are interesting in the sense that they provide information on specific groups of MSM 
that play a particular role in the spread of the virus. While it is known that the MSM 
population is heterogeneous with some being hidden from the active gay scene, few studies 
actually report information on the latter. Although the measured STI prevalence is lower 
than what has been observed among more active MSM it was found to be substantially 
higher than among men who did not report sex with men in that survey, which has 
implications for the transmission of STI among their female partners. The study looking at 
HIV positive MSM suggests these have a higher prevalence of both HSV-2 and recent syphilis 
infection corroborating the findings from several other studies that identify STI infection and 
history of STI diagnosis or symptoms as strong risk factors for HIV infection 
[95,99,100,101,103,110,111]. Finally, hepatitis B has been found to be highly prevalent 
among MSM in Argentina [101,111]. Considering that the risk of developing chronic HBV 
infection is estimated to be 5 to 6 times higher among individuals co-infected with HIV, this 
is a worrying finding[101]. Researchers in the field have actively recommended the 
implementation of vaccination campaigns among MSM in Argentina and since 2000 HBV 
vaccination for new-borns and children up to 11 is mandatory in Argentina, which should 
have an impact in the rates of HBV infection in the years to come[101]. 
 
Figure 8. Sexually transmitted infections among MSM in Latin American countries 
Notes: Information for El Salvador, Guatemala, Honduras, Nicaragua and Panama from Sentinel Surveillance of 
Sexually Transmitted Infections/HIV and Risk Behaviors in Vulnerable Populations in 5 Central American 
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Countries, Soto et al 2007. El Salvador*: Correlates of Bisexual Behaviors Among Men who have Sex with Men in 
El Salvador, Kim et al 2007. 
Peru 1: Sanchez et al (2007).  HIV-1, sexually transmitted infections, and sexual behavior trends among men who 
have sex with men in Lima, Peru. 
Peru 2: Lama et al (2006) Association of herpes simplex virus type 2 infection and syphilis with human 
immunodeficiency virus infection among men who have sex with men in Peru.  
Peru (MESM) Clark et al. (2007) Prevalence of Same-Sex Sexual Behavior and Associated Characteristics among 
Low-Income Urban Males in Peru 
Peru (HIV+): Clark et al (2008) Risk factors for the spread of HIV and other sexually transmitted infections among 
men who have sex with men infected with HIV in Lima, Peru 
Argentina 1: Pando et al (2006) Epidemiology of Human Immunodeficiency Virus, Viral Hepatitis (B and C), 
Treponema pallidum, and Human T-Cell Lymphotropic I/II Virus Among Men Who Have Sex With Men in Buenos 
Aires, Argentina 
Argentina 2: Pando (2012) HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men 
Recruited by RDS in Buenos Aires, Argentina: High HIV and HPV Infection.  
Argentina 3: Segura et al (2010) HIV/STI co-infections, syphilis incidence, and hepatitis B vaccination: the Buenos 
Aires cohort of men who have sex with men. 
 
6.3.2.5.1 STIs and sexual role 
Regarding STI prevalence by sexual role, important (and significant) differences were 
observed between activos and the other two groups of men (Figure 9). These were much 
less likely to test positive for syphilis (both past and recent infection) and for HSV-2 [74]. 
Conversely, they were more likely to have a urethral chlamydial or gonococcal infection 
(only significant when compared to pasivos). While the latter finding is likely a reflection of 
their sexual positioning during anal sex, the lower prevalence ulcerative STIs cannot be fully 
explained by the differences in sexual positioning as these are easily transmissible through 
mucosal contact. As suggested by the authors, this difference is likely to be the result of 
higher risk behaviours among those practicing receptive sex, including a higher number of 
partners, higher rates of unprotected anal sex and more exposure to high prevalence 
networks, all of which were observed among pasivos. A multivariable analysis controlling for 
these potential confounders would allow shedding some light on this question.  Lower 
prevalence among men who report engaging exclusively in insertive anal sex and to also 
have sex with women has been found in other studies in the region [112]. 
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Figure 9. Prevalence of STIs according to sexual role identification among MSM in Lima according to [74]. 
 
Table 1 provides a description of MSM cultural and sexual practices depending on their 
identification by sexual role summarising the results presented in this section. 
  
Cultural identification Sexual practices 
  
Sexual         
identity 
Attitude/        
Appearance 
Sexual 
positioning 
Sex with 
women 
Sexual 
role 
identity 
Activo Heterosexual Masculine Insertive Yes 
Moderno Homosexual Masculine Versatile Sometimes 
Pasivo Homosexual/ 
Trans 
Feminine Receptive 
Rarely/        
never 
Table 1. Simplified description of MSM cultural identification and sexual practices by sexual role identity  
Note: based on the literature review and reinforced by Clark et al findings [74]. 
 
6.3.2.6 Drug use 
While substance abuse has been widely investigated as a risk factor for HIV associated risk 
behaviours among MSM in the U.S., Australia and Europe; it has not been a focus of research 
on MSM in Latin America. As an example, the study summarising findings from the sentinel 
surveillance carried out among MSM in Lima, Peru from 1996 onwards does not report 
statistics on alcohol or drug use [92]. However, prevalence of alcohol and drug use have 
been found to be higher among MSM than in the general population; for instance among 
heterosexually identified young men in low-income coastal Peru, those reporting sex with 
other men were significantly more likely to report alcohol use and illegal drug use prior to 
sex [113]. In the multicity study carried out among MSM in South America, cocaine use was 
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found to be an independent risk factor for HIV infection in Bolivia, Uruguay and Paraguay 
and IDU was also associated with infection in Bolivia and Uruguay [99]. The use of cocaine 
before or during sex was also identified as a predictor of HIV infection in the 2002-2003 
sentinel surveillance round among MSM in Peru [100]. A substantial amount of research on 
substance abuse and associated risk behaviours has been carried out among Latino-MSM in 
the U.S. but the findings cannot be generalised to Latin America as acculturation appears to 
play an important role [114,115].  
6.4 Female Sex Workers 
FSW in Latin America have been affected by the epidemic to different degrees but high 
levels of condom use achieved in several countries are thought to have restrained the 
spread among this population. In fact, FSW in Brazil, Ecuador [116], Peru [117], Mexico [118] 
Honduras [119] and Chile [120] have reported high rates of condom use with clients. In the 
2009 report on universal access by the WHO, gathering data collected between 2006 and 
2008, the median reported condom use with the most recent client for the region was 
95%[104]. However, condom use with regular partners has been shown to be consistently 
low[121].  
Low prevalence, similar to that in the general population was observed in several studies 
carried out in the 1990s and early 2000’s in Mexico, Panama, Costa, Bolivia, Colombia [121]. 
This has been maintained in some countries such as in Chile where a recent study among 
626 FSW did not find a single HIV case [120]. In general, FSW in Central American countries 
experience higher rates of infection, reflecting higher general population prevalence. In 
Guatemala and El Salvador prevalence is estimated between 3 and 5% [95]. Honduras has 
reported higher levels ranging from about 9% in Tegucigalpa the capital, San Lorenzo and 
Pueblo Cortez to 13% in San Pedro Sula, on the Caribbean coast [121]. However, a decline is 
becoming apparent across the country and prevalence is now estimated between 2 and 5% 
[122]. In South America, prevalence has remained low in Andean countries at 1% or less, 
while it is higher in the southern cone at about 2.6% in Paraguay and 5% in Argentina 
according to a study carried out in 9 South American countries sampling over 13,000 FSW 
between 1999 and 2002 [123]. Prevalence has been shown to vary depending on the setting 
of sex work (street vs. brothel) and on the particular risk profile of the sample.  Higher 
involvement in drug use and especially IDU has been associated with much higher HIV 
prevalence among FSW in the region. For instance, prevalence among a sample of FSW in 
Tijuana, Mexico was 6% but reached 14% among those who injected drugs [124]. Another 
 
51 The Latin American epidemic 
factor affecting risk among this population is migration. Migration is common among FSW, 
initially because they move away from home in the search for better opportunities and end 
up resorting to sex work when these fail to concretize and later on to follow the sex business 
where it is more flourishing or less penalised. In Latin America there is migration within 
countries, such as in Mexico where a South-North movement is driven by the differences in 
wealth between these two poles and by the proximity of the U.S., and there is migration 
between countries. In Central America, FSW have been found to move to Mexico, either to 
settle south or to take the road to the U.S.   In South America, migration patterns among 
FSW have varied with the countries’ economic situation, but it mostly occurs between 
neighbouring countries, such as from Peru and Colombia to Ecuador, where the U.S. dollar is 
the official currency since 2000. Migration generally causes vulnerability as it entails the 
distancing from ones’ social network and references to face a new and foreign environment 
with, in most cases, a limited skills’ set. In the context of sex work, it means women are 
more easily controlled by pimps or sex business networks. A study carried out in South 
America to investigate the impact of migration on the risk behaviours of FSW found that 
these varied depending on the country and that foreign FSW were not necessarily at higher 
risk everywhere [125]. In Ecuador, they were more likely to use illegal drugs and to use 
condoms inconsistently with their clients [125].  
With the exception of a few hotspots such as the Mexico-U.S. borders or Honduras, data on 
FSW is relatively dated as recent efforts have concentrated on gathering information on 
MSM and Trans populations. However, prevention work among FSW started much earlier 
and has been more intensive than among MSM and positive outcomes are becoming 
noticeable [1]. 
6.5 Injecting Drug Users 
Research on illicit drug use in Latin America has not been a priority, although governmental 
initiatives and international collaborations have recently started to build a more organised 
system for investigating this issue [126]. According to a literature review carried out in 2006, 
the most widely used drug is marijuana with between 1 and 10% of school students 
reporting its use in Costa Rica, the Dominican Republic, El Salvador, Guatemala, Honduras, 
Mexico, Nicaragua, Panama, and Uruguay [126]. The use of cocaine is relatively common and 
is mainly taken in the form of powder or crack and the consumption of heroin and other 
opiate derivatives is rare [126]. However, most of the large surveys on illicit drug use have 
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been made in schools, universities or households meaning that the chances of reaching IDUs 
are small.  
Nonetheless, injecting drug use has been practiced in the region for decades and has 
followed the development and evolution of drug markets. It is estimated that there is over 1 
million IDU in Latin America out of 13 million in the world [127]. Naturally, estimates vary 
widely as it is a hidden practice susceptible to many variation sources including high death 
rates and mobility. The majority of IDUs are found in three countries: Brazil, Argentina and 
Mexico and are concentrated in main urban areas. Estimates have ranged between 196,000 
and 800,000 in Brazil [128], with the IDU reference group estimating 540,000 IDU and from 
40,600 to 73,000 in Argentina [128,129]. It has been estimated that there are 96,000 in 
Mexico [128], although experts in Mexico consider it is closer to 50,000[130]. Tijuana and 
Ciudad Juarez are the main hubs where IDU occurs with about 10,000 and 6,000 IDUs in 
each city respectively [128]. IDU is not common in the Caribbean except for Puerto Rico 
where between 15,000 to over 29,000 are estimated to inject drugs [121,128].  
Drug consumption has developed and evolved with drug markets following production hubs 
and trafficking routes. Cocaine is produced in the Andean countries (in Colombia, Peru and 
Bolivia), and consumption mostly happens in Brazil, Argentina, Uruguay and Paraguay; while 
heroin is produced in the North of Mexico and more recently in Colombia [131]. Although 
local heroin consumption was rare initially, it has been growing in Mexico-U.S. border cities 
in the past two decades [132]. Interestingly, despite cocaine being produced in Peru and 
Bolivia, IDU is a rare practice and cocaine is mostly consumed by chewing the coca leaves or 
smoking coca leaf paste in the rural areas and by snorting among the middle and higher class 
in urban areas [133].  
In terms of the contribution of IDU to the HIV epidemic in the region, about one quarter of 
AIDS cases were recorded as IDU in Latin America in 1992 [121]. This declined to 4.2% in 
2007 reflecting a reduction in IDU-associated AIDS cases in most countries, except in 
Uruguay where it has remained stable [121]. The proportion of new infections attributed to 
this mode of transmission was estimated around 1.6% for the region and higher at about 
5.4% in Argentina and 10.6% in Uruguay based on new HIV cases in 2006 [121].[134]Data on 
HIV prevalence among IDU in the region is only available for a few countries where this 
practice is well established and acknowledged by the government. Most surveys were 
carried out in the late 1990’s early 2000’s and so must be interpreted with this limitation in 
mind. Prevalence estimates in Brazil have varied widely; it was 52% in a study carried out in 
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several main cities in 1998, 7.9% in Rio de Janeiro in 1999 and 36.5% in several main cities 
again in 2000[121]. It was 44.3% in Buenos Aires, Argentina in 2001, 18.5% in Montevideo, 
Uruguay in 2003 and 3.7% in Paraguay in 2006 [121]. An important factor thought to have 
influenced the epidemic among IDUs in Brazil and the southern cone has been the transition 
to other drug administration modes. Smoked cocaine and especially crack use became more 
widespread in the early 2000s leading to decreased transmission through injections [133]. 
However, crack use has been shown to be associated with unprotected sex and other high 
risk practices and prevalence among crack users has been found to be high at about 6.2% in 
Argentina and 9.8% in Uruguay in 2003 [121].  
In Mexico, prevalence among IDU is estimated to be much lower at about 3% in Ciudad 
Juarez and Tijuana in 2007 [135]. In Puerto Rico, which technically is part of the U.S. and 
therefore treated separately from the Caribbean by UNAIDS; the impact of IDU has been 
more aggressive with prevalence estimates in the capital city ranging between 28.8 and 
55.2% [128]. Due to its proximity to the U.S., the epidemic in Puerto Rico is believed to be 
strongly influenced by migration of IDUs between these two countries. However, studies 
comparing HIV prevalence and associated risk behaviours among Puerto Rican IDU in the 
U.S. and Puerto Rico suggest much higher risk practices among the latter [136,137].  
6.6 Migrants 
When observing the situation among the previous key populations, it becomes apparent 
that migration can increase the risk for HIV transmission. The combined economic needs, 
social inequalities, isolation and fear of deportation among migrant populations shape their 
vulnerability to infection, among many other negative outcomes [138,139]. Although 
international migration is common in the region and has been fuelled by economic 
disparities between countries as well as alternating authoritarian political regimes, the most 
studied migratory flow has been that sustained by labour migrants from Mexico and Central 
America to the U.S.[140] Investigations have taken place in three main settings: the rural 
States in Mexico where migration is most common, the northern and southern Mexican 
borders, and the U.S. centres with important Latin American immigrant populations [138]. 
This reflects the three main stages of migration: origin, transit and destination where 
different conditions imply different risks [138]. The main motivation driving migration 
among Mexican and Central American migrants is the search for better economic 
opportunities [139,140].  A poor socio-economic background and a low educational level are 
therefore characteristic of this population and often imply lower access to health care and to 
information regarding HIV/STI transmission and prevention [139]. Additionally, very 
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traditional values attached to gender and sexuality including homophobia prevail in this 
section of society [140]. In contrast, the road taken to reach destination and especially 
borders (transit stations) are sowed with hotspots where commercial and transactional sex 
are common, sexual practices diverse and drugs more readily available, as described by 
qualitative and ethnographic studies [139,140]. Coercion, economic need, loneliness and 
curiosity are among the reasons behind the involvement is riskier sexual and drug using 
practices among migrants during their transit [138]. Rape, survival sex and sex as a payment 
to pass the border have been reported by female migrants [139,140]. Men generally travel 
alone (above 70% in Rangel study [141]) and a high proportion has reported paying for sex at 
the borders [141].  
For those who reach their destination, the conditions at arrival are hard. In general, 
immigrants in the U.S., and especially those undocumented, earn low wages and struggle 
with the language barrier. HIV prevalence in the U.S. is higher than in Mexico increasing the 
probability of exposure to positive partners but probably of greater importance are the 
dissolution of social networks and the exposure to a more permissive culture that offers the 
possibility to experiment new practices, far away from the judgment of family and 
acquaintances. It has been shown that migrants experience less risk aversion, which allows 
them to undertake a dangerous journey but also encourages them to engage in riskier 
practices[142]. Several studies comparing the sexual behaviour of migrants and non-
migrants, have reported a higher number of partners, higher frequency of sex with higher 
risk partners (casual, FSW, transvestites, IDU) and higher levels of drug consumption among 
the former [138,141,143,144]. However, they have also found migrants in the U.S. to be 
more likely to use condoms use and to get tested for HIV. This trade off in the risks imposed 
by each setting has been documented by others and behaviours have also been shown to 
change with time of residence in the U.S. [145]. Although the prevalence of risky sexual and 
drug using behaviours is elevated among this population [145,146,147], the prevalence of 
HIV seems to have remained low [106]. It has proven difficult to ascertain it due to great 
heterogeneity in behaviours depending on migratory patterns [106]. One study recruiting 
over 1,000 migrants in Tijuana between 2001-2003 found no HIV cases [106] while a study in 
California among 600 migrant workers found a prevalence of 0.9% [106]. A more recent 
study carried out among deported migrants in Tijuana found a weighted prevalence of 0.8% 
among men and no cases were found among women[148].  A study among migrants living in 
the counties of San Diego and Fresno in 2005 found a low unweighted prevalence of 0.19% 
among male migrants recruited at their work place, a higher prevalence of 1.99% when 
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recruiting in bars (where 50% of participants identified as MSM) and no infections when 
recruiting in the communities [149].  Nonetheless, very high prevalence has been found 
among migrants who have sex with men or inject drugs[106]. The behaviour of Hispanic or 
Latino MSM has been studied more extensively in the U.S. showing their limited experience 
or negative perception of homosexuality often leads to riskier practices [114,150,151].  
In addition to experiencing higher risk of infection, migrants can also be efficient vehicles for 
the spread of infection. In Mexico, migrants are believed to be important in contributing to 
the ruralisation and feminisation of the HIV epidemic as higher HIV prevalence has been 
observed in areas of high emigration such as Michoacán, Zacatecas or Guanajuato compared 
to other States of the country [138,152]. The proportion of AIDS cases that have a history of 
residing in the U.S. has been used as an indicator. This was above 50% in the first decade of 
the epidemic and by the year 2000 it had declined to 12.7% [106]. The strong value 
attributed to fidelity by both migrants and the women they leave behind, renders the use of 
condoms difficult upon their return [153,154]. Women also acquire infection during their 
own journey or stay in the U.S. as an increasing number migrate north nowadays and a high 
percentage of these reports exchanging sex for money or favours and having a higher 
number of sexual partners [139,144].  
6.7 Prison inmates 
In general, prison inmates come from unprivileged and marginalised neighbourhoods or 
populations, where drug use is widespread, access to education substandard, family 
environments dysfunctional and job opportunities scarce [155]. All these factors encourage 
the involvement in delinquency and other risk behaviours. In addition, living conditions in 
prisons often contribute to the deterioration of inmates’ health: overcrowding, poor diet, 
poor ventilation, limited access to clean water, violence and fear and the lack of appropriate 
mental health services, are only the most common examples [156,157,158].  
HIV has been very efficient at spreading among individuals that have riskier lifestyles and 
experience social marginalisation. Prison inmates make no exception. HIV research in prisons 
has mostly been carried out in the U.S., Australia and Spain.  The U.S. has the highest 
incarceration rate in the world and its inmate population has been disproportionally affected 
by the epidemic. Up to one in every 4 people living with HIV in the U.S. pass through the 
correctional system in a year [159]. Overall, HIV prevalence in prisons is estimated at 2.3% 
nationally and goes up to 8.9% in New York compared to a general population prevalence of 
0.6% [160]. Australia has been rather avant-garde and progressive in its management of STIs 
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and HIV from early in the epidemic. Depending on the States, compulsory, voluntary or 
targeted testing in prisons has been in place since the 1990’s [161]. Cross sectional surveys 
have also been carried out independently [162]. Spain witnessed a severe HIV epidemic 
among prison inmates mostly linked to IDU and is recognised for its efforts in controlling the 
spread [163]. In other industrialized countries, such as the U.K. or France, HIV prevalence 
has consistently been shown to be higher among the prison population than general 
population [164,165].  
A review on HIV in prisons in low and middle income countries showed that HIV prevalence 
was over 10% in 20 countries of which only 3 had general population prevalence higher than 
10% [166]. In all of the 20 countries and in most other countries included in the study, 
prevalence in prisons was higher than country prevalence [166]. The overrepresentation of 
IDUs in prisons is an important contributor to the higher prevalence of HIV in prisoners, but 
other risk factors such as sex work which are also linked to incarceration in the many places 
where this activity is illegal [167] or simply unprotected sex due to unawareness of STIs, 
alcohol and drug use or peer pressure are implicated. The work in this thesis entirely 
focusses on male inmates. However, although female inmates represent a minority of the 
total number of prison inmates they have been shown to be at heightened risk of HIV and 
STIs compared to male inmates in many settings [166]. They also experience a high burden 
of mental health and drug addiction problems [166]. 
6.7.1 Prison as a risk context for HIV transmission?  
While it is widely accepted that HIV prevalence in prisons is higher because they concentrate 
individuals who are more likely to engage in risk behaviours, there is still debate on whether 
the prison context further increases the risk of transmission [156]. This has in contrast been 
well documented for TB, as unhygienic conditions, overcrowding and lack of aeration in the 
dorms has resulted in TB outbreaks in several prisons [158]. Outbreaks of other respiratory 
infections, gastro‐intestinal infections and skin rashes are often documented in prisons. It is 
much harder to identify the transmission of HIV within the prison setting because of its long 
asymptomatic period. Also, people who enter prison often go back several times in their 
lives making it harder to track where they acquired the virus from. Prospective studies that 
test inmates at their entry to prison and at their exit can allow identifying within prison 
transmission but these have to take into account the window period from infection to 
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possible detection and are complicated to put in place. However, there are several ways in 
which the prison environment can modify the risk of HIV exposure.  
Firstly, incarceration implies a modification and sometimes a complete interruption of the 
day to day interaction with intimate partners. Maintaining relationships with intimate 
partners while in prison will be very dependent on the regulations imposed by the 
authorities. In the UK, for instance, conjugal visits are not permitted. In the U.S. sex in the 
premises is considered a crime and access to conjugal visits is only available in a handful of 
States and restricted to inmates who are legally bound with their partner and who meet a 
list of eligibility criteria. In Australia conjugal visits are allowed and in Canada they take place 
in spaces designed to look like a home so that they approximate the family environment. 
Inmates can spend up to three days per week with their partner and family. Initially, 
conjugal visits were created to increase work productivity in prisons by giving inmates an 
incentive and to control their behaviour. Today, in certain countries, maintaining 
relationships and family bounds is seen as an adjuvant for a more successful re-integration 
into society upon release, which ultimately would result in lower recidivism rates. 
Restrictions to the access of conjugal visits as well as many of the tensions associated with 
incarceration can affect intimate relationships.  Partnership dissolution as a result of 
incarceration has been documented and investigated by researchers in the U.S. and has 
been found to lead to risky sexual behaviours such as unprotected sex with multiple 
partners.  
Secondly, the choice of potential sexual partners is modified in prison. This is at most times a 
single sex environment and if no conjugal visits are allowed the choice might be restricted to 
men. Sex work occurs in prison and is often practiced by transgender inmates or inmates 
who were sex workers before entering. In some prisons where access to FSW is available, 
partner choice might be shifted towards them. On the other hand, when no attractive 
options are available, incarceration can simply lead to abstinence. Not only the choice of 
partners but also the access to prevention measures is modified. Sex is often forbidden or 
officially happens only under extreme measures of security in correctional settings, so 
condoms can be scarce if at all available. 
Additionally, prisons are a dangerous setting where sex might be used, aside than for 
pleasure, as a form of payment, punishment or dominance (Awofeso and Naoum, 2002), 
also contributing to the modification in partner choice and characteristics of sex (consensual 
vs. violent, protected vs. unprotected). Rape can take many forms depending on the 
 
58 The Latin American epidemic 
motivations. It can go from a single act inflicted by a single perpetrator to multiple acts 
inflicted by multiple perpetrators. A recent study estimating the number of HIV infections 
due to rape in the U.S. correctional system stated that between 0.5% and 1.5% of inmates 
were raped during their stay in prison. However, obtaining information on coerced or forced 
sex is difficult due to the sensitivity and danger associated with reporting these events. 
The widespread availability of drugs in prison and circumstances under which these are sold 
can also modify partner choice and sexual practices. Substance abuse has repeatedly been 
associated with sexual risk behaviours among several populations including prison inmates 
[114,168,169,170]. The need to finance a drug habit has been found to lead to sex work both 
in the community and within prisons. In particular, IDU in prisons implies high risk of 
infection as it is much harder to obtain clean syringes and needles or adequate material to 
sterilize them than outside [156]. To our knowledge, two outbreaks associated with sharing 
of contaminated needles in prison have been documented [171,172] and there is strong 
evidence supporting a relationship between incarceration and HIV outbreaks among IDUs in 
Bangkok, Thailand at two time points  [173,174]. Tattooing, also generally banned, is 
another practice commonly seen in prisons, the devices are often unhygienic and used on 
several people. Although it is still not clear whether it is a mode of transmission for HIV it 
definitely is for HBV and HCV [165].   
The role played by prisons in the HIV epidemic among inmates is a key question which will 
be approached from several angles in this work. In Chapter 4 we characterise HIV associated 
behaviours among a sample of inmates in the Lurigancho prison in Peru and pay special 
attention to whether exposure to prison is associated with their practice. Also in that 
Chapter, we investigate the causal pathways leading to HIV infection among this population 
and include exposure to prison as one of the underlying determinants that could promote 
behaviours responsible for infection. In Chapter 5 we investigate this question at the prison 
scale by testing whether high transmission rates in Lurigancho would be consistent with the 
prevalence trends observed taking population movement into account. Finally, in Chapter 6 
we develop a conceptual framework of HIV risk among this population based on an 
extensive literature review and investigate determinants of infection specific to the prison 
context. The section below presents an overview of the prison population in Latin America. 
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6.7.2 The Latin American context 
Delinquency was perceived as the main problem in Latin America by citizens from 18 
countries across the region participating to a large scale survey sampling over 20,000 people 
[175].  The region has in fact experienced extremely high crime rates over the past decades, 
only comparable to what was observed in Russia and Eastern Europe under the former 
communist regime [176]. The estimates of mortality due to violence surpass by far figures 
observed in North America or Europe [176]. When looking at three common crimes: theft, 
burglary and contact crimes (which include robbery, sexual incidents and assaults) the 
highest rates are also observed in Latin America [176]. 
This phenomenon is driven by social issues characteristic of the region (and of transitional 
countries in general) which can be briefly defined as higher proportion of young people, 
poverty, abysmal socio-economic inequities and inefficient response from the governments 
[176]. High levels of corruption, harsh penalties for minor offences and a slow and 
overloaded justice system contribute to the concentration of the poorest and most 
marginalised sections of the population inside Latin American prisons. The majority of 
inmates in this region are incarcerated for theft and robbery, although drug offences are 
increasingly contributing to the numbers. Even among the latter, it is generally those at the 
lower end of the chain that are incarcerated [177].While incarceration rates are comparable 
to those observed in other regions [178], they have been steadily increasing over the past 
two decades with no parallel increase in penitentiary system budgets, resulting in 
exceptionally high rates of overcrowding [177]. The Latin American prison system is 
currently experiencing a crisis which has serious implications for the living conditions behind 
walls [177]. The minimum international standards of life for prisoners are not respected in 
the Latin American countries that have been studied [177]. In Bolivia, Ecuador and Peru, 
where the situation is most serious, the food budget per prisoner has fallen to 0.80, 1.60 and 
2.00 USD respectively [177].   
Within prisons 
In Latin America, although regulations restrict conjugal visits to legally bound partners, in 
practice these occur freely with any type of partner including female sex workers, at least in 
medium security prisons. Visitors are essential to make up for the system deficiencies in 
terms of food, hygiene products and clothes, as only the strict minimum is provided to 
inmates by the prison. Staff numbers are generally small in comparison to inmates and 
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controlling sexual contacts between inmates and their visitors would be challenging. More 
importantly, allowing conjugal visits improves the atmosphere in the prison at several levels. 
Inmates are less likely to look for sexual satisfaction from other inmates which reduces the 
risk of sexual coercion and rape. Conjugal visits give inmates something to look forward to, 
improving their mood and alleviating tensions. This facilitates the task of maintaining order 
within premises. They also provide an incentive to make the place clean and censure violent 
behaviours for a period of time once or twice per week. This is well described by Drauzio 
Varella in his book Carandiru, where he writes about his experience working as a doctor in 
what used to be the largest prison in Latin America. Female visitors ought to have a positive 
impression of the prison and feel safe within walls or they might stop coming. Respect for 
other inmates’ partners and for their moments of intimacy is repeatedly mentioned when 
this issue is approached in either written accounts of prison life or in interviews with inmates 
or prison workers. In some prisons such as in the Reclusorio Norte in Mexico City, huts are 
built in the main square with sticks and blankets to create an intimate space to have sex 
during visiting hours [179]. These spaces are rented by inmates and a share goes to the 
guards to allow this practice to continue [179]. Generally conjugal visits in Latin American 
prisons only happen during visiting hours, however; in countries with high poverty levels, 
partners and children are allowed to live in the premises [177]. Incarceration of the 
breadwinner can mean the loss of housing for some families and living in the prison is 
sometimes the only alternative to the streets.  
6.7.3 HIV Prevalence 
HIV monitoring is not done routinely in the vast majority of Latin American prisons. In fact 
the HIV epidemic in this population has been rather overlooked by both the government and 
academia with the exception of Brazil where the widespread use of injected drugs among 
inmates resulted in alarming prevalence figures in the 1990’s. Initiatives looking at improving 
the understanding and management of HIV among prison inmates in the region have 
recently emerged. The creation of the “Monitoring Centre for HIV/AIDS in Latin America and 
the Caribbean” by UNAIDS and UNODC in 2007 has resulted in the implementation of 
studies evaluating the HIV infrastructure in place by the penitentiary system of several 
countries across the region [180].  In general this was found to be limited to testing inmates 
on demand and treating HIV patients. Few countries had established screening systems 
although a few such as Argentina had started implementing them in the years previous to 
the study. All reported carrying out some type of HIV prevention activity. While the situation 
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is expected to improve most of the information currently available on HIV prevalence and 
associated behaviours comes from punctual surveillance studies.  
Table 2 presents the most recent published prevalence estimates from countries for which 
information was available and compares them against country prevalence as reported by 
UNAIDS for the year 2009. The latter was chosen over taking the UNAIDS estimates 
corresponding to the year of the prison prevalence estimate because they were considered 
to be more accurate as the methods used by UNAIDS have undergone substantial 
improvements since 2007 [32] and the country prevalence is expected to remain relatively 
stable over such short periods. Some of the prison population estimates were taken from 
reports carried out in the context of the UNODC/UNAIDS monitoring project mentioned 
above and the methods used to obtain them are not always described. In particular, 
countries penitentiary systems mostly work with number of cases over a certain time period 
and it is possible that this figure is divided over total population to obtain prevalence which 
is not necessarily correct when considering population movement. This is an issue that will 
be brought up in this work in Chapter 4, in the context of HIV surveillance in Lurigancho. This 
disconnect between operational data collection activities and research needs is an 
important issue to be tackled to maximise the use of the limited information available. The 
estimates obtained from studies, in contrast, truly are point estimates and are backed up 
with a description of the methods followed. In several countries only information on the 
number of cases identified to date is available. Only 9 had been diagnosed in Nicaragua, 49 
in Honduras and 29 in Dominican Republic as of 2008, which points towards severe under-
diagnosis. Similarly, the reports for Colombia and Bolivia only reported number of HIV 
positive inmates in 2010: 156 and 23 respectively. Figure 10 presents the same data under a 
graphic format in order to visualise the difference between prison population and country 
HIV prevalence. For most of the Central American countries, prison prevalence is slightly 
higher than country prevalence. In Mexico and Costa Rica it is about double the country 
prevalence, while in Panama it is about 4 times higher. Similar ratios are observed in the 
Caribbean for Belize and Suriname. The difference is more marked in South American 
countries where prevalence among prison inmates is up to 13 times higher than country 
prevalence as seen for Uruguay. This pattern can be explained by the more widespread use 
of injected drugs in South America and particularly in prisons.  Earlier prevalence estimates 
for Brazil were much higher at 16% in 1993/1994 and then decreased to 4.9% in 2001 and 
2.15% in 2003 [181,182]. This trend is believed to be the result of a shift from the use of 
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injected cocaine to crack [181], supporting the hypothesis that the geographical differences 
observed are due to differences in the prevalence of IDU. 
 
Country Prison Prevalence Country prevalence Year of study Source type and reference 
Mexico 0.7% 0.3% 2010 study[183] 
Costa Rica 0.6% 0.3% 2007 PS[184] 
Ecuador 0.4% 0.4% 2007 PS[184] 
Guatemala 1.0% 0.8% 2007 PS[184] 
El Salvador 0.9% 0.8% 2009 PS[185] 
Panama 3.3-4.1%¹ 0.9% 2000¹ PS[186] 
Brazil 2.2% 0.3-0.6% 2003 study[181] 
Venezuela 0.8%² NA 2007 PS[187] 
Peru 1.1%³ 0.4% 2000 study[188] 
Chile 1.9% 0.4% 2008 PS[184] 
Argentina 4.0% 0.5% 2008 PS[189] 
Uruguay 6.5% 0.5% 2005 study[190] 
Belize 4.0% 2.3% 2005 study[191]  
Suriname 1.4-2.9% 1.0% 2008 study[192] 
Table 2. HIV prevalence among prison inmates as compared to country prevalence in a selection of Latin 
American countries 
Notes: PS=penitentiary system, ¹ The report included more recent data but both the method and the unit were 
unclear, ² Cited in a governmental report but the method followed was not described. A study carried out in 
1998-2001 reported a prevalence of 4% across 6 prisons in the country. ³ More recent data are available but 
unpublished 
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Figure 10. HIV prevalence among prison inmates as compared to country prevalence in a selection of Latin 
American countries 
6.7.4 Risk factors 
Risk factors for HIV infection among prison inmates have been explored in several countries, 
obtaining similar findings with the consideration that the epidemic observed among this 
population if often a reflection of the epidemic in the country or at least the study area. A 
study carried out in Indonesia for instance, found that after adjusting for potential 
confounders, IDU was the only significant risk factor for HIV infection (history of 
incarceration lost significance once controlled for IDU) which was consistent with the 
country’s epidemic [193]. A study in Belize showed that having sex with men outside of 
prison, being older than 25, and living in the Belize district were independent factors for HIV 
infection. Again this is in accordance with the patterns of infection observed in the country 
where MSM are particularly affected by the epidemic and where prevalence is higher in the 
Belize district [191]. In Brazil, Argentina and Uruguay, IDU was the strongest risk factor 
associated with HIV infection, as previously described in these three countries IDU is an 
important component of the epidemic. Exposure to prison, either having been incarcerated 
for longer or in the past, was also associated with infection [182,189,190]. Some risk factors 
are common across geographical regions: having multiple partners, having sex with men and 
exposure to prison were associated with HIV infection in studies carried out in Nigeria, North 
Carolina and Ghana [194,195,196]. IDU and sex with FSW were also identified as risk factors 
in North Carolina, Ghana and Italy [195,196,197].  
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7 The Latin American response to the epidemic 
7.1 Treatment 
The Latin American response to the epidemic has been strongly focussed on treatment. 
Brazil in particular has played a pivotal role in setting the grounds for universal access to 
treatment both by applying it and by challenging the pharmaceutical companies to make the 
drugs more affordable. In 1991 when the first drug for HIV (AZT) became available, the 
Brazilian government started providing it to those in need in the country and a few years 
later it launched into manufacturing a generic version. This happened in the context of a 
democratic transition following a long period of dictatorship resulting in a strong impetus for 
the defence of human rights, including freedom of expression, respect for sexual diversity 
and equality[198,199]. The HIV epidemic exemplified many of these causes as it mainly 
affected homosexual men who had been severely repressed during the dictatorship and it 
touched upon equality in the right of access to health care [198,199]. Several activist 
movements developed to protect people with HIV and ensure they could access treatment 
independently of their socio-economic status [199].  In 1996 Highly Active Antiretroviral 
Therapy (HAART), a much more effective drug combining 3 antiretrovirals targeting different 
stages of the virus cycle, was discovered [198]. That same year, the Brazilian government 
issued a law warrantying its free access to all citizens in need of treatment but the cost was 
high and new patent laws prevented the national companies from manufacturing it 
[198,200]. A long process of negotiations started which would involve many players and 
revolutionise the way in which the public and private sectors interact [198]. Drug prices 
decreased tremendously as a result in Africa and low income countries, but ironically, not as 
substantially for Latin American countries as most classify as middle income countries [3]. In 
2008, after years of putting pressure on the pharmaceutical companies, Brazil made use of 
the emergency clause included in the patent’s laws stating that in case of a national 
emergency, the patent restriction can be overridden and HAART started being manufactured 
in Brazil [200]. This sparked controversy over the potential impact of this move on drug 
development but has also resulted in very high treatment coverage in Brazil undoubtedly 
playing a major role in the control of the epidemic especially considering  the pessimistic 
projections envisaged for the Brazilian epidemic at a couple of decades ago [199,200]. This 
success story has not been replicated in all the countries of the region as most started 
providing treatment for free much later and increases in coverage have been unequal. Along 
with Brazil, Argentina started provided treatment since 1991 and by 2001 it is estimated that 
these two countries were covering nearly all of those in need [201]. Uruguay, Chile, 
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Venezuela, Cuba and Mexico provided a similar response [201]. In Bolivia, Peru, Paraguay 
and in Central American and Caribbean countries coverage was still limited in 2001 [201].  By 
2010 over 60% of those in need in the region were receiving treatment which was above the 
average global coverage of 47% [202]. This is based on the new WHO guidelines increasing 
the CD4 count threshold indicative of treatment need from 200 to 350 cells/mm3. Coverage 
varied geographically with only Guyana attaining universal coverage (>80%), several 
countries providing treatment to more than half of those in need (Brazil, Argentina, Chile, 
Costa Rica, Honduras, Ecuador, Mexico, Nicaragua, El Salvador and Suriname) and still some 
countries failing to reach that goal. In particular coverage in Bolivia was below 20% in 2009 
[203].  
Mortality due to AIDS has declined in the past decade mostly due to this notable expansion 
of treatment coverage. A small decline in the number of new infections has been observed 
in the past decade going from 99,000 [85,000–120,000] to 92,000 [70,000–120,000] for 
Central and South America and from 20,000 [17,000–23,000] to 17,000 [13,000–21,000] in 
the Caribbean in 2001 and 2009, respectively [1].   
7.2 Prevention 
While HIV treatment expansion has been relatively successful with most countries being able 
to implement it widely and sustain their own demand, prevention has not been a priority for 
most Latin American governments. This has been attributed to the perception that the 
epidemic is not a serious problem, especially when compared to its extent in sub-Saharan 
Africa or to other health problems afflicting the Latin American population, in particular 
chronic diseases.  Although some would doubt the urgency in addressing HIV prevention 
needs, there are many reasons to tackle them effectively. Firstly, and as described 
previously, some populations experience high rates of infection. While MSM continue to be 
badly hit across the region, the epidemic among IDU was devastating in the southern cone in 
the 1990’s and although it has been controlled to a certain extent in some countries it is 
growing in others, especially in Mexico. In some countries up to 10% of FSW are infected. 
Further infections among these groups must be prevented. Additionally, epidemic patterns 
are subject to change. The potential for transmission has been consistently shown among 
migrants and variation in infection rates among FSW serve as a warning for the possible 
consequences of decreases in condom use. While little is known about the epidemic among 
prison inmates the high prevalence observed in some places and the changing environment 
that these settings are experiencing as a result of the war on drugs might favour the 
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epidemic. Finally, although transmission to the lower risk population has fortunately 
happened rather slowly in the region (with the exception of countries in the Caribbean and 
Central America), the epidemic is established in the general population and the spread will 
continue, especially if it is not controlled at its source, namely among key populations.  
Paradoxically, Latin American governments have attributed only a small (if any) percentage 
of their already limited prevention budgets, to the implementation of interventions among 
key populations [3]. A recent analysis of HIV/AIDS spending among countries in the region 
showed that about 15% was allocated to prevention[3]. With 36% of its prevention budget 
going towards key populations, Peru is the country that gives most priority to these groups 
[3]. 9 out of 20 countries did not direct any funding towards key populations and only a 
handful of countries directed a proportion of their domestic funding to these groups: 
Colombia, Mexico, Venezuela and Chile with 1, 3, 5 and 12% of their prevention spending 
respectively [3]. International funding represents less than 6% of the spending but the 
majority of it is directed to prevention among key populations, meaning that these activities 
largely rely on external funding [3]. Figure 11 illustrates the disproportionality between the 
proportion of the prevention spending directed at MSM and the impact of the epidemic 
among this group in several countries in the region.  
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Figure 11. Proportion of preventive spending directed at MSM and HIV prevalence among MSM in a selection 
of Latin American countries. Source: Aran-Matero et al., 2011 [3]. 
Prevention has in fact been mostly oriented towards the general population and especially 
youth and has consisted in large scale messaging campaigns that promote the delay in 
sexual activity and monogamy [61]. These have been criticized for being too broad and 
sensationalist, resulting in a loss of credibility [61]. Prevention of Mother to Child 
Transmission (PMTCT) has also been given a high priority by governments, both because it is 
relatively straightforward to implement within the established health care services and 
because it benefits from universal acceptance as it entails saving the lives of children. It is 
therefore more easily included in the political agendas of candidates than harm reduction 
for IDUs, to mention an example. 
However, this does not translate in a complete absence of prevention interventions for key 
populations. Along with some governmental initiatives, NGOs across the region have been 
delivering prevention to these groups from the early days of the epidemic. Recently an effort 
to characterise the work carried out by NGOs around the world has been undertaken and 
has provided a better picture of their organisation and activities [204]. One NGO from each 
of the 23 Latin American countries included in the study was described. All had a prevention 
component in their programmes and although the vast majority (82.6%) provided 
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prevention services to the general population and to children and adolescents (34.8%), they 
also carried out outreach to key populations (30.4% to MSM, 13% to FSW and 8.7% to IDU) 
[204]. HIV positive people and their family were also important recipients of prevention 
interventions (with 22% of NGOs reporting activities among this group), especially in 
countries with larger epidemics [204]. The types of activities listed were broad but the 
majority consisted in capacity building activities followed by individual and face to face 
programmes [204]. The authors noted that in general, HIV/STI prevention was approached in 
a holistic manner by these organisation as it was included in a broader frame of sexual and 
reproductive health as well as human rights; an approach that has taken much longer to 
emerge within the research and political spheres [204]. It is likely that these interventions 
are more culturally sensitive and better adapted to the needs of key populations because 
they have been developed by members of these groups or individuals with an experience of 
these risk environments. Additionally, in contrast with governmental activities they do not 
represent a threat for those involved in illegal activities [205]. 
Several initiatives directed at FSW have resulted in very high levels of condom use and STI 
testing and treatment. These have included individual and group training to increase HIV/STI 
knowledge and condom negotiation skills, as well as changes in the way health care is 
provided to this population and structural changes involving the inclusion of laws that 
protect FSW from abuse. In Peru, a large scale project was undertaken among FSW that 
consisted in implementing mobile-team outreach for STI screening and treatment, periodic 
presumptive treatment for trichomoniasis, condom promotion and training of pharmacy 
workers in the recognition of STI symptoms to provide adequate treatment [206]. The latter 
is particularly relevant to the Latin American context as many drugs are available over the 
counter and so self-medication is common, especially when it involves STI symptoms as 
these are considered embarrassing [117]. Mobile STI treatment and prevention teams have 
also been implemented in Tijuana to facilitate access to condoms and care among FSW[207]. 
Innovative prevention interventions involving role playing to improve negotiation skills with 
clients have also been implemented in Tijuana and Ciudad Juarez [208]. In the Dominican 
Republic aside from the monthly STI check-ups mandatory for FSW, an intervention based 
on the 100% condom programme in Thailand was implemented in two main cities [209]. This 
involved sensitising owners and employers of sex work establishments to the prevention of 
HIV/STIs, working with FSW to engage them in the project and training clinicians to perform 
a better job at carrying the health check-ups and have a more in depth understanding of the 
importance of prevention [209]. In one of the cities sanctions were imposed if the 
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establishments did not comply with the programme’s regulation [209]. A similar intervention 
was also implemented in Brazil [210].  However, as seen in Figure 12 the coverage of 
prevention services among sex workers is highly variable between countries and especially 
low in some as reported to UNAIDS in 2009.  
 
Figure 12. Percentage of sex workers reached by HIV prevention programmes in the past 12 months as 
reported by a selection of Latin American countries for the 2009 WHO universal access report [104]. Source: 
PAHO website 
 
Stories of success are also available regarding prevention among IDU, mostly thanks to NGO 
and the involvement of international organisations. Governments have remained inflexible 
in their policies regarding drug use and the rates of incarcerations of small dealers and users 
keep increasing [128]. The governmental response has focussed on abstinence from drug 
use and so treatment centres providing opiate substitution have been established in Mexico 
and Puerto Rico where heroin is consumed [121]. However, harm reduction programmes 
started being implemented in the 1980’s in Brazil and Argentina and the distribution of 
sterile needles and syringes started in Brazil in 1994 followed by Argentina in 1999 [211]. 
Syringe exchange programmes were not available in Paraguay until 2004 and even later in 
Uruguay [211]. Puerto Rico was the first country in the Caribbean to put in place harm 
reduction and since 2001 the Caribbean Drug Abuse Research Institute (CDARI) has been 
investigating drug use and its consequences in the region, focussing on crack cocaine which 
is more common in these countries [211]. The Latin American region has received funding 
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from UNAIDS and UNODC to expand these initiatives and collect information in a way that 
allows comparison between countries. Although improvements have taken place these have 
been slow in some countries and still face difficulties in their implementation. 
 
The potential role of migrants in spreading infection from the U.S. to Mexico and back has 
encouraged the development of collaborations between these two countries and several 
data collection and prevention projects have emerged. “Go healthy, come back healthy” 
(VSRS is its acronym in Spanish) provides information to migrants on the health risks that 
they might face in their journey [138]. The California-Mexico Epidemiological Surveillance 
Pilot (CMESP), a bi-national surveillance project has been collecting data on HIV prevalence 
and risk behaviours among migrants for a few years [212]. In general, HIV prevention in the 
U.S. is being increasingly adapted to Latin American population needs, starting by the use of 
the Spanish language in prevention messages and interventions but also by taking a more 
culturally sensitive approach.   
 
Regarding prison inmates, the lack of interventions is consistently mentioned in the 
literature. Even in the most advanced countries in terms of harm reduction and inclusiveness 
of key populations, prison inmates have been broadly ignored. No country in the region 
offers syringe exchange programmes in prisons [213]. Of the NGOs included in the 
international review describing the organisation and scope of a selection of NGOs in each 
region, none offered services to the prison inmate population in Latin America [205]. More 
recently, condom use promotion and distribution has started being implemented across 
countries and in the recent reports produced for the monitoring collaborative project all 
countries reported the existence of prevention activities in the prison [180]. However, these 
are of unequal quality and coverage. 
 
The response among MSM will be further discussed in Chapter 3 but this has been mostly 
focussed on condom promotion and has had insufficient coverage as seen in Figure 13. 
Recently, there has been an increasing mobilisation for the defence of sexual diversity and 
homosexuality in particular. In 2004, Brazil launched the “Brazil without homophobia” 
programme and in 2008 the first demonstration for the rights of MSM was held at the 
International AIDS conference in Mexico City [109]. In this same year the first LGTB 
conference was convened to address issues particular to these populations [109]. Legal 
reforms have started taking place such as the right of legal union in Mexico City [214]. 
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Changing a mentality involves targeting many audiences that have influences at different 
levels and will take time. 
 
 
Figure 13. Percentage of MSM reached with HIV prevention programmes in the past 12 months as reported by 
a selection of Latin American countries for the 2009 WHO universal access report  [104]. Source: PAHO website 
 
Aside from the insufficient coverage attained, interventions directed ay key populations in 
the region have been poorly documented and largely unevaluated. In the 2008 Cochrane 
review on behavioural interventions among MSM it is stated that “some populations at high 
risk, particularly African-American and Latino MSM and MSM in countries where English is 
not the primary language have been underrepresented in intervention research”[215]. In 
fact, only one of the studies included was carried out in Latin America. As previously 
mentioned, a great proportion of these initiatives have been implemented by NGOs either 
independently or in partnership with the government and therefore outcomes have not 
been measured or reported following research standards. The criteria for inclusion into 
Cochrane reviews are strict; however, the exact same pattern is observed in a meta-analysis 
looking at HIV prevention interventions in Latin America specifically [58].  Out of 28 studies 
selected, less than half were directed at key populations, and only one of those reported 
results of an intervention among MSM [58]. Considering that this is, without the shadow of a 
doubt, the population that has been most affected in the region and that MSM concentrated 
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epidemics are mostly found in Latin America, it is perplexing that no more studies have been 
carried out. In the same way, a study reviewing the evaluation of the cost-effectiveness (CE) 
of prevention interventions across the world only included 2 studies from Latin America 
[216]. No study provided information on the CE of studies among MSM or among prison 
inmates in the region.  
8 Aims and organisation of chapters 
Achieving an effective response to control the epidemic requires knowledge of the 
distribution and intensity of infection and of the behaviours and structural contexts behind 
it. As shown above, there is a need for evidence within the HIV prevention field in Latin 
America. Through the application and development of statistical and mathematical models 
and keeping in sight the social and structural determinants of infection, we aim to use 
available data to improve the understanding of the epidemic and, where possible, guide the 
response.  
Among the tools in use to estimate HIV incidence in the population is the Modes of 
Transmission model, which was conceived to help countries direct their prevention efforts 
towards the populations that most contribute to the epidemic in order to maximise impact. 
This model estimates the distribution of new infections in the next year by type of 
behaviour. In Chapter 2, we apply it to three countries in North America, South America and 
the Caribbean to investigate the different epidemic typologies co-existing in the region, 
provide recommendations for prevention and shed light of data collection gaps. 
MSM contribute to a substantial proportion of new infections in the region, across the 
different epidemic types encountered. Effective prevention strategies are urgently needed 
to control spread among this population and further. In Chapter 3 we develop a 
mathematical model of HIV transmission among MSM and transgender women in Lima Peru 
to investigate the potential cost-effectiveness of PrEP in a Latin American setting.  
In Chapter 4, we introduce a less visible key population: prison inmates. We focus on the 
Lurigancho prison in Lima Peru, as it is representative of large prisons in the capital cities of 
Latin America in terms of population size and living conditions but has a well-established HIV 
monitoring system in place. We analyse sentinel surveillance data to describe and 
characterise risk behaviours and pathways to HIV infection among this population. 
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In chapter 5 we translate individual risk to population spread through the development of a 
mathematical model of HIV transmission among Lurigancho inmates based on the data 
analysis carried out in chapter 4. We carry out an epidemiological analysis to characterise 
the magnitude of the epidemic through time and test hypotheses regarding the relationship 
between inside and outside prison transmission and the potential impact of increases in 
condon use. 
In chapter 6, we move from quantitative analyses to a mixed methods approach involving 
qualitative work and an extensive literature search to investigate the social determinants of 
HIV infection among prison inmates in the Latin American setting. We develop a conceptual 
framework of HIV risk and design a questionnaire to test it.  
In Chapter 7, we summarise our main findings, place this work within the broader context of 
HIV research and propose avenues for further work. We discuss the uses of modelling in 
improving the HIV response and the need to consider the local and context specific 
behaviours that can shape epidemic spread among key populations when modelling HIV 
spread amon these. Finally, we argue for the need to consider structural interventions to 
tackle HIV among key populations. These suffer from a range of problems that are 
associated with HIV but that require upstream action to be solved. Prison inmates epitomise 
this reality. 
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Chapter 2: Estimating the distribution of new HIV 
infections by type of exposure in three Latin 
American countries using the UNAIDS Modes of 
Transmission model  
1 Introduction 
A great number of prevention initiatives have been implemented globally since the 
beginning of the HIV epidemic using measures proven efficacious at the individual level such 
as condom use or STI treatment [217,218]. However, it has been surprisingly difficult to 
prove their effectiveness at the population level and to show that these efforts have made a 
difference to the epidemic overall, although some examples of success do exist, including 
the PREVEN trial in Peru [206,219,220]. This may be partly explained by the fact that it is 
complex to account and control for all the factors and confounders that play a role in the 
course of the epidemic, but also because prevention has not always been directed at those 
individuals who need it the most [221].  
The UNAIDS classification of the epidemic described in the main introduction and originally 
conceived to help countries better understand their individual epidemics, has been 
interpreted and used for programmatic purposes in a rigid and sometimes reductionist 
manner [2,221]. Countries with generalised epidemics have concentrated their efforts in 
controlling infection in the general population, despite the fact that key populations are 
often still disproportionately affected. Policy is usually influenced by the values considered 
moral by society at the time which often translates in women and children in the general 
population being prioritized over sex workers (SW) or Injection Drug Users (IDU), even in 
countries where the epidemic has had very little impact among the general population 
[221]. As resources are limited and are likely to be affected by the current global financial 
situation, it is essential to employ them in the most efficient way [222]. The first step to 
maximise efficiency of prevention efforts is to direct them towards groups with higher 
incidence of infection.  
Incidence is a valuable indicator for prevention planning since, as opposed to prevalence, it 
informs on current epidemic trends, but it is difficult to obtain estimates from the field 
[223]. The gold standard for incidence estimation is the prospective cohort study which 
involves a substantial amount of planning and organisation, and significant ethical 
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considerations as well as the commitment of human and financial resources over an 
extended period [224]. It depends on participants’ willingness and ability to take part and 
remain in the study and yet is subject to numerous biases [224]. An alternative is the cross-
sectional measurement of incidence through biological assays that detect early HIV infection 
such as the BED assay which detects antibodies against HIV produced at the start of the 
immune response. HIV Nucleic Acid Amplification Testing (NAAT), carried out using PCR 
(Polymerase Chain Reation), detects the virus’ genetic material and therefore allows 
identification of HIV infection prior to the production of antibodies [225]. Antigen tests 
detect HIV antigens such as p24, produced in excess early in infection, also allowing earlier 
detection. “Fourth generation” tests combine antigen and antibody testing to increase the 
probability of detecting infection [225]. Currently, one is approved by the Food and Drug 
Administration (FDA) in the U.S.[225]. Many of these tests, and especially those such as the 
BED that attempt to differentiate recent infection from later infection through characterising 
antibodies’ properties, have several limitations. They require substantial background 
epidemiological information on non-recently infected individuals in the population of 
interest in order to make the adequate corrections to the test’s results [223,224]. Others are 
still in development and are likely to be costly once approved [225].  
 
Statistical methods and mathematical models for estimating incidence have been developed 
to circumvent some of the issues inherent to field epidemiology methods and to maximise 
the data already available from HIV surveillance and demographic surveys. Back calculation 
methods obtain estimates of past incidence from recent AIDS cases, these control for sub-
notification and delays in reporting [226,227]. Methods such as developed by Hallett et al. 
[228] use prevalence data from Demographic Health Surveys (DHS) to estimate incidence. 
These require information on mortality among HIV infected and uninfected individuals. 
Mathematical models that simulate the dynamics of infection also estimate incidence. The 
Estimation Projection Package (EPP) and Spectrum AIDS impact model have been widely 
applied across the world by UNAIDS [41]. These have been part of the set of modelling tools 
used to improve the understanding of the epidemic within each country and guide their 
policy. EPP and Spectrum fit an epidemic curve to available prevalence data and help to 
translate the information into estimates of HIV and AIDS cases as well as treatment needs 
and other useful indicators [41,224].  
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Although these methods and models are useful in many respects, they do not answer the 
fundamental question at the basis of prevention planning: Who should prevention efforts 
prioritise to obtain the largest impact on the epidemic course?  
Back calculation methods tell us about past incidence which might be different to current 
and future trends as a result of natural epidemic dynamics or of changes in behaviour. The 
DHS surveys are not representative of key populations and so incidence estimated from 
these will not be informative in this respect. In the same way, EPP and Spectrum model the 
overall epidemic and tell us more about geographic variation than population variation.  
In response to the need to answer this question, the UNAIDS Reference Group for modelling 
estimates and projections developed the Modes of Transmission Model (MoT), a simple 
mathematical model that estimates the distribution of new infections in the next year by 
type of exposure. Although it is recognised in most countries that particular populations are 
being disproportionately affected by the epidemic, the contribution of these groups to the 
epidemic is often unclear. As key populations are generally small it is tempting to believe 
that their contribution to the overall epidemic is also small, especially in countries where the 
epidemic is sustained in the general population. Having an estimate of the proportion of 
infection that occurs in each group is therefore valuable information both for directing 
interventions and for advocacy purposes.   
The first piece of work presenting this modelling approach was published by Pisani and 
colleagues in 2003 and called for a return to basics in terms of prevention [221]. By this they 
meant investigating who is getting infected and how. They argued that although these 
questions might seem obvious, few countries actually undertook research specifically meant 
to answer them [221]. This work presented results from the MoT model applied in five 
countries at two different time points and highlighted that epidemics under the same 
umbrella of the term “generalised” could actually exhibit very different incidence scenarios. 
They also showed that prevalence in specific groups did not always relate to current 
incidence trends, especially where large scale interventions had taken place such as in 
Thailand. Prevalence among sex workers was very high as a result of very high transmission 
early in the epidemic but incidence had drastically declined following the 100% condom 
campaign in the country [221]. In 2006, Gouws and colleagues described the model more 
thoroughly and applied it to Kenya and Thailand to illustrate differences in incidence 
patterns [229]. The MoT is part of the modelling tools used by UNAIDS to achieve a better 
understanding of individual countries’ epidemics and has been applied in more than 25 
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countries since 2007 in different regions across the world, including Latin America and the 
Caribbean but also East, West and Southern Africa, Middle East and North Africa, Eastern 
Europe and Asia [230]. 
1.1 Aims 
Here we used the MoT modelling approach to estimate the distribution of new infections by 
type of exposure in three countries in the region: the Dominican Republic (DR), Mexico and 
Peru. Our aims were: 
 to provide evidence for directing prevention efforts to populations that most need 
it  
  to investigate how differences in prevalence patterns translate in terms of 
incidence distribution. This included verifying whether the characterisation of the 
epidemics as concentrated in Mexico and Peru and generalised in DR is in fact 
reflected in the incidence patterns obtained with this method 
 to characterise patterns of data availability which of itself is an important outcome, 
as it can highlight areas of particular deficiency and promote data collection 
activities. Particular emphasis was given to the data sources used for model 
parameterisation in this work.  
The Dominican Republic shares the island of Hispaniola with neighbouring Haiti, and 
together they account for close to three quarters of HIV cases in the Caribbean Region [231]. 
With a population of over 9 million, the Dominican Republic’s HIV adult prevalence is 0.9%, 
against a prevalence of 1.9% in Haiti [231]. 57,000 are currently living with HIV/AIDS [231].  
The country’s epidemic has been characterised as generalised as transmission is sustained in 
the general population. However, prevalence is higher among certain populations, such as 
drug users (7.1%), MSM (6.1%), FSW (4.8%) and residents of “Bateyes” (3.2%) [232]. The 
latter are inhabitants of (ex-)sugar cane plantations that emigrated from Haiti to work and 
who have stayed on after the harvesting period and formed families [233]. Currently other 
immigrants and visitors from Haiti still reside in “Bateyes” with family or acquaintances 
[233]. They have consistently had a higher HIV prevalence than the general population in DR 
and a DHS specifically focused on this group was carried out in 2007[1].  
In Mexico, 220,000 people were estimated to be living with HIV in 2009, making the 
epidemic the 3rd largest in the American continent (after the U.S. and Brazil) [1].  The HIV 
epidemic in Mexico typifies that in several other Latin American countries, with MSM 
presenting a higher prevalence than any other population. This has been estimated to range 
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between 10.4% and 25.6% [105,234]. The other highly affected groups have been IDUs, 
among whom HIV prevalence has been estimated at 3 to 4% with high differences by gender 
[135,235]. Several surveys have indicated that FSW may not be more likely to be infected 
than members of the “general population”. However, this appears to be different in cities 
adjacent to the U.S. border where prevalence among FSW has been estimated at 6% and is 
higher among those who inject drugs [236]. Recent studies among migrants to the U.S. 
suggest that their prevalence is around 0.6%, so closer to the U.S. than to the Mexican 
general population prevalence [106]. National HIV prevalence in Mexico is low (0.3%), 
although highly heterogeneous, with 50% of cases concentrated in 5 States. Incidence is 
highest is Mexico City, Baja California on the northern border and Yucatán in the south 
[237]. There is also evidence that the types of risk behaviour driving transmission vary across 
Mexico. In broad terms, the epidemic in the south has mainly been associated with sex 
work, possibly because it includes the poorer States of the country and immigration from 
Central and South America is often accompanied with entry to sex work [238]. In the centre 
of the country, MSM have been the most affected group. In the north, cases in IDUs have 
been more common, likely reflecting the more widespread availability of illegal drugs in 
these parts [239]. Also, HIV prevalence is higher in border cities in the north, such as Tijuana 
or Ciudad Juárez due to the concurrence of the availability of drugs, high rates of transit, and 
large numbers of SW [239].  
 In Peru national prevalence has been estimated at 0.4% corresponding to over 70,000 
people currently living with HIV/AIDS [1]. As in Mexico, the most affected population have 
been MSM with prevalence estimates ranging from 9 to 23% [92,100]. Transgender women 
in particular have been shown to be particularly vulnerable with a high prevalence of about 
30% [70]. Prevalence among FSW has been consistently low, likely due to the high levels of 
reported condom use [206,240]. Injecting drugs has not emerged as a common practice in 
Peru and so this population is not prominent in the epidemic. Geographical variations in the 
epidemic follow the land’s natural divisions with prevalence being lowest in the highlands, 
higher in the coast, and highest in the tropical forest [241,242]. 
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2 Methods 
2.1 The model 
The MoT model is a simple probabilistic model that estimates the number of infections in a 
specific group over one year resulting from a specified average number of contacts with 
individuals that have a certain probability of being infected (prevalence). It is based on the 
Bernoulli theorem and defines “the risk of infection in a susceptible individual [as] a simple 
binomial function of their number of partners and number of sex acts with each partner” 
[243]. The model requires data on the number of people in each exposure group, the 
prevalence of infection (HIV and STIs) in these groups and their rates of exposure. 
The estimation of incidence of HIV by sexual and parenteral transmission (during IDU) in 
each group i is obtained from equations 1 and 2, respectively. The groups included and the 
transmission patterns considered in the model are shown in Figure 1.  Transmission through 
medical injections and blood transfusion is based on the same equation than for parenteral 
transmission through IDU but it considers prevalence in the total population rather than in a 
single group. 
 
I= incidence in the group of interest  
S= number of susceptible individuals in this group  
p= partners’ HIV prevalence  
B= Partners’ STI prevalence  
β= HIV transmission probability  
β’= HIV transmission probability in the presence of an STI  
α= number of sex acts per partner  
v= proportion of acts protected by condom use  
n= number of partners  
 
The number of new infections in a group through sexual transmission is equal to the number 
of susceptible individuals in that group times 1 minus the probability of NOT getting infected 
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(1-β) after α sex acts  of which (1-v) are unprotected with each of their n number of 
partners. This is based on the multiplicative rule to calculate probabilities. 
These n partners are either:  
-HIV infected and have an STI,  
-HIV infected with no STI  
-or HIV negative.  
Each of these are a proportion of n and the sum of the three types of partners must be equal 
to 1: pB+ p(1-B)+ (1-p)=1  
The sex acts they have with non-infected partners are not obviously represented in the 
equation because they imply no risk of infection (β=0) and the probability of NOT getting 
infected after the α acts with these partners is 1: (1-0)α(1-ν)=1. The effect of STIs on HIV 
transmission is accounted in the probability of transmitting infection but not in the 
probability of acquiring infection. The model assumes that the risk of transmitting infection 
among those with and STI is increased 4 folds based on Fleming et al 1999 [16] and Gray et 
al 2001 [244].  
The effect of circumcision on the probability of transmission is taken into account by 
decreasing the female to male probability of transmission by a factor of 60% times the 
proportion of men circumcised based on Gray et al. 2007 [15]. This modified female to male 
transmission probability is applied to all sex acts between men and women, meaning that it 
assumed that the proportion of men circumcised is equal in all male groups represented in 
the model.  
The groups included in the model are IDUs and their sexual partners, FSW, their clients and 
the female sexual partners of clients, MSM and their female sexual partners, men and 
women who have casual heterosexual sex (CHS) and their sexual partners, men and women 
who have low risk sex (i.e. who are in a monogamous relationship) and people who are at no 
risk, meaning that they have not had sex or injected drugs in the last year. The sexual 
partners of people engaging in risky behaviours are defined as their stable partners 
(husband, wife or cohabiting partner) whose only risk is having sex with their partner.  
Individuals who engage in more than one risk behaviour are assigned to the behaviour that 
implies the highest risk of transmission. In this way, the risk for one group only comes from 
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ONE source, the riskiest, as illustrated in Figure 1. As an example, risk among IDU only comes 
from sharing injecting equipment, even though these also have sexual partners.  
 
Figure 1. Groups included in the standard MoT model and transmission patterns. 
Note: The red arrows indicate the direction of HIV transmission from one group to the other as represented in 
the model. 
2.2 Uncertainty analysis  
Because the MoT model is demanding in terms of data, it is unlikely that any country will 
ever have all the information needed to complete it with solely national data. Estimates are 
taken from other countries or inferred in a variety of ways, creating multiple sources of 
uncertainty and therefore a reduced credibility in the outputs. To respond to this problem 
which was raised during previous workshops held in West Africa a simple method was 
developed to calculate uncertainty bounds around the estimates. 
This follows a simple Monte Carlo sampling method, where all user‐specified inputs are 
allowed to vary independently and uniformly within a pre-determined interval for 1,000 
model runs. Each run will result in a different estimate of the number of incident cases per 
exposure group and of the total number of new infections. The range obtained from 
Spectrum for the total number of new infections is used to select plausible outputs: runs 
which give a total incidence outside these bounds are discarded. The median of all selected 
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outputs is calculated and the uncertainty is described by uncertainty bounds defined as the 
2.5 and 97.5 percentiles. The range of variation around each input is given in the form of a 
percentage ranging from 0 to 100% and is determined by expert opinion (of the national 
consultants) based on the type of study (a national survey should have stronger estimates 
than a small study), on the sample size, on how recent the data are and on how 
representative of the population of interest they are. Estimates that have resulted from 
calculations (such as mid‐points between two study results) are allowed greater variation 
and so are estimates obtained from data in other countries.  
Other restrictions are directly imposed into the calculations: the total male and female 
population is set to add up to 100% by setting the proportion of low risk individuals as the 
residual of the other groups. Similarly, the total population prevalence is maintained by 
making the prevalence among the low risk group a residual of the total prevalence resulting 
from the other groups. To prevent the prevalence among the low risk group from reaching 
implausible values, a filter is set on this output at the selection stage. Also, in order to keep 
the total number of sex acts equal for FSW and clients, the number of clients’ sex acts is 
calculated as a function of the number of clients, FSW and the number of clients and sex acts 
per client among FSW. The size of the stable partners’ groups is calculated as a fixed 
percentage of the size of the group to which they are linked. For instance, if it was assumed 
that 30% of MSM had a female stable partner in the initial model, then rather than allowing 
the size of the partners of MSM group to vary randomly it is calculated as 30% of the size of 
the MSM group obtained in each run. 
2.3 The process 
To apply the model across regions, UNAIDS commissions national consultants and 
workshops are organised to familiarise them with the model and assess whether the 
countries have sufficient data to parameterise it. It is important that the project is led by a 
national team to ensure its subsequent use among decision makers in the country. For the 
Latin American region the workshop took place in November 2008 in Buenos Aires, 
Argentina. The participating countries were Argentina, Brazil, Colombia, Mexico, Paraguay 
and Peru based on a previous assessment of data availability. During this first workshop 
national consultants complete a first version of the model with guidance from the 
international consultants. This is followed by a period of data collation to complete the 
model and by successive rounds of feedback from the international consultant. Data sources 
include national surveys, peer reviewed scientific literature, grey literature as well as 
unpublished data from academic or routine studies. When the model is considered finalised 
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a consultation is held to present it to national HIV experts and solicit their comments. 
Modifications are made to the model accordingly and once validated a full report presenting 
the sources of information used to parameterise the model, the results and the 
recommendations issued from this process  is then passed to UNAIDS for dissemination. 
These are available at: 
 http://www.unaids.org/en/dataanalysis/datatools/incidencebymodesoftransmission/  
My role was to provide modelling expertise to the national consultants leading the project in 
each country. This involved introducing the model, training and guiding national consultants 
on its parameterisation and revising the outputs. A jointly authored manuscript describing 
the MoT study in Peru has been submitted for publication. I also contributed to writing a 
review assessing the limitations of the MoT process and proposing solutions to ensure a 
better use of this tool. This has been accepted for publication. A manuscript presenting an 
overview of the results obtained from the MoT from all countries where it has been applied 
so far in which I participated has also been submitted for publication. The two former 
manuscripts are included in appendix as they are more relevant to the work presented here. 
2.4 The data sources: overview and scoring 
The availability of data of sufficient quality to inform the model inputs is a fundamental 
determinant to the production of reliable outputs. In order to evaluate these, we developed 
a scoring algorithm whereby sources for each input parameter were classified as “National” 
(N), “National Inference” (NF), “International” (I) or “Assumption” (A) corresponding to a 
score of 3, 2, 1 and 0 respectively. The concept of the scoring algorithm was based on the 
work by Aceijas et al (2006) [245] reviewing information on IDU in transitional countries, and 
adapted to represent the main types of data obtained for parameterising the MoT. 
“National” refers to data that was obtained from a survey or study carried out in the country 
but does not necessarily mean it is representative at the national level. “National Inference” 
refers to inputs that were obtained from two or more national sources through the 
application of a formula or correction. “International” refers to data borrowed from a 
neighbouring or similar country, meta-analysis, or international/regional review. 
“Assumption” refers to the application of an arbitrary rule formulated by either the UNAIDS 
international consultants or by the national experts in the absence of available data to 
inform the model parameterisation. This is a broad classification which was only intended as 
a screening test to identify areas of particular data deficiency and highlight differences 
between countries. 
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The DR has carried out 4 DHS surveys in the general population (1996, 1999, 2002, 2007) 
and one special DHS among Bateyes’ residents (2007) [246]. It carried out its first national 
biological and behavioural sentinel survey in 2008 and this included MSM, FSW and drug 
users (including IDU) [78]. Recently there has been an interest from academics in the 
epidemic in DR and a few studies have emerged that have helped better characterise the 
epidemic [247,248,249,250]. 
Mexico has not been carrying out the DHS since 1987 (Encuesta Nacional de Fecundidad y 
Salud), but it has an equivalent demographic survey called ENADID (Encuesta Nacional de la 
Dinámica Demográfica) carried out in 1992, 1997, 2006 and 2009 [251]. A national 
reproductive health survey (ENSAR) was also carried out in 2003 [251]. CENSIDA (the 
National HIV programme) has produced several reports synthesising the findings from 
studies carried out by the centre as well as by national research institutes [106,234]. 
National sentinel surveys have investigated the epidemic among pregnant women, blood 
donors and key populations (FSW, MSM, truck drivers). The scientific literature on key 
populations in Mexico is also quite rich although very biased geographically towards the 
Mexico-U.S. border cities and the capital.   
In Peru, the Division of Epidemiology of the Health Ministry carries out ANC sentinel 
surveillance periodically. The last round was in 2005 and provides the most reliable 
estimates of HIV prevalence among the general population. DHS have been carried out since 
1986, 9 rounds have been completed to date. Other national surveys include the population 
Census which provides socio‐demographic information on the general population. This is 
carried out by the Institute of Statistics and Informatics (INEI) and the eleventh round was 
finalised in 2007[252]. The national commission for development and prevention of drug 
use, DEVIDA, collects information on drug use among the general population; the most 
recent data is from 2006 [253]. A useful source of information on the general population is 
the PREVEN study [206]. This study aimed to evaluate the impact of a community‐based 
hybrid STI and HIV preventive intervention on the prevalence and incidence of STI 
(gonorrhoea, chlamydia, trichomoniasis, syphilis) and HIV in a high risk group of FSW and in 
the lower risk group of the young adult general population [206,254]. This study collected 
data from 2002 until 2006.  
Table 1 summarises the classification and score given to each input for each of the 3 
countries studied and a summary of data sources is given for each sexual behaviour group. 
As mentioned in the methods this is a broad classification solely based on the data 
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provenance and whether the input was directly taken from the source or inferred in the case 
of national data. It therefore does not provide information on data quality. The rows 
correspond to the parameters for each sexual behaviour group. The total country score for 
each sexual behaviour group is presented at the bottom end of each group while the total 
score for each input is presented in the last column. The maximum score per sexual 
behaviour group is 18 and 15 for partners of key populations. The total score for each 
country is presented on the last row of Table 1 (second part of the table). The maximum 
score per country is 156. Particularly low scores are highlighted in pink. 
  
DR Mexico Peru 
Group Parameter Data Score Data Score Data Score 
IDU Proportion NF 2 I 1 N 3 
 
HIV prevalence N 3 N 3 I 1 
 
STI prevalence N 3 N 3 I/NF 1 
 
Number of partners I 1 N 3 I 1 
 
Number of acts/partner I 1 NF 2 I 1 
 
Protection N 3 NF 2 I 1 
Score   
 
13 
 
14 
 
8 
IDU sex.  Proportion A 0 A 0 A 0 
partners HIV prevalence A 0 A 0 N 3 
 
Number of partners A 0 A 0 A 0 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use A 0 A 0 A 0 
Score   
 
0 
 
0 
 
3 
FSW Proportion N 3 I 1 I 1 
 
HIV prevalence N 3 N 3 N 3 
 
STI prevalence N 3 N 3 N 3 
 
Number of partners N 3 N 3 N 3 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use N 3 N 3 N 3 
Score   
 
15 
 
13 
 
13 
Clients Proportion N 3 I 1 N 3 
 
HIV prevalence A 0 N 3 N 2 
 
STI prevalence A 0 NF/A 1.5 N 3 
 
Number of partners NF 2 NF/A 2 F 2 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use N 3 N 3 N 3 
Score   
 
8 
 
11 
 
13 
Clients  Proportion NF 2 A 0 A 0 
partners HIV prevalence A 0 A 0 NF 2 
 
Number of partners A 0 A 0 A 0 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use A 0 A 0 A 0 
Score   
 
2 
 
0 
 
2 
MSM Proportion I 1 I 1 N 3 
 
HIV prevalence N 3 N 3 N 3 
 
STI prevalence N 3 N 3 N 3 
 
Number of partners I 1 N 3 N 3 
 
Number of acts/partner NF 2 A 0 N 3 
 
Condom use N 3 N 3 N 3 
Score   
 
12 
 
13 
 
18 
Table 1. Data sources and scores for each input 
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DR      Mexico Peru 
Group Parameter Data Score Data Score Data Score 
MSM  Proportion NF 2 NF 2 NF 2 
partners HIV prevalence A 0 A 0 NF 2 
 
Number of partners A 0 A 0 A 0 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use A 0 A 0 A 0 
Score   
 
2 
 
2 
 
4 
CHS Proportion N 3 NF/A 1.5 N 3 
 
HIV prevalence N 3 A 0 NF 2 
 
STI prevalence N 3 NF/A 2 NF 2 
 
Number of partners A 0 N 1.5 N 3 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use N 3 N 3 N 3 
Score   
 
12 
 
8 
 
13 
Partners  Proportion NF 2 NF/A 1.5 A 0 
CHS HIV prevalence A 0 A 0 A 0 
 
Number of partners A 0 A 0 A 0 
 
Number of acts/partner A 0 A 0 A 0 
 
Condom use A 0 A 0 A 0 
Score   
 
2 
 
1.5 
 
0 
Low risk Proportion NF 2 NF 2 NF 2 
 
HIV prevalence N 3 N 3 N 3 
 
STI prevalence N 3 N 3 N 3 
 
Number of partners N 3 N 3 N 3 
 
Number of acts/partner N 3 N 3 N 3 
 
Condom use N 3 N 3 N 3 
Score   
 
17 
 
17 
 
17 
No risk Proportion N 3 N 3 N 3 
 
HIV prevalence A 0 A 0 A 0 
Score   
 
3 
 
3 
 
3 
Total score 
 
86 0 82 0 94 
Total maximum score possible 156  156  156 
Table 1(continued). Data sources and scores for each input  
 
2.4.1.1 IDU 
DR: DR recently carried out a survey among key population including 1,200 drug users [78]. 
Less than 5% of these were IDU and therefore the information available is based on a very 
small sample size. It is believed that there are very few IDU in the country.  
Mexico: A body of scientific publications mostly by Strathdee and colleagues is available 
concerning this key population in Mexico [235,255,256]. However, the studies were all 
carried out in Ciudad Juarez or in Tijuana (two important cities on the border between 
Mexico and the U.S.) and are therefore unlikely to be representative of the IDU population 
across the country. On the other hand, a great proportion of IDUs in Mexico live in the 
northern region where drugs are more widely available due to the proximity to trafficking 
routes. Although the IDU population is well characterised, these studies do not necessarily 
provide the information required to complete the model. 
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Peru: Apart from the DEVIDA survey, there is little information on IDU in Peru (the country 
score was 8 against 13 and 15 for DR and Mexico respectively). Data from a study looking at 
140,976 serum samples collected between 1986 and 1990 found that prevalence among the 
145 participants who reported IDU was 13%. However, it varied from 1% to 27% when 
comparing the samples collected in the periods 1986-1988 and 1989-1990 respectively 
[134]. Data on behaviours such as number of injecting partners and acts per year were 
obtained from studies in other countries: Brazil, the U.S. and Spain. 
Information varied between countries but in general, the most poorly informed parameters 
were the number of injecting partners and the number of injections per year. 
2.4.1.2 IDU sexual partners:  
There was no information available on this group in two of the three countries (scores were 
0 in DR and Mexico and 3 in Peru). The HIV prevalence among female partners of IDU in Peru 
was estimated from a study among pregnant women in which they were asked whether 
their partner was an IDU [258]. 
2.4.1.3 FSW 
These correspond to women who sold sex regularly in the last year, i.e. women whose main 
income comes from sex work rather than women who sporadically exchange sex against 
goods or favours. Traditionally FSW have been a focus for HIV/AIDS research and prevention 
in Latin American countries and there is sufficient information available to complete the 
model with little variation between countries (scores go from 13 to 15). 
Peru: Most studies use data that was collected in the 1990s. Estimates on prevalence of HIV 
and STIs among FSW were obtained from Montano et al. [240] and Sanchez et al [259] 
respectively. Trujillo et al. [260] included data on condom use among FSW in Lima. The 
PREVEN intervention also included a mobile outreach team visiting sex work venues in eight 
weeks cycles to screen and treat FSW for STIs, to promote and provide condoms, and to 
encourage FSW to visit their local public health clinic for routine screening and treatment 
[117]. Being the most recent estimates and having precise information on the prevalence of 
HIV, STIs and behaviours such as the number of clients per FSW, they were used to inform 
several inputs. An effort was made to take into account the differences between FSW in 
Lima and in the rest of the country by weighting the estimates of HIV prevalence 
accordingly.  
 
Data was missing in all countries for one input: the number of sex acts per client. This 
question is not included in behavioural questionnaires. Information on the proportion of 
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clients that are regular can provide a surrogate source of information for the frequency of 
sex with clients.  
2.4.1.4 Clients:  
These correspond to men reporting having paid for sex in the last year. Information on 
FSWs’ clients is less readily available. The proportion of men that are clients can be 
estimated from DHS surveys although these have been shown to underestimate the size of 
this population [261] and for the purposes of this exercise it is indirectly calculated based on 
the number of FSW and their reported number of clients.  
DR: There was particularly little information on this group in DR despite the scale of the sex 
industry in the country (score was 8). Some qualitative studies give a good snapshot of this 
population [262]; however, quantitative studies are needed to help estimating their risk and 
contribution to the epidemic. 
Mexico: No studies on the client population had been carried out until recently, in the 
border cities [263,264,265,266]. Clients of FSW in Ciudad Juarez and Tijuana are likely to 
have higher risk behaviours than elsewhere in the country because of the availability of 
drugs and the general conditions of the sex industry in that part of the country [239]. One 
study  on truck drivers is potentially informative as this population is often involved in 
buying sex [106].  
Peru: Information on clients was mainly taken from one published study [267] and from the 
PREVEN study. Data on prevalence in this group was inferred from calculating prevalence 
ratios among pregnant women who reported that their partner paid for sex compared to 
those who did not [258] and applying them to the prevalence among partners of pregnant 
women obtained during the HIV sentinel surveillance carried out by the DGE (2005) and by 
Clark et al [268].  
2.4.1.5 Partners of clients:  
These correspond to stable female partners of FSWs’ clients. There is no information on this 
population (scores going from 0 to 2). Only the proportion of women that are partners of 
clients of FSW could be inferred from Barrington et al. [262] in DR and the HIV prevalence 
was obtained for Peru using the study mentioned above which asked pregnant women 
about their partner’s sexual behaviour. 
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2.4.1.6 MSM:  
These correspond to men who have had anal sex with another man in the past year. Data on 
MSM is available in all countries. All countries have carried out national scale biological and 
behavioural surveys and the PREVEN study in Peru collected information among MSM in 
urban centres across Peru (Score 18). Extensive information on MSM is available in Peru 
from academic studies. Caution must be taken as some investigate specific MSM groups not 
representative of the total population (i.e. very high risk). There is important heterogeneity 
among this population so it is inaccurate to represent it as a single entity. 
Again, there was little data to inform the number of sex acts per partner and there is still a 
need to improve the estimates of this population’s size. 
2.4.1.7 Female partners of MSM:  
These correspond to stable female partners of MSM. The only information available 
regarding this group for all countries was an estimate of the size of the population based on 
the proportion of MSM reporting being married or cohabiting with a woman. The HIV 
prevalence in this group could be inferred for Peru using the study mentioned previously 
[258]. Scores go from 2 to 4. 
2.4.1.8 Casual heterosexual sex:  
This population was defined as people reporting sex outside union and therefore includes all 
single people reporting sex in the last year independently of the number of partners they 
had. For the DR and Peru, the DHS survey was used to parameterise the model. It was more 
difficult for Mexico as it does not have a DHS survey and the equivalent national surveys do 
not include biological indicators (low score: 8). There was no information on the number of 
sex acts per partner for any of the countries. 
2.4.1.9 Partners of CHS:  
These correspond to the wives, husbands or cohabiting partners of those who report being 
married or cohabiting and having more than one partner. As for the other groups 
corresponding to sexual partners of key populations, there was very little information 
available (score: 0 to 2).  
2.4.1.10 Low risk:  
This population corresponds to married or cohabiting individuals reporting a single partner 
in the last year. This is commonly referred to as “the general population” and is generally the 
largest group. It is well captured in the DHS or equivalent reproductive health surveys. All 
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countries had information to complete the model for this population (all countries scored 17 
for this group).  
2.4.1.11 No risk:  
These correspond to individuals who have not reported sex or shared injecting equipment in 
the last year and who should therefore be at minimal risk of HIV. Only the size and the 
prevalence of this population are needed and can be obtained from the DHS or equivalent 
surveys.  
2.5 Parameterisation 
A snapshot of the model for each country as well as the data sources and justification for the 
inputs are available in appendix. The results presented below aim to provide an overview of 
the model parameterisation so that differences between countries as well as similarities 
resulting from assumptions can be appreciated.  
Distribution of the population: The distribution of the male and female populations 
for each country is illustrated in Figure 2. 20 to 30% of men were at no risk of acquiring HIV, 
with Peru having the greatest proportion reported of sexually inactive men. The proportion 
of women in the “no risk” group was slightly larger for all countries. The proportion of men 
and women in the low risk group varied from 20% in Peru to over 40% in Mexico and from 
35% in Peru to nearly 50% in DR respectively. Nearly 30% of men belonged to the CHS group 
in DR against 20% in Mexico and Peru. The proportion in this group was lower among 
women at about 10%. The proportion of partners of CHS was therefore small among men 
(under 1% in DR) and higher among women (up to 11% in Peru). The proportion of MSM was 
estimated between 3.5% in Mexico to 6% in Peru. Mexico did not have national data to 
inform this parameter while Peru had information from the PREVEN study. The proportion of 
females who were partners of MSM was approximately 1% in the three countries. The 
proportion of FSWs’ clients was of about 7% in DR and Mexico and of about 15% in Peru. The 
difference is mostly due to the sources of data used in each country: in DR an earlier DHS 
survey was used (as the most recent one estimated that about 4% of men were clients of 
FSW which appeared unrealistic considering reported numbers of clients among FSW); in 
Peru this estimate was inferred from the number of sex workers and reported clients to 
produce a plausible number of visits per client. While the latter might be an overestimate it 
is likely that the number of clients in DR is larger than estimated. The proportion of women 
who were FSW was below 1% in both Mexico and Peru and was of 4.5% in DR. Although this 
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might appear high the estimate is the median obtained from several sourced source 
[209,269]. The proportion of IDU was below 0.2% in all countries.  
  
Figure 2. Distribution of the male and female populations by risk behaviour in DR, Mexico and Peru according 
to the MoT parameterisation 
2.5.1 Behavioural parameters 
Regarding behavioural parameters, the model needs information on the number of partners, 
the number of acts per partner and the proportion of protected acts. The number of 
partners was highest and varied most among FSW, going from 156 partners/year in DR to 
over 800 partners/year in Peru as shown in Figure 3A.  The right panel of Figure 3 presents 
the same numbers as in the lef panel but on a smaller scale to allow visualising differences 
among other groups. The number of partners among clients also varies importantly, from 17 
in Mexico to 60 in DR. The latter corresponds to over one visit per week in DR which seems 
high; however, qualitative research suggests that the sex business in DR is embedded in a 
social routine among clients. In Barrington et al [262], a high percentage of clients of FSW 
report going to the establishment where they buy sex everyday as it also is a place to gather 
with friends and have a drink. In Mexico and Peru commercial sex appears to happen less 
casually, in the context of brothels or in the street. The number of partners among MSM 
varied from 2.3 in DR to 9 in Mexico. It is difficult to say if these correspond to real 
differences in behaviour between countries or to study variations. Among IDU the number 
of partners in DR was borrowed from the Mexican estimate and from a study in Barcelona in 
the case of Peru so no conclusions can be drawn. The numbers of partners among 
individuals having CHS was low in the three countries (between 1.5 and 2). This is because 
most individuals in this group are in a monogamous relationship but are not married or 
cohabiting. It is likely to be a reflection of a traditional society where there are still 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
DR Mexico Peru
Male distribution 
Bateyes
No risk
Low risk
CHS p.
CHS
MSM
Clients
IDU sex. p.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Female distribution 
Bateyes
No risk
Low risk
CHS p.
CHS
MSM fem. p.
Clients p.
FSW
 
92 Chapter 2: Estimating the distribution of new infections in three Latin American countries 
restrictions around sex, especially for women [60]. Among the low risk group, the number of 
partners was 1 in all countries. Residents of Bateyes had 2.1 partners on average which 
approximates the behaviour among the CHS group. 
  
Figure 3. Number of partners for each of the groups in DR, Mexico and Peru according to the MoT 
parameterisation.  
Note: The figure on the right is a close-up of the figure on the left restricting the y axis to 70 partners. 
The estimated numbers of acts per partner were relatively similar between countries as 
shown in Figure 4. The greatest variation was obtained for the number of injecting acts per 
partner with 80 acts for DR and Mexico (again the DR estimate was borrowed from Mexico) 
and 170 acts in Peru (estimate taken from a study among Latino IDU in Chicago). There is 
great variation in injecting patterns among IDU depending on their situation. Sharing 
injecting equipment generally happens in threatened contexts where drug use prosecuted 
by the authorities and sterile needles are scarce. The number of partners also depends on 
injecting practices: while some might inject with their sexual partner or close friend, others 
attend shooting galleries where the number of partners will be high [270,271]. It is therefore 
difficult to work with averages for this group but the general lack of information impedes 
any type of analysis. The number of sex acts per partner is show in Figure 4. Among IDU it 
was assumed to be equal that among the low risk population in DR and Peru but was 
assumed to be lower in Mexico based on the fact that IDU have a lower sex drive and 
addiction affects stable relationships. The number of sex acts per partner among FSW was 
assumed to be between 1 and 1.5 depending on the countries based on the assumption that 
a small proportion of clients are regular. Among MSM it was calculated based on the 
assumption that all groups (except FSW and their clients) have the same number of acts on 
average so  it was equal to the quotient of the number of acts among the low risk group by 
the number of partners among MSM. In the case of Mexico the total number of sex acts in 
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this group was assumed to be lower considering that high partner change rates result in 
fewer sex acts than with a stable partner. The number of sex acts among the CHS group was 
calculated based on the assumption described above. Among the low risk group it was 
obtained from early DHS surveys carried out in the 1980’s. This question was subsequently 
taken out of the questionnaire. The reproductive health survey in Mexico (ENADID) does 
collect this information. The number of sex acts among residents of Bateyes was calculated 
based on the assumption described above. 
Regarding the estimated proportion of protected acts, this was between 72 and 92% among 
injecting drug users when referring to injections while condom use with sexual partners was 
assumed to be the same as in the low risk population for DR and Peru. In Mexico this was 
higher and based on national studies. The frequency of condom use among FSWs and clients 
was between 80 and 85% in the three countries. Prevention measures among FSW in Latin 
America have proven efficacious in terms of consitent condom use with clients (but much 
less so with other partners). Condom use among MSM was lowest in DR with 54% reporting 
condom use at last receptive sex act and highest in Mexico with 85% (corresponding to the 
mid point between two cross-sectional surveys). Among individuals engaging in CHS this 
went from 27% in Peru to 53% in DR based on the DHS surveys. Condom use among the low 
risk group was low in all countries going from 2% in DR to 7.5% in Peru, also based on the 
DHS surveys. Finally in Bateyes condom use was 25% based on the special DHS survey. 
  
Figure 4. Number of contacts (left) and the proportion of these that are protected (right) for each behaviour 
group in DR, Mexico and Peru according to the MoT parameterisation. 
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2.5.2 Biological parameters 
HIV prevalence estimates (shown in Figure 5) were highest among IDUs in DR and Peru 
[78,257]. Among MSM it was highest in Mexico at 11% [234]whereas it was estimated at 6% 
in DR [78]and 5.16% in Peru. The latter was obtained from dividing the number of HIV cases 
reported between 1983 and 2007 over the total population of MSM in 2007, adjusting for 
mortality and under-reporting (see parameters’ table in appendix). The PREVEN study found 
a prevalence of 2.5% among MSM suggesting this could be an overestimate; however, the 
study did not include Lima and was a household sample which might have excluded MSM at 
higher risk. MSM and IDU were the two groups among which prevalence values above 5% 
were assumed which is characteristic of concentrated epidemics. Nonetheless, prevalence 
was also high among FSW in DR at 4.8% [78]and among Bateyes residents at 3.2% (special 
DHS). HIV prevalence among FSW in Mexico and Peru was 2% and 1% respectively. 
Prevalence in these groups has remained consistently low in the region (Chapter 1) although 
it is higher in some Central American and Caribbean countries [1]. In relation to estimated 
prevalence among stable partners of key populations, namely partners of IDU, FSW’s clients 
and MSM, this was above 2% among IDU partners in Peru and was below 2% for all other 
groups. These estimates were drawn from assumptions for Mexico and Peru and from 
inferences using a dated study in Peru. Prevalence in the low risk, CHS and their partners, as 
well as in the no risk group, were all very low in Mexico and Peru (below 0.5%) and higher in 
DR (around 1%). 
Regarding STI prevalence (shown in Figure 5), this was estimated to be highest among FSW 
in Mexico and Peru and among individuals engaging in CHS in DR. This is strongly dependent 
on the particular STI used to inform the model which is in turn dependent on the availability 
of studies. The figure for Mexico corresponded to the prevalence of any STI (including 
gonorrhoea, chlamydia, syphilis and HIV) among FSW in Tijuana and Ciudad Juarez [124]. It 
therefore related to a population at particular risk (FSW in border cities with the U.S. 
generally have a higher prevalence of STI than elsewhere in the country) and used a broad 
indicator. In contrast, the figure for DR was syphilis prevalence in a national survey [78]. STI 
prevalence among MSM was similar between the three countries (between 4 and 6%) 
despite originating from different types of studies and using different indicators: for both 
Mexico and DR syphilis prevalence was used, but the estimate from DR came from a national 
survey [78] whereas the estimate from Mexico came from a study carried out in STI clinics in 
Mexico City [272]. Peru used data from the PREVEN study on chlamydia prevalence [206]. 
Interestingly STI prevalence among the CHS and low risk groups in Peru was higher than 
 
95 Chapter 2: Estimating the distribution of new infections in three Latin American countries 
among clients of FSW and MSM which is not implausible as condom use among the former 
groups is much lower. Prevalence among the CHS group was taken from a study in an 
antenatal and family planning clinic [273] and from the PREVEN study for the low risk group 
(which again focused on young individulas from 18 to 29 years old) [206]. 
 
Figure 5. HIV and STI prevalence for each behaviour group for DR, Mexico and Peru according to the MoT 
parameterisation 
3 Results 
3.1 Distribution of new infections 
The distribution of new infections by sexual behaviour group resulting from the 
parameterisation of the MoT model for DR, Mexico and Peru is summarised in Figure 6 and 
described in detail below for each country. In all countries the greatest contribution of new 
infections was estimated among MSM, with over 50% of new infections occurring in this 
group in Mexico and in Peru and slightly over 30% in DR. The low risk group contributed 
nearly the same proportion of new infections than among MSM in DR which contrasts with 
the figures obtained for Mexico (12%) and Peru (15%) for this population. This reflects the 
differences in prevalence among the general population between the countries. The second 
and third most important contributors to the number of new infections in Mexico were, 
respectively, IDUs and female partners of MSM. In Peru, the low risk group was the second 
most important contributor and partners of MSM, partners of clients, individuals who 
engage in CHS and their stable partners all had a similar contribution to the number of new 
infections. In the DR people who engage in CHS and residents of Bateyes made the most 
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important contribution after MSM and the low risk group confirming that the epidemic is 
well established in different sections of the general population. Sex work provided the 
greatest contribution in DR with approximately 12% of all new infections happening among 
FSW, clients and their partners (clients were more affected), the total contribution was 
similar in Peru (over 8%) although the distribution was different with client partners being 
the more affected group. In Mexico the contribution of sex work was smaller (6%) with client 
partners’ being the more affected group. 
 
Figure 6. Distribution of new infections by sexual (and injecting) behaviour for the year 2010 in DR, Mexico and 
Peru according to the MoT 
3.1.1 Peru: a primarily MSM driven epidemic 
The model predicted that there would be 4 346 new infections in 2010 which is close to the 
lower bound of new infections predicted by Spectrum (3 168‐10 005). According to the 
model, the majority (56%) of new infections occurred among MSM and another 6% of new 
infections occurred among their stable female sexual partners (see Figure 7).  
The low risk group contributed to 15% of new infections and another 12% happened among 
people having casual heterosexual sex and their stable partners, meaning that close to one 
third of new infections affected heterosexual people who have one or more sexual partners. 
Although FSW and clients accounted for only 2% of new infections, the stable partners of 
clients contributed to 6% of these. Finally, IDUs accounted for 2% of new infections. 
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Figure 7. Distribution of new infections by sexual or injecting behaviour in Peru in 2010 showing uncertainty 
bounds 
When looking at the proportion of infections to occur in each group it is essential to 
compare it with the corresponding proportion of the population that they represent. As 
shown in Figure 8, the contribution of MSM to the proportion of new infections is over 10 
times higher than its contribution to the the total population. Only the proportion of new 
infections among IDU, partners of MSM and of FSWs’ clients are also higher than their 
contribution to the total population. 
 
Figure 8. Contribution of each behaviour group to the proportion of new infections as compared to their 
contribution to the total population size in Peru, 2010 
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3.1.2 Mexico: MSM and emerging IDU epidemic 
The model predicted that there would be 12,951 new infections in 2011 which approximates 
the higher bound of the Spectrum estimates (7,100-15,000). Over 50% of new infections 
corresponded to MSM. In 2011, 42% of AIDS cases notified among young men between 15 
and 29 years old were attributed to MSM sex and 21% to bisexual sex [274], suggesting this 
might be an under-estimation. Another 14% of new infections corresponded to their female 
partners, resulting in 65% of new infections originating from MSM transmission (see Figure 
9). The uncertainty interval around the proportion of new infections among MSM was broad 
(95%CrI: 28%-68%) as there was uncertainty around the population size estimate and small 
variations in condom use strongly affect the outputs. Nevertheless, this group remains the 
most important contributor to total incidence. The low risk group accounted for 12% of new 
infections. The broad uncertainty interval (95%UI: 4%-24%) can be attributed to the 
calibration methods applied to the uncertainty module: the size and prevalence of this group 
is calculated as the residual of the other groups to obtain the total population size and 
prevalence. In order to minimise the risk of unrealistic estimates the prevalence estimates 
for the low risk group were restricted to vary between 0.04% and 0.2%. IDU and their 
partners contributed to 9% of new infections while they represent less than 0.2% of the 
population. There was considerable uncertainty around all inputs for this population as they 
all come from small studies in two border cities with the U.S. and there is a lot of 
heterogeneity between findings. The estimates suggest the contribution of IDU could be as 
high as 20% and it is therefore essential to promote further research among this population. 
Individuals who engage in CHS and their partners accounted for nearly 7% of new infections. 
Sex work accounted for about 5% of new infections. Interestingly client partners 
represented two thirds of this figure. High levels of condom use among FSW protect clients 
but once these get infected, transmission to their stable partners is facilitated by low levels 
of condom use.  Medical injections and blood transfusions contributed to a negligible 
fraction of new infections. 
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Figure 9. Distribution of new infections by sexual or injecting behaviour in Mexico in 2010 showing uncertainty 
bounds 
As seen in Peru, the contribution of MSM to the proportion of new infections is several folds 
higher than their contribution to the total population (see Figure 10). This is also true for 
their partners and for IDU. Partners of clients also contribute more to the number of new 
infections than to the total population. The relative gap between the contribution to new 
infections and to the total population among the low risk and the CHS groups is larger in 
Peru. 
 
Figure 10. Contribution of each behaviour group to the proportion of new infections as compared to their 
contribution to the total population size in Mexico, 2010 
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3.1.3 Dominican Republic: Mixed epidemic 
The distribution of new infections in DR differed from what was obtained in Mexico and Peru 
because there was no single major contributor of new infections; instead new infections 
were mainly accounted for by both MSM and their partners (over 35%) and the low risk 
population (over 30%). The credibility intervals for the MSM and the low risk groups overlap 
with the proportion of new infections occurring among MSM going from 24 to 44% and the 
proportion of new infections among the low risk group ranging between 23% and 38% (see 
Figure 11). Sex work was the third major contributor to the number of new infections with 
over 12% of infections occurring among FSW, their clients and their stable partners. Sex 
work in the DR appears to be a rather common practice among women, likely associated 
with the difficult economic context. Despite high levels of condom use the contribution of 
the sex industry to the number of new infections is considerable. Individuals engaging in CHS 
and their stable partners also contributed significantly to the number of new infections with 
nearly 12% occurring in this group. Residents of Bateyes contributed to nearly 9% of new 
infections although they represent less than 4% of the total population. Overall, 
heterosexual sex among the general population (i.e. excluding MSM, their stable female 
partners and those involved in sex work) accounted for 54% of new infections. 
 
Figure 11. Distribution of new infections by sexual or injecting behaviour in DR in 2010 showing uncertainty 
bounds 
Although the contribtion of MSM to the number of new infection in DR is lower than in 
Mexico and Peru, a very similar pattern is seen when comparing this to the contribution to 
the total population size, suggesting that in DR this population is also highly 
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disproportionately affected by the epidemic (see Figure 12). However the disparity between 
the two measures for all other groups is much more restricted, reflecting the more 
widespread nature of the epidemic in this country. 
 
Figure 12. Contribution of each behaviour group to the proportion of new infections as compared to their 
contribution to the total population size in DR, 2010 
For DR the model was further modified to include other groups that had emerged as 
particularly at risk in either the DHS or the BBS survey. Non-injecting drug users had a very 
high prevalence (8%) and women with no education were about 4 times more likely to be 
infected than women in the general population.  As these do not share an obvious source of 
transmission, NIDU were included by assuming that a fraction of both MSM and FSWs’ 
clients were NIDU and by adjusting the parameters accordingly. A simple inference was 
made for women with no education. An attempt was also made at estimating the potential 
contribution of transgender women to the epidemic with the limited data available. The 
results are shown in appendix. 
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4 Discussion 
4.1 Main findings 
The MoT model, which provides an estimate of the distribution of new infections in the next 
year, was applied in three countries of the Latin American and Caribbean region. The results 
suggest that despite signs of a feminisation of the epidemic in Mexico and Peru (decreasing 
male to female ratio in terms of HIV cases), the majority of infections still occur among MSM 
and their partners. These accounted for estimates of 65% and 62% in Mexico and Peru 
respectively when they represent less than 2.5% and 4% of the total adult population.  It is 
known from a very extensive body of information, that this population is very 
heterogeneous in terms of both behaviours and prevalence implying the need for more 
precise modelling to adequately address this issue and provide more reliable estimates of 
incidence. Epidemic spread among the heterosexual population was estimated to remain 
quite low although its contribution is more important in Peru than in Mexico. A considerable 
percentage of estimated new infections occurring among women are directly related to 
sexual contact with members of key populations. In Peru, these were evenly spread between 
groups making it harder to direct prevention efforts towards a particular section of the 
population. Partner notification services might prove particularly efficacious in this context. 
Sex work accounted for over 8% of estimated new infections in Peru and 5% in Mexico. As 
noted previously, although condom use is thought to be high among FSW and their clients, 
sex work results in secondary infections through sex between clients and their stable 
partners. In fact, in both countries the majority of infections attributable to sex work were 
estimated to occur among client partners. In Mexico, IDU is growing as a localised problem 
with approximately 9% of new infections occurring among this group despite having a 
relatively low prevalence (5%). Although opioid traffic from Mexico to the U.S. has been 
known for the last century, local consumption is a relatively recent phenomenon.  
The estimated distribution of incidence obtained for the Dominican Republic exhibits a 
different pattern. No group contributes to the majority of infections with MSM and the low 
risk group each accounting for 30% of new infections. However, it is important to highlight 
that while the low risk group represents 41% of the total population, MSM represent just 
over 2%. Commercial sex plays an important role in the epidemic. Even with the high rates of 
condom use considered in the model, it accounts for about 12% of new infections. This can 
be explained by the relatively high number of people involved and by the frequency of 
exposure among clients. Residents of Bateyes contribute to nearly 9% of new infections 
when they account for less than 4% of the total population, highlighting the importance of 
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considering populations specific to a country that are outside the classic list of key 
populations.  With the modified version of the model, it was estimated that over 11% of 
infections would occur among NIDU and over 6% among women with no education. The 
former is likely to be an over-estimate as over half of NIDU were assumed to have sex with 
men but reminds us about the overlap in risks among key populations. Lowering levels of 
drug use among MSM in DR might be efficient in decreasing transmission levels. 
Transwomen were also shown to be at high risk with a prevalence of 17%. These share a 
mode of transmission and it would be simple to integrate them in the model. However, data 
was insufficient to parameterise the model and so a simple inference was made estimating 
that 0.4% to 4.3% of all infections could arise in this population. Considering its potentially 
high contribution to incidence in comparison to its small size, efforts should be made to 
reach this population with prevention programmes.  
4.2 Data availability 
Regarding data availability, there was variation between countries but some major gaps 
emerged from the analysis. Information on partners of key populations (IDU, FSWs’ clients, 
MSM and individuals engaging in CHS) is missing in all countries. These are very hard to 
reach as many may be unaware of their own risk. Partner notification programmes could 
provide a means to identify and characterise them through short behavioural surveys. The 
limitation is that only partners of STI/HIV positive individuals would be reached through this 
path.  More importantly, this depends on individuals being willing to disclose their infection 
or even their suspicion of infection to their partner. Routine sexual health check-ups should 
be promoted through campaigns to normalise this practice and facilitate the process. In fact, 
this lack of data reflects one of the main problems hindering STI control among stable 
partners which is the disclosure over other partnerships, especially among married MSM. 
Estimates of the size of key populations rarely originate from rigorous studies designed for 
this purpose. This information is also of relevance for the design of prevention interventions 
and for the planning of health services provision in general so should be high in the list of 
priorities of national HIV programmes. Data on the number of sex acts or injections per 
partner was also largely unavailable. Considering the important uncertainty around the per 
act transmission probability of HIV, it might be more appropriate to use the per partnership 
probability in the model and circumvent this problem. In all countries data on clients of sex 
workers was scarce. A better understanding of this population, especially in DR would help 
preventing secondary transmission to other partners. Regarding each country, there was a 
lack of information on IDU, in Peru attributed to the low prevalence of this practice. It is 
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important to ensure that this is in fact the case. In Mexico, the information on MSM is not 
optimal considering their important contribution to the epidemic and more information on 
their STI prevalence and sexual practices is necessary.  
4.2.1 The Epi-Tool 
To ensure that countries have enough data and of acceptable quality to complete the model, 
a stage previous to the application of the MoT has recently been conceived by UNAIDS. This 
consists of a systematic and standardised review of the information available in the country 
for each of the model’s inputs and for each sub-population. This information is entered in a 
formatted worksheet named the “Epi-tool” which allows scoring the sources for each input. 
If the total score is below a certain threshold then the country’s data is considered 
insufficient to carry on the MoT.   Apart from serving as a filter to prevent unreliable results 
from being produced it also serves as a tool to highlight gaps in data availability and 
therefore to set priorities for data collection activities. Countries that do not have enough 
data to complete the model will carry out other activities suggested by UNAIDS that will help 
improving the understanding of their epidemic. The Epi-tool was tested on the MoT for 
Mexico as this was the only country that had not finalised its process when the tool was 
developed. 
The first stage of the Epi-tool analysis requires determining which subpopulations are 
relevant to the epidemic in the country and indicating whether there is data available for 
each of the inputs describing prevalence and risk behaviours characterising each population 
(see Figure 13). Once the table is filled in, the tool calculates a score rating the data 
availability. The score obtained for Mexico when tested was 64%.  
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Figure 13. Screenshot of the Epi-review checklist for Mexico.  
Note: Blue squares indicate that there is data available, yellow squares indicate there is no data available. 
 
Following this, detail on the sources available for each subpopulation has to be entered 
(Figure 14). The number of data sources, the year the study took place, the estimate, the 
confidence interval and the reference of each source have to be given for each of the inputs. 
Based on this, the user determines whether the quality of the data for each input is good, 
limited, poor. The woksheet for MSM is shown as an example. 
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Figure 14. Screenshot of the data sources for MSM for Mexico.
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The results of the data quality scoring are summarised in the Results worksheet shown in Figure 15 
below. 
 
Figure 15. Screenshot of the Epi-review results sheet for Mexico 
The data is considered to be sufficient to complete the MoT if the availability score is above 50% and 
the quality score for the subpopulations is generally above 1.  
In this case based on the Epi-tool, the availability score was above 50% and the quality score was 
above 1 for the low risk group, the casual heterosexual risk group and all the key populations but it 
was below 1 for all the partners of members of key populations. This would therefore be borderline 
acceptable to complete the MoT as 1/3 of the subpopulations have a quality score below 1. This 
contrasts with UNAIDS experts’ opinion at the time the Mexican data was evaluated for the MoT. In 
comparison to other countries data availability was much greater for Mexico and so it seemed 
evident that it could carry out the MoT. 
4.3 Limitations 
Aside from gaps in data availability, the model itself has its shortcomings and has been subject to 
substantial criticism in the past couple of years. The model structure does not take into account 
overlap in risk behaviours and thereby assumes assortative mixing between or within groups. 
Overlap in risk behaviours is an important facilitator of transmission as it can efficiently work as a 
bridge for the virus to pass from one population to another (for instance FSW who inject drugs can 
spread infection from other IDU to their clients). In particular, this can lead to over-estimations of 
the impact of prevention interventions among a specific group as other modes of exposure are 
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ignored [275]. In the same way, it does not incorporate heterogeneities in behaviour within risk 
groups. Using averages for entire groups can substantially affect the results, which is why many 
mathematical models of infectious disease transmission include heterogeneities in risk and define 
contact mixing patterns. IDU for instance might share injecting equipment only within a specific 
cluster while some FSWs clients might only visit a particular type of FSW. Similarly, the model 
ignores geographic heterogeneity (in prevalence and behaviours) which, as seen for Mexico and 
Peru, can be important. These issues can be addressed by disaggregating groups when data 
availability permits it and by applying the model to specific regions or cities if it is considered more 
appropriate. The model does not incorporate characteristics of the natural history of HIV infection 
such as differences in transmission probability during the course of infection or under anti-retroviral 
treatment. A revised version of the MoT has been developed to incorporate the impact of ART 
treatment. It assumes that prevalence remains constant during the period simulated which can be a 
problem if the epidemic is at a stage of rapid change but this is only a short term projection so it 
should not be an important source of error.  
The data used to estimate the inputs comes from a variety of sources that may vary in reliability but, 
more importantly, that are obtained from different studies, at different times and sometimes in 
different places and which are applied to a single population. This is because it is rare to have a large 
study that covers all the questions needed by the model. It is a problem with the MSM population 
because many studies have been carried out among very high risk groups [276]which are probably 
not representative of the whole population. However, because there were a variety of data available 
it was possible to recognise this issue and choose the most appropriate studies to attempt to 
mitigate this issue. Furthermore, the definition of the populations is not always consistent which 
also makes the choice of data sources difficult (as in the case of the CHS group). Variations in certain 
parameters (such as the size of each population as mentioned above) have an important effect on 
the outputs which can easily lead to different conclusions regarding the groups to be prioritised by 
prevention. The size of the low risk group is often calculated as the residual of the other groups, so 
under or over-estimations of the size of key populations will doubly affect the results. This carries 
important implications as the estimate of the contribution of the low risk group to new infections is 
a defining number in terms of the characterisation of the epidemic and the subsequent 
recommendations for prevention. Mishra and colleagues demonstrated this by applying the MoT 
model to the state of Belgaum in India using different data sources for the estimate of the number 
of FSWs. They obtained contrasting patterns of incidence distribution [277]. In fact, although some 
countries such as Kenya have compared the MoT outputs to data [230] the model has not been 
formally validated. This could be done by applying the MoT to data from the early 1990s and 
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comparing the distribution of infections to that of AIDS cases reported 10 years later, preferably in 
countries where access to ART started late and expanded slowly. Comparing the outputs to more 
recent data on HIV cases would be a better option since data to parameterise the model has become 
increasingly available with time, but HIV cases reflect transmission at different times. If however, the 
distribution of HIV cases by group has remained stable over time, it would be reasonable to do it. 
Both these potential validation methods carry the limitation of biases in the classification of cases, 
emerging from both the patients and practitioners.  
Another point made in Mishra et al. study is the risk of producing a misleading representation of the 
epidemic drivers through the MoT. This is especially relevant to countries with generalised 
epidemics where a high proportion of new infections will be ascribed to the low risk population 
when in fact, a substantial proportion of these might originate from earlier contact with members of 
key populations (the most common case being that of clients of sex workers who later on get 
married and pass on the infection to their partner). As the MoT provides a short term projection it 
does not take into account individual changes in behaviour over their life course and therefore can 
ignore the primary source of infection among individuals that are now in the low risk category [277]. 
In this case, inferring that most infections occur in the low risk group and directing prevention 
towards this group would not be effective in the long term as the epidemic would constantly be fed 
by the primary source of infection. Rather than a methodological issue, this has to do with the 
interpretation of results and highlights the need to combine methods to inform policy. 
The MoT is designed to produce a simple message which, in its brevity, can give a false impression of 
accuracy and validity and this is why it is especially important to be cautious when producing and 
presenting results obtained with this model. The uncertainty analysis provides a sense of how robust 
the results are and helps communicating the model limitations to decision makers.  However, this 
too carries important limitations. The model is fit by varying the size and prevalence among the low 
risk group and therefore does not provide a valid uncertainty range for this group. Parameters can 
only vary within 100% of their estimate; if this is a small number the maximum and minimum values 
will not differ much from the point estimate despite attributing it the highest uncertainty range. If 
this number is applied to a large population, the true uncertainty will be much larger than estimated 
through this method. Additionally, the method assumes there is no inherent bias in the data and so 
uncertainty will always be equal on each side of the point estimate. Some parameters such as 
condom use or the number of partners might be systematically biased as a result of social 
desirability for instance. It might also be appropriate to assign a larger weight to parameters that 
have a strong impact on the results such as the number of partners among MSM. A more thorough 
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analysis of the implications of these limitations in terms of policy guidance and proposed solutions 
to optimise the MoT are given in Case et al paper included in appendix. 
4.4 Conclusions 
In conclusion, clearly, the HIV epidemic is different in each country, but the application of the MoT 
to these three countries has underlined the need for individual analyses to be carried out if we are 
to design appropriate measures to control it. Similar epidemic patterns emerged in Mexico and Peru, 
with MSM contributing to the majority of new infections but the substantial contribution of IDU to 
the number of new infections in Mexico deserves particular attention. MSM were found to 
contribute to a large share of new infections in Dominican Republic, comparable to that of the low 
risk group. This prompts us to suggest that the term “mixed” might be more appropriate than 
“generalised” to describe this epidemic and that the prevention efforts should be allocated 
accordingly. In each of these countries, directing prevention efforts towards MSM is likely to have a 
significant impact on incidence. Conversely, only a small proportion of the resources available for 
HIV/AIDS have been allocated to prevention among this population while PMTCT services have 
received larger budgets [3]. This work can be useful for advocacy purposes while keeping in mind the 
limitations of the model. For instance, the Dominican Republic recently incorporated the results 
from the MoT to their proposal for the next round of funding from the Global Fund.  At this stage it 
is sensible to trust the magnitude of the results obtained from the MoT, rather than the actual 
numbers. In fact, the strength of the MoT lies on the process which forces a thorough scrutiny of the 
available data in the view of producing results. It is only by taking on the task that gaps and issues 
become apparent and so this is a very useful exercise. The inclusion of the Epi-tool as a preliminary 
step to completing the model will help strengthening this process and allow a better judgment of the 
reliability of results. Triangulation between data sources and methods is a good alternative to 
validate models results and should be carried out whenever possible [223]. Finally, using more 
specified models that address some of these limitations is necessary to produce sounder results and 
therefore stronger advice for policy. This is undertaken in the next chapter where we model the HIV 
epidemic among MSM in Lima, Peru to estimate the potential effect of a prevention intervention 
and guide its design to improve effectiveness.  
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Chapter 3: Estimating the potential impact of pre-
exposure prophylaxis for HIV prevention among men 
who have sex with men in Lima, Peru  
1 Contributions 
In addition to my supervisors, I am indebted to Gabriela Gómez (Amsterdam Institute for Global 
Health and Development) for the close collaboration that allowed developing the paper forming the 
basis of the chapter. This has been accepted for publication and is included in appendix. Together, 
we formulated the study’s question, produced, interpreted and presented the findings. In particular, 
she is responsible for setting up the grounds of the cost-effectiveness analysis and I developed the 
mathematical model on which this analysis is based. I am also grateful to Carlos Cáceres and Eddy 
Segura (Instituto de Salud, Sexualidad y Desarrollo, Universidad Cayetano Heredia in Lima) for their 
insightful advice regarding the representation of the MSM and Trans population in Lima as well as 
for sharing unpublished data from on-going cohorts. For his help in translating the outcomes of the 
IPrEX trial to modelling purposes and for sharing information from the trial, I am grateful to Robert 
Grant (Gladstone Institutes, University of California at San Francisco).  
2 Introduction 
As described in Chapter 1, the MSM population in Latin America has been severely affected by the 
HIV epidemic. Prevalence has remained stable at very high levels over the past two decades in this 
population and this is not only the reflection of a high incidence at the start of the epidemic but of a 
continuing flow of new infections. The application of the Modes of Transmission model to three 
distinct epidemics in the region (Peru, Mexico and Dominican Republic) presented in the previous 
chapter suggests that the MSM group contributes to a high proportion of new infections 
independently of how established the epidemic is in the general population. Indeed, preventing 
infections among MSM would have a strong impact on these epidemics despite the small size of this 
population. For prevention efforts to be successful, effective interventions tailored to this 
populations’ reality and successful outreach programmes would be needed. As described in Chapter 
1, the type of messages conveyed by existing prevention campaigns often follow the same script as 
the general population campaigns promoting monogamy and care of the partner; failing to address 
the needs particular to the MSM population [61]. This is well illustrated by Barreda et al (2010) in 
their qualitative study of sexuality of MSM in Buenos Aires [278]. Men describe their sexual 
encounters as punctual and furtive, the relationship with the partner initiating and finishing with this 
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sexual encounter. Although there is heterogeneity in MSM sexual behaviours, this is a reality 
common to many MSM across the world and prevention needs to be tailored to it [279,280,281]. 
With regards to the drivers of the epidemic among MSM at the population level, several have been 
identified, among them are: high transmission probability during anal sex, high number of sexual 
partners, unprotected receptive anal sex, and illegal substance use [282,283]. The findings mainly 
come from U.S. studies but these factors have also been recognised as important determinants of 
infection in other MSM populations around the world, including Latin America [281]. Behavioural 
interventions aimed at reducing the number of partners have been shown to have a small impact 
[284]. Condom use among MSM is quite high in some settings, especially where the MSM 
community has been actively involved in prevention and has ensured the availability of condoms and 
promoted their use. However, consistent condom use is still far from 100% and alcohol and drug 
use, among other issues, hampers its uptake further. A study carried out by Celum et al, investigated 
the sexual history of recently infected MSM in the three months previous to their first positive HIV 
test [285]. The majority of MSM in the study had reported at least one unprotected anal intercourse 
in each week previous to the 1st positive test (see Figure 1).   
 
Figure 1. Unprotected anal sex episodes with men of unknown or positive status among 70 HIV positive MSM 3 months 
prior to their 1st positive test.  
Note: Source: Celum et al(2001). Each row represents a recently infected MSM, each column represents a week covering 
the 3 months prior to the first positive test. Each black circle designs at least one episode of unprotected anal sex with a 
partner of unknown or negative HIV status during the week.  
 
As illustrated, risk of exposure seems to be frequent and maintaining consistent condom use across 
all potentially risky encounters is a challenge. Interventions independent of behavioural decisions, 
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such as pre-esposure prophylaxis (PrEP), could complement the use of condoms and other 
behavioural strategies and therefore optimise prevention programmes.  
PrEP, defined as the use of antiretroviral drugs by HIV uninfected people to prevent acquisition of 
infection, is one of the bio-medical alternatives being considered as a potential tool in HIV 
prevention [286]. In 2010, the results of the first phase III clinical trial of PrEP were published: Pre-
Exposure Prophylaxis Initiative (iPrEX) was a multinational trial of daily oral tenofovir/emtricitabine 
(TDF/FTC, brand name Truvada) to prevent acquisition of HIV among high risk men who have sex 
with men (MSM)[287]. It showed that this regime was safe and reduced the risk of HIV acquisition by 
44% [287]. This was the first randomised control trial to demonstrate the effectiveness of an HIV 
prevention intervention among MSM and the first large scale HIV prevention trial to recruit the 
majority of its participants in Latin America. Of the 2,499 participants, 82% were recruited in Latin 
American urban sites, (Peru, 55%; Brazil,15%; Ecuador,12%). Other participating sites were located 
in the U.S. (9%), Thailand (5%) and South Africa (4%) [287]. Thus, the results of this trial can be 
considered representative of the region and be used subsequently to inform ancillary analyses such 
as the one presented in this chapter. PrEP trials among heterosexual populations have produced 
mixed results. Both the Partners PrEP and CDC TDF2 studies found PrEP to be effective. Partners 
PrEP enrolled serodiscordant couples in Kenya and Uganda and found an effectiveness of  62% and 
73%  in the TDF only arm and in the FTC/TDF arm respectively when compared to the placebo 
arm[288]. A similar result of 62.6% effectiveness of oral TDF/FTC was found in the TDF2 trial among 
uninfected heterosexual male and female participants in Botswana. However, FEM-PrEP, a trial 
recruiting heterosexual women in South Africa, Tanzania and Kenya was closed prematurely  when 
the data review committee stated that it would not be able to demonstrate an effect of PrEP among 
these women[289]. Additionally, two trials have tested the efficacy of 1% tenofovir gel in preventing 
HIV acquisition among women: the CAPRISA 004 found a reduction in risk of 38%[290]; while the 
VOICE trial’s gel arm was stopped after this being found to be safe but not effective[291].  
Nevertheless, the Center for Disease Control and Prevention (USA), the British Association For Sexual 
Health and HIV (UK) and the South African HIV Clinicians society have published interim guidance on 
PrEP [292,293,294], recommending its use as part of a programme of comprehensive HIV prevention 
for MSM and more recently the WHO published guidelines on PrEP use in the context of 
demonstration projects among MSM, transgender women and sero-discordant heterosexual couples 
[295]. Additionally, consultations are taking place to inform public health policy makers in the 
development of service guidelines regarding PrEP programme implementation. In May 2012 the FDA 
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approved Truvada for its use in HIV prevention, further increasing the need for guidance on PrEP use 
[296]. 
One of the main questions central to the potential scale up of PrEP is whether it would be a cost 
effective intervention at the population level within the current context of prevention and 
expanding access to treatment. Although trials can demonstrate effectiveness in reducing an 
individual’s chance of acquiring HIV, they do not show the extent to which a PrEP intervention would 
reduce the spread of HIV at the population level. Questions remain about how to optimally 
implement PrEP when multiple forms of delivery, prioritisation, and scale-up are possible in context 
of other HIV prevention interventions. Another major issue in considering the impact of PrEP 
interventions is whether individuals using PrEP will reduce how often they use condoms. Social 
research studies investigating the potential decline in condom use due to the perception of 
protection through PrEP suggest this is a likely consequence: in focus groups carried out among HIV 
negative Australian MSM, “relaxing the condom rule” and “forgetting all about condoms” were 
mentioned when addressing this issue [297]. This was confirmed in a survey among 180 HIV negative 
MSM in New York City  where over 35% of those willing to use PrEP reported they would decrease 
condom use if the pill was at least 80% effective [298]. Rather than occurring homogeneously across 
PrEP users, changes in condom use might vary depending on individual characteristics. As explained 
by Golub et al (2010) in their work synthesising the role of other disciplines in improving the 
understanding and implementation of PrEP, risky or preventive behaviours can be associated with a 
specific identity, such as being a “barebacker” or being an HIV activist respectively [299]. Some 
individuals might consistently use and combine several preventive measures because they are 
affiliated to the HIV cause or have a very controlling personality, while others might accumulate risk 
behaviours because of low risk perception or because they do not attach a high value to their life as 
a result of depression for instance [299]. 
 In response, we have built a mathematical model of the HIV epidemic among MSM in Lima, Peru to 
investigate the potential population impact of PrEP in this setting. As described previously, the HIV 
epidemic in Lima, Peru is concentrated among MSM, comparable to most of Latin America and 
multiple high-income countries[300]. As such, it provides a ‘test case’ for which there are high 
quality behavioural and epidemiological data to adequately specify a mathematical model. 
Moreover, the majority of iPrEX participants were recruited in Peru, allowing us to include 
representative information on potential PrEP use. Our analysis aims to provide information to assist 
the process of translating recent trials results into cost-effective programmes. 
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2 Methods 
The potential benefits and costs of a hypothetical PrEP intervention are presented using a 
deterministic, compartmental model to represent the sexual transmission of HIV amongst MSM and 
transgender women in Lima, Peru. The aim was to investigate the impact of a feasible intervention 
taking into account the current levels of prevention and ART treatment and to determine the most 
efficient strategies for its roll out in this population. It was particularly important to explore the 
impact of coverage, adherence and prioritisation on both health benefits and costs to the health 
system.  
 
2.1 Model definitions 
2.1.1 Sexual behaviour 
The MSM population in this model was defined as men and transgender women that have reported 
a sexual partnership with a man in the last 12 months. Characterising sexual behaviour among MSM 
in a diverse population such as the one of Lima is a complex task. As described in Chapter 1, 
behaviours and preferences of the subgroups are not always clear cut but follow a gradient with 
great variation within the population. The main determinants of HIV transmission risk among MSM 
and transgender women to be considered in a model are: sex distribution of sexual partners 
(majority of men or women), type of partners within each sex (stable, casual, commercial) and 
frequency of sex, condom use and sexual positioning with each partner type. Sexual positioning is a 
determinant of risk at the individual level as insertive and receptive anal sex imply different 
transmission probabilities but it will also have an impact on transmission at the population level. 
Versatility in particular can be an efficient means of STI transmission as it conveys both a greater risk 
of acquiring infection and a high probability of transmitting it [73]. For HIV this can be especially 
important during the acute phase of infection as the efficient period of transmission is concentrated 
over a short period [11]. Based on these considerations and balancing information on behaviour and 
identity to capture the most relevant determinants of transmission in a way that would be 
meaningful to programmatic activities, four interacting groups of individuals were defined: men who 
mostly have sex with women (MMSW), men who mostly have sex with men (MMSM), sex workers, 
and transgender women (including transsexuals and transvestites) at higher risk.  These definitions 
broadly followed the classification commonly used in research studies in Peru[300]. Sex work was 
defined as the exchange of anal sex for money, drugs, gifts, or favours. The terms “bisexual”, “gay” 
or “homosexual” were avoided in the definitions of the groups as these can be attributed to a 
variety of sexual behaviours. Frequency and type of sex with other men was considered more 
relevant to this analysis, especially since women are not included in the model. Indeed, HIV 
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prevalence in Lima among the general population is low, and therefore the risk of transmission to 
MSM and transgender women from other sources was not included.  
The groups were further subdivided into mutually exclusive compartments according to their sexual 
positioning in anal sex (insertive, receptive, or versatile) resulting in a total of nine groups (Figure 2). 
Men who mostly have sex with women (MMSW) may sporadically form commercial or casual 
partnerships with other men; sexual roles for MMSW were restricted to insertive and versatile 
(which includes both insertive and receptive anal sex acts) as the exclusively receptive role is rarely 
reported among men who identify themselves as heterosexual. Men who mostly have sex with men 
represent men who generally self-identify as gay or homosexual. They might be in a stable 
partnership with another man, and occasionally form commercial partnerships with other men. They 
can be insertives, receptives or versatiles. Sex workers may have sex with men and women but their 
main source of risk is to report compensated sex with other men. They form commercial 
partnerships mainly with MMSW and MMSM, and occasionally with trans. Sex workers can be 
insertives, receptives or versatiles. Transgender women at higher risk represent a high risk sub-group 
of the transgender women population. They self-identify as “trans”, have a large number of partners 
in average, higher prevalence, and a high proportion reports compensated sex. This sub-group was 
assumed to always play the receptive role during anal sex, as this is the role reported by the large 
majority of trans [70]. Sero-adaptive behaviours including serosorting (which refers to having 
unprotected sex only with partners who are believed to have the same HIV serostatus) and strategic 
positioning (which involves choosing sexual role in function of sero-status or perceived risk) were 
not considered in the model as, to our knowledge, there is very little information available on the 
extent to which these practices are used in Peru. However, due to the low prevalence of testing 
among MSM, it could be expected that these strategies are also uncommon.  
Studies describing the proportion of MSM reporting sex with a woman in the last year and/or the 
proportion of MSM self-identified as heterosexuals or bisexuals (for MMSW), as homosexuals/gay 
(for MMSM), and as transgender, transvestite or transsexual were reviewed to estimate the 
distribution of MSM into the different risk groups. The proportion of sex workers is the difference 
between the total and all the proportions of MMSW, MMSM, and transgender people. This estimate 
was then compared against reported proportions of MSM being involved in commercial sex during 
the last year [88,92,98,107,108,276]. Frequency of partnership formation was based on reported 
number of sexual partners from published studies and unpublished data from ongoing cohorts of 
transgender women (Trans-Amfar study)[70,301]    and MSM (CPOS study)[302]. Stable, casual and 
commercial partnerships were defined by frequencies of sex acts. For the versatile group, the total 
  
117 Chapter 3: Estimating the potential population level impact of PrEP among MSM in Lima 
number of sex acts was divided into a proportion of insertive or receptive acts. Condom use was 
estimated from reported condom use data at last sex act for different partnership types. If data 
were available for both the insertive and receptive partners, the probability of using a condom was 
determined by the receptive partner. Receptive partners have a higher probability of infection than 
insertive partners and condom use will have a higher impact on the receptive partner.  
 
Figure 2. Model representation of sexual mixing and sexual positioning among MSM and transgender women.   
MMSW: men that mostly have sex with women; MMSM: men that mostly have sex with men. Insertive and receptive men 
always take the insertive and receptive role during anal sex respectively. Versatile men take either the insertive or the 
receptive role during anal sex. Arrows indicate sexual partnerships being formed between individuals within groups – the 
width shows the number of partnerships and the direction illustrates sexual positioning (from insertive towards receptive). 
For each category: insertives will only form partnerships with receptives and versatiles (the latter in a receptive role), 
versatiles will form partnerships with insertives and both other versatiles and receptives depending on their role per sex 
act; receptives will only form partnerships with insertives or versatiles (the latter in an insertive role).  
 
2.1.2 Natural history of infection 
Following previous work, the natural course of HIV infection was represented as four phases of 
disease progression defined by duration and infectiousness (Figure 3). When an individual gets 
infected, he enters a phase of acute infection (short duration, high infectiousness) and progresses to 
a latent phase (long duration, low infectiousness), before entering a pre-AIDS phase (short duration, 
high infectiousness). The disease finally progresses to an AIDS phase (short duration, no 
infectiousness due to an interruption of sexual activity), followed by death [11,303,304,305]. A 
proportion of infected individuals receive antiretroviral treatment (ART) when their CD4 count is 
under 200 cells /mm3, and are assumed to stay on treatment for 12 years before they enter the pre-
AIDS stage. ART reduces infectiousness and extends survival [306]. Late entry to treatment was 
assumed on the bases that Peru has not yet changed its guidelines to CD4<350 as recommended by 
the WHO and on data from HIV patients showing high heterogeneity in CD4 count at start with a 
mean count of 79 (IQR 32, 164) [307]. The relatively short survival on ART was based on the default 
value for survival used in spectrum for low and middle income countries which corresponds to 9.5 
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years. We used a higher value than recommended by UNAIDS because survival in Latin American 
countries appeared higher [308] but kept it relatively low because full adherence to treatment and 
zero drop out were assumed in the model. ART has only been available for free in Peru since 2004 
[309] and there is therefore little country-specific information on survival on ART. To our knowledge 
three studies have reported survival estimates. Corey et al. found high annual survival rates (on the 
order of 98%) which would result in life expectancy estimates of 55 years [310]. In the study by 
Muñoz et al. which looked at the effectiveness of an intervention to increase adherence to 
treatment in resource poor settings, life expectancy was much lower at 6.6 years for the control arm 
and 19.5 years for the intervention arm [311]. Bern et al. also found very low survival rates (6.6 
years) but their study was not designed to study survival on ART [312]. As there is important 
heterogeneity in results and some point towards very low survival rates, using standard assumptions 
that are conservative about life expectancy on ART seemed to be the most reasonable option. 
 
 
Figure 3. Progression of HIV infection  
 
The introduction of ART in the model was simulated through a small coverage starting in 2002 and a 
linear increase up to a 2007 coverage level of 48%[313]. It then continues to increase and stabilises 
at 80% coverage, based on data from the UNAIDS epidemiological fact sheet until 2007 and from the 
UNGASS Country Progress reports thereafter. Figure 4 shows the estimated ART coverage in Peru 
from 2004. 
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Figure 4. ART coverage in Peru.  
Coverage estimates were obtained from the UNAIDS Epidemiological fact sheet up to 2007 and from the UNGASS Country 
progress reports thereafter. A trend line suggests it approximates a linear increase. 
 
2.2 Model specifications 
2.2.1 Initial conditions and natural history of infection 
The model is defined by a set of ordinary differential equations to simulate how HIV spreads over 
time in this population. They are shown below. The state variables are given by )(, tX
s
ak  and )(, tXP
s
ak  
corresponding to people who are not on PrEP and to people either on PrEP (while susceptible) or 
who have been on PrEP (if infected), respectively. t is the time elapsed in the simulation; s is the 
infection-status (1= susceptible; 2= acute infection; 3= latent infection; 4= pre-AIDS; 5= AIDS;  6= 
ART), k is ‘sexual behaviour’ (1= Insertive MMSW; 2=Versatile MMSW; 3=Insertive MMSM; 
4=Versatile MMSM; 5=Receptive MMSM; 6=Insertive sex worker; 7=Versatile sex worker; 
8=Receptive sex worker; 9= receptive transgender women at a higher risk), a is the PrEP adherence 
group (1=good; 2=average; 3=poor).  
Men initially enter the model as susceptible and spend an average time period in each group. 
MMSM and MMSW have a slower turnover than transgender at higher risk and sex workers to 
reflect the transitional aspect of sex work. Once individuals exit the model, they are replaced and 
new individuals are allocated to each group according to the initial population distribution by group. 
The population grows at an average rate of 2%, representative of the population growth reported in 
Peru [252].  
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, (1)          G     
 G corresponds to the growth of the population and is modelled through replacing all background 
deaths, with μ being the natural death rate, and adding a growth rate α. This is applied to the entire 
population independently of infectious stage, sexual behaviour and PrEP status.   
  (2)          5,55 
a
k
akk XPX  
A corresponds to the AIDS deaths that need to be replaced to obtain the desired population growth. 
σ5 is the progression rate from AIDS to death and so it is applied to all those in the AIDS stage 
indenpendently of sexual behaviour or PrEP status (having been on PrEP is not assumed to 
accelerate or slower AIDS progression). 
  (3)          ,  






k
s
a
s
ak
s
kk XPX  
T corresponds to those exiting the population through a turnover rate τ and that need to be replaced 
to obtain the desired population growth. The turnover rate is independent from infectious stage of 
PrEP status but specific to each sexual behaviour group k and so the number exciting from each 
sexual behaviour group is calculated separately and then added up.  
All the new entries are distributed into the sexual behaviour and PrEP adherence groups according 
to the initial population distribution defined by ϒk,a as shown in equation 4 below. Individuals get 
infected at a rate λk, namely the force of infection, which is dependent on the sexual behaviour (k). 
Infected individuals progress to the next infection stage at a rate σs as shown in equations 5 to 9. 
After the pre-AIDS stage a certain proportion of infected individuals receive ART depending on 
coverage at time t (  t ) while the others progress to AIDS as shown in equations 8 and 9. 
  
121 Chapter 3: Estimating the potential population level impact of PrEP among MSM in Lima 
 
 
 
 
    
    (9)          
)(
(8)          1
)(
(7)          
)(
(6)          
)(
(5)          
)(
(4)          )(
)(
6
6
4
4
6
5
5
6
6
4
4
5
4
4
3
3
4
3
3
2
2
3
2
2
1
2
11
,
1
kkk
k
kkkk
k
kkk
k
kkk
k
kkkk
k
kkkkak
k
XXt
dt
tdX
XXXt
dt
tdX
XX
dt
tdX
XX
dt
tdX
XX
dt
tdX
XXG
dt
tdX












 Susceptible individuals who are not on PrEP continuously move to the “susceptible on PrEP” 
compartment ( )(
1
, tXP ak ) so that the PrEP coverage at that time point  tk  is maintained. For this, a 
number of individuals in 1kX  is transferred to 
1
,akXP  calculated by multiplying the total number of 
susceptible individuals in each sexual behaviour k by the PrEP coverage  tk  to obtain the number 
who should be on PrEP at that time point and subtracting those already on PrEP as shown in 
equation 10.   They are distributed into each adherence group according to a  as shown in equation 
11.
  
 
  (11)          )(
(10)          )(
PrEP  toFlow
1
,
1
,
1
k
1
,
1
,
1
,
1
,
1
k
11










a
ak
a
akkaakak
a
ak
a
akkkk
XPXPXtXPXP
XPXPXtXX


 
On PrEP, individuals become infected at a rate λk,a which is dependent on the sexual behaviour group 
k but also on the PrEP adherence group a as shown in equation 12. Once infected, they progress 
through the different infection stages in exactly the same way as those who have never been on 
PrEP and have the same probability of receiving ART treatment, as shown in equations 13 to 17. 
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At the start of the simulation, 0N is the size of the MSM and transwomen population and Ω is the 
HIV prevalence in all parts of the population. HIV positive individuals are assumed to be in the 
chronic stage of infection. The population is therefore distributed between the susceptible and the 
chronic stage of infection and by sexual behaviour group and PrEP adherence group according to ϒk,a, 
as shown in equations 18 and 19. 
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2.2.2 Force of infection 
The force of infection determines the rate of progression from susceptible to infected. The force of 
infection through sexual contact depends on: the number of insertive and receptive partnerships 
iC and rC , respectively; the pattern of sexual partnership formation with respect to sexual 
behaviour (i.e. the proportion of partnerships formed with each of the sexual behaviour groups for 
insertive and receptive partnerships (
i
kk ',  and
r
kk ',  respectively) and the probability of acquiring 
infection within each of these partnerships which in turn depends on the number of sex acts 
occurring (
',kk ) and the probability of transmission within those sex acts. The latter varies 
according to the infection-status and stage of infection of the partner; the type of sex practiced 
(insertive or receptive), the fraction of sex acts in which a condom is used ( ',kk ); and the efficacy of 
condoms in reducing the risk of HIV transmission ( ). is and 
r
s  are the probabilities of HIV 
transmission per sex act for each stage of infection for insertive and receptive anal sex respectively. 
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As the probability of transmission varies by stage of infection, the prevalence of HIV among each 
partner of sexual behaviour group k’ defined as skH '  is calculated for each infectious stage s as 
shown in equation 20 and multiplied by the corresponding risk of acquiring infection defined as isR  
and rsR ,  when taking the insertive and the receptive role respectively. As shown in equations 21 
and 22, this is equal to 1 minus the probability of NOT getting infected in ωk,k’ sex acts of which φk,k’ 
are protected by using a condom and therefore have a lower transmission probability, determined 
by ψ.  
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For individuals using PrEP, the risk of acquiring infection will also depend on both their adherence to 
the PrEP regimen, which determines the proportion of sex acts protected by PrEP ( a ), and on the 
efficacy of PrEP ( ). This is defined by R* in equations 23 and 24. 
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The resulting force of infection off PrEP (λk) and on PrEP (λk,a) are given in equations 25 and 26 
respectively. 
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The rate of sex acts in a partnership is set at three levels: (i) rate of sex acts in commercial 
partnerships, (ii) rate of sex acts in occasional partnerships, and (iii) rate of sex acts in stable 
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partnerships. Table illustrates the contact network and type of partnerships between groups. 
Condom use was modelled to increase linearly from 1995 until 2005, and to remain constant at the 
rate reported thereafter. 
   
MMSW MMSM Sex workers Transgender 
 
Sexual Role 
 
insertive versatile insertive versatile receptive insertive versatile receptive receptive 
  
k index 1 2 3 4 5 6 7 8 9 
MMSW 
insertive 1 
         
versatile 2 
         
MMSM 
insertive 3 
         
versatile 4 
         
receptive 5 
         
Sex workers 
insertive 6 
         
versatile 7 
         
receptive 8 
         
Transgender receptive 9 
         
Table 1.   Contact patterns and type of partnerships formed between groups.  
Note: Light pink, darker pink and very dark pink corresponds to stable, occasional and commercial partnerships 
respectively; blank corresponds to no contact. 
2.2.3 Mixing matrix 
The mixing matrix designs the proportion of partnerships that are formed with individuals from each 
of the groups. The first step is to determine who has sex with whom. Since the groups are divided in 
insertive, receptive and versatile roles, there are certain combinations that cannot occur, for 
instance, two insertive individuals cannot form a partnership as illustrated in Table 1. To balance the 
number of insertive and receptive partnerships, first a mixing matrix Ak,k’ was defined for the 
insertive individuals, reflecting their preference for certain types of partners -this assumes that the 
amount of sex the “providers” have is totally dependent of the demand. 
',kkA is the expected 
proportion of partnerships that insertive individuals in group k will have with receptive individuals in 
group k’. Secondly, a random mixing matrix Bk,k’ was defined where insertive individuals chose their 
partner according to the proportion of sex acts offered by each of the receptive groups -this mixing 
based on sexual role is dependent on availability and is defined in equation 27. 
',kkB is the 
proportion of receptive partnerships given by receptive individuals in group k’ out of the total 
number of partnerships 
rC  given by all receptive individuals in all groups   
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The extent to which the mixing was closer to satisfy the preferences of insertive individuals was 
determined by a parameter  varying from one (totally assortative mixing) to zero (totally random 
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mixing) as shown in equation 28.  ',
i
kk defines the proportion of total partnerships in sexual 
behaviour group k that are formed with group k’ for insertive partnerships. 
(28)           )1( ',',', kkkk
i
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The total number of partners among the receptive groups 'rkC  was then recalculated to respond to 
the demand as shown in equation 29 and the mixing matrix for receptive individuals was updated as 
shown in equation 30.  
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2.2.4 Identifying the most likely epidemiological scenario 
Three sources of information were used to calibrate the model: reported behaviour, HIV natural 
history, and data on prevalence and incidence for MSM and transgender sub-populations in Lima 
from the Peruvian Ministry of Health and published studies. These sources and values are detailed in 
Tables 2 to 5. We used a frequentist approach to combine these sources of information and account 
for uncertainty around parameter estimates [314,315]. This procedure consists in allowing certain 
parameters to vary within a specified prior distribution reflecting its uncertainty. The parameters 
allowed to vary were those describing sexual behaviour as well as some describing the natural 
history of infection and are presented in Table 2 and Table 3. Behavioural parameters are specific to 
each setting and are most vulnerable to biases in the sampling method and to reporting bias.   
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Parameter 
Prior Value       
Mode [min-max] 
Reference 
Proportion of all MSM: MMSW 0·2 [0·08-0·3] [64,92,98,100,276] 
Proportion of all MSM: sex worker 0·15 [0·1-0·25] [88,92,98,107,108,276] 
Proportion of all MSM: Transgender 0·05 [0·043-0·1] [98] 
Mean duration: MMSW 20-30 Assumption 
Mean duration: MMSM  25-35 Assumption 
Mean duration: sex worker 2-10 Assumption 
Mean duration: Transgender 10-20 Assumption 
N sex acts per commercial partnership 1-2 Assumption 
N sex acts per stable partnership  40-80 [316] 
N sex acts per casual partnership 3-15 [113] 
Condom change 1.5-2 [92,98,301,302] 
Epsi (mixing matrix) 0.6[0.4-0.99] Assumption 
Sexual behaviour: MMSW   
 
Pr of all MMSW: insertive  0·85 [0·8-0·9] [267] 
N partnerships/year: MMSW insertive  2[1-4] [302,317] 
Pr of protected sex acts: MMSW insertive  0·3-0·35 [113,267,317] 
N partnerships/year: MMSW versatile 3·5 [1.5-4] [113,267,302,317] 
Pr of protected sex acts: MMSW versatile 0·3-0·45 [113,317] 
Sexual behaviour: MMSM     
Pr of all MMSM: insertive  0·25 [0·2-0·3] [100,108] 
N partnerships/year: MMSM insertive  1·2 [1-3] [73,302] 
Pr of protected sex acts: MMSM insertive  0·2-0·35 [317] 
Pr of all MMSM: receptive 0·325 [0·3-0·35] [100,108] 
N partnerships/year: MMSM receptive 3[1-4] [302,317] 
Pr of protected sex acts: MMSM receptive 0·3-0·45 [317] 
N partnerships/year: MMSM versatile 3.5 [1.5-4] [302,317] 
Pr of protected sex acts: MMSM versatile 0·25-0·4 [317] 
Sexual behaviour: sex worker     
Pr of all sex worker: insertive  0·2 [0·15-0·25] [73] 
N partnerships/year: sex worker insertive  30 [10-35] [73] 
Pr of protected sex acts: sex worker insertive  0·05-0·2 [73] 
Pr of all sex worker: receptive 0·4 [0·35-0·5] [73] 
N partnerships/year: sex worker receptive 30 [10-50] [73] 
Pr of protected sex acts: sex worker receptive 0·2-0·3 [73] 
N partnerships/year: sex worker versatile 50 [30-60] [73] 
Pr of protected sex acts: sex worker versatile 0·1-0·25 [73] 
Sexual behaviour: transgender     
N partnerships/year: transgender 80 [50-150] [113,302] 
Pr of protected sex acts: transgender 0·35-0·45 [317] 
Table 2. Distribution of risk in the population and risk behaviours  
Note: N: number; Pr: proportion; min: minimum; max: maximum; ref: reference. 
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Parameters that define the natural history of HIV (Table 3) were estimated from the general 
scientific literature and generalised across all settings. For reasons of computational efficiency, the 
uncertainty in these parameter values is not reflected in the estimates of uncertainty, with the 
exception of 
43  which corresponds to the baseline HIV transmission probability during an 
insertive anal sex act in the latent phase of infection and of the year of start of the epidemic. 
 
Parameters Description Symbol 
Prior Value       mode 
[min-max] 
Reference  
Average transmission rate of HIV per 
sex act  
if latent HIV 
infection 
β
3-4
 0·0028[0·002-0·004] [43] 
Start of the epidemic Year   [1970-1982] [318] 
Relative transmission rate per 
insertive anal sex act  
    1 Def. 
Relative transmission rate per 
receptive anal sex act  
 (ref. insertive anal 
sex) 
ξ 5 [5,319] 
Relative infectiousness in acute 
phase infection  
(ref. latent 
infection) 
β
2
 27 [11] 
Relative infectiousness in latent 
phase infection  
  β
3-4
 1 Def.  
Relative infectiousness in pre-AIDS 
phase infection  
(ref. latent 
infection) 
 β
5
 7·2 [11] 
Relative infectiousness in AIDS phase 
infection  
(ref. latent 
infection) 
β
6
 0 [11] 
Relative infectiousness of virally-
suppressed individuals on ART  
(ref. latent 
infection) 
β
7-8
 0·08 [11,320] 
Mean duration of acute phase 
infection  
Months 1/σ2 3 [11,320] 
Mean duration of latent phase  Years 1/σ3 10 [11,320] 
Mean interval with elevated viral 
load, pre-AIDS  
Months 1/σ4 10 [11,320] 
Mean interval with AIDS before 
death  
Months 1/σ5 9 [11,320] 
Mean duration of late ART viral 
suppression 
Years 1/σ6 12 [320,321] 
Mean ART coverage of those in need 
(CD4<200)  
2007 ART_cov 0·48 [313,322] 
Efficacy of condoms   Ψ 0.8 [323,324] 
Table 3. Natural history of HIV infection 
 
Parameters that describe the basic demography of the population (Table 4) are based on census 
data. Published studies specific to Peru were used to estimate the proportion of the Peruvian male 
population that are MSM. These two studies were the PREVEN trial carried out from 2002 to 
2006[206] and from a systematic review investigating the prevalence and risk behaviours of MSM in 
low and middle income countries [64]. The estimate for prevalence of male to male sex in the past 
year was between 1 and 8% for the Latin American region, including the point estimate of 6% 
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obtained in the PREVEN trial. Based on the 2007 Census restricted to Lima, it was estimated that 
there were about 140,000 MSM in the capital at that time. Considering the population growth of 2%, 
the population of MSM at the start of the epidemic was estimated at 67,000. This was fixed for all 
runs. 
 
Parameters Description Value Reference  
Population 15 to 49y 2007 4,767,148 [252] 
Population 15 to 49y 1981 2,503,140 [325] 
First report of AIDS cases in Peru  1983 [318] 
Proportion of the population that are men in Lima, Peru 2007 0·489 [252] 
Proportion of male-to-male sex in general population  0·06 [64,206,326] 
Table 4. Basic demography of the population 
The sampling of parameter values was carried out using Latin Hypercube Sampling (LHS)[327], a 
statistical method first developed by Mc Kay et al (1979) and formalised by Iman and Conover which 
follows the basic concept of the Monte Carlo (MC) stochastic sampling method but provides an 
important advantage. Unlike MC sampling which randomly samples parameter values within its 
probability density function (PDF), LHS ensures that the parameter space is evenly explored, by 
dividing the PDF in small areas of equal probability and sampling from each of these areas once. As a 
result, for a smaller number of draws, the distribution of samples drawn is closer to the input 
probability distribution, the estimate of the mean is unbiased and the variance is smaller [328]. This 
also translates into faster computation times because fewer model simulations are needed [328]. 
This method was introduced in the field of infectious disease modelling by Blower and Dowlatabadi 
[327] to assess the uncertainty and sensitivity of an HIV transmission model and of R0 estimates of 
tuberculosis later on [329]. It has since then been used by others in the field such as de Silva et al 
[330], Kakehashi [331], Porco [332], Foss et al [333]. Each model run is therefore the result of a 
different combination of parameters values. The epidemic was simulated with 10,000 different 
parameter sets. A run was accepted if it fitted within prior limits corresponding to two prevalence 
values in each of the groups and within prior limits around the proportion of people in each sexual 
behaviour group. The two data points for prevalence were chosen giving preference to large sample 
size studies: one closest to the beginning of the epidemic and one closer to the present date 
(coloured in blue in Table 5). To produce lower and higher bounds, 0.2 was arbitrarily subtracted and 
added to these data points, respectively. If the lower bound produced a negative prevalence 
estimate, it was replaced by zero. The prior limits for the proportion in each sexual behaviour group 
are given in Table 6.  
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Population Year Sample size Prevalence Reference  
All MSM 1985 98 0·112 [334] 
All MSM 1988 124 0·065 [335] 
All MSM 1990 4300 0·262 [134] 
All MSM 1996 444 0·185 [92] 
All MSM 1997 1328 0·16 [336] 
All MSM 1998 4858 0·122 [337] 
All MSM 1998 1211 0·178 [92] 
All MSM 1998 469 0·182 [336] 
All MSM 2000 3200 0·165 [336] 
All MSM 2000 1357 0·197 [92] 
All MSM 2000 7041 0·139 [240] 
All MSM 2002 1358 0·223 [92] 
All MSM 2007 559 0·222 [108] 
All MSM 2008 225 0·093 [27] 
All MSM 2008 170 0·117 [27] 
All MSM 2008 390 0·21 [27] 
All MSM 2008 318 0·179 [302] 
MMSW 1996 129 0·139 [92,317] 
MMSW 1998 263 0·091 [92] 
MMSW 2000 533 0·084 [92] 
MMSW 2002 511 0·129 [92] 
MMSW 2002 165 0·025 [206] 
MMSW 2002 1124 0·073 [100] 
MMSW 2008 109 0·055 [27] 
MMSW 2008 21 0·29 [302] 
MMSM 1996 265 0·18 [92,317] 
MMSM 1998 796 0·181 [92] 
MMSM 2000 661 0·26 [92] 
MMSM 2002 562 0·262 [92] 
MMSM 2002 1760 0·195 [100] 
MMSM 2008 253 0·186 [302] 
Transgender 1996 48 0·333 [92,317] 
Transgender 1998 134 0·343 [92] 
Transgender 2000 96 0·448 [92] 
Transgender 2002 255 0·322 [92] 
Transgender 2008 208 0·178 [302] 
Transgender 2009 459 0·296 [301] 
Sex workers 2008 169 0·243 [27] 
Sex workers 2008 181 0·265 [27] 
Sex workers 2008 183 0·284 [27] 
Sex workers 2008 391 0·207 [302] 
Table 5. HIV Prevalence by group 
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Population 
Prior limit on 
proportion of 
total population 
Justification 
Trans <10% 
Double the consensus estimate and half the 
upper bound estimated presented by 
Caceres[98] 
Sex worker <15% & >Trans Experts' opinion and half the upper bound 
estimated presented by Caceres [98] 
MMSW >MSW Experts opinion 
Table 6. Prior limits for proportion of individuals in each sexual behaviour group 
 
Of 10,000 runs performed, 449 were selected. The most discriminative prior was the high prevalence 
observed among transgender people relatively early in the epidemic. The parameters for which the 
posterior distributions diverged the most from the prior distribution were the basic transmission 
probability (towards higher values) and the year at which the epidemic started (towards an earlier 
start) as well as the sex workers turnover (towards a slower turnover), the number of sex acts in a 
commercial partnership (towards higher values) and the number of sex acts in a stable partnership 
(towards lower values). In general, the selection process favoured parameter values that increased 
risk among sex workers and transgender people and decreased risk among MMSW. The best fitting 
set of parameters was determined using the log likelihood based on prevalence data for four sub-
groups and the overall population. Figure 5A shows the best fit as compared to all the selected runs 
and Figure 5B gives detail on the data sources for each of the prevalence estimates.  
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Figure 5. Best fit based on prevalence data for four sub-groups and the overall population as compared to (A) all model 
runs and (B) HIV prevalence data.  
Legend: Selected runs are represented in grey; the best fit is in red. The runs were selected based on bounds (black lines) 
defined from prevalence data (blue crosses) for four sub-groups and the overall population. 
 
A 
B 
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The best fit was then used for the primary analyses. To ensure it was representative of the most 
likely epidemiological scenario, the uncertainty due to the epidemiological assumptions was 
explored and the results obtained using the best fit was compared to those from all other runs 
selected. The distribution of infections averted obtained from all selected runs and the 50 best fits 
are presented in Figure 2 and table 1 of the appendix and compared to the estimates obtained from 
the best fit for the most relevant scenarios.   
 
2.2.5 Modelling pre-exposure prophylaxis  
PrEP effectiveness in the model is assumed to result from the combination of a reduction in 
susceptibility to HIV infection during a PrEP-protected sex act (“conditional efficacy” parameter) and 
a proportion of sex acts protected (adherence parameter). A daily regimen of PrEP is reflected in the 
model. In a retrospective analysis of data from the iPrEX trial, for those with detectable levels of 
drug in blood samples, HIV incidence was reduced by 92% [95%CI 40-99]. These findings show  an 
efficacy of PrEP that varies with individual-level adherence, in accordance to results presented this 
year  whereby biological determinants did not explain the differential efficacy observed in the iPrEX 
trial[338]. We refer to this parameter as a “conditional efficacy” in the model that reflects an 
assumption of high intrinsic efficacy of PrEP (equivalent to 92%) but large population-level 
heterogeneity in adherence behaviours. Therefore, we divided PrEP-users into three adherence 
groups using point estimates: good (95%), average (45%), and poor (15%). The proportion in each 
group was altered to reflect three adherence profiles: the “iPrEX adherence” profile, for which the 
proportions were as observed in the trial, the “less adherence”” scenario and the “more adherence” 
scenario. The “less adherence” scenario aimed to account for the potential decrease in adherence 
that could be observed outside the trial context, where users will be less closely monitored and 
counselling might not be as intense. Clinical trials provide incentives for cohort participation, 
including payments for visits, in contrast to “real world” programs which would not pay PrEP users 
for coming to the clinic, and could even require the PrEP user to pay part of the costs. The “more 
adherence” scenario considered the possibility of an increase in adherence associated with knowing 
that the drug works, a hypothesis being tested in the open label extension of the iPrEX trial. Pill use 
in clinical trials like iPrEX is undermined by use of placebo and repeated information that the pill may 
not be safe nor effective. This scenario also considers the possibility of integrating an adherence 
support component to the programme.  For all adherence scenarios, when both the “conditional 
efficacy” and adherence profiles are combined, the functional effectiveness calculated falls within 
the 95% CI of the effectiveness observed in the iPrEX trial, 44% [95%CI 15-63][287]. Table 7 shows 
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the assumptions made for “conditional efficacy” and adherence as well as the resulting functional 
effectiveness for each profile. 
 
Efficacy/adherence 1: iPrEX 2: low adherence 3: High adherence 
Conditional efficacy  0.92 [0.4-0.99] 0.92 [0.4-0.99] 0.92 [0.4-0.99] 
Adherence 1* 0.95 0.95 0.95 
Adherence 2* 0.40 0.40 0.40 
Adherence 3* 0.15 0.15 0.15 
Proportion in adherence group 1  0.50 0.30 0·60 
Proportion in adherence group 2 0.00 0.10 0·10 
Proportion in adherence group 3 0.50 0.60 0·30 
Functional effectiveness 0.52 0.35 0·62 
Table 7. Scenarios: Impact of PrEP by adherence and efficacy.  
* The iPrEX study reported a distribution of participants by ranges of adherence. We included a point estimate within those 
ranges. 
 
2.3 Set up of the PrEP intervention 
The aim was to investigate the impact of a feasible PrEP intervention and to explore the differential 
impact of the programmes’ characteristics (i.e. coverage, prioritisation, scale up). For this, we 
constructed two scenarios for overall scale-up of PrEP programmes: (i) “low coverage” and (ii) “high 
coverage”, whereby 5% and 20% of uninfected individuals use PrEP, respectively. In both scenarios, 
scale-up begins in 2012, coverage is reached in five years, and maintained thereafter for five extra 
years. We quantified the contribution of each sub-population to the number of future HIV infections 
and the relative impact of PrEP if used in each group separately to identify key groups for an 
intervention. We looked at the impact of distributing a fixed amount of PrEP (25,000 person-years, 
corresponding to the PrEP-equivalent of 10% resource allocation from the national prevention 
programme[322]) to each group in isolation. PrEP could then be distributed evenly to all MSM and 
transgender people (“uniform” coverage), or certain key groups could be prioritised for PrEP 
allocation (“prioritisation”). Prioritised scenarios could result in “some prioritisation”, where a higher 
coverage is achieved in key populations such as the transgender and sex workers groups (but no 
more than 50%) compared to MMSW and MMSM; and in a “high prioritisation” scenario, once 90% 
of transgender group receive PrEP, the residual amount (to achieve 5% or 20% overall coverage) is 
divided among the three other populations prioritising sex workers over MMSW and MMSM. Table 8 
shows the coverage assumptions of PrEP for each scenario. 
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(B) Coverage 1: low coverage (5%) 2: high coverage (20%) 
Uniform coverage overall  0.05 0.2 
 MMSW 0.05 0.2 
 MMSM  0.05 0.2 
 MSW  0.05 0.2 
 Trans 0.05 0.2 
Some prioritisation overall  0.05 0.2 
 MMSW 0 0.462 
 MMSM  0 0.085 
 MSW  0.26 0.5 
 Trans  0.5 0.5 
High prioritisation overall  0.05 0.2 
 MMSW  0 0.215 
 MMSM  0 0.039 
 MSW  0.11 0.9 
 Trans  0.9 0.9 
Table 8. Scenarios: Impact of PrEP by coverage and prioritisation.  
MMSW: men who mostly have sex with women; MMSM: men who mostly have sex with men; MSW: men sex workers; 
trans: transgender people at higher risk. 
2.4 Potential for resistance to ART treatment associated to PrEP 
An important concern regarding the scale up of PrEP is the potential for the development and 
spread of resistance as a result of taking an incomplete treatment while infected. PrEP use during 
the primary infection period and transmission of a resistant strain during PrEP use both have the 
potential to lead to resistance. Indeed, one participant in the iPrEX trial and one in the TDF2 trial 
developed resistance to ART agents following PrEP initiation during the acute phase of HIV. There 
was one case of possibly acquired resistance observed in the iPrEX trial. No resistant cases were 
reported in the CAPRISA 004 trial and analyses are ongoing in the Partners PrEP trial[339].  
Modelling studies have investigated this at a population level.  Abbas et al estimated that in a 
heterosexual HIV epidemic the main drivers of resistance would be the rate and duration of 
inadvertent PrEP use by individuals already infected with HIV[340]. Supervie et al[341] looked at the 
interactions between ongoing treatment programmes and potential PrEP  in resource-constrained 
countries. They concluded that PrEP might increase the need for second-line therapies in individuals 
naive to treatment, and the main driver of this need was the individual level of adherence to the 
PrEP programme. Supervie et al investigated this in the U.S. context and presented “the paradox of 
PrEP”, whereby resistance appears to be increasing relatively, but is actually decreasing in absolute 
numbers following PrEP introduction as a result of an overall reduction in the number of infections. 
However, the authors argued that in the event of an substantial increase of risk behaviour, PrEP 
could significantly increase transmitted resistance[342]. Paltiel et al looked at the influence of 
resistance on the cost-effectiveness of a potential PrEP programme among high risk MSM in the U.S. 
and found it to have no effect in the context of a potential PrEP programme [343].  
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We did not investigate the spread of resistance in this model as this would have required a different 
conception of its structure and it was outside the scope of this work. However, this was addressed in 
a simplified way by estimating the number of person years during which individuals would be 
receiving PrEP while infected as a result of either being mistakenly enrolled for PrEP (false negative 
test or being in the window period for detection) or of getting infected while on PrEP. This was 
calculated for the most relevant scenario corresponding to low coverage (5%) and high prioritisation 
of transgender people (where 90% of susceptible transgender people at higher risk and 11% of sex 
workers are given PrEP).  
The number of HIV positive individuals who are mistakenly classified as negative due to testing is a 
function of the total number of people presenting for PrEP, the HIV prevalence and the HIV test 
sensitivity. The number of infected individuals enrolled within the window period is a function of 
incidence in the last month and number of susceptible individuals. Participants are assumed to 
receive a second HIV test one month after enrolment, they will therefore spend at least one month 
on PrEP while infected. The probability that the test is negative for the second and subsequent tests 
is negligible and ignored in this exercise. 
The number of individuals who get infected while taking PrEP is a function of incidence among PrEP 
users and number on PrEP. Incidence on PrEP was estimated using the functional effectiveness of 
PrEP observed under the IPrEX adherence profile in the model (52%). The duration between HIV 
tests was assumed to be of three months as this is the recommended frequency of testing while on 
PrEP. The duration of PrEP use while infected was fixed at 1.5 months on average as individuals get 
infected at some point between two tests.  To consider other testing regimens, we repeated the 
calculation for testing periods of every six months, meaning that individuals who get infected while 
on PrEP take it for three months on average (full detail on the method used is available in appendix).  
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2.5 Cost-effectiveness calculations 
2.5.1 Costing of a PrEP intervention in Lima 
We estimated the annual costs of providing a hypothetical PrEP intervention to individuals, from a 
health provider perspective, based on the CDC interim guidelines for PrEP in MSM [292]. In 
accordance with these clinical recommendations, we included: HIV testing before starting PrEP, HIV 
testing every three months during use of PrEP, HIV confirmatory testing if an individual is found 
positive, one creatinine/BUN test per year during PrEP use, outreach and counselling services, 
condom and lubricant promotion and provision. The estimation also includes additional costs for 
human resources but it does not include costs related to HIV treatment after infection, resistance 
testing, testing and treatment of other sexually transmitted infection. We included a 5% extra costs 
to allow for the creation of an enabling environment at project level, programme management 
costs, or monitoring and evaluation costs at project level [344]. This 5% mark-up was chosen based 
on the budget reported for management and monitoring and evaluation of HIV programmes at 
national level[322]. We do not include indirect costs such as potential earning forgone by patients or 
carers. We present all costs in Table 9 as market prices unadjusted, specific to Peru [322,345,346]. 
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Table 9. Estimated cost of a hypothetical PrEP intervention.   
Group Trans Sex worker MMSM MMSW 
Number of people on PrEP  1,000 1,000 1,000 1,000 
1. Behaviour change communication (including outreach and peer-outreach activities) 
a. Peer education      
Peer educator to person on PrEP ratio  
(UNAIDS recommended ratio 1:10 to 1:20)[344] 
15 15 20 20 
(Total number of peer educators) 66·6 66·6 50 50 
Cost peer educator/day[347] 16·5 16·5 16·5 16·5 
Number of days of work/week (peer educator)[344]  2 2 2 2 
b. Peer educator training/support (outreach workers)      
Number of trainers required per training course[344,347]  2 2 2 2 
Number of days in one course[344,347] 2 2 2 2 
Number of peer educators attending each course[344,347] 20 20 20 20 
Daily allowance to attend course/participant[347] 16·5 16·5 16·5 16·5 
Trainer fees/day[347] 33 33 33 33 
Cost of materials/participant/course[347] 5·5 5·5 5·5 5·5 
Cost of food and refreshment/participant/course[347] 11 11 11 11 
Outreach workers to peer educator ratio[344,347] 17 17 17 17 
Monthly salary: outreach worker[347] 330 330 330 330 
2. Delivery of tools, services for prevention, and care 
a. Provision of condoms and lubricant     
Average number of partners/year (per group) 100 30 2·5 2·5 
Average number of sex acts/partner (per group) 2 4 45 4 
Proportion of condoms used consistently (per group) 0·68 0·34 0·595 0·595 
Proportion of condoms covered by the programme 0·4 0·4 0·4 0·4 
Cost/male condom and lubricant[347] 0·022 0·022 0·022 0·022 
b. Services for prevention (PrEP, counselling and testing)     
Number of doctors/PrEP unit 1 1 1 1 
Number of nurses/PrEP unit 2 2 2 2 
Number of counsellors/PrEP unit 3 3 3 3 
Monthly salary: doctor[347,348] 1,300 1,300 1,300 1,300 
Monthly salary: nurse[347,348] 850 850 850 850 
Monthly salary: counsellor[347,348] 650 650 650 650 
Cost of ARV for PrEP/year (*estimated $35 or 
50/month/person[345]) 
420/600 420/600 420/600 420/600 
Average number of HIV tests/year/person[292] 4 4 4 4 
Cost of single HIV test[347] 2·23 2·23 2·23 2·23 
Prevalence HIV (estimate for each group) 0·4 0·3 0·2 0·05 
Cost confirmation HIV test[347] 9·8 9·8 9·8 9·8 
Cost of creatinine/BUN tests[349,350] 7·7 7·7 7·7 7·7 
Number of tests/year[292] 1 1 1 1 
Unit cost: management/M&E (programme excl. outreach)** 25.1/34.1 25.0/34.0 24.9/33.9 24.8/33.8 
Unit cost: management/M&E (programme incl. outreach)** 30.4/39.4 30.3/39.3 29.0/38.0 28.9/37.9 
Total (cost/person-year on PrEP – excl. outreach)** 526.2/715.2 524.3/713.3 523.5/712.5 521.4/710.4 
Total (cost/person-year on PrEP – incl. outreach)** 638.7/827.7 636.8/825.8 608.0/797.0 605.9/794.9 
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Notes: all costs in US$. *Estimated discounted cost in discussion should Truvada (tenofovir disoproxil fumarate [TDF: 300 
mg] plus emtricitabine [FTC: 200 mg]) be approved for prevention use in Peru.**unit cost of programme if PrEP drugs were 
cost $35 or $50. 
We estimated the unit cost of a hypothetical PrEP intervention to be between US$525 and US$830 
per year. As expected, this estimate is higher than estimates for South Africa (US$150/year)[351] but 
less expensive that an equivalent programme in the US (>US720/month) [343]. However, in this as 
well as for all estimates, the costs of drugs are the most important contributor. For instance, in our 
calculations the cost of PrEP drugs represented over two thirds of the total estimate. The cost of 
drugs used for PrEP was set to be between US$420 and US$600 per year based on Gilead’s cost data 
provided (Viread® US$30 and Truvada® US$45, plus 10 to 15% distributor mark-up per bottle, one 
bottle cost per month)[345].  
2.5.2 DALYs averted per HIV infection averted 
For the cost-effectiveness analysis, our principal outcome was the cost per DALY (disability-adjusted 
life years) averted. PrEP implementation scenarios were assessed against a “no PrEP intervention” 
scenario. Total number of DALYs averted were then calculated using the number of infections 
averted in each scenario multiplied by the estimated number of DALYs associated with one HIV 
infection averted. The latter was calculated as the sum of the number of years of life lost (YLLs) and 
the number of years lost due to disability (YLDs) using published methods[346,352]. This implies that 
infections averted during the 10 year intervention period are averted forever, which is an acceptable 
assumption for the groups with a high turnover such as male sex workers, but is an optimistic 
assumption for MMSM that are exposed for longer periods. We explored this issue by running the 
model for an extra 60 years after the end of the intervention (corresponding to life expectancy in the 
model) and found that the number of infections averted was greater when looking further into the 
future (results available in Table 2 of the appendix). This suggests averting infections during the 10 
years of the intervention results in averting secondary infections later on and therefore this 
simplification should not over-estimate the impact of PrEP.  
 
The DALYs calculations included weights for Peruvian life expectancy, age, future time, and disability. 
Duration of disability was calculated on the basis of local clinical data for HIV positive patients 
presenting to care[353] and the disability weights for HIV related conditions were obtained from the 
Global Burden of Disease study[354]. We estimated approximately 12.3 discounted DALYs averted 
per infection averted, including access to ART for 80% of infected individuals. When we exclude the 
age weighting function, we estimated 11.5 discounted DALYs averted. This is the equivalent of 27.09 
(and 27.12 when we exclude the age weighting function) DALYs averted per infection averted if no 
discounting is assumed, comparable to other estimates in the HIV literature [347,351]. A summary of 
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the DALY estimates depending on age-weighting and discounting is given in Table 10 and complete 
detail of the calculations is provided in section 3 of the appendix.  Future costs and health gains were 
discounted at a rate of 3%.  
 Assumptions 
[0.03,1,0.04] 
Assumptions 
[0.03,0,0] 
Assumptions 
[0,1,0.04] 
Assumptions 
[0,0,0] 
DALYs averted (ART) 18.86 16.53 38.01 35.63 
DALYs averted (no ART) 10.65 10.19 24.36 24.99 
DALYs averted (80% ART coverage) 12.29 11.46 27.09 27.12 
Table 10. Summary comparison of DALYs averted per HIV infection averted in Peruvian male adults varying assumptions 
of age-weighting and discounting[346,352,353,354].  
Assumptions are presented as [r,K,β]; where r is the discount rate (0.03 or 0), K is the age weighting modulation factor (1 or 
0), β is the parameter from the age weighting function (0.04 or 0). 
 
A sensitivity analysis looking at the impact of downstream ARV costs averted as a result of 
preventing infection on the cost effectiveness of the PrEP intervention was carried out. The cost of 
anti-retroviral treatment for this analysis varies from US$1,000[355] to US$3,500[347]. It was 
assumed that each infection averted corresponded to saving the costs of 12 years of ART treatment.  
 
2.5.3 Cost effectiveness thresholds 
Currently, there is a subjective selection of cost-effectiveness thresholds in the literature[356]. We 
refer to two thresholds commonly used. The WHO Choosing Interventions that are Cost-Effective 
(WHO-CHOICE) initiative considers an intervention to be: 1) very cost-effective if its cost is less than 
the gross domestic product (GDP) per capita (<US$5,401) per DALY averted; 2) cost-effective for a 
cost between one and three times the GDP per capita (US$5,401 to US$16,203) per DALY averted; 
and 3) not cost-effective if it costs more than three times the GDP per capita (>US$16,203) per DALY 
averted. These GDP values are those estimated for Peru in 2010[346,357]. The second threshold 
shown is a more conservative cut off point suggested by the World Bank in 1993 for middle-income 
countries[358]: < $US100 per DALY averted to reflect a highly cost-effective intervention, between 
US$100 to US$500 for a cost-effective intervention, and >US$500 for an intervention to be 
considered not cost-effective. These cut off points were considered in the analysis inflated to their 
2010 equivalent – US$149 and US$745 respectively. 
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2.6 Analysis 
We quantified the impact, cost and cost-effectiveness of different patterns of PrEP use across the 
population, identifying dependencies on coverage, scale-up period, prioritisation of key groups, and 
adherence. The impact of risk compensation, where those on PrEP reduce condom use, was 
investigated. We then used the model to find intervention scenarios that would result in reducing 
the number of new infections by one third, representing a potential planning target for Lima. 
3 Results 
 
3.1 Key groups to prioritise among MSM and transgender people 
To establish an appropriate set of strategies for using PrEP and maximise the investment, it is 
important to identify the most suitable groups to prioritise. Individuals who might be a priority could 
be determined by (i) the number of similar people and the ease of reaching them, (ii) their own risk 
of acquiring HIV, and (iii) their relative contribution to onward transmission once infected. In Lima, 
the majority of MSM are men that mostly have sex with men (approx. 70%) and men that mostly 
have sex with women (approx. 15%), but these experience a relatively low risk of infection (2.5 and 
1.0 % modelled incidence in 2010, respectively). Transgender people (approx. 5%) and sex workers 
(approx. 10%) are smaller groups, but are at higher risk of infection (7.3 and 3.1% modelled 
incidence in 2010, respectively). A fixed amount of PrEP (25,000 person-years) would allow covering 
60% of transgender people, 20% of sex workers, 3% of MMSM and 16% of MMSW over 10 years (in 
isolation). Used by the transgender sub-group or sex workers 25,000 person-years of  PrEP would be 
expected to avert 4.7% or 3.4% of infections over ten years in the whole population respectively; 
whereas the same amount of PrEP used in other groups would avert fewer infections – 0.9%, 1.2%, 
for MMSW and MMSM (Figure 6). For these reasons, in this epidemic context, strategies that 
prioritise transgender people at higher risk and sex workers could be expected to have higher impact 
for the same cost, including amongst those not taking PrEP due to preventing downstream infection.  
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Figure 6. Proportion of total new infections averted over ten years by giving 25,000 PrEP person-years to each group in 
isolation.  
MMSW: men who mostly have sex with women; MMSM: men who mostly have sex with men; ins:insertive; rec:receptive; 
ver:versatile. The error bars reflect the iPrEX efficacy estimate 92% [95%CI 40 to 99] 
 
3.2 Potential impact of PrEP programmes as a function of adherence, 
coverage, and prioritisation strategies. 
We estimated the impact of a PrEP intervention over ten years under a range of implementation 
strategies. Figure 7A, 7B and 7C show the number of infections averted over ten years, the number 
of infections averted per 1,000 person-years on PrEP and the proportion of infections averted over 
ten years  respectively. For a modest programme of 5% PrEP coverage, over 8% of infections could 
be averted with good adherence (iPrEX adherence profile) and prioritisation (high prioritisation 
scenario) of the groups most likely to become infected. Prioritising PrEP to sex workers and 
transgender people rather than achieving a uniform coverage increases the impact of interventions. 
This is particularly the case when overall coverage is low with the number of infections averted with 
a uniform coverage (970 [394-1,060]) nearly doubling by prioritising PrEP (2,519 [1,086-
2,713]).Decreased individual adherence to PrEP decreases its estimated impact at the population 
level. With higher coverage levels, the impact of PrEP interventions is greater but the relative benefit 
reduced (the numbers of infections averted per year of PrEP decreases).This is because, in the high 
coverage scenario, person-years of PrEP become relatively less efficiently allocated to individuals 
with low risk. 
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Figure 7. Estimated impact of PrEP with respect to coverage, adherence, and  prioritisation of key populations  in terms 
of A. absolute number of infections averted; B. Number of infections averted/1,000 PrEP-PY; C. Percentage of total new 
infections averted.  
The error bars reflect the uncertainty in iPrEX efficacy estimate 92% [95%CI 40 to 99]. We show two scenarios: low 
coverage in green; high coverage in blue and include three prioritisation strategies – uniform, where the coverage is the same 
in each sub-group; some prioritisation: a higher coverage achieved in the transgender women at higher risk and sex worker 
populations (but no more than 50% covered) compared to men that mostly have sex with women and men that mostly have 
sex with men; and high prioritisation, where 90% of transgender women at higher risk and 11% of sex workers receive PrEP 
in the low coverage scenario, or 90% of transgender women at higher risk, 90% of sex workers, 3.9 % of men that mostly 
have sex with men and 21.5% of men that mostly have sex with women receive PrEP in the high coverage scenario. Each set 
of three columns represents a different adherence scenario going from low adherence, IPrEX adherence and more 
adherence. 
 
3.3 Potential for resistance to ART treatment associated to PrEP 
The number of dangerous PrEP person-years while infected per 1,000 person years on PrEP was 3.9 
for the 3 months testing regimen against 7.7 for the 6 months testing regimen as shown in Table 11 
(complete detail of the calculations is available in the technical appendix). 
 
Trans MSW Total 
90% suceptible Trans/11% susceptible MSW 3879 1574 
 Number infected at recruitment who receive PrEP 28 5 
 Number infected while on PrEP 1229 215 
 Number of months on PrEP while infected with 3 m. testing interval 1872 328 2200 
Number of months on PrEP while infected with 6 m. testing interval 3715 651 4366 
Total PrEP years (accounting for PrEP discontinuation among infected) 47146 
PrEP-PY infected/1,000 PrEP-PY 3 months testing 
  
4 
PrEP-PY infected/1,000 PrEP-PY 6 months testing 
  
8 
Table 11. Estimation of the of PY on PrEP while infected for every 1,000 PreP-PY 
 
3.4 Cost-Effectiveness of PrEP interventions. 
3.4.1 Not including ART costs-saved 
The cost per DALY averted was quantified for PrEP interventions assuming the iPrEX profile of 
adherence (Figure 8A). Across all scenarios the highest estimated cost per DALY averted (US$1,780) 
is below the WHO recommended threshold for cost-effective interventions for Peru 
(<US$5,401/DALY averted)[346], while only prioritisation scenarios (some and high) for a low 
coverage and the low bound of a high prioritisation scenario for a high coverage are likely to be cost-
effective using a more conservative threshold suggested by the World Bank (<US$745/DALY 
averted)[358]. None of the scenarios appeared to be very cost-effective using the World Bank 
threshold of <US$149/DALY averted. In Table 12, we present the cost-effectiveness results for our 
six main scenarios together with the total cost over ten years for each scenario. For the same total 
investment, prioritisation improves cost-effectiveness. Figure 8B compared the cost-effectiveness of 
PrEP to that estimated for other prevention interventions in Peru– the comparison estimates for 
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other interventions were derived from Aldridge et al, specific to Peru [347]. Their estimates were 
obtained using Stover’s Goals’ model and did not include ARV costs averted. The comparison shows 
that, depending on the implementation strategy, PrEP could be as cost-effective as STI treatment or 
MSM outreach, or less expensive than HAART. It also suggests that PrEP should be considered as an 
additional intervention available as part of a comprehensive combination HIV prevention approach.  
 
 
Figure 8.  Cost-effectiveness of PrEP, estimated as cost per DALY averted. A. PrEP cost per DALY averted with regard to 
coverage levels and strategies. B. Comparison of PrEP cost per DALY averted with other HIV prevention strategies.  
The error bars reflect the uncertainty in iPrEX efficacy estimate 92% [95%CI 40 to 99]. The height of the bars shows the 
variation due only to the cost assumptions of one person year on PrEP.DALY, disability-adjusted life year. In panel A, 
iPrEX adherence profile used for these scenarios. In green: low coverage scenario: 5%: in blue: high coverage scenario: 
20%. In panel B, the variation in cost for the interventions reflects different coverage strategies assumed and the uncertainty 
in the costing. Values from Aldridge, R. et al. (2009)[39] presented in this paper were calculated using assumptions from the 
GOALS model on coverage and intervention design. These assumptions can be consulted in Stover, J. et al. (2006)[54]. 
PrEP estimated cost/DALY was calculated for both a uniform and high prioritisation strategies (including 5% and 20% 
coverage scenarios). The cost-effectiveness thresholds shown (red lines on the figure) correspond to: 1. World Bank: cost-
effective intervention <US$745/DALY averted; 2. World Bank: highly cost-effective intervention <US$149/DALY averted. 
 
 
 
 
 
 
B 
A 
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Distribution  Coverage  Total PY  Cost/DALY (1) Cost/DALY (2) Total cost 
Uniform  0.05 45,325  [1,076 -1,702]  
 
[419-4,182]  23,795,696-
37,619,863 
Uniform  0.20  182,596  [1,125-1,779]  
 
[428-4,254] 95,863,381-
151,555,440 
Some 
prioritisation  
0.05 
(0,0,0.26,0.5)  
44,925  [447-707] 
 
[159-1,596] 23,852,467-
37,709,615 
Some 
prioritisation  
0.20 
(0.04,0.08,0.5,0.5)  
187,116  [886-1,400] 
 
[397-3,133] 96,398,735-
152,401,810  
High 
prioritisation  
0.05 
(0,0,0.11,0.9)  
44,002  [403-637] 
 
[163-1,553] 23,877,220-
37,748,747 
High 
prioritisation  
0.20 
(0.21,0.03,0.9,0.9)  
183,851  [665-1,052] 
 
[310-2,258] 96,071,585-
151,884,601  
Table 12. Cost-effectiveness and total cost of PrEP over 10 years.  
Downstream ARV costs averted not included. Total PY, total number of person-years on PrEP over ten years; Cost/DALY: 
cost in US$ per disability-adjusted life years. Cost/DALY (1) values in brackets refer to the variation in the cost/DALY due 
to the cost assumptions only (correspond to the height of the coloured bars in Figure 5A). Cost/DALY (2) values show in 
brackets the variation due to the toal uncertainty - including both cost and PrEP efficacy assumptions as well as 
epidemiological assumptions. Total cost: total cost of PrEP intervention over ten years; the range reflects the uncertainty of 
PrEP programme costs only. Coverage in the uniform distribution strategy is equal in all subgroups (MMSW – men that 
mostly have sex with women, MMSM – men that mostly have sex with men, sex workers, and transgender women at higher 
risk). The coverage showed in both strategies involving prioritisation (some and high) are given as overall population 
coverage and in brackets, the coverage in each subpopulation (MMSW/MMSM/sex workers/transgender people at higher 
risk). 
 
3.4.2 Including ART costs-saved 
The downstream costs of ARV averted are included at two levels US$1,000/year [355] and at 
US$3,500/year[347].  Again, the cost per DALY averted was quantified for PrEP interventions 
assuming the iPrEX profile of adherence and results are presented in Figure 9A and 9B for ART costs 
estimated at US$1,000/year and US$3,500/year respectively. PrEP interventions would be cost-
effective in most scenarios if low ARV cost of infections averted are included and could be 
potentially cost saving if high ARV cost are assumed. Figure 10 summarises the results and illustrates 
how including ART costs saved impacts conclusions on cost effectiveness, especially when 
considering the uncertainty around ART costs.  
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Figure 9. Cost-effectiveness of PrEP, estimated as cost per DALY averted.  
A. Downstream ARV costs averted included at US$1,000/PY-ARV. B. Downstream ARV costs averted included at 
US$3,500/PY-ARV. DALY, disability-adjusted life year. iPrEX adherence profile used for these scenarios. In green: low 
coverage scenario: 5%: in blue: high coverage scenario: 20%. The variation in costs reflects the uncertainty in the costing of 
one person year on PrEP. The cost-effectiveness thresholds shown (red lines on the figure) correspond to: 1. World Bank: 
cost-effective intervention <US$745/DALY averted; 2. World Bank: highly cost-effective intervention <US$149/DALY 
averted. 
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Figure 10. Cost-effectiveness and total cost of PrEP over 10 years  
for: A. Downstream ARV costs not included; B. Downstream ARV costs averted included at US$1,000/PY-ARV ; C. 
Downstream ARV costs averted included at US$3,500/PY-ARV. DALY, disability-adjusted life year. iPrEX adherence profile 
used for all scenarios. In green: low coverage scenario: 5%; in blue: high coverage scenario: 20%. Lines are plotted against 
the Y axis of cost/DALY averted in US$ and against the X axis – total number of DALYs averted over 10 years. The numbers 
over the lines signal the data points as follows – 1, Low coverage, uniform scenario; 2, Low coverage, some prioritisation 
scenario; 3, Low coverage, high prioritisation scenario; 4, High coverage, uniform scenario; 5, High coverage, some 
prioritisation scenario; 6, High coverage, high prioritisation scenario. These data points have uncertainty bars representing 
the variation in the costing of one person year on PrEP. The boxes are plotted against the right hand axis only. They 
represent the total cost of scenarios. The variation in costs (height of boxes) reflects the uncertainty in the costing of one 
person year on PrEP. 
B 
C 
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3.5 Behaviour change associated with PrEP use  
We estimated the impact of PrEP programmes making different assumptions about condom use 
changes of individuals on PrEP, ranging from complete cessation of use (-100% condom use), to a 
small increase in use (+20% condom use). In Figure 11, we examine how number of infections 
averted and the cost per DALY averted are affected by these changes, in the context of a low or high 
coverage intervention with a high degree of prioritisation (plots for other prioritisation strategies 
given in Figure 3 and 4 of the appendix). Compared with no change in behaviour, a complete 
cessation of condom use among those on PrEP reduces the number of infections averted over ten 
years between 1,500 (32%) and 2,250 (45%); and increases the cost per DALY averted by US$200-
315 for a high coverage programme (blue bars). The effect is greater for a low coverage programme 
(green bars). This is because only those at highest risk of acquiring and transmitting infection are 
receiving PrEP, so that each break-through infection has greater potential to cause onward epidemic 
spread.  This analysis was also carried out including ARV costs averted and are presented in Figures 5 
to 7 of the appendix) 
 
Figure 11. Population impact and cost of PrEP with respect to changes in condom use for a high prioritisation strategy.   
A. Behaviour change and population impact of PrEP. B. Behaviour change and PrEP cost per infection averted. This figure 
assumes there is no correlation between adherence and risk compensation. We explored this issue separately in the 
supplementary material. DALY, disability-adjusted life year. iPrEX adherence profile used for these scenarios. In green: low 
coverage scenario: 5%; in blue: high coverage scenario: 20%. The cost-effectiveness thresholds shown (red lines on the 
figure) correspond to: 1. World Bank: cost-effective intervention <US$745/DALY averted; 2. World Bank: highly cost-
effective intervention <US$149/DALY averted. The height of the bars shows the variation due only to the cost assumptions 
of one person year on PrEP. 
B 
A 
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As condom use and adherence might be correlated, we explored two different scenarios where 
behaviour change happened only among high adherers and low adherers respectively. We found 
that the effect on HIV incidence of behavioural change in those with high adherence only is modest 
(because if they do consistently take the pills, then the degree of protection is very high). This effect 
is greater if those with bad adherence are found to change their behaviour (Figure 12A and B). 
Nevertheless, communication programmes to limit risk compensation may be a cost-effective 
complement to PrEP interventions.  
 
Figure 12. Population impact of PrEP with respect to differential changes in condom use assuming the iPrEX adherence 
profile.  
A. Only good adherers change their behaviour B. Only bad adherers change their behaviour. This figure assumes there is 
a correlation between adherence and risk compensation. iPrEX adherence profile used for these scenarios. In green: low 
coverage scenario: 5%; in blue: high coverage scenario: 20%. Reference is no change in condom use.  
 
The potential for a PrEP intervention to have the net effect of generating more new infections is 
theoretically possible but highly unlikely, requiring the lowest empirical estimate of intrinsic efficacy 
of PrEP (40% is the lower bound of the confidence interval of effectiveness among participants with 
drug levels in their blood [95%CI 40-99]) to be true and all users reduce their condom use by at least 
50% when PrEP is prioritised to groups at highest risk of infections and assuming the iPrEX 
adherence profile. Exact values are shown in Table 13.  
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Percent change in 
condom use 
Number of infections 
averted 
+20% 1685 
+10% 1413 
0.0 1146 
-10% 884 
-20% 627 
-30% 375 
-40% 127 
-50% -115 
-60% -352 
-70% -585 
-80% -813 
-90% -1036 
-100% -1255 
Table 13. Number of infections averted by a PrEP programme for different assumptions regarding change in condom use 
among PrEP users. This assumed a high prioritisation scenario, low PrEP efficacy (40%) and IPrEX adherence profile. 
 
3.6 Averting one third of new infections using PrEP 
Finally, we identify alternative strategies that would be expected to reduce the number of infections 
over ten years by one third (Table 14). With a rapid scale-up of two years and a highly prioritised 
strategy, a minimum of 435,000 PrEP person-years would be required, at an estimated cost of 
US$196M-310M over ten years. The same impact would be generated with a slower scale-up and a 
uniform distribution, but at a higher cost: US$277M-439M over ten years. With all strategies, a 
longer period to reach an intended coverage level increases the amount of person-years on PrEP 
needed. We also included in appendix the total cost and cost-effectiveness of different PrEP 
strategies to avert one third of infections, including downstream ARV costs averted. While the 
resources needed are still important, the cost-effectiveness is greatly improved. 
 
Distribution Scale up Coverage Total PY Cost/DALY Total cost 
Uniform Two years 0.46 597,165 [1,189-1,880] 269,888,000-
426,680,500  
Uniform Five years 0.57 625,155 [1,263-1,996] 277,445,500-
438,628,500 
Some 
prioritisation 
Two years 0.40 
(0.26/0.38/0.63/0.63) 
521,040 [1,046-1,654] 235,447,000-
372,232,000 
Some 
prioritisation 
Five years 0.54 
(0.51/0.51/0.7/0.7) 
591,730 [997-1,879] 262,597,000-
415,153,500  
High 
prioritisation 
Two years 0.34 
(0.27/0.22/0.9/0.9) 
433,810 [870-1,375] 195,959,000-
309,802,000 
High 
prioritisation 
Five years 0.49 
(0.42/0.41/0.9/0.9) 
535,155 [1,073-1,696] 237,555,000-
375,563,000 
 
Table 14. Scenarios to achieve one third of new infections averted over ten years.  
Total PY, total number of person-years on PrEP over ten years; Cost/DALY: cost in US$ per disability-adjusted life year. 
The range observed in this column and in the Total cost column represents the variation observed in the estimated costs per 
PREP-year; Total cost: total cost of PrEP intervention over ten years. Coverage in the uniform distribution strategy is equal 
in all subgroups (MMSW – men that mostly have sex with women, MMSM – men that mostly have sex with men, sex 
workers, and transgender women at higher risk). The coverage showed in both strategies involving prioritisation (some and 
high) are given as overall population coverage and in brackets, the coverage in each subpopulation (MMSW/MMSM/sex 
workers/transgender women at higher risk). 
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4 Discussion 
We estimated the potential impact of PrEP under different intervention scenarios, examining the 
relative importance of implementation strategies and individual adherence. Our model shows an 
important epidemiological impact of PrEP use, largely driven by the characteristics of the 
implementation programme – coverage, prioritisation strategy and time to scale up – and both risk 
compensation behaviour (reduction in condom use) and adherence. 
Overall, PrEP is predicted to be cost-effective in this population by WHO CHOICE guidelines and 
borderline cost-effective by more conservative World Bank guidelines if the intervention is 
prioritised to those most vulnerable to infection and when downstream costs of ARV averted are 
excluded. Most PrEP scenarios are found to be cost-effective if these costs are included, and even 
cost saving in a minority of scenarios. This argues for PrEP to be considered among the set of proven 
efficacious and cost-effective interventions that should be included in a comprehensive combination 
of HIV prevention interventions for MSM in this setting.  
 
Adherence will be a determinant of the impact of PrEP. On-going studies such as the iPreX Open 
Label Extension (“OLE”) will inform us on the levels of adherence that can be expected in “natural 
conditions”. Lessons to increase adherence levels learned from the use of prophylactic treatment in 
other fields such as malaria or tuberculosis as well as from the experience of adherence to ART 
treatment in the HIV field should be incorporated to any PrEP programme to maximise the potential 
benefits [299]. The possibility of intermittent PrEP use during periods or episodes of risk is also being 
investigated and could potentially improve adherence as well as cost-effectiveness. To date only one 
trial carried out among MSM and FSW in Kenya has reported results on intermittent dosing and 
showed adherence to be lower than for daily dosing in this population [359]. This is likely to vary by 
population and by dosing strategy and identifying successful approaches is hindered by the difficulty 
in measuring adherence. Finally, other modes of delivery such as injection are being developed and 
might provide a solution to adherence problems. Long term use of PrEP among unifected individuals 
could result in side effects that undermine the benefit of HIV prevention. The side effects of ART 
among HIV positive people are now relatively well described and tolerance has improved as new 
drugs have been made available. Using the high tolerance drugs for PrEP regimens would allow 
reducing side effects, however; considerations such as the drugs’ half life must be made as this will 
affect the duration of protection conferred and the potential for resistance. 
Consistent with the significant heterogeneity in risk behaviours among MSM and transgender 
women, our results show that prioritising people in higher risk situations (eg: transgender women) 
when implementing PrEP would have the largest impact. Additionally, perception of being at risk 
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could also increase uptake of PrEP. A recent study carried out in Australia to measure PrEP 
acceptability among MSM found that about a quarter on men would be willing to use PrEP and this 
was associated with the perception of being at risk of HIV and with reporting anal intercourse with 
casual partners. Only 8% of these reported they would be less likely to use condoms if on PrEP [360].  
The programmatic implications of these findings are in agreement with the results from our study as 
they would translate in covering a small proportion of individuals who are at most risk. While risk 
compensation could reduce the impact of PrEP, our results suggest that under a range of 
assumptions, PrEP is still likely to be cost-effective. However, this does not take into account the 
potential increase in the spread of other STIs, the cost of treating these and the effect it would have 
on HIV transmission.  On the other hand, unprotected anal intercourse appears as a predictor of 
willingness to use PrEP in the previous study as well as in studies carried out in Beijing, China [361] 
and the U.S. [362]. Among these men, PrEP would at least confer protection from HIV. 
 
A higher coverage strengthens the impact on incidence, with a rapid scale up of the intervention 
increasing the impact over ten years. However, implementation of PrEP in isolation and to a scale 
that it would arrest the epidemic would require more resources than have been available. To reduce 
new infections by one third, the total cost of introducing PrEP will amount to at least US$20M on 
average per year (over US$200M over 10 years). As a comparison, the total HIV spending in Peru for 
the year 2009 has been reported to be just over US$40M [3,363]. Furthermore, while Peru has been 
an important aid recipient from The Global Fund to Fight AIDS, Tuberculosis and Malaria in Latin 
America, the total approved HIV grants amount to date has been just over US$85M[364].  
 
These are one of the first results to quantify the potential population impact of PrEP incorporating 
data from the only clinical trial carried out in an MSM population. We highlighted the need to 
represent heterogeneity in adherence behaviour and a high intrinsic efficacy of PrEP if used. It is also 
the first model to examine impact among MSM and transgender women in a low and middle income 
country. In high income countries (US), Koppenhaver et al also incorporate iPrEX results and found 
that reductions in new HIV cases following PrEP introduction among MSM in New York led to 
substantial reductions in treatment costs. However, these savings were largely offset by high PrEP 
costs[365]. The authors assumed costs including costs of implementing PrEP and those for 
tenofovir/emtricitabine (valued at $22/day) as well as a coverage of 100% of all susceptible. Juusola 
et al.[366] varied the coverage of susceptible MSM and also included high costs of PrEP consistent 
with US costs. The authors also concluded that “PrEP in the general MSM population could prevent a 
substantial number of HIV infections, but it is expensive”.  
 
  
153 Chapter 3: Estimating the potential population level impact of PrEP among MSM in Lima 
Our results are also broadly consistent with previous modelling work (pre-iPrEX) on the impact of 
PrEP among MSM in the U.S. Desai et al.[367] found that a PrEP program was cost-effective under 
most variations in efficacy and adherence – a high impact was possible for an efficacy of 70% and 
program adherence of 50%. Paltiel et al. also found that PrEP could have a substantial effect on 
lifetime HIV infection risk, especially among younger populations, and that it could be a cost-saving 
intervention with drug efficacy levels over 70% and annual PrEP cost of US$2,500 or less[343]. 
Results from modelling studies of PrEP use in generalised epidemics have been conflicting. Abbas et 
al.[368] found that with high effectiveness, PrEP could have a beneficial impact when targeted to 
those at highest risk if it did not lead to an increase in risk behaviours. Pretorius et al.[351] found a 
PrEP intervention to be cost-effective under the WHO CHOICE thresholds but concluded that it did 
not provide value for money when compared to the scale up of ART. Hallett et al [369] found the use 
of PrEP in serodiscordant couples to be a cost effective alternative, especially in couples with 
increased risk behaviours. Although our findings cannot be directly compared with these as the 
settings differ greatly, one explanation for their different results obtained could be the difference in 
incidence assumptions (higher incidence rates among MSM lead to prevention interventions having 
a greater value). 
 
Beyond the needed balance of heterogeneity considerations with data availability and the 
programmatic relevance of distinguishing particular sub-groups, our study has additional limitations. 
Several structural assumptions will affect the results, for instance, the distribution of the population 
by sexual behaviour at entry (initiation of sexual activity) was assumed to remain constant through 
time meaning that if there was an important depletion of transwomen due to increased AIDS deaths, 
these were not be replaced and their proportion fell through time. While this might approximate 
reality in this particular case, it might not be true for sex workers which numbers might depend on 
demand and so might be more constant in size independently of survival. Similarly, individuals are 
assumed to maintain their sexual activity levels constant through time. There is evidence suggesting, 
MSM are most active when they are young and that numbers of partners decrease relatively rapidly 
with age. This could lead to overestimating the impact of PrEP on incidence. However, the turnover 
of some groups such as sex workers was assumed to be short and the intervention period was of 10 
years which is also relatively short. In addition, the model did not assume a specific duration on PrEP 
but simply ensured the coverage was maintained through time which could correspond to new 
entries. If age was found to be a strong determinant of risk, stratifying the population by age would 
be necessary and PrEP could be prioritised according to age.  
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The model is also limited by the need to capture important variation and complexity in sexual 
behaviour in this population into a simplified framework. To account for this, we have applied a 
frequentist model calibration procedure. By using the best fitting set of parameter values to perform 
the analysis, the remaining uncertainties are not fully represented in the current pattern of HIV 
transmission. We explored the potential effect of this on one of the main outputs (i.e. the number of 
infections averted) and observe that although the range is broad, it does not change the main 
messages obtained from this analysis. The model does not capture the possibility of evolution of 
drug resistance generated by individuals using PrEP after break-through infection, which has been a 
concern. However, several models suggest that the amount of resistance generated this way 
(individuals using PrEP after break-through infection) will be small compared to that generated by 
ART itself[370], provided individuals on PrEP are tested frequently. Accordingly, our results suggest 
that only 3.9 of every 1,000 PrEP person-years would be wrongly allocated to infected individuals (in 
a low coverage, high prioritisation scenario) if individuals on PrEP are tested every three months. 
This increases to 7.7 of every 1,000 PrEP person-years if the delay between tests is set to every six 
months.  
 
The validity of DALYs as an aggregate measure of effectiveness depends on assumptions made for 
disability weighting, discounting, age weighting, and life expectancy. We followed standard practices 
regarding these assumptions aiming to increase the comparability of our analysis while providing 
meaningful results for policy makers. We recognize that standard assumptions about DALYs averted 
by averting HIV transmission do not fully consider strong preferences to remain HIV uninfected given 
the burden of life-long daily therapy and stigma.In addition, we limited the calculation of the total 
DALYs averted to a function of the number of infections averted during the 10 year intervention 
period, assuming 80% of these would have received treatment otherwise. By doing this, we provide 
a conservative estimate of the cost effectiveness of PrEP (i.e. we did not include the savings due to 
treatment costs averted). However, this could also represent an optimistic approximation of 
potential benefits as we assume that those infections averted during the intervention will not 
happen afterwards. We tested this by running the model for an additional 60 years after the end of 
the intervention and found that the number of infections averted overall is greater than that 
observed during the intervention period. The spread of infection is a dynamic process, stopping 
infections during that period protects others from being infected further down the line in a similar 
way that vaccines do. We did not use this information to produce results to ensure comparability 
with other cost-effectiveness analyses using mathematical models of HIV transmission. Additionally, 
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recognising that we made a large number of assumptions to estimate the effect of PrEP during the 
10 years of the intervention, we preferred not to extrapolate behavioural assumptions afterwards.  
 
Another limitation of this study is that interactions between PrEP and earlier treatment for 
prevention of onward transmission are not fully considered. How PrEP and treatment programs will 
interact in practice remains to be learned. Although capacity for manufacturing antiretroviral drugs, 
including generic formulations of the most popular agents, has not been limiting, the funding 
available to purchase these drugs has. Theoretically, PrEP could compete with treatment scale up by 
using limited funding or limited clinic capacity and this should be avoided. Alternatively, PrEP could 
enable treatment programs by allowing greater volume discounts on drug prices and costs and by 
increasing testing coverage. In the absence of information about how these various possibilities will 
play out, we have aimed to evaluate the potential impact of PrEP as a prevention strategy among a 
population with relatively high risk of infection and to explore the effect of different programmatic 
factors such as prioritisation and coverage. While widespread treatment is assumed in this model in 
the context of universal ART access along current guidelines, a detailed analysis of how PrEP could 
affect treatment coverage is beyond the scope of available information at this time. 
 
Finally, but most importantly, the social and legal environments must be favourable to its 
implementation. The rights of MSM and particularly transgender women must be respected within 
the health services and in the community. MSM and Trans are still marginalised and subject to 
violence in Peru and other Latin American countries. This discourages them to access health services 
as they could be demeaned for their sexual orientation and experience shame and rejection [86]. In 
the more extreme case of Trans, their access to health services is further reduced due of lack of 
employment (no rights to social security). Structural responses to foment understanding and respect 
towards sexual diversity among health providers are essential to the positive development of a 
biomedical intervention entailing frequent testing and health checking such as PrEP [61]. In many 
countries there is still a need to improve the laws concerning these populations and this is not 
limited to those where homosexuality is still criminalised. Moreover, the acceptance of PrEP by 
these communities is essential to its success as a prevention intervention. Work would be needed to 
develop a sense of ownership of this strategy. There is a risk that communities might perceive this 
intervention as an easy alternative to solving the real issues that affect them, which could potentially 
lead to a rejection of the intervention.  Social research studies looking at PrEP acceptability among 
different key populations in Peru when this was still a hypothetical prevention method, showed a 
good disposition towards it [371,372]. The main obstacles to PrEP use were out-of-pocket costs and 
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potential secondary effects but possible stigma and discrimination associated with use and mistrust 
of health professionals were also mentioned [371]. Working closely with the communities and 
monitoring their response to this novel prevention initiative will help prevent negative reactions. 
 
We have shown that if prioritised to key groups and following a rapid scale up, PrEP could be a cost-
effective intervention for MSM populations and transgender people in Lima, Peru. Despite cost-
effectiveness, at apparently feasible levels of coverage and uptake, high expenditures and human 
resources will be required to generate a significant reduction in incidence. These expenditures 
should not be considered unless well performing ART services are already in place, which is not the 
case everywhere in Peru and even less so across the region. Further research will be beneficial to 
understand how prepared the health care services are to assume this responsibility. If such 
conditions are assured, however, a strategically implemented PrEP programme could make a 
significant contribution as a part in a combination package of priority, well implemented 
interventions for MSM/transgender women populations in concentrated epidemics after a scale up 
of ART.  
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Chapter 4: HIV trends and risk among inmates at 
Lurigancho prison in Lima, Peru 
1 Context 
We set up a collaboration with the Epidemiology Unit (Dirección General de Epidemiología) at the 
Peruvian Ministry of Health to study the HIV epidemic among prison inmates in Peru. Two national 
HIV/Syphilis surveillance surveys were carried out among prison inmates in 2000 and 2005. We were 
given access to this data and I had the opportunity to visit the main prison in Peru, Lurigancho, and 
to establish links with the staff working for the HIV/STI programme in place in the prison.  
Lurigancho is an exceptional prison in terms of HIV data collection, interventions and care in the 
region but also in comparison to most prisons worldwide. Considering the particular conditions 
characterising this prison and its importance in terms of HIV in the country, we decided to focus our 
work on its epidemic. 
2 Introduction 
2.1 The Peruvian penitentiary system 
In March 2011 there were 47 164 prisoners in Peru which corresponds to an incarceration rate of 
159 per 100,000 inhabitants [178].  This is slightly lower than the median incarceration rate in South 
America of 175 per 100,000 [178]. Since 2001 the Peruvian prison population has been growing at a 
rapid pace as a result of high crime rates linked to the economic situation and of policy changes. In 
particular, the response to drug crimes has toughened in the past decade as part of the “war on 
drugs” encouraged by the U.S. [177]. The entry of Peru into the Free Trade Agreement (FTA) is partly 
dependent of its participation in this enterprise and so an increasing number of people are being 
incarcerated for drug crimes, contributing to the growth of the prison population [177]. The laws 
regulating drug trafficking are often ambiguous and wrongly applied resulting in unjustified 
incarcerations and disproportionate punishments [177].  
Despite the consistent growth of the prison population over the years, the response has mostly been 
short term based, relying on transfers of inmates towards less populated prisons or on the 
rearrangement of space within existing prisons. The National Penitentiary Institute (INPE being its 
acronym in Spanish) which is the main entity controlling the Peruvian prison system had 6 directors 
from August 2006 to March 2010 as a result of public scandals or problems in the prisons (escapes, 
riots) [177]. This coupled with the cuts in public spending, affected the development of large scale 
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projects.  Recently 2 new facilities were built in Lima to respond to the unsustainable level of 
overcrowding. In December 2009, the total number of prisoners was 1.79 times larger than the 
infrastructure’s capacity meaning that overall prisons were holding nearly twice the number of 
inmates they were built for. The overcrowding score varies between prisons and has been as high as 
8 in Lurigancho in 2009, before they closed the prison to new entries for a period of two years.   
The stillness of the prison infrastructure is just the most visible consequence of the budget 
stagnation. All other aspects that determine the functioning of the prison system have experienced 
the same phenomenon and witnessed an increase of the prisoner-service ratio. Table 1 provides a 
summary of basic indicators on the quality of the prison system. There are not enough public 
lawyers to defend inmates, the number of prison guards is insufficient to ensure basic safety within 
the premises, the health care capacity is overwhelmed by the heavy disease burden at its door and 
the rehabilitation programmes are scarce if at all available. Under these conditions prisons can only 
worsen the already precarious future of those who fill them [373].  
Population 33, 010 
Overpopulation 62.0% 
Expenditure per person per year 1,300 USD 
Food 1.28 USD/day 
Number of prisons 84 prisons 
Water, electricity, and drainage services 89% in fair or poor condition 
Medical treatment services 71% in fair or poor condition 
Average growth of the prison population 12% to 13% annually 
On trial/convicted 70.5%/29.5% 
Population in prison for drug related offenses 7,853= 23.8% of total population 
From 5 to 10 years in prison 34.40% 
Table 1. Indicators of Peruvian prisons' performance in 2008 (modified from Soberon, 2011 [177]) 
 
During the rest of the chapter we will focus on the Lurigancho prison, the most populated prison in 
the country. Larger numbers imply larger problems when it comes to prisons and so most issues 
suffered by the Peruvian prison system will be exacerbated in Lurigancho, including HIV.  
2.2 Lurigancho 
The Lurigancho prison, 10 km north of Lima, holds 7308 male inmates as of March 2012, making it 
one of the largest prisons in Latin America [374]. In 2009 it reached nearly 12,000 inmates as shown 
in Figure 1 and was closed to new entries for nearly 2 years as the situation was unsustainable.  Its 
official name: “Establecimiento Penitenciario a Régimen Cerrado Ordinario Lurigancho” (EPERCOL) 
literally translated by “Penitentiary establishment for ordinary closed regime” refers to its medium 
security level. This type of prisons withholds inmates who have been incarcerated for common 
crimes and are considered to be capable of easily readapting to society but inmates accused of rape 
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or murder can also be found in Lurigancho. It is mainly a temporary prison for detainees awaiting 
trial but a considerable proportion of inmates are there to serve their sentence (25% in 2010). 
Although most inmates are waiting for trial, the average duration of stay in Lurigancho is of about 2 
years. This is due to the slow functioning of the justice system and to the mix of inmates with short 
and long sentences. The majority of inmates in Lurigancho are first time offenders. This proportion 
was stable at 60% from 2004 to 2007 and has been growing recently reaching nearly 70% in 2010 
[375]. In 2009, 60% of inmates were incarcerated for crimes against property and 24% for crimes 
against health, most of which are drug crimes.  
 
Figure 1. Size of the inmate population in Lurigancho from its opening in 1964 to 2012.  
The INPE has been reporting population size since November 2006 [374]. Earlier estimates were obtained from a prison 
census carried out by the National Institute of Statistics and from a quote in a study by Veeken et al., 2000 [376]. 
 
2.3 Chronology of HIV monitoring and prevention initiatives in 
Lurigancho 
2.3.1 The early days: case finding 
There is little information available on HIV/STI surveillance in Lurigancho during the first decade of 
the epidemic. The national STI and HIV control programme (PROCETSS is its acronym in Spanish) was 
present in the prison but its capacity in terms of staff and tests was limited resulting in HIV detection 
mainly occurring when patients were symptomatic or considered at high risk of HIV infection. For 
the same reasons, STI management was focussed on treating existing cases. From 1994 to 1996, the 
Universidad Cayetano Heredia donated 300 tests per year and in 1997, the prison received tests for 
1 year. Unfortunately, it has not been possible to obtain results from these surveys or to get a 
description of the sampling method followed. 
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2.3.2 Sentinel Surveillance 
In 2000 a national HIV/Syphilis sentinel surveillance survey was carried out among the prison 
population by the Dirección General de Epidemiología (DGE), at the Ministry of Health (MoH). This 
covered 22 prisons across the country and sampled 6963 inmates. Lurigancho being the most 
populated prison in the country represented an important proportion of this sample with 1886 
inmates participating to the study. The survey obtained information on HIV and STI prevalence and 
applied a short behavioural questionnaire. It found a country prison population prevalence of 1.1% 
(95%CI: 0.9%-1.3%). Of all the prisons, prevalence was highest in Lurigancho with 2.6% (95%CI: 1.9%-
3.3%) of inmates infected with HIV. In 2005 the survey was repeated following the same sampling 
method and applying the same behavioural questionnaire. 7841 inmates were sampled in total, 
2492 coming from Lurigancho. Total prevalence was 0.41% (95%CI: 0.28%-0.58%) while prevalence 
in Lurigancho was 1.1% (95%CI: 0.7%-1.5%). The potential reasons for this decrease will be explored 
in this Chapter and in Chapter 5. 
2.3.3 MSF period 
In 1998, Médecins sans Frontières (MSF) arrived to Lurigancho to provide medical and logistical 
assistance focussing on three main issues: HIV, STIs and Tuberculosis. Through an evaluation of the 
situation they identified the main failures in the health system and provided logistical help as well as 
an improvement in the infrastructure and medical staff numbers and training. They characterised 
groups at particular risk of HIV and offered STI treatment. They implemented HIV testing in a more 
systematic way among specific populations including patients with STI symptoms, TB patients and 
members of groups identified to be at higher risk such as transgender women. They made VCT more 
accessible to all. They also organised prevention campaigns directed at specific groups or at the 
general inmate population, using art and performance to convey messages. A report describing their 
work has been published [82].  MSF were present and actively involved in delivering health services 
until 2009; however their capacity substantially increased when resources from the Global Fund (GF) 
became available in 2004. 
2.3.4 Global Fund 
In 2003 Peru obtained funding from the GF to strengthen HIV/AIDS and Tuberculosis prevention and 
control in the country. Part of this effort was directed towards the penitentiary system as prison 
inmates were considered a vulnerable population to both HIV and TB. In regards to the prison 
population, the proposal heavily centred on improving TB detection and care with the clear aim of 
decreasing incidence from 2364 to less than 1,000  positive smear TB cases per 100,000 inmates by 
2007 [377]. The plan was to target the 9 larger prisons in the country (including Lurigancho) by 
improving both the identification and management of TB patients and the health infrastructure in 
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the prisons. The first component consisted in setting up TB screening at entry, isolating TB positive 
inmates, separating Multi-Drug Resistant TB (MDR-TB) patients and decreasing the dropout rates 
from Directly Observed Therapy Strategy (DOTS) treatment [377]. The second component involved 
provision of well ventilated quarters with ultraviolet lights for persons with TB and MDR-TB and 
access to N-95 respiratory masks for health staff. In order to put these improvements in practice 
training of the health personnel was provided. To ensure long term improvements of TB control, a 
guide for management of TB and HIV in prisons inspired from WHO guidelines but adapted to 
Peruvian context was produced and distributed to all prisons [378]. Additionally, those involved at 
the managerial level underwent an advocacy plan that resulted in the formulation of regulations to 
be applied in the prisons. Finally, prison inmates received information about TB through campaigns 
repeated every two months [377].  
Within the plan to improve TB management in prisons, HIV detection and treatment were brought 
forward as priorities since HIV infection is a risk factor for TB. Detecting HIV positive inmates would 
allow separating them from TB patients and treating HIV would strengthen their immune system 
both contributing to the reduction in TB incidence[377]. Although MSF had started scaling up testing 
among TB patients at the time, coverage was still low and the HIV/STI services were not linked to the 
TB services.  The plan was to make “VCT available to at least 20% of the prison population 
nationwide (2960 prisoners) [377]. This activity started from 2004 until 2007 and was funded by GF 
as follows: 100% during the first year, 75% during the second year, 50% during the third year, 25% 
during the fourth year, and in the fifth year this was fully assumed by the Ministry of Health” [377]. 
This resulted in much greater availability of tests in Lurigancho allowing the implementation of 
testing campaigns reaching thousands of inmates and shortly after of opt out routine screening at 
entry. These initiatives will be described in more detail further down. 
Regarding HIV treatment, in most prisons the healthcare personnel were not experienced in the 
area, hence a doctor and a nurse in each of the prisons were trained on issues such as treatment 
initiation and adherence, managing adverse reactions and drug interactions when treating 
opportunistic infections [377]. Lurigancho was privileged in this sense as MSF presence was already 
strong at the time. In fact, the implementation of the GF programme in Lurigancho was coordinated 
by MSF who were an integral part of the health care services in Lurigancho.  
 
In contrast to the proposal on TB control, the GF HIV proposal did not put emphasis on the prison 
population but one of the aims was to maintain HIV prevalence among prison inmates below 
2%[377]. This would be achieved through promoting STI treatment by increasing awareness and 
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facilitating access to the health services and increasing condom use. The chosen indicators to 
measure the success of the interventions were the proportion of inmates with knowledge of STI 
prevention and the proportion of inmates reporting condom use in their last sexual encounter [377]. 
The baseline for STI prevention knowledge in 2001 was 60% and the objective was to increase it to 
over 95% by 2007. There was no reported baseline for condom use at last sex (although this 
information is available for 2000 from the sentinel surveillance survey) and the objective was based 
on having 50% condom use in 2003 and attaining over 90% condom use in 2007. “Six annual 
education days [were] planned for STI prevention, to involve at least 500 members of the [prison 
population]. 100 peer-group promoters for the prison population [would] be trained in 6 annual 
courses for 50 participants” [377]. The different initiatives relevant to HIV surveillance are 
summarised in Figure 2 below. 
 
Figure 2 Timeline of HIV testing activities in Lurigancho.  
The coloured bars and dots represent the different testing mechanisms in place. Although some of these were in use 
before 2000, data is unavailable before this date. 
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2.4 Aims 
As can be appreciated from the description of HIV surveillance in Lurigancho, this prison represents 
an exceptionally rich source of data that has not been exploited for research purposes. The HIV 
programme has been gathering large quantities of information using a variety of strategies that have 
expanded with the involvement of international help and funding. In particular, having information 
on HIV prevalence at entry through screening and later on during the prison stay through  VCT and 
campaigns (among other strategies) is very rare in Latin American prisons (and elsewhere) and offers 
an opportunity to investigate fundamental questions regarding the higher HIV prevalence among 
prison inmates. In fact, HIV prevalence in Lurigancho has been found to be 2 to nearly 7 times higher 
than in the general population.  
As explained in the main introduction, it is accepted that prevalence among prison inmates is higher 
because these come from riskier strata of the population. However, it is unclear how much prisons 
contribute to this increased risk. This is likely to vary between prisons depending on their security 
level, geographical location, regulations, social organisation and health care facilities. We have a 
considerable amount of contextual information for Lurigancho, regarding HIV programme activities 
allowing a more grounded interpretation of results.  An additional advantage is the availability of 
information on HIV infection, demographics, prison history and sexual and drug using behaviours 
from two sentinel surveillance surveys carried out at two time points characterised by different 
conditions in terms of testing and treatment. In 2000, the HIV programme capacity was very limited 
in Lurigancho and MSF had just initiated their work. HIV testing was opportunistic, prevention 
services were poor and treatment was not available for free in Peru [82]. In 2005, MSF had been 
working in Lurigancho for over 5 years, HIV prevention was carried out through distribution of 
condoms and health information campaigns, VCT had expanded, groups at higher risk were tested 
on regular bases and an HIV testing campaign had been carried out in January 2005 [375]. 
Additionally, ART was available for free in Peru since 2004 (although it was not available in 
Lurigancho until July 2005, overlapping with the last month of the survey) [375].  
We aimed to explore these different sources of information to improve our understanding of HIV 
risk among the inmate population in Lurigancho and gain some insight on the dual hypothesis 
explaining HIV prevalence in prisons. Few studies have investigated this question among inmates in 
Latin America and since prisons in this region differ greatly in their organisation from U.S., Australian 
or European prisons it is important to set the grounds for further research on HIV prevention among 
this population. This involved:  
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 Providing a general picture of HIV in Lurigancho through time and from the different data 
collection mechanisms in place. 
 Describing this population in terms of demography, prison history and behaviours to gain 
some general knowledge on who inmates are and what might put them at risk.  
 Characterising inmates who exhibit behaviours generally associated with HIV risk (sex with 
FSW, sex with men, unprotected sex and abstinence) to define particular risk profiles. 
Exploring heterogeneity in behaviour and identifying risk patterns was particularly relevant 
to the development of a mathematical model of HIV transmission in Lurigancho that will be 
described in the following chapter.  
Particular attention was given to the role played by incarceration itself to determine which 
behaviours might be influenced by it and to what extent.   
 Identifying causal pathways to HIV infection taking the proximate determinants framework 
approach to understand infection from a broader perspective and propose targets for 
prevention. In Peru, the study reporting aggregate findings for all prisons participating to the 
2000 HIV surveillance survey identified tattoos, multiple partners, genital ulcers and 
previous incarcerations to be the strongest predictors of HIV infection [188].   
 
In parallel, a focus on the survey instruments and data reporting was maintained throughout the 
analysis in order to provide recommendations for their improvement. Currently, the data collection 
efforts of the HIV programme in Lurigancho are driven by operational questions and needs. 
Additionally, only data relevant to the management of HIV positives is available in electronic format, 
while the rest is kept in paper archives. This is the first time this data is approached with a research 
perspective and so we have endeavoured to adapt the information in a way that is relevant to 
epidemiological questions, which averred difficult at times. However, as a result of discussions on 
the potential uses of this data during our collaboration, the DGE launched an initiative to produce a 
database for HIV surveillance in Lurigancho. Information on a selection of years is now available but 
could not be included in this work due to time restrictions. The long term plan is to integrate this to 
the data management system in Lurigancho to ensure that information is periodically updated and 
available for analysis. Basic aggregated indicators on HIV testing, prevention and treatment from the 
HIV programme are presented and further analyses are carried out using the two rounds of sentinel 
surveillance data. 
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3 Data 
3.1 HIV programme data 
As broadly described in the introduction, there are several pathways for HIV testing in Lurigancho 
that provide information on different populations. Testing is never mandatory and inmates always 
receive their result immediately through the use of rapid tests. During pre-testing counselling a short 
questionnaire is administered face to face to collect information on the socio-demographic 
background of inmates, their drug using and sexual behaviours and to record the results from the 
test and the strategy to be followed depending on these. The questionnaire, translated into English, 
is available in appendix. However, we only present results from testing here as the information from 
the questionnaires was not yet available when this work was carried out. The different mechanisms 
for testing are described below in Table 2: 
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Table 2. HIV testing mechanisms in place in Lurigancho 
Testing 
mechanism Periodicity 
Access 
Description 
 STI clinic 
Punctual Opt-out 
Inmates accessing the HIV/STI services because they 
experience STI symptoms and are diagnosed and treated 
using syndromic management 
Comunidad 
Virgen de la 
Puerta (CVP) 
programme:  
Routine Opt-out 
This is the name given to the transgender women (TW) 
community in the prison. Peru remains a very catholic 
country and the virgin of Puerta is considered the protector 
of the town of Otuzco which was home to the TW that 
originally funded the community in Lurigancho. TW in Lima 
mostly work as sex workers as they are heavily marginalised 
and it is difficult for them to find a job. HIV prevalence 
levels among TW in Lima have been consistently high over 
time going from 20% to 40% depending on the surveys. In 
Lurigancho they were identified by MSF as one of the 
groups at most risk of HIV in the prison and a programme 
was put in place to monitor their HIV status and prevent 
infection. Members of this community have a weekly group 
session with a psychologist to deal with self-esteem and 
other relevant issues and are offered HIV testing every 
three months 
VCT 
Punctual Voluntary 
Inmates accessing the VCT services on their own initiative 
because they wish to be tested. They have had practices 
that put them at risk of HIV/STIs 
TB 
programme 
Routine Opt-out 
One of the weaknesses of the healthcare system in 
Lurigancho highlighted by MSF was the lack of 
communication between the HIV/STI programme and the 
TB programme. TB/HIV co-infection is common in the 
prison with 40% of HIV positive inmates also infected with 
TB in 2005. TB patients are tested for HIV when they are 
diagnosed and once every year thereafter.  
Campaigns 
Routine Voluntary 
HIV/STI awareness and testing campaigns  are carried out 
every one or two years over a period of two months. The 
HIV/STI team goes to every ward in the prison to inform 
inmates about HIV and STI through chats and games and 
offers VCT to all. Participation is voluntary and therefore 
HIV positive inmates who are aware of their status 
generally abstain. These campaigns are carried out with the 
aim of identifying new cases. In 2005 students and staff 
from the Universidad Nacional San Marcos in Lima 
participated in the implementation of the campaign.   
Screening at 
entry  
Routine Opt-out 
Since 2006 inmates who are new to Lurigancho are tested 
at their arrival. This includes first offenders as well as 
recidivists that have been incarcerated in other prisons 
before. A mechanism to share inmates’ medical files 
between prisons is not in place in Peru and the medical 
services do not have access to the criminal records of 
inmates, meaning that they are not able to trace whether 
new inmates have been incarcerated before. Screening at 
entry is very rare in prisons due to the costs and logistic 
efforts implicated. In Lurigancho, the turnover of inmates is 
high (about 3,000 new inmates each year) and about 60% 
off entries are first offenders, so having this system in place 
is exceptional. 
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The programme also monitors health outcomes among HIV positive inmates including mortality, TB 
prevalence, CD4 count and viral load and there is a record of the consultations and health problems 
of each HIV patient along time. Here we only present data on mortality and TB prevalence. 
3.2 Sentinel surveillance data 
The first HIV/Syphilis surveillance survey among prison inmates across Peru was carried out by the 
MoH in 2000 as part of the UNAIDS/WHO second generation surveillance and repeated in 2005 with 
support from the Global Fund. The first survey was carried out between November 1999 and January 
2000, and the second between April and June 2005 [379]. For each study, the total sample size was 
calculated based on the hypothesised HIV prevalence among the inmate population. The 22 most 
populated prisons in the country (out of 83) were selected to participate. A constant proportion of 
inmates (33%) was sampled at random in each prison (using the prison system’s lists) and invited to 
take part [188]. After giving their informed consent participants provided a blood sample to be 
tested for HIV and Syphilis antibodies using rapid tests and confirmatory enzyme linked 
Immunosorbent assay (ELISA) and rapid plasma reagin test (RPR) respectively if positive. The HIV test 
was unlinked from the participants’ identification code and inmates with a positive syphilis test 
received treatment. A short behavioural questionnaire collecting information on the demographic 
background, criminal history, sexual and drug using behaviours as well as STI symptoms was 
administered face to face. The original questionnaire was written in Spanish and is available in 
appendix together with a translated version. The information obtained from the questionnaire and 
testing is summarised in Table 3. 
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Socio-demographic 
Province of residence previous to incarceration 
District of residence previous to incarceration 
Marital status  
Married/ Cohabiting/ Single/ Divorced/ Widower 
Age  
Incarceration history 
Date of entry to prison during the current incarceration 
Age at entry to prison for current incarceration* 
Time in prison during current incarceration* 
Number of previous incarcerations  
Drug use 
Alcohol use in past 12 months 
Marihuana use in past 12 months 
Cocaine paste use in past 12 months 
Cocaine use in past 12 months 
IDU in past 12 months 
Exposure to HIV 
Tattoo in past 5 years 
Blood transfusion in past 5 years 
Sexual behaviour 
Number of sexual partners in past 12 months  
Sex with men in past 3 months 
Sex with wife in past 3 months 
Sex with FSW in past 3 months 
Sex with female friends in past 3 months 
Condom use last sex casual partner  
            Yes/No/Does not have a casual partner 
Condom use last sex stable partner  
           Yes/No/Does not have a stable partner 
Consistent condom use* 
Partner type* 
            Stable only/Casual only/Both/None 
Sex under influence of alcohol  
Never/ almost never/ sometimes/ nearly always/ always 
Sex under influence of drugs  
Never/ almost never/ sometimes/ nearly always/ always 
STI symptoms in past 12 months 
Having had an STI in past 12 months  
Having experienced pus or secretion on penis 
Having experienced Itching or burning while urinating in past 12 months 
Having experienced ulcers on penis in past 12 months 
Biological indicators 
HIV 
Syphilis  
Table 3. Data obtained from sentinel surveillance surveys.  
Note: *question not directly included in the questionnaire but inferred from other questions. 
 
The data from both the 2000 and 2005 databases corresponding to Lurigancho was extracted and 
cleaned.  As the survey was not designed specifically to answer our research questions some 
variables were modified or created to suit our needs. Age at entry for the current incarceration and 
time spent in prison during the current incarceration were created. Because the question on 
condom use informed on both condom use and partnership status, it was recoded to obtain two 
  
169 Chapter 4: HIV trends and risks among inmates at Lurigancho prison 
separate variables and disentangle the effects of these two factors on HIV status in some of the 
analyses. The first informed on condom use only and was defined as “yes” if condom use was 
reported consistently (with casual or stable partner for those who only had one type of partner, with 
both partners for those who reported both types of partners). It was defined as “no” if a condom 
had not been used in any of the possible partner combinations. Those who reported not having 
either a stable or a casual partner were coded as missing. The second variable was partner type and 
it was divided in 4 categories: stable only, casual only, both or none. 
The statistical analyses were carried out using the R software version 2.13. 
4 Methods 
4.1 HIV programme data summary 
A first assessment of the data available from the HIV programme was carried out during the 
February 2011 visit to Lurigancho. Several meeting and exchanges with the head of the HIV 
surveillance programme in Lurigancho followed to have a clearer understanding the population 
captured by each of the services offering testing. This was needed to interpret the data. During the 
process we requested additional information to produce indicators relevant to epidemiological 
questions. 
4.2 Descriptive statistical analysis 
Descriptive statistics for Lurigancho prison inmates were obtained from the two sentinel surveillance 
surveys.  Differences between the 2000 and 2005 samples were tested using the proportion test for 
binary variables and the Wilcoxon rank sum test was used for comparing continuous variables that 
these were not normally distributed. The Chi squared test was used for comparing categorical 
variables with more than 2 categories. Frequency histograms of the prison history variables were 
plotted and the relationship between these variables was evaluated using logistic regression. Two 
variables, condom use and number of partners were stratified according to the type of sexual 
partner to obtain point estimates for different risk behaviours. HIV prevalence was disaggregated by 
prison history characteristics and their effect was tested using logistic regression. 
4.3 Characterisation of risk behaviours 
The behaviours investigated were: sex with FSW, sex with men, unprotected sex at last sex with 
casual partner and sexual abstinence defined as having 0 partners in the past 12 months.  
Univariable models between each of the outcomes of interest and the variables obtained from the 
survey questionnaire were carried out. Significant variables in the univariable analysis were included 
in a multivariable model for each outcome. Variables that lost significance once controlled for others 
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were taken out following manual backwards stepwise regression choosing the variable with the 
highest p value. Variables were left out if the significance of association between other variables in 
the model and the outcome was not affected and if it did not result in a difference in the AIC score 
larger than 3 as recommended by Burnham and Anderson [380]. Once the model was built variables 
that were not significant in the univariable analysis were added to check that once controlled for 
important factors they did not have an impact on the results. If they produced no change in the 
model following the criteria described above, they were left out. The manual method was chosen 
over automated procedures as it allows thinking about the relationship between variables and 
understanding their effect. Automated procedures can result in an over-optimistic impression of the 
predicting capacity of the model as described by Kirkwood and Stern. However, correspondence 
between the final model and the model obtained using the R function “dropterm”, which also uses 
the AIC to select variables was verified [381]. 
4.4 Causal pathways analysis for HIV infection 
To characterise risk of HIV infection in this population  we used the proximate determinants 
framework for HIV infection developed by Boerma and Weir [382], as it allows identifying pathways 
for infection rather than isolated risk factors and therefore provides better guidance for prevention 
interventions. This particular conceptual framework was initially developed to explain fertility rates 
in demographic studies [383] and extended posteriorly to investigate it in the context of the HIV 
epidemic [384] before being adapted by Boerma and Weir to investigate HIV infection through a 
broader perspective. The framework was then tested to investigate pathways of infection among the 
general population in rural Zimbabwe by Lewis et al[385] and to explain incidence patterns in this 
population by Lopman et al [386].  This framework, along with expansions of it from the field of 
social epidemiology [387], is based on the idea that although HIV infection results from individual 
behaviours, these are influenced by external conditions defined by the socio-economic, legal and 
political contexts. Identifying the external factors that lead to infection and the pathways 
(behaviours) through which they operate is the basis to designing effective prevention interventions. 
In more detail, there are several layers of risk for HIV infection which can be defined as the 
biological, the proximate and the underlying determinants. The biological determinants constitute 
the core of infection which is dependent on three main factors: the transmission probability, the 
duration of infection and the likelihood of being exposed to an infected individual [382]. All factors 
directly influencing biological determinants (such as STI infection, or condom use) are named 
proximal determinants. These are in turn influenced by underlying determinants: living in a city 
where prevalence of HIV is high will increase the risk of having sex with an infected individual, using 
drugs might increase the risk of having unprotected sex. Considering that prison inmates engage in a 
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variety of risk behaviours, it is especially important to understand how these may lead to HIV 
infection. Although the questionnaire used in the surveillance survey was short and did not include 
information on socio-economic status, education or wider structural factors, investigating how sex 
with different types of partners, drug use and exposure to prison associate with HIV infection, is a 
valuable undertaking.  
The method used is a modified form of multivariable logistic regression, where rather than treating 
some variables as confounders and controlling for them, these are seen as potential precursors of 
the variables directly associated for infection and their relationship is investigated. The theory 
behind the causal pathways analysis stipulates that if proximate determinants of infection have been 
well captured and measured in a study, they will explain the effect of identified underlying 
determinants and these will lose their significance in a regression analysis [385]. Variables were 
classified as proximate or underlying determinants as described in Table 4.  
Biological 
determinants Proximate determinants Underlying determinants 
Exposure Tattoo in past 5 years Age 
  Blood transfusion in past 5 years Civil status 
  Injected drugs in past 12 months Place of residence 
      
  Number of partners in past 12 months Time in prison 
  Sex with wife in past 3 months 
Age at entry to prison for current 
incarceration 
  Sex with FSW in past 3 months Number of incarcerations 
  Sex with female friends in past 3 months   
  Sex with men in past 3 months Drug use in past 12 months 
    Alcohol 
  Having a stable partner Marihuana 
  Having a casual partner Cocaine paste 
    Cocaine 
Transmission 
probability Condom use at last sex with stable partner 
Frequency of sex under the influence 
of alcohol 
  Condom use at last sex with casual partner 
Frequency sex under the influence of 
drugs 
      
  STI in past 12 months   
  Secretion or pus from penis in past 12 months   
  
Burning when urinating or itching on penis in 
past 12 months   
  Wound or ulcer on penis in past 12 months   
  Syphilis positive   
      
Duration of 
infection None available from the data   
Table 4. Study variables classified as proximate or underlying determinants and according to the biological mechanisms 
that they might affect 
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The data from each survey were analysed separately because the periods at which they were carried 
out differed dramatically in terms of HIV services in the prison and in the country as explained 
previously.  
For the 2000 analysis the method described in Lewis et al [385]was followed: univariable logistic 
regression with HIV infection being the outcome of interest was carried out for all variables and 
multivariable models including all proximate and all underlying determinants were built separately. 
A best model explaining HIV infection with proximate determinants only was built using manual 
backwards stepwise selection as described above. The area under the curve (AUC) was calculated to 
estimate the predictive ability of the model. To test the proximate determinant framework, the 
proximate determinants which best explained HIV infection were incorporated into the multivariable 
model containing all underlying determinants. A final best model was then built by eliminating one 
by one variables representing underlying determinants that did not result in a difference in the AIC 
score larger than 3 [380] and the AUC of this model was calculated.  
 For the 2005 survey, the method was slightly modified because the number of HIV cases was 
smaller which limited the number of covariates that could be included in multivariable models. The 
categories of some of the variables were combined into two to avoid having zero cases in some of 
them when adjusting for other variables. The method described in Lopman et al. [386] to identify the 
causal pathways for HIV incidence was followed with the difference that logistic regression was used 
instead of poisson regression given that our outcome was a binary variable, with people being 
infected or not at a specific point in time. Univariable analysis was carried out for all the variables 
and identified (significant or borderline significant) proximate determinants were controlled for 
other significant proximate determinants. The same was done for underlying determinants and the 
model was adjusted for proximate determinants that had remained significant and borderline 
significant.   
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5 Results  
5.1 HIV Epidemiological trends in Lurigancho from HIV programme data 
 
5.1.1 HIV testing 
As MSF presence grew in Lurigancho and the Global Fund’s money became available HIV testing 
expanded from the groups considered at highest risk of HIV to the general inmate population. Figure 
3 illustrates the sharp increase in testing from 2004 and the decrease observed after 2008. The GF 
provided 9,850 tests in 2008, 9,000 in 2009 and the INPE took over in 2010 providing 5,800 tests 
[375]. The proportion testing positive decreased with time due to improvements in testing coverage. 
Testing acceptance grew from 92% in 2004 to nearly 99% in 2010 [375]. These numbers cannot be 
interpreted as prevalence since they do not correspond to the proportion of people infected at one 
point in time but to the proportion of tests found positive throughout the entire year. More 
importantly, the sample is not randomly drawn from the total inmate population but obtained from 
different testing mechanisms described previously. 
 
 
Figure 3 Number of rapid HIV tests carried out in Lurigancho per year and percent positive  
Source: PROCETTS Lurigancho, personal communication 
1: Sharp increase in testing due to availability of resources from GF funding  
2: Initiation of routine screening at entry resulting in another sharp increase in testing numbers and a change in the 
population tested  
3: Retirement of the GF resulting in a decline in testing numbers 
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Figure 4A presents the numbers of tests carried out per year disaggregated by the main reasons for 
testing. Campaigns and screening at entry account for the vast majority of tests.  A decrease in the 
number of inmates tested at entry is visible after 2008 corresponding to decreases in resources 
following the termination of the GF period. The number of tests carried out among inmates with STI 
symptoms, inmates referred by the GP and inmates belonging to the CVP is low and reflects the 
scale of each of these issues. The proportion accessing VCT as a result of risk behaviours has 
decreased since 2006, probably as a result of the scale up of screening at entry and of testing 
campaigns in 2007 and 2008. The increase in the number of TB patients tested reflects 
improvements in the programme.  
Figure 4B presents the proportion of positive tests for each of these groups. All these represent new 
cases identified in Lurigancho. We observe high variations among members of the CVP (from less 
than 2% to 11%). As previously mentioned, this group is small with about 30 transwomen in 
Lurigancho at any time point and these are tested every 3 months. As a result, the numbers obtained 
will be very sensitive to new transwomen entering the prison. The proportion testing positive among 
inmates with risk behaviours declined from 4% to about 1% after 2005. This could reflect genuine 
decreases in prevalence but further investigation is required to confirm this. A similar decrease was 
observed among TB patients which could be attributed to increases in the testing coverage in this 
group. The proportion testing positive among inmates referred by the general health services 
increased from 0% to over 4%. Again, this could be attributed to expansions in testing through 
screening and campaigns. The proportion testing positive among new inmates has remained 
relatively stable at about 1.3% since 2006. This is about 3 times higher than the general population 
prevalence in Peru and close to the total prevalence in Lurigancho presented in Figure 5. Finally, the 
proportion testing positive during the campaigns has decreased over time, starting at 1% in 2005, 
0.6% in 2007 and 0.1% in 2008. As more cases are identified at entry through higher screening 
coverage, less new cases are identified through campaigns. 
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Figure 4. Number of rapid HIV tests carried out in Lurigancho per year (A.) and proportion testing positive(B.) 
disaggregated by reason for testing [375].  
 
Given that the numbers presented above cannot be interpreted as prevalence an alternative was 
found to obtain this indicator. Information on the number of HIV positive inmates each month is 
available from the PROCETSS records [375]. This is likely to be very close to the total number of HIV 
positive inmates in Lurigancho as most are tested at entry and the other testing mechanisms in place 
allow identifying missed or new cases. The prevalence shown in Figure 5 was calculated based on 
this number and on the estimated size of the population each month provided by the INPE [374]. 
There is data available on the number of HIV positive inmates in 2004 but the INPE had not started 
sharing data on prison population sizes at the time. Prevalence seems to have been stable at 1.5% 
between 2007 and 2009 and to have then gradually increased to reach 2% in 2011. 
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Figure 5. HIV prevalence in Lurigancho.  
Note: Prevalence calculated as the number of HIV positive inmates in Lurigancho each month as recorded by PROCETSS 
divided by the total population size as reported by INPE. 
 
5.1.2 HIV prevention 
HIV prevention is carried out through pre and post testing counselling during routine screening at 
entry to prison. Inmates get a pack with information about STIs (how to prevent them, how to 
recognise symptoms, where to receive treatment), condoms and lubricant [375]. As mentioned 
previously, VCT is also available on demand from the inmates and during testing campaigns.  
Prevention messages are also delivered at group level during health campaigns. The transmission of 
HIV and STIs is explained through performances during which health promoters wear penis shaped 
suits representing different symptoms of STIs as well as condom suits [375]. Condoms are 
distributed during these campaigns and monthly in each ward. Figure 6 shows the total number of 
condoms distributed each year. The drop in condoms distributed in 2010 is linked to the retirement 
of the GF.  
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Figure 6. Number of condoms distributed in Lurigancho per year [375] 
 
5.1.3 HIV treatment 
Treatment has been available in Lurigancho since July 2005. It is currently provided by the MoH to 
inmates with a CD4 count<300 [375], which is higher than recommended in the national treatment 
guidelines that still use the 200 threshold but in use in an increasing number of HIV clinics in the 
country. Monitoring is carried out through CD4 cell count and the frequency of it depends on the 
results (200-400: every 3 months; 400-600: every 6 months, 600-800: every 9 months; 800 – 1,000: 
every year). The samples are sent and processed at the National Health Institute (INS) [375]. 
Adherence to treatment is generally poor in the prison setting, especially among patients with drug 
using habits. In Lurigancho, HIV positive inmates collect their treatment from the HIV programme 
every day and when these fail to attend they are found by the health promoters. When an inmate is  
experiencing problems with adherence, they are given support by a health promoter or by another 
inmate in whom they trust [375].  As a result, the programme estimates a 97% adherence to 
treatment among inmates in Lurigancho[375]. The proportion of HIV patients starting ART each year 
since 2005 is shown in Figure 7A. This has been relatively stable at around 15% probably reflecting 
the constant age of the inmate population through time. The slight increase observed in 2010 could 
be a reflection of the changes in treatment guidelines adopted during that year. The proportion of 
HIV positive inmates co-infected with TB decreased from 23% in 2005 to 10.8% in 2008 but it was 
around 17% in 2009 and 2010 as shown in Figure 7B [375]. The proportion of HIV positive inmates 
dying in Lurigancho each year has decreased from over 10% in 2004 to around 3% in 2010 (Figure 
7C) [375]. This improvement is likely due to treatment availability in 2005 and rates are now 
comparable to the 2.6% rate estimated in South American countries [308]. 
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Figure 7 Health indicators for HIV positive inmates  
A. Proportion of HIV positive inmates in Lurigancho who were co-infected with TB as reported by the HIV programme 
[375].  
B. Mortality among HIV positive inmates as reported by the HIV programme [375] 
C.  Proportion of HIV positive inmates starting ART treatment every year (corresponding to inmates starting ART each 
year over total HIV positive inmates in Lurigancho each year [375])  
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The information available from the programme allowed building a general picture of the current HIV 
situation in Lurigancho and provided some hints about infection patterns. The total prevalence in 
Lurigancho has been relatively stable between 1.5 and 2% since 2005 and prevalence at entry has 
also been stable since 2006 at about 1.3%. This suggests an important proportion of infected 
inmates is already infected at entry and that transmission inside might not be so common. However, 
it is not possible to draw any conclusions as trends will be influenced by population movement and 
an analysis accounting for this important factor is carried out in the next Chapter. These trends also 
suggest some groups are at much higher risk of infection than others.  Individual information on HIV 
infection and behaviours needed to better characterise differences in risk was not available when 
this work was carried out.  Fortunately, we were granted access to the data obtained from the two 
sentinel surveillance surveys in 2000 and 2005. In the following section we analyse this data to 
describe the inmate population in Lurigancho and study heterogeneity in sexual behaviour and 
infection. 
 
5.2 Characterisation of Lurigancho’s population based on sentinel 
surveillance data 
5.2.1 General 
Basic descriptive statistics for Lurigancho inmates from 2000 and 2005 are given in Table 5. In 2000, 
most inmates reported cohabiting with their partner prior to prison (40%) or being single (33%), 
about 15% were married and a very small proportion were widowers. This reflects the young age of 
the population with a mean age of 33 years old, 50% being under 30 and 75% being under 38.  The 
mean number of previous incarcerations was 1 with 63% of inmates having never been incarcerated 
before. Mean time spent in prison and mean age at entry for the current incarceration was 1.8 years 
and 29.8 years. About one quarter of inmates had a tattoo and nearly 5% had received a blood 
transfusion. Drug use in the past 12 months was common among this sample of inmates with over 
60% reporting drinking alcohol, over 18% reporting using marihuana and cocaine paste, 24% 
reporting using cocaine and 0.8% reporting having injected drugs. Regarding sexual behaviour the 
mean number of partners in the past 12 months was 2.2. When asked about who they had had sex 
with in the past 3 months, 57% reported sex with their wife or cohabiting partner, 39% reported sex 
with female friends, 20% reported sex with FSW and nearly 13% reported sex with another man 
(these are not mutually exclusive options). 35.6% reported having used a condom in their last sex 
acts with a casual partner and 12.6% with their stable partner. Nearly 80% and 91% reported never 
having sex under the influence of alcohol and drugs respectively. 5.5% reported having had an STI in 
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the past 12 months, 3.6% reported secretion or pus, 15.3% reported itching or burning and 7.4% 
reported ulcers on their penis.  
In 2005 the distribution by civil status followed a similar pattern with less inmates being married and 
more being single. Inmates in 2005 were on average slightly but significantly older. They had spent 
on average 2.4 years in prison during the current incarceration which was significantly longer than in 
2000 and they were slightly less likely to have been incarcerated before. More inmates reported 
having a tattoo and less reported having received a blood transfusion. Drug use was much less 
common in this sample of inmates with significantly less inmates reporting alcohol use (from 61% to 
37%), cocaine paste use (from 19% to 15%), much less cocaine use (from 24% to 13%). More inmates 
reported marihuana use (from 18% to 21%) and slightly more inmates reported IDU but the 
difference was non-significant. Regarding sexual behaviour there was a general trend for lower 
prevalence of risk behaviours in 2005: the mean number of sexual partners reported in the past 12 
months was significantly lower, inmates were much less likely to report having had sex with friends 
(27% compared to 39%), sex with FSW (12.4% compared to 20%), sex with other men (4.4% 
compared to 12.8%). Condom use at last sex was significantly higher with both casual and stable 
partner (from 35% to 52% and from 12% to 17% respectively). Inmates were more likely to report 
never having sex under the influence of alcohol but they were more likely to report nearly always 
having sex under the influence of drugs. Finally inmates in 2005 were significantly less likely to 
report having had an STI in the last 12 months and to report any of the associate symptoms. In terms 
of STI prevalence they were less likely to be HIV positive and syphilis prevalence was also lower but 
the difference was not statistically significant. 
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Year Comparison 
 
2000 2005 Statistical test p value 
Socio-demographic         
Marital status (%)   
 
Chi2 test <0.0001 
Married 15.0 10.5 
Cohabiting 40.5 43.4 
Single 33.2 37.0 
Divorced  10.6 8.0 
Widower 0.7 1.1 
Age (mean)  32.0 33.1 Wilcoxon rank sum <0.05 
Incarceration history   
 
    
Time in prison (years)  1.8 2.4 
Wilcoxon rank sum 
test 
<0.0001 
Previous incarcerations (number)   1.0 0.9 <0.01 
Age at entry (mean) 29.8 30.7 <0.05 
Drug use   
 
    
Alcohol 61.2 37.2 proportion test <0.0001 
Marihuana 18.0 21.4 proportion test <0.01 
Cocaine paste 18.9 15.1 proportion test <0.05 
Cocaine 23.9 13.1 proportion test <0.0001 
IDU 0.8 0.9 proportion test - 
Exposure to HIV   
 
    
Tattoo (%) 26.5 31.1 Proportion test <0.01 
Blood transfusion (%) 4.7 2.1 Proportion test <0.0001 
Sexual behaviour   
 
    
Partners in past 12 months (number) 2.208 1.873 Wilcoxon rank sum <0.0001 
Sex with men (%) 12.8 4.4 Proportion test <0.0001 
Sex with wife (%) 57.0 54.4 Proportion test - 
Sex with FSW (%) 20.0 12.4 Proportion test <0.0001 
Sex with female friends (%) 39.0 27.0 Proportion test <0.0001 
Condom use last sex casual partner (%) 35.6 52.1 Proportion test <0.001 
Condom use last sex stable partner (%) 12.6 17.7 Proportion test <0.0001 
Sex under influence of alcohol (%)   
 
    
Never 79.6 85.4 
Chi2 test 
  
almost never 13.3 10.6   
sometimes 3.2 1.2 <0.0001 
nearly always 3.3 2.6   
always 0.5 0.2   
Sex under influence of drugs (%)   
 
    
Never 91.1 90.3 
Chi2 test 
  
almost never 4.6 6.3   
sometimes 2.4 0.5 <0.0001 
nearly always 1.4 2.7   
always 0.4 0.3   
STI symptoms in past 12 months   
 
    
STI (%) 5.5 2.8 Proportion test <0.0001 
Pus (%) 3.6 0.8 Proportion test <0.0001 
Itching/burning (%) 15.3 4.1 Proportion test <0.0001 
Ulcers (%) 7.4 4.3 Proportion test <0.0001 
STI prevalence   
 
    
HIV 2.6 1.1 Proportion test <0.001 
Syphilis  3.4 2.9 Proportion test - 
Table 5. Characteristics and behaviours of Lurigancho inmates in 2000 and 2005 and comparison between the two 
samples. 
 Note: Blue and red coloured boxes indicate a significant decrease and increase in risk behaviours/biological outcomes, 
respectively from 2000 to 2005.  
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The age distribution was similar in the two surveys as shown in Figure 8. Mean age was 32 in 2000 
and 33.1 in 2005. Median age was 30.0 (IQR: 25-38) in 2000 and 30.8(IQR: 25-40) in 2005. 
 
Figure 8. Age distribution in the sentinel surveillance surveys of 2000 (A) and 2005 (B)  
 
5.2.2 Prison history: 
Patterns of contact with the prison system were explored in more detail. The time spent in prison 
during the current incarceration varied from 0 to 41.8 years in 2000 and from 0 to 25.5 years in 2005 
so the range was broad. Median length of stay was 1.3 and 1.7 years and 75% of observations were 
below 2.2 years and 3.3 years in 2000 and 2005 respectively. The vast majority of inmates in 
Lurigancho are there for a relatively short period while a small number can spend many years. Figure 
9 shows the distribution of inmates according to time spent in prison: nearly 40% had been in for 
less than a year in 2000 and less than 5% had been in for more than 4 years. The distribution of this 
variable was more dispersed in 2005, with less inmates having been in prison for less than 1 and 2 
years. Regarding patterns of recidivism, the mean number of previous incarcerations was 1.0 in 2000 
and 0.9 in 2005 while the median was 0 in both years. Again, the range was broad: from 0 to 21 in 
2000 and from 0 to 32 in 2005. 
A 
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Figure 9. Distribution of time spent in prison during the current incarceration and number of previous incarcerations 
among Lurigancho inmates in the 2000 and 2005 surveys.  
Note: For the years spent in prisons, only observations going up to 12 years are presented as there were very few higher 
than this threshold in both years. 
 
Correlation between time spent in prison in the current sentence and number of previous 
incarceration was investigated using linear regression. A significant positive association was found 
between the two variables. For each previous incarceration the estimated increase in duration of 
time spent in prison was of 0.06 and 0.08 years in 2000 and 2005 respectively which corresponds to 
22 and 29 days respectively. P values were 0.03 and 0.004 respectively. This is a relatively small 
increase compared the average sentence length of around 2 years.  
5.2.3 Sexual behaviour 
Risk behaviours among the inmate population in 2000 and 2005 were explored with a view to 
understanding the distribution of risk to inform the mathematical model structure and 
parameterisation in the next chapter. The mean number of partners in the past 12 months was 2.2 
and 1.9 and 75% of inmates reported less than 3 and less than 2 partners in 2000 and 2005 
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respectively. Variance was much larger in 2005 (27.2) than in 2000 (5.3). When looking at the 
distribution of number of partners in each of the surveys the overall shape is very similar between 
the two years, with over 50% of inmates reporting 1 partner in the past 12 months and the 
proportion of inmates decreasing as the number of partners increases (see Figure 10). A noticeable 
difference between the two samples is the proportion of inmates reporting 0 partners in the past 12 
months, this was under 5% in 2000 and was over 15% in 2005. As a result the proportion reporting 
more than 1 partner in 2005 is smaller but the tail of the distribution is longer in 2005 with more 
inmates reporting over 20 partners in the past 12 months. Maximum number of partners reported in 
2000 was 30 compared to 200 in 2005.  
 
 
Figure 10. Distribution of the number of sexual partners in the past 12 months reported in the 2000 (A.) and 2005 (B.) 
surveys 
 
Aside from partners’ numbers, risk is also determined by who these partners are. Based on the 4 
partner types included in the survey (wife, female friend, FSW and man), 16 profiles were identified, 
going from not having had sex with any of these to having had sex with all of them. The distribution 
of inmates in each of these profiles is shown in Figure 11 for 2000 and 2005. The profiles are 
presented following a hypothesised ascendant risk gradient based on the assumptions that the least 
risky partners were wives, followed by friends, FSW and MSM. These constituted the 4 main 
divisions and within these divisions risk increased by adding less risky partners in an ascending order 
of risk: for the FSW division for instance, the next level of risk was FSW and wives, the following was 
FSW and friends and the last was FSW, friends and wife. Risk was based on a rather traditional 
classification: wives are considered more likely to be monogamous, friends are considered casual 
partners but still belong to the so called general population, FSW are considered more at risk 
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because they have many sexual partners and MSM are considered at highest risk because the 
probability of HIV transmission during anal sex is higher and because prevalence among MSM in 
Lima is high.  However, this conceptualisation does not necessarily translate in risk of HIV because 
condom use with each partner type is not incorporated in the reasoning.  
 
 
Figure 11 Distribution of inmates by sexual partner profile in the last 3 months for 2000 (A) and 2005 (B).  
Note: Orange: None of these partners, dark blue: wife or cohabiting partner only, Purple: Casual heterosexual sex, Grey: 
Bisexual men, turquoise: sex with men exclusively.  
 
Since some of the profiles only accounted for a very small proportion of inmates it was decided to 
aggregate the groups into 5 main groups that represented general types of sexual behaviour and 
that are shown in different colours in Figure 11:  
 No partners (men who did not have sex with any of these partners), in orange 
 Monogamous men (those who only reported having sex with their wife), in dark blue 
 Men who have heterosexual casual sex (men who reported sex with friends and/or FSW), in 
purple  
 Bisexual men (other men and friends and/or wives and/or FSW), in grey  
 Men who reported sex exclusively with men, in turquoise 
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This characterisation of behaviours was especially relevant to informing and parameterising the 
mathematical model of HIV transmission in Lurigancho that is described in Chapter 5. Among those 
who reported no sexual partners in the past 3 months, an important proportion had a partner in the 
past year. To obtain the distribution of men into the partner profiles, we adjusted for this by 
distributing these men into each of the 4 remaining partner type groups. We assumed their 
behaviour would follow the same distribution as that observed for the other men. The result in 
distribution is shown in Figure 12. 
  
Figure 12. Distribution of inmates into 5 main sexual behaviour groups  
Note: This was based on partner types in the past 3 months and adjusting for the reporting of partners in the past 12 
months among those who reported no partners in the past 3 months. 
 
To further characterise heterogeneity in behaviour the number of partners and condom use among 
inmates with different partner type profiles was examined. As shown in Table 3, men who reported 
having sex only with their wife in the past 3 months reported 1.3 partners on average in the past 12 
months in both 2000 and 2005. Those who reported having sex with either friends or FSW reported 
2.9 and 2.8 partners in 2000 and 2005 respectively. Men who reported sex with both men and 
women reported 3.4 and 7.3 partners on average. In 2005 one participant in this group reported 
having had 100 partners in the past year; if we exclude this outlier the average number of partners 
in this group is 5. Among men who reported having had sex exclusively with men, the average 
number of partners was 2.6 in 2000 and 9.8 in 2005. Again, one participant in this group reported 
200 partners, if we exclude this observation the average goes down to 2.2. It is likely that those who 
reported 100 and 200 partners were involved in sex work and their behaviour is therefore not 
representative of the group. If we take this into account, average partner numbers in each group 
were very similar in the two surveys suggesting there were no behaviour changes in this regard. 
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NUMBER OF PARTNERS IN 
PAST 12 MONTHS AMONG 
MEN WHO HAD SEX WITH:  
Year  
(Number of NA) Mean Median 
25th-75th 
percentiles Range 
Monogamous   
2000 (n=1766) 1.3 1 1.0-1.0 1.0-20.0 
2005 (n=2084) 1.3 1 1.0-1.0 0.0-13.0 
Casual heterosexual sex  2000 (n=1692) 2.9 2 2.0-4.0 0.0-30.0 
2005 (n=1906) 2.8 2 1.0-3.0 0.0-20.0 
Sex with men and women  
2000 (n=1665) 3.4 3 2.0-4.0 0.0-15.0 
2005 (n=1889) 7.3/5* 4 3.0-6.0 1.0-100.0 
Sex with men only 
2000 (n=1833) 2.6 1 1.0-3.2 0.0-10.0 
2005 (n=2370) 9.8/2.2* 2 1.0-3.0 0.0-200.0 
*when removing outliers 
Table 3. Descriptive statistics for the number of partners among inmates in each of the partner type profiles for 2000 
and 2005 
Condom use with each of the partner types was estimated by looking at condom use at last sex 
among those who reported only having had sex with one partner type in the past 3 months (see 
Table 4). Participants were asked about condom use with last stable and last causal partner. To 
simplify the interpretation we assumed that wives or cohabiting partners were considered as stable 
partners and that FSW and female friends were considered as casual partners. For those who only 
reported sex with men in the past 3 months we report both condom use with last stable and last 
casual partner to take into account same-sex long term relationships. Condom use with a wife or 
cohabiting partner remained stable between the two time points at 12.0% and 15.5% in 2000 and 
2005 respectively. It increased with female friends from 24.5% to 46.6% and with FSW from 72.3% to 
88.7%. Condom use with men in the past 3 months was low in 2000 at 22.5% and was higher in 2005 
at 59.1% when asking about condom use wit last casual partner. When referring to condom use with 
the last stable sexual partner, this was very close to 0% in both years. It is interesting that this value 
remained stable in both surveys while all others increased considerably and it might reflect isolation 
from or resistance to prevention initiatives among these men. 
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Year 
 
2000 2005 
Condom use with casual partners (%)     
Man  22.5 59.1 
FSW  72.3 88.7 
Female friend 24.5 46.6 
Condom with stable partners (%)     
Man  0 0.1 
Wife/cohabiting partner 12 15.5 
Table 4. Condom use with each of the partner types for 2000 and 2005. 
Note: This was estimated by extracting information on condom use at last sex with casual partner among those who had 
only reported sex with Men, FSW and female friends for the three first rows and by extracting information on condom use 
at last sex with stable partner among those who only reported sex with men and with wife/cohabiting partner for the 4
th
 
and 5
th
 rows. 
5.2.4 HIV prevalence 
Determinants of HIV infection will be explored in detail further in this chapter but a preliminary 
analysis looking at HIV prevalence by prison history characteristics was carried out to have a clear 
idea on the distribution of disease depending on exposure to the prison context. Figure 13 shows 
prevalence of HIV by number of previous incarcerations. In 2000 the odds ratios for HIV infection 
among inmates who had been in prison one, two, three and 4 or more times before were 4.6 
(95%CI: 2.1-9.9, p-value<0.0001), 3.2 (95%CI=1.5-6.8,p-value:0.001),3.2 (95%CI:1.2-8.2, p-value:0.01) 
and 1.23 (95%CI:0.3-4.9,p-value:0.87) respectively compared to those who had not been 
incarcerated before. This difference was less marked in 2005. HIV prevalence was about 2 folds 
higher among those who had been in prison once or twice before compared to new offenders but it 
was lower among frequent offenders. These differences were non-significant when testing with 
logistic regression (Wald test). 
 
 
Figure 13. HIV prevalence by number of previous incarcerations 
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To explore the effect of time spent in prison we restricted the following analysis to new offenders as 
there is no information on cumulated prison time from this survey. We compared prevalence among 
those who had just entered and among those who had been in for more than 3 months. This 
threshold corresponds to the window period for HIV detection with antibody assays. Although this 
varies it is estimated that the average time to seroconversion is 25 days and that the vast majority of 
people seroconvert after 3 months [388]. We explored this value plus and minus 1 month and 
results were similar for all thresholds so only the 3 months threshold is presented (Figure 14). 
Prevalence at entry was nearly 4 folds higher than prevalence among other inmates for the 2000 
data (OR=0.28, 95%CI: 0.09-0.89, p-value: 0.03). For the 2005 data it was nearly 2 folds higher at 
entry but the difference was not significant (OR=0.58, 95%CI: 0.07-4.5, p-value: 0.61).  
 
 
Figure 14. HIV prevalence among 1st offenders by time in prison during current incarceration 
This descriptive analysis provides an overview of the inmate population in Lurigancho. This is a 
young population with a high prevalence of sexual and drug using risk behaviours when compared to 
the general population, especially among the 2000 sample. The proportion reporting use of cocaine 
paste and cocaine in the past 12 months was 18% and 24% respectively compared to 2.1% and 1.8% 
reporting ever consuming cocaine paste and cocaine respectively in the national drug survey carried 
out in 2002 and representative of the urban population between 12 and 64 years old [389]. Similarly 
low prevalence of drug use was observed in a study carried out in 1997 among young men (15 to 24 
years old) in Lima [390]. In the 2000 survey sex with FSW in the past 3 months was 20.5% while it is 
estimated at about 15% in the general population (PREVEN study 2002). Sex with men in the past 3 
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months was reported by over 12% of men while it was estimated to concern 6% of men in Peru 
when looking at the past year (PREVEN study 2002). Reported condom use with FSW corresponded 
to what has been observed in other studies in Lima [260,267], in contrast condom use with other 
men was low at 22.5%. Studies carried out among MSM in Peru in the same period reported levels of 
condom use between 60% and 90% [88,92]. Condom use was also low with wife or cohabiting 
partner and with female friends. However this is also true among the general population [391].  In 
2005, prevalence of drug use and sexual risk behaviours decreased considerably. Increases in 
condom use could be related to the distribution of condoms started by MSF as well as to the STI/HIV 
information campaigns that they carried out. There was a decrease in the report of STI symptoms 
which would suggest the increase in condom use is a fact rather than the result of social desirability 
bias. Decreases in the report of sex with FSW and sex with men could also be due to prevention 
messages. It is not possible to attribute any of these changes to the interventions in the prison as 
there is no information on exposure to these. Men stay for relatively short periods of time in 
Lurigancho and it would be interesting to know if it is enough to result in behaviour change. 
Additionally, we cannot exclude the possibility that the samples simply represent different inmate 
populations either because of the sampling or because of changes in the inmate population over 
time.  More sophisticated analyses are required to make further conjectures on the decrease in risk 
behaviours and HIV prevalence observed between these two time points. This question will be 
investigated in the next Chapter through the use of mathematical modelling. Regarding the potential 
effect of incarceration on HIV risk, these preliminary results reiterate that prevalence is already high 
at entry and suggest time in prison does not increase risk of infection. However, HIV prevalence 
increases with increasing numbers of incarcerations (especially among the 2000 sample). Frequent 
offenders might have higher risk behaviours outside leading to both incarceration and HIV infection. 
Firm conclusions cannot be drawn from this analysis as confounders such as age have not been 
controlled for.  This will be done in the next section, where the heterogeneities in risk behaviours 
described here will be explored and special attention will be given to exposure to prison. 
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5.3 Characterisation of HIV/STI risk profiles among Lurigancho inmates    
Inmates reporting sex with FSW, sex with men, unprotected sex with casual partners and sexual 
abstinence in the two sentinel surveillance surveys were characterised through the construction of 
multivariable models using logistic regression. Results from the univariable models for 2000 and 
2005 are available in appendix.  The final multivariable models for the 2000 and 2005 analyses are 
presented below but only results for the 2000 analysis are described in detail and differences 
observed in 2005 analysis are highlighted. 
5.3.1 Sex with FSW 
The best multivariable model predicting for sex with FSW in the 2000 survey contained the following 
variables: age, time in prison, number of partners in past 12 months, sex with men/wife/female 
friends, condom use at last sex with casual partner and having had an STI in the past 12 months 
(Table 5). The 2005 analysis resulted in a very similar model with OR and significance levels for 
common variables remaining quite stable. Age, sex with men and STI symptoms were not included in 
the model while the number of previous incarcerations was found to be significantly associated with 
the outcome. 
 
Men who had sex with FSW reported a high number of partners but were less likely to have had sex 
with a cohabiting partner or with a female friend, suggesting paying for sex might be a regular 
practice for them. However, these men were also much more likely to report condom use with 
casual partners. High levels of condom use have been observed in several studies among clients and 
FSW in Latin America [116,121,392]. Men who reported sex with FSW had been in prison for longer 
(and repeatedly for the 2005 sample) and in 2000 they were more likely to report STI symptoms but 
this was not the case in 2005. 
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  Sex with FSW 
  2000 2005 
Multivariable  OR [95%CI] 
Socio-demographic     
Age      
18 to 30 Reference   
31 to 40 1.8 [1.2-2.8]**   
41 to 50 1.8 [1.0-3.2]˜   
Over 50 2.3 [0.8-6.7]   
Incarceration history     
Time in prison     
under 1 year Reference Reference 
1 to 4 years 1.9 [1.3-2.8]*** 1.7 [1.1-2.8]* 
over 4 years 2.1 [0.9-4.7]˜ 2.5 [1.4-4.4]** 
Previous incarcerations     
0   Reference 
1 to 3 
 
1.8 [1.2-2.8]** 
4 and more 
 
1.4 [0.9-2.2] 
Drug use     
Cocaine paste   1.0 [0.6-1.7] 
Sexual behaviour     
Partners in past 12 months      
1 Reference Reference 
0 NA NA 
2 5.4 [2.8-10.4]*** 2.5 [1.4-4.5]*** 
3 and more 19.8 [10.2-38.3]*** 8.0 [4.7-13.7]*** 
Partners in the past 3 months     
Sex with men  0.9 [0.6-1.5]   
Sex with wife  0.4 [0.3-0.6]*** 0.4 [0.2-0.6]*** 
Sex with female friends 0.2 [0.1-0.3]*** 0.3 [0.2-0.4]*** 
Condom use last sex casual partner     
No Reference Reference 
Yes 3.2 [2.2-4.6]*** 4.6 [2.9-7.3]*** 
Does not have a casual partner 0.1 [0.0-0.1]*** 0.1 [0.0-0.3]*** 
STI symptoms in past 12 months     
Itching/Burning 1.62 [1.0-2.5]*   
Table 5.Multivariable models for prediction of having had sex with FSW in the past 3 months.  
p values are reported as follows: ˜= borderline significant, *<0.05, **<0.01, ***<0.001 
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5.3.2 Sex with men 
The variables included in the best model predicting for sex with men for the 2000 survey were: age, 
time in prison, cocaine paste use, IDU, number of partners, sex with wife, sex with FSW and sex with 
female friends, sex under the influence of alcohol, having had pus secretions in the past 12 months 
and having a positive syphilis antibody test (see Table 6). The model obtained for the 2005 data 
shared many of the variables described above with a few differences: number of previous 
incarcerations, rather than time in prison was significantly associated with sex with men. Reporting 
sex with wife or female friends were not included but reporting not having a casual partner was 
strongly negatively associated with having sex with men. Sex under the influence of drugs rather 
than alcohol provided a better model fit. Finally, reporting ulcers on penis in the past 12 months was 
included in the model but having a positive syphilis antibody test was not. 
 
Men who had sex with men in Lurigancho can be described as young men, with more exposure to 
the prison context (in 2000 time in prison was an important predictor while in 2005 number of 
incarcerations was strongly associated with sex with men), who used drugs (cocaine paste use was 
an important predictor in 2000) and had sex under the influence (of alcohol in 2000, of drugs in 
2005), who had multiple partners and who were likely to have experienced STI symptoms in the past 
year. In 2000 men who reported sex with men were also more likely to report sex with FSW 
suggesting these men had multiple risk behaviours and did not belong to a closed network of MSM. 
When compared to men who had sex with FSW, MSM in Lurigancho had a higher risk profile as they 
seemed more involved in drug use, they did not report high levels of condom use and were more 
likely to have experienced STI symptoms; in 2000 they were more likely to have had a positive 
syphilis antibody test.  
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Sex with men 
 
2000 2005 
Multivariable  OR [95%CI] 
Socio-demographic     
Age      
18 to 30 Reference Reference 
31 to 40 0.5 [0.3-0.9]** 0.4 [0.2-0.9]* 
41 to 50 0.2 [0.1-0.5]** 0.4 [0.1-1.0]˜ 
Over 50 0.5 [0.1-2.2] NA 
Incarceration history     
Time in prison     
under 1 year Reference   
1 to 4 years 3.1 [1.9-5.0]***   
over 4 years 3.8 [1.5-9.3]**   
Previous incarcerations     
0   Reference 
1 to 3   1.1 [0.5-2.1] 
4 and more   4.9 [1.8-13.0]** 
Drug use     
Cocaine paste 3.3 [2.1-5.3]*** 1.3 [0.6-2.6] 
IDU 1.5 [0.2-10.2]   
Sexual behaviour     
Partners in past 12 months      
1 Reference Reference 
0 NA NA 
2 4.9 [2.4-10.3]*** 1.1 [0.4-3.1] 
3 and more 13.1 [6.4-26.5]*** 3.4 [1.4-8.2]** 
Partners in the past 3 months     
Sex with wife  0.4 [0.2-0.6]***   
Sex with FSW  1.6 [1.0-2.6]* 1.6 [0.8-3.2] 
Sex with female friends 0.4 [0.2-0.6]***   
Condom use last sex casual partner     
No   Reference 
Yes   1.5 [0.7-2.9] 
Does not have a casual partner   0.2 [0.1-0.7]* 
Sex under influence of alcohol     
Never Reference   
almost never 1.2 [0.6-2.2]   
Sometimes 3.0 [1.4-6.7]**   
nearly always 1.3 [0.5-3.0]   
Always 23.5 [2.5-224.1]**   
Sex under influence of drugs     
Never   Reference 
almost never   4.2 [2.0-8.7]*** 
Sometimes   14.0 [1.5-130.9]* 
nearly always   3.9 [1.5-10.5]** 
Always   3.5 [0.3-46.1] 
STI symptoms in past 12 months     
Pus  2.4 [1.1-5.5]* 9.5 [2.5-36.7]** 
Ulcers    2.7 [1.1-6.5]* 
Biological outcomes     
Syphilis antibodies 4.1 [1.5-11.1]**   
Table 6. Multivariable models for the prediction of sex with other men in the past 3 months 
p values are reported as follows:  ˜= borderline significant, *<0.05, **<0.01, ***<0.001 
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5.3.3 Unprotected sex at last sex with casual partner 
The best model predicting for unprotected sex with last casual partner in the 2000 analysis 
contained the following variables: time in prison, previous incarcerations, cocaine paste use and IDU, 
number of partners, sex with men, sex with FSW, condom use with last stable partner, sex under the 
influence of alcohol and HIV status (see Table 7). Results for 2005 were similar but age, alcohol and 
marihuana use were included while time in prison was not. 
Men who had unprotected sex with their last casual partner had a higher exposure to the prison 
context, although findings were mixed here as time in prison was positively associated with condom 
use in 2000. This is somehow unexpected as intuitively, it could be thought that long sentences 
result in more careless behaviours or even depression that would also be reflected in non-use of 
preventive measures. Men who had unprotected sex used cocaine paste and had sex under the 
influence of alcohol. They were less likely to report sex with FSW and having had multiple partners; 
suggesting that men who engage in these behaviours are aware of the potential risks taken and they 
protect themselves or their partners by using condoms. Interestingly, this reaction is not observed 
when the risk is having sex with men. 
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Unprotected sex with last casual 
partner 
 
2000 2005 
Multivariable  OR [95%CI] 
Socio-demographic     
Age      
18 to 30   Reference 
31 to 40   0.5 [0.3-0.7]*** 
41 to 50   0.4 [0.2-0.7]*** 
Over 50   0.7 [0.3-1.5] 
Incarceration history     
Time in prison     
under 1 year Reference   
1 to 4 years 0.6 [0.4-0.9]**   
over 4 years 0.9 [0.4-2.1]   
Previous incarcerations     
0 Reference Reference 
1 to 3 1.5 [1-2.3]* 1.2 [0.9-1.7] 
4 and more 2.2 [1.0-4.9]˜ 2.4 [1.2-4.5]** 
Drug use     
Alcohol   0.6 [0.4-0.9]* 
Marihuana   0.6 [0.4-0.9]* 
Cocaine paste 1.8 [1.1-3.0]* 1.7 [1.1-2.7]* 
IDU 1.7[0.3-10.6]   
Sexual behaviour     
Partners in past 12 months      
1 Reference Reference 
0 4.3 [0.5-41.4] 1.3 [0.7-2.4] 
2 0.9 [0.5-1.4] 0.7 [0.4-1.0]* 
3 and more 0.8 [0.5-1.3] 0.4 [0.3-0.7]*** 
Partners in the past 3 months     
Sex with men  1.1 [0.7-1.7]   
Sex with FSW  0.3 [0.2-0.4]*** 0.2 [0.1-0.3]*** 
Sex with female friends   1.4 [1.0-1.9]˜ 
Condom use last sex stable partner      
No Reference Reference 
Yes 0.2 [0.1-0.3]*** 0.1 [0.1-0.3]*** 
Does not have a stable partner 0.6 [0.4-0.9]* 0.5 [0.4-0.7]*** 
Sex under influence of alcohol     
Never Reference Reference 
almost never 1.6 [1.0-2.7]˜ 1.7 [1.0-2.9]˜ 
Sometimes 3.5 [1.3-9.6]* 10.3 [2.3-46.4]** 
nearly always 1.4 [0.7-3.0] 4.3 [1.7-10.8]** 
Always 1.5 [0.1-20.0] 2.9 [0.3-26.7] 
Table 7. Multivariable models for the prediction of unprotected sex at last sex with a casual partner. 
p values are reported as follows:  ˜= borderline significant, *<0.05, **<0.01, ***<0.001 
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5.3.4 No sexual partners in the past 12 months 
The variables that were included in the model for not having sexual partners in the last 12 months in 
the 2000 survey were: civil status, age, previous incarcerations and cocaine paste use (see Table 8). 
Similar results were obtained from the 2005 but a few more variable were included in the model and 
the confidence intervals were narrower as a higher proportion of men reported abstinence in this 
survey. 
Men who reported abstinence from sex in the past year were mostly single (including divorced and 
widower), older, had been fewer times incarcerated but for longer (the latter only applies to inmates 
in 2005), they were likely to be cocaine paste users and to have a history of STIs.  
 
No sexual partner in past 12 months 
 
2000 2005 
Multivariable  OR [95%CI] 
Socio-demographic     
Marital status     
Married Reference Reference 
Cohabiting 0.6 [0.1-4.6] 0.8 [0.5-1.3] 
Single 10.4 [2.1-51.1]** 4.6 [2.8-7.6]*** 
Divorced  2.0 [0.3-14.3] 3.4 [2.0-5.9]*** 
Widower NA 5.2 [2.0-13.1]*** 
Age      
18 to 30 Reference Reference 
31 to 40 4.8 [1.6-14.5]** 1.3 [1.0-1.8]˜ 
41 to 50 7.0 [1.7-28.5]** 1.7 [1.1-2.5]* 
Over 50 18.9 [3.0-119.6]** 4.1 [2.5-6.6]*** 
Incarceration history     
Time in prison (years)      
under 1 year   Reference 
1 to 4 years   2.0 [1.5-2.7]*** 
over 4 years   1.4 [1.0-2.1]˜ 
Previous incarcerations     
0 Reference Reference 
1 to 3 1.2 [0.5-3.1] 1.0 [0.8-1.3] 
4 and more 0.5 [0.1-4.7] 0.5 [0.3-0.9]* 
Drug use     
Alcohol   0.6 [0.5-0.8]** 
Cocaine paste 3.7 [1.4-9.7]** 1.9 [1.3-2.6]*** 
Biological outcomes     
Syphilis antibodies   2.1 [1.1-4.0]* 
Table 8. Multivariable models for the prediction of having no sexual partners in the past 12 months. 
p values are reported as follows:  ˜= borderline significant, *<0.05, **<0.01, ***<0.001 
 
Based on the multivariable models the profiles describing inmates engaging in risk behaviours can be 
summarised as follows: men who report sex with FSW have a high number of sexual partners but 
high levels of condom use. In contrast men who report sex with other men seem to have a higher 
risk profile including alcohol and drug use and a history of STIs. Men who report unprotected sex 
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with their last casual partner also report higher frequency of sex under the influence but lower 
numbers of partners and are less likely to have sex with FSW. Those reporting abstinence in the past 
12 months are older men, single, widowers or divorced, who use drugs and have a history of STIs.  
Although sex with FSW was associated with STI symptoms in 2000, only itching/burning remained 
significant in the multivariable model and in 2005 there were no significant associations between sex 
with FSW and STI symptoms. That can probably be explained by the high rates of condom use 
reported with FSW. In general HIV/STI prevention among FSW in Peru has been successful as they 
report high rates of condom use and have relatively low prevalence of HIV. Sex with men was 
associated with syphilis in 2000 and with pus and ulcers in 2005 suggesting the latter might 
represent a higher risk for the acquisition of STIs. 
Exposure to prison was found to be an important factor influencing all of these behaviours. These 
relationships will be further explored in the discussion but in brief men who had spent a longer time 
in prison were more likely to report sex with FSW in both surveys and sex with men in 2000. In 2000 
they were less likely to report unprotected sex and in 2005 they were more likely to report 
abstinence.  Time in prison appears to lead to both riskier and preventive behaviours among inmates 
in Lurigancho. In contrast, number of incarcerations seemed to be more consistently associated with 
riskier behaviours. Men who reported frequent contact with the prison system were more likely to 
report sex with FSW and sex with men in 2005 and they were more likely to report unprotected sex 
in both surveys. They were also less likely to report abstinence in both surveys.  
The next step is to investigate how these behaviours profiles and risk interactions translate into HIV 
infection. The causal pathways analysis can shed more light on how patterns of exposure to prison 
act on behaviours to generate HIV risk. 
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5.4 Identification of causal pathways for HIV infections among Lurigancho 
inmates  
 
5.4.1 Proximate determinants for HIV infection 
In the univariable analysis for proximate determinants 4 out of 15 variables were found to be 
significantly associated with HIV infection (Table 9). The number of sexual partners in the last 12 
months and having had sex with a wife or cohabiting partner in the past 3 months were protective 
against HIV infection while having a positive RPR test and condom use with last stable partner were 
positively associated with HIV infection.  
 
As the questions on condom use at last sex with stable and other partner provided information on 
two different issues (use of condom and type of partnership), modified variables were used to 
distinguish their individual impact. Univariable analyses were carried out between HIV status and 
three variables informing on condom use (condom use with last stable partner, condom use with last 
casual partner and consistent condom use) and one variable informing on partnership type (see 
appendix). Condom use with last stable partner was positively and significantly associated with HIV 
infection while condom at last sex with casual partner was not. Consistent condom use was 
significantly and positively associated with HIV infection. Those who reported no partners or a casual 
partner only were significantly more likely to be HIV positive compared to those who reported a 
stable partner. Having a stable partner is therefore protective from HIV infection but condom use 
with stable partner is a predictor of infection. Reporting no sexual partners is also a predictor of 
infection. These modified variables were not used in the multivariable analysis as some of the 
categories were collinear. 
 
In the multivariable analysis controlling for all proximate determinants, having had sex with a wife or 
cohabiting partner in the past 3 months lost significance (Table 9). This could be because this 
variable is correlated with condom use at last sex with a stable partner which remained a very strong 
predictor of HIV infection. It is possible that these men are aware of their serostatus and wish to 
protect their partner from infection.  Reporting not having a stable and not having a casual partner 
to the condom use questions were both positively and significantly associated with infection, 
confirming the findings from the univariable analyses. Additionally having had no sexual partners in 
the past 12 months was also strongly associated with HIV infection. Those who had 1 or more 
partners in the past 12 months were about 98% less likely to be HIV positive. It is possible that those 
who had no partners are no longer sexually active because they are in an advanced stage of disease.  
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Having a positive syphilis antibody test remained positively associated with HIV infection and the 
strength of the relationship increased. This is a marker of past and current infection so it does not 
inform us on recent sexual behaviour. Finally, having had a tattoo done in the past 5 years and 
having had an STI in the past 12 months became borderline significant. Interestingly, none of the 
behaviours that are considered as risky for HIV infection, such as having sex with FSW, same sex 
partners, casual partners, having a high number of partners, unprotected sex with casual partners or 
injecting drugs were associated with HIV infection among these men.  
The best model predicting HIV infection with proximate determinants included number of partners 
in the past 12 months, condom use at last sex with stable partner, having had an STI in the past 12 
months, having a positive syphilis antibody test result (Table 9). The area under the ROC curve (see 
Figure 15) for this model was 0.73 which, according to Hosmer and Lemeshow is acceptable in terms 
of discriminating HIV positive individuals from HIV negative ones [393]. 
Proximate determinants Percentage 
distribution 
Unadjusted OR           
(95%CI) 
Adjusted OR†           
(95% CI) 
Best model OR    
(95% CI) 
Blood transfusion 4.7 0.83 (0.21-3.35) 0.40 (0.07-2.25)   
Tattoo 26.5 1.40 (0.76-2.58) 1.99 (0.97-4.06)˜   
IDU 0.8 2.69 (0.34-20.97) 2.12 (0.19-23.06)   
    
  
  
Number of partners (12 months)   
  
  
0 1.9 1.00 1.00 1.00 
1 52.4 0.02 (0.01-0.05) *** 0.02 (0.01-0.07) *** 0.04 (0.01-0.11)*** 
2 to 4  36.5 0.03 (0.01-0.07) *** 0.03 (0.01-0.11) *** 0.04 (0.01-0.10)*** 
5 to 9 6.4 0.02 (0.00-0.11) *** 0.01 (0.00-0.08) *** 0.02 (0.00-0.09)*** 
10 and more  2.9 0.02 (0.00-0.20) *** 0.02 (0.00-0.18) *** 0.02 (0.00-0.22)** 
Sex with FSW  19.9 1.20 (0.61-2.38) 1.43 (0.57-3.56)   
Sex with men  12.8 0.97 (0.41-2.31) 0.74 (0.24-2.31)   
Sex with female friends  39.2 0.93 (0.52-1.67) 1.50 (0.60-3.78)   
Sex with wife/cohabiting partner 57 0.33 (0.18-0.62) *** 1.63 (0.41-6.48)   
    
  
  
Condom use with stable partner   
  
  
No 57.8 1.00 1.00 1.00 
Yes 8.3 6.45 (2.45-16.98)***  6.03 (2.18-16.67) *** 6.96 (3.12-15.54)*** 
does not have a stable partner  33.9 6.13 (2.90-12.95) *** 10.12 (2.43-42.20) ** 6.17 (2.32-16.44)*** 
Condom use with other partner   
  
  
No 32.4 
  
  
Yes 17.9 1.84 (0.82-4.14) 1.65(0.64-4.25)   
does not have another partner 49.7 1.31 (0.65-2.65) 3.14 (1.05-9.48) *   
    
  
  
STI  5.3 1.02 (0.48-2.18) 3.08 (0.90-10.51)˜ 2.48 (0.91-6.75)˜ 
Secretion or pus from penis 3.6 0.57 (0.08-4.18) 0.26 (0.02-3.68)   
Burning/itching while urinating  15.3 0.94 (0.42-2.12) 1.13 (0.41-3.10)   
Ulcer or wound on penis 7.3 1.15 (0.41-3.25) 1.52 (0.41-5.58)   
Syphilis AB 3.4 4.27 (1.77-10.32) ** 7.49 (2.28-24.58) *** 3.97 (1.33-11.91)* 
Table 9. Percentage distributions of proximate determinants and their association with HIV sero-status. 
p values are reported as follows:  ˜= borderline significant, *<0.05, **<0.01, ***<0.00. †Adjusted OR are adjusted for all 
proximate determinants in the table 
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Figure 15. ROC curve for the best proximate determinants model for the prediction of HIV infection 
5.4.2 Underlying determinants for HIV infection 
From the 13 underlying determinants, 4 were found to be significantly associated with HIV infection 
in the univariable analysis (see Table 10). Having been a resident in the district of Lima before 
incarceration compared to in other districts, having been in prison for over 4 years during the 
current incarceration compared to for less than a year, having been incarcerated between 1 and 3 
times before compared to never before and having had cocaine paste in the past 12 months were all 
predictors of HIV infection. After adjustment for all underlying determinants having lived in Lima 
previous to being in prison and cocaine paste use became non-significant (Table 10). Lima as many 
other capital cities is the most affected area in Peru in terms of HIV cases [241]. Its positive 
association with HIV infection was therefore not surprising but it is interesting that it became non-
significant by adjusting for other underlying determinants only. Living in Lima was correlated with 
cocaine paste use as well as with number of incarceration and lost significance when controlling by 
any of these two variables. Cocaine paste use was correlated with civil status (cocaine paste users 
were less likely to be married) and with number of incarcerations and it lost significance when 
controlling for both these variables.  
After adjustment for the proximate determinants that were included in the best model to predict 
HIV infection, only the number of previous incarcerations remained significant (Table 10). The 
magnitude of the association increased and the significance level stayed unchanged. Being 
separated within the civil status variable became borderline significant. Time spent in prison during 
the current incarceration lost significance once adjusted for two of any of the following variables: 
number of partners, condom use and syphilis antibodies. Those who had been in prison for long 
were more likely to report not having a partner, to use condoms with their stable partner and to 
have a positive syphilis AB test. 
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Underlying determinants % Unadjusted OR 
(95%CI) 
Adjusted OR for 
underlying(95% CI) 
Adjusted OR for 
proximate (95% CI) 
Socio-demographic         
Age      
 
  
under 25 22.8 Reference 
25 to 30 23.5 1.47 (0.65-3.31) 0.65 (0.20-2.16) 0.58 (0.15-2.31) 
30 to 38 28.1 1.22 (0.54-2.75) 0.33 (0.07-1.66) 0.10 (0.01-0.77) * 
38 to 50 21.2 0.53 (0.21-1.36) 0.22 (0.03-1.75) 0.07 (0.00-0.86) * 
over 50 4.4 1.56 (0.42-5.82) 0.54 (0.06-5.24) 0.12 (0.01-2.21) 
Civil status     
 
  
Married 15.0 Reference 
Cohabiting 40.5 0.89 (0.31-2.54) 0.63 (0.20-2.01) 0.67 (0.17-2.62) 
Single 33.2 2.40 (0.91-6.33)˜ 2.02 (0.68-6.00) 0.57 (0.13-2.46) 
Divorced 10.6 1.14 (0.30-4.29) 0.75 (0.19-3.02) 0.28 (0.05-1.66) 
Widower 0.7 4.26 (0.46-39.16) 6.75 (0.62-73.96) 3.22 (0.20-50.77) 
Place of Residence     
 
  
Other 16.0 Reference 
Lima  84.0 4.49 (1.08-18.58)* 2.86 (0.67-12.29) 3.39 (0.67-17.04) 
Prison history         
Time in prison      
 
  
< 1 year 37.7 Reference 
1 to 4 years 57.0 1.06 (0.55-2.04) 1.14 (0.57-2.31) 1.28 (0.58-2.85) 
> 4 years  5.2 3.56(1.41-8.97) ** 4.44 (1.38-14.21) * 5.42 (1.16-25.40)* 
Number of incarcerations      
 
  
0 62.7 Reference 
1 to 3 30.7 3.61 (1.97-6.63) *** 3.23 (1.64-6.37) *** 3.73 (1.68-8.27) ** 
4 and more 6.6 1.13 (0.26-4.93) 1.01 (0.21-4.97) 2.01 (0.32-12.50) 
Age at entry     
 
  
under 20 10.7 Reference 
20-25 26.2 1.20(0.38-3.76) 1.30 (0.36-4.66) 1.56 (0.39-6.28) 
25-30 20.1 2.11 (0.70-6.41) 4.37 (0.83-23.06) ˜ 6.31 (0.97-41.21)˜ 
over 30 43.0 0.84 (0.27-2.59) 3.37 (0.43-26.68) 7.87 (0.64-96.70) 
Drug use         
Alcohol 61.2 1.27 (0.69-2.34) 0.98 (0.46-2.08) 1.59 (0.61-4.14) 
Marihuana 18.0 1.21 (0.59-2.44) 0.94 (0.42-2.13) 0.99 (0.38-2.58) 
Cocaine paste  18.9 2.21 (1.20-4.07) * 1.90 (0.91-3.94)˜ 1.63 (0.66-4.02) 
Cocaine 23.9 1.32 (0.70-2.48) 1.10 (0.52-2.31) 1.09 (0.45-2.62) 
Sex under the influence of 
alcohol     
 
  
Never 79.6   
 
  
Almost never 13.3 1.17 (0.52-2.66) 1.1 (0.40-3.32) 1.07 (0.33-3.55) 
Sometimes 3.2 1.39 (0.33-5.91) 1.93 (0.26-14.09) 2.89 (0.35-24.13) 
Almost always 3.3 2.05 (0.61-6.85) 3.31 (0.84-13.12)˜ 2.33 (0.50-10.76) 
Always 0.5 0.00 (0.00-inf) 0.00 (0.00-inf) 0.00 (0.00-inf) 
Sex under the influence of 
drugs     
 
  
Never 91.2   
 
  
Almost never 4.6 1.92 (0.67-5.49) 0.89 (0.21-3.70) 1.11 (0.22-5.54) 
Sometimes 2.4 0.92 (0.12-6.81) 0.33 (0.02-4.44) 0.21 (0.01-3.48) 
Almost always 1.4 1.58 (0.21-11.90) 0.47 (0.05-4.50) 0.66 (0.06-7.04) 
Always 0.4 0.00 (0.00-inf) 0.00 (0.00-inf) 0.00 (0.00-inf) 
Table 10. Percentage distributions of underlying determinants and their association with HIV serostatus for 2000 survey. 
p values are reported as follows:  ˜ = borderline significant, *<0.05, **<0.01, ***<0.001. Adjusted OR for underlying are 
adjusted for all underlying determinants in this table. Adjusted OR for proximate are adjusted for proximate determinants 
included in the best model for prediction of HIV infection in Table 9. 
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The underlying determinants that better predicted HIV infection were selected using backwards 
stepwise regression (starting with the multivariable model including all underlying determinants but 
no proximate determinants) and these were then incorporated into the proximate determinants 
model (Table 11). The area under the ROC curve for this final model was 0.82 which is considered to 
be an excellent fit to the data [393]. 
 
 
Adjusted OR (95% CI) 
Exposure   
Number of partners (12m)   
0 Reference 
1 0.02 (0.01-0.09)*** 
2 to 4  0.02 (0.00-0.07)*** 
5 to 9 0.01 (0.00-0.08)*** 
10 and more  0.01 (0.00-0.15)*** 
Transmission probability   
Condom use w. stable 
partner 
  
No Reference  
Yes 10.90 (3.65-32.60) *** 
does not have a stable 
partner  
9.38 (3.79-23.22)*** 
STI in past 12 months 2.70 (0.91-8.04)* 
Syphilis AB 3.45 (1.04-11.44)˜ 
Socio-demographic   
Age    
under 25 Reference  
25 to 30 0.54 (0.14-2.01) 
30 to 38 0.12 (0.02-0.81)* 
38 to 50 0.07 (0.01-0.82)* 
over 50 0.12 (0.01-1.87) 
Prison history   
Time in prison    
< 1 year Reference  
1 to 4 years 1.08 (0.50-2.30) 
> 4 years  4.43 (1.09-18.00)* 
Number of incarcerations    
0 Reference  
1 to 3 4.15 (1.98-8.71)*** 
4 and more 2.94 (0.58-14.96) 
Age at entry   
under 20 Reference  
20-25 1.52 (0.40-5.84) 
25-30 5.51 (0.93-32.73)˜ 
over 30 6.00 (0.57-63.45) 
Table 11. Best model including proximate determinants to predict HIV infection and corresponding ROC curve. 
p values are reported as follows:  ˜ = borderline significant, *<0.05, **<0.01, ***<0.001. Adjusted OR are adjusted for all 
determinants in the table 
 
In both analyses, the proximate determinants associated with HIV infection were characteristic of 
preventive behaviours against HIV. Condom use at last sex was a predictor of HIV infection in both 
samples (the association was strong for condom use with stable partner in 2000 and with last casual 
AUC=0.82 
  
204 Chapter 4: HIV trends and risks among inmates at Lurigancho prison 
partner in 2005). Having no partner was also a predictor of HIV in the 2000 sample. None of the 
behaviours traditionally considered as being risk factors for HIV and that have been consistently 
associated with HIV infection in studies among prison inmates (such as sex with men, FSW or IDU)  
were found to be important and the proximate determinants measured did not explain the effect of 
underlying determinants. Possible explanations will be proposed in the discussion. 
6 Discussion 
6.1 Summary and interpretation of findings 
In this Chapter we have introduced the subject of prison inmates as a vulnerable population to HIV 
infection and we have explored it in the context of the Lurigancho prison in Peru. An increasing 
number of young men are incarcerated every year in Latin American prisons in ever more difficult 
conditions due to escalating rates of overcrowding and lack of resources. Lurigancho is a 
representative example of the issues affecting prisons in the region and has also had an exceptional 
journey in terms of HIV surveillance, prevention and care in the past decade. It therefore provides 
both the problems and the tools to study them. HIV prevalence in Lurigancho was estimated at 2.6% 
and 1.1% in 2000 and 2005 respectively through sentinel surveillance and has been relatively stable 
since, between 1.5 and 2.2%, according to HIV programme data. This is comparable to what has 
been observed recently in Mexico [183,394] and lower than found in Brazil [182] or Puerto Rico 
[395]. It is lower compared to other regions, especially eastern European countries. The difference is 
likely due to the limited practice of IDU among Peruvian inmates. In Argentina for instance, 
prevalence among inmates was high in 1995 when IDU was relatively widespread [396]. However, 
prevalence among Lurigancho inmates is 3 to 7 times higher than the estimated prevalence among 
the general population, suggesting these men are at increased risk of infection. When looking at the 
prevalence of risk behaviours such as sex with FSW or sex with men, these were higher than 
estimated among the general population; especially when we refer to the first sentinel surveillance 
survey carried out in 2000.   
The multivariable analysis for the prediction of risk behaviours suggests condom use with FSW is 
high and this behaviour is not associated with STI symptoms. Men who reported sex with wife, 
cohabiting partner or female friends were much less likely to report sex with FSW suggesting that 
the permissive regulations in terms of conjugal visits in place in Lurigancho contribute to decreasing 
risk behaviours. It is possible that the risk to HIV remains unchanged by the prison context among 
those who are able to maintain their relationship with intimate partners.  
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In contrast to sex with FSW, sex with men appeared to be riskier as it was not associated with high 
levels of condom use and it was associated with STI symptoms, drug use and sex under the 
influence. The hypothesis linking increased prevalence of sex between men in prison with the 
abnormal demographic conditions imposed by this environment is not transferable to Lurigancho as 
female visitors are allowed and numerous. Nonetheless, time and space are constantly shared with 
other men and the use of drugs is widespread, likely contributing to this finding.  In fact, men who 
reported sex with men were also more likely to report sex under the influence of alcohol or drugs. 
Coerced sex and rape are more common in prisons [397,398] and could also explain the 
relationships observed between increased exposure to prison and sex with men, but no information 
on forced sex was included in this questionnaire. Several studies have found that that most men who 
report sex with men in prison also report sex with men in the community [191,399,400,401]. 
Unfortunately, this survey did not provide information on behaviour previous to incarceration.  
Unprotected sex with casual partners was found to be common among inmates at Lurigancho, 
especially among inmates who had had frequent contacts with the prison system and who used 
drugs. The association between delinquency and unprotected sex has been documented in several 
studies mostly among adolescent offenders. Rowe et al. showed that among juvenile offenders in 
the U.S., delinquency was a common predictor for substance use disorders and HIV/STI risk 
behaviours (including unprotected sex) [402] and although number of incarcerations is not a direct 
measure of delinquency it is an indicator of the frequency of delinquent behaviours. Khan et al 
found that men with a history of incarceration in the past year were more likely to have unprotected 
sex with multiple partnerships than those who had no recent history of incarceration [403]. Among 
illicit drug users (cocaine paste, cocaine and IDU) the association was non-significant because a great 
proportion reported unprotected sex with multiple partners independently of incarceration [403]. 
Among inmates from Lurigancho, the number of previous incarcerations remained significant after 
controlling for cocaine paste use and high number of partners in both the 2000 and 2005 samples. In 
the 2000 analysis men with a longer stay in prison were less likely to report unprotected sex. This 
remained significant in the 2000 analysis after adjustment for sex with FSW and lost significance in 
the 2005 survey after adjustment for age and sex with FSW. To our knowledge this relationship 
between time in prison and condom use has not been observed before and since this was observed 
prior to the scale up of MSF prevention programmes in the prison, it is not possible to attribute it to 
the potential success of their intervention.  
Abstinence among inmates in Lurigancho was common in the 2005 sample among older men, who 
used cocaine paste, had been in prison for longer and might have had risk behaviours in the past as 
suggested by the higher odds of syphilis infection observed.  As mentioned previously, incarceration 
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can lead to partnership dissolution and some men might not want to engage in sexual relationships 
unless they find another stable partner, which is difficult while in prison. In contrast, men who had 
been in prison several times were less likely to report abstinence. In a study comparing men with 
different incarceration patterns, men who had been incarcerated for a period shorter than a month 
were more likely to have had multiple partnerships compared to men who had not been 
incarcerated before while those who had longer incarcerations were not. It is postulated that upon 
release inmates engage in sexual risk behaviours including multiple and concurrent partnerships and 
that this might be partly mediated by dissolution of main partnership during incarceration. So the 
effect of partnership dissolution might be different depending on sentence length, age (with older 
inmates being less likely to find new partnerships while in prison), substance use (as demonstrated 
by others) and probably previous beliefs and attitudes about sex.   
To reconcile this information on risk behaviours with HIV infection in this population, we applied the 
proximate determinants framework for HIV infection described by Boerma and Weir to this data. 
The proximate determinants associated with infection were all reflective of preventive behaviours or 
cessation of sexual activity and therefore did not explain the pathways through which the underlying 
determinants acted. It is possible that inmates were reluctant to share sensitive information and so 
associations between HIV and risk behaviours would have been blurred. However, as already shown, 
the proportion of inmates reporting sex with men and sex with FSW in the 2000 survey was 
substantially higher than observed in studies among the general population in Peru (it was closer in 
2005). A more likely explanation is that HIV positive inmates were aware of their status or were 
suffering from AIDS symptoms and had changed their behaviour as a result. Apart from the 
questions on number of partners, drug use and sex under the influence, which referred to the 12 
months previous to the interview, the others questions referred to more recent behaviours: the 
questions on condom use referred to last sex, so presumably a recent event, and the questions on 
types of partners referred to the 3 months previous to the interview. It seems likely that questions 
referring to recent behaviours in these samples are uninformative about how they acquired 
infection.  
In 2000, abstinence was the strongest predictor for HIV infection despite having very low numbers of 
men in this group. Abstinence as a response to HIV has been documented elsewhere, especially 
before treatment became available. Bogart et al. [404] studied the correlates of deliberate 
abstinence using data collected between 1996 and 1998 among HIV positive men and women in the 
U.S. Not having a primary relationship was a significant predictor among both men (including gay 
and bisexual men) and women. Among gay and bisexual men, higher perceived responsibility of 
limiting transmission was also a predictor for deliberate abstinence and this was associated with 
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alcohol abstinence. The authors believe this is related to the sense of community existent among gay 
men in the U.S. at the time which was amplified by having witnessed the death of others around 
them. In the late 80s and 90s much of the prevention campaigns were based on provoking guilt 
around risk behaviours and it is likely that HIV positive inmates felt a responsibility to protect others 
from infection. Another predictor of deliberate abstinence among heterosexual men in the Bogart 
study, which is likely to be very important among inmates in Lurigancho in 2000, was bad health. 
Treatment was not available for free in Peru until 2004 and mean age of HIV positive inmates at the 
moment of the interview was 31 which corresponds to the mean age of AIDS diagnosis in Peru [241]. 
In fact, abstinence was not significantly associated with HIV infection among the 2005 sample. 
However, AIDS symptoms cannot explain all findings as a much higher frequency of condom use was 
also observed among HIV positive inmates.  Explaining these results for the 2005 sample is 
straightforward considering the HIV services in place in Lurigancho at that time. Post-HIV testing 
counselling has been proven to encourage preventive behaviours among HIV positive individuals in 
other settings [405]. It could be similar among this sample of inmates and it is tempting to interpret 
this as a successful outcome of the improved HIV programme in the prison. However, given that the 
results from 2000 also point towards similar conclusions we cannot make this extrapolation. 
Additionally, the questionnaire did not ask about knowledge of status or previous HIV testing and it 
did not ask about current physical condition either so, these suppositions can only remain 
hypotheses. It would have made the interpretation much clearer to be able to associate preventive 
behaviours to awareness of status or disease.   
Interestingly, the two variables characterising prison history were significantly associated with HIV in 
the 2000 survey. The effect of these variables was not explained by the proximate determinants. 
This means that the proximate determinants that lie in the causal pathway between this variable 
and HIV infection have either not been captured or have not been measured properly. Being 
incarcerated is related to behaviours outside prison, so longer and repeated incarcerations might 
reflect a riskier lifestyle. Unfortunately, the survey does not provide direct information on behaviour 
outside prison.  
 It is interesting that exposure to prison was associated with HIV in the 2000 sample but not in 2005. 
An intuitive interpretation would be that prisons used to increment exposure to risk but that the 
improvements made to the HIV services in prison have changed that reality. However, this is a 
complex issue and many questions come into play. Firstly, an association between HIV and prison 
exposure does not necessarily mean that inmates are getting HIV in prison or because they have 
been in prison. Inmates are more likely to be HIV positive to start with because it is a population 
characterised by having risk behaviours that lead them to prison but also to HIV infection. More 
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frequent or longer exposures to prison can simply be the reflection of more frequent or dangerous 
risk behaviours outside. Improvements in HIV services in Lurigancho could have had an effect on the 
impact of sentence length on HIV but it is difficult to extend this to repeated incarcerations. The time 
span between the two surveys might also be too short to observe an effect of HIV incidence among 
people exposed to prison. Although these improvements might prevent transmission not only inside 
prison but also outside simply by informing inmates of their status and advising them on how to lead 
a safer sexual life, the impact among reoffenders would have to be very strong to observe such an 
effect.  Changes in the criteria for sending offenders to Lurigancho or simply differences in the 
sampled population are more likely to account for these differences. 
Finally, drug use and especially sex under the influence of alcohol and drugs stood out as an 
important determinant for HIV infection among inmates in the 2005 sample (results shown in 
appendix). Drug use is very common among prison inmates across the world [406]. It is the actual 
cause for incarceration in many cases (illicit drug use is considered a crime in most countries), a 
contributing factor in many others (as feeding an addiction can lead to crime) and can also be a 
consequence of incarceration (since drug use is common in prison and can help escaping reality) 
[406,407,408].  
The association between injecting drug use and HIV is clearly established in the prison system and 
beyond. Injecting drug use is a rare practice in Peru, and among inmates in Lurigancho 0.8% and 
0.9% reported injecting drugs compared to 23% and 13% reporting cocaine use and 18% and 15% 
reporting cocaine paste use in the past 12 months in 2000 and 2005 respectively. Prevalence of HIV 
and other STIs has also been found to be higher among non-injecting drug users. A study carried out 
among NIDU in New York City found high prevalence of both HIV and HSV-2 (16% and 61% 
respectively)[409], in Buenos Aires a study among non-injecting cocaine users found that 6.3% had 
HIV, 9% had HBV, 7.5% had HCV and 4.2% had a positive VDRL test[410]. More precisely, alcohol and 
drug abuse have been significantly associated with sexual risk behaviours such as multiple partners 
and unprotected sex among inmates in the U.S. [169,411]. In these samples cocaine paste and 
cocaine were associated with HIV in univariable analysis in the 2000 and 2005 sample respectively. 
Sex under the influence was not associated with HIV in the 2000 analysis but was a very strong 
predictor for HIV infection in 2005. Sex under the influence of drugs was associated with several risk 
behaviours in this sample including multiple partners and unprotected sex but also sex with men and 
FSW. This is likely to be a useful predictor of risky sexual behaviours in this population and appears 
to be the only determinant to be unaffected by potential changes in behaviour related to awareness 
of status.   
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When looking at the different data sources and analyses carried out, several findings hint at the 
potential importance of infection previous to entry to Lurigancho: prevalence among inmates at 
entry is high and close to total prevalence in the prison, recent behaviour does not seem to inform 
on the routes to infections and the results suggest behaviour change among positive inmates. On 
the other hand, exposure to prison is associated with several HIV associated risk behaviours. 
Understanding how these different prevalence and behaviour patterns translate into epidemic 
potential inside the prison requires more complex analyses that take into account the movement of 
the prison population. The following Chapter investigates these questions through the use of 
mathematical modelling. 
6.2 Limitations 
 
This study has some limitations. For the causal pathways analysis, the number of HIV cases was 
small, especially in 2005, and some associations might have been missed due to a lack of power. We 
tried to minimise this problem by decreasing the number of categories to a minimum in the 2005 
analysis and obtained several significant associations but this remains an issue. Aside the 
methodological issues, there are limitations inherent to the data collected. These are self-reported 
behaviours from men in a situation of confinement. There is a variety of reasons why they might 
have miss-reported their behaviours. Also, recall-bias might be particularly important in this 
population considering its high exposure to alcohol and drugs.  
6.3 Recommendations  
6.3.1  Survey instruments 
This study represents an opportunistic use of data that was originally collected for surveillance and 
monitoring purposes. The information available did not always fit our research questions and 
therefore some remained unanswered and new ones emerged. One of the central interests of this 
work was the impact of the prison environment on behaviour and HIV risk. In the sentinel 
surveillance studies the time frames of the questions did not necessarily correspond to a period of 
incarceration. Most inmates had been in for over 3 months when the survey was carried out but 
questions related to the past year captured behaviour inside and outside prison among 
approximately 30% of respondents. In order to ascertain and quantify the potential differences in 
behaviour inside and outside prison it is necessary to have two separate sections in the 
questionnaire covering specific time periods inside and outside prison. In particular, different 
patterns of exposure to prison might result in different risk behaviours. In this study a high number 
of incarcerations was rather consistently associated with risk behaviours including multiple partners 
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and unprotected sex while time in prison was also associated with abstinence and condom use. 
Having a better understanding on how these patterns of exposure act is important to the design 
adequate prevention interventions. Others have found that the period immediately following 
release is characterised by high risk behaviours so including specific questions on it for inmates who 
have been in prison several times would be useful.  Additionally, this study highlighted the need to 
reconsider the time scale of some of the questions. Asking about recent risk behaviours does not 
seem to provide information on the sources of infection and so including questions referring to life 
time exposures (lifetime number of partners, ever having sex with a man, ever paying for sex) would 
provide a better picture of risk. Also, including questions that provide information on knowledge of 
status and health status would be a valuable addition to interpret the presence or absence of 
preventive behaviours. The questionnaire routinely accompanying HIV testing in Lurigancho is very 
similar to the HIV surveillance survey instrument with some additional questions. We realise that 
adding several questions to this instrument would be unpractical but it would be worth having an 
extended version of the questionnaire to be randomly applied to a small fraction of inmates.  
6.3.2 Screening strategy 
 This type of analyses has previously been used to identify key determinants of HIV infection to be 
included in filter questionnaires for targeted testing. Targeted testing or opt-in testing can be 
preferred over opt-out or compulsory testing when resources are limited. In the case of Lurigancho 
where only 1 to 2% of all tests will be positive, it could be argued that a considerable fraction of 
resources are being lost in testing negative individuals and that targeted testing should be 
considered. However, the information obtained from the sentinel surveillance does not allow 
building a risk profile for HIV infection that could be used for selecting inmates to be tested. 
Moreover, targeted testing relies on inmates being comfortable with sharing sensitive information at 
entry to prison and failure to do so would result in wasting the opportunity to identify cases. 
Recently a study carried out in the prisons of North Carolina compared opt-in and opt-out screening 
and found that although opt-out screening resulted in a higher proportion of inmates getting tested, 
the proportion of previously undetected cases was not significantly larger [412]. It is important to 
keep in mind that background testing is much higher in the U.S. and that the screening system in 
North Carolina prisons is particularly efficient. Among inmates in Lurigancho, this might be the only 
opportunity for them to be tested and informed about risks and prevention measures. As prevalence 
is higher than among the general population it is a strategic place to implement testing and direct 
HIV positive individuals to treatment, preventing further transmission both inside and outside 
prison. 
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6.3.3 Prevention interventions 
The findings from this study are in agreement with what has been observed among inmate 
populations in other latitudes. Incarceration and substance use contribute to the emergence of 
sexual risk behaviours among this population.  Reinforcing prevention messages for men who have 
sex with men would be a first step to control transmission but further research on the contexts in 
which risk is taken among these men would allow designing more appropriate interventions. If these 
men are generally similar to MSM in the general population then interventions that have proven 
efficacious among MSM in Peru could be imported to the prison environment. However, if sex 
between men among inmates is influenced or governed by prison’s rules and customs, then 
interventions should be tailored to these specific issues. Substance use is especially linked with 
unprotected sex and sex with men. This is a pervasive problem of inmate populations and 
interventions to tackle it have been put in place in other countries [413]. Stable partnerships appear 
to be protective against transactional sex with FSW. It would be interesting to understand what 
differentiates men who abstain from sex from men who resort to transactional sex or sex with men. 
Higher levels of condom use were observed among men who had transactional sex and multiple 
partnerships which is an optimistic finding. Finally, at least 3 distinct activities are regularly carried 
out: condom inundation, health promotion campaigns and group psychology sessions for the CVP. 
Investigating the impact and cost of these different initiatives would help implementing evidence 
based programmes in prisons in the region. We recognise that this would involve several challenges 
at the study design level and that additional funding and resources would be required. 
6.4 Further work 
The data collected by the HIV programme represents a wealth of information and offers the 
possibility to address many research questions relevant to the prevention and HIV care in this 
population. In particular, data from the routine screening at entry that has been carried since 2006 is 
of particular value since over 1% of inmates are already infected when they get to Lurigancho.  We 
plan to expand this work to characterise inmates at entry to prison and after to further understand 
risk inside and outside of prison. Additionally, analysing the data collected by each of the different 
testing mechanisms would also provide insight on the risk behaviours of key populations to the HIV 
epidemic inside Lurigancho, especially transgender women and inmates presenting STI symptoms. A 
case-control study focussing on HIV positive inmates would also be an efficient mean to develop a 
risk profile for HIV acquisition. We hope that the efforts undertaken to make this information 
available in electronic format and to systematise the data collection process will facilitate its use. 
Further involvement of research institutions in general would allow adapting the data collection and 
reporting process to academic purposes. 
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Chapter 5: Characterisation of the HIV epidemic 
among prison inmates in the Lurigancho prison, Lima 
Peru, through mathematical modelling 
1 Introduction 
It is established that HIV prevalence is often higher among prison inmates than in the general 
population. Several studies investigating the determinants of HIV infection among prison inmates in 
Latin American countries such as the one presented in the previous Chapter have been done. These 
are useful to identify behaviours or circumstances that may be putting these individuals at risk and 
therefore to point prevention towards the right direction. However, they do not inform us on the 
magnitude, course and characteristics of the epidemic. As snapshots of a population that is in 
continuous movement, they only tell us about the superficial outcome (prevalence) of a dynamic 
process resulting from the interaction between the epidemic and the prison demography. The latter 
is relatively complex and prison prevalence estimates can mask a diversity of epidemic scenarios 
depending on the turnover and reoffending rates. An additional complication is the role played by 
the prison in the epidemic. HIV prevalence is higher among prison inmates because individuals with 
higher risk behaviours are over-represented. While the prison might be a neutral settings where 
transmission follows its course, it could also act as an amplifier of the epidemic through increasing 
the risk of exposure to an infected individual (since prevalence in prison is higher than in the 
community), through creating conditions conducive to rape and coerced sex and through decreasing 
access to prevention measures. On the contrary, prisons could also reduce transmission through 
testing and counselling, condom distribution, methadone maintenance and other harm reduction 
programmes.  
 These factors as well as the demographic factors and the epidemic itself will be particular to a 
country’s prison system and often to the prison as a unit as these differ in their organisation within a 
country, state or town. It is necessary to have a better understanding of the epidemic in order to 
estimate its burden in this population and to develop effective strategies to monitor and control it. 
Mathematical models allow studying multiple interacting dynamic processes through time and offer 
the possibility to investigate different aspects of the epidemic that may be important when it comes 
to programmatic decisions regarding screening, treatment and prevention. Three main issues must 
be integrated in the model to study HIV transmission in prison: the natural history of HIV infection 
(including access to HIV testing and treatment in prison), sex in prison and prison “demography”. 
This term will be used along this Chapter to refer to the changes in size and composition of the 
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prison population over time that are determined by patterns of incarceration and reoffending as 
well as sentence length. 
1.1 Natural history of infection 
The progression of HIV infection can be influenced by several factors. Among prison inmates the 
high prevalence of other infectious diseases such as TB and other respiratory infections, Hepatitis B 
and C and gastro-intestinal infections, could accelerate the progression from AIDS to death or even 
the disease progression in general. The higher prevalence of drug use observed among prison 
inmates might also affect progression. Although these are plausible phenomena, there is little 
evidence supporting them and so they have not been considered in the model. 
1.1.1 Testing and treatment 
Factors particular to the prison environment will be crucial in determining inmates’ access to testing 
and treatment which will in turn have an effect of disease progression. HIV screening policies in 
prison vary by country and State. Most prisons in Latin America do not have a screening system in 
place and testing is done at the discretion of the institution, either when requested by the prison’s 
health services or because the inmates themselves ask to be tested. Knowledge of positive status 
can lead to changes in behaviour and is also the first step to accessing treatment. Treatment 
coverage, guidelines and monitoring are all criteria governing disease progression and transmission 
and will also vary depending on the prisons. In general inmates will receive the same standard of 
care as provided to the general population but due to the restricted capacity of the prisons health 
services common to many countries, this is not always respected. Another important aspect of 
treatment that is invariably problematic in the prison setting is adherence [414]. Drug consumption 
is a major obstacle to consistent pill taking and health is not valued as highly by inmates as they have 
to face more immediate problems on daily bases, some of which might be life threatening. Other 
factors such as mental health problems can have an impact on adherence [414]. As described in the 
previous Chapter, screening at entry, referral to treatment and high adherence to treatment are all 
present in Lurigancho. Disease progression and treatment were therefore modelled in a simple way. 
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1.2 Sex in Lurigancho 
1.2.1 Conjugal visits 
 In Lurigancho, female visitors are allowed two days per week and inmates can bring their visitor into 
their cell to have sex. If several inmates are receiving visitors, they separate the beds using blankets 
and sheets to build what they call “carretajes” [375]. Several thousand women enter the prison on 
visit days, including a small group of FSW who regularly sell their services to inmates [375]. It is 
essential, when considering sexual transmission of HIV in a Latin American prison, to take these 
partners into account.  
1.2.2 Sex between inmates  
Little is known about sex between inmates in Lurigancho. From the sentinel surveillance surveys we 
have an estimate of the prevalence of same-sex sex and have built a behavioural profile of MSM. We 
have endeavoured to complement this information with other sources including the MSF report and 
personal communications from the HIV programme staff in Lurigancho. The importance of the 
transgender women community (Comunidad Virgen de La Puerta) was emphasised in both accounts. 
No information on rape or coerced sex was available and although these events might be included in 
the reporting of sex with men in the sentinel surveillance surveys, these might differ from other 
sexual encounters between men in terms of transmission probability, number of partners and 
frequency of sex. We have prioritised issues for which there was evidence in order to keep the 
model structure relatively simple. 
1.3 Prison demography 
As mentioned earlier, the prison population is in constant movement. The speed of this movement is 
determined by the sentence length and the rate at which new inmates and recidivists are 
incarcerated. The average length of stay in prison is generally dependent on the type of prison. High 
security prisons withhold inmates who have committed serious crimes and are therefore given long 
sentences while medium or low security prisons generally withhold inmates for shorter periods. The 
length of stay in prison is also influenced by the wait preceding the trial, which can be longer than 
the sentence itself if the system is inefficient. Theoretically, prisoners awaiting for trial and prisoners 
serving their sentence should be kept separate from each other but this rarely happens in Latin 
American prisons due to limitations in the infrastructure’s capacity. In the same way serious 
criminals and petty thefts often cohabit in the same prison. There can therefore be important 
differences in length of stay within a single establishment. Recidivism, which in legal terms refers to 
the re-incarceration of former prison inmates, is a common phenomenon across penitentiary 
systems. In the U.S., over 50% of inmates released in 1994 went back to prison in the 3 years to 
follow [415], in the U.K. 36% of those released in 1997 went back to prison within two years [416]. In 
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Peru in March 2012, 31% of inmates had been incarcerated before [417]. Depending on their 
background, or “criminal career” inmates will only have one contact with the prison system, serve a 
few sentences or repeatedly come back to prison (frequent/habituated offenders).  This is an 
important issue to take into account to get an insight on the magnitude of the HIV epidemic among 
prison inmates as prevalence in prison can reflect a variety of incidence scenarios. Additionally, since 
the inmate population is a mix of individuals with different patterns of exposure to the prison 
context it is important to represent this heterogeneity in the model to understand whether the 
prison conditions affect the risk of HIV.  
1.3.1 Modelling prisons 
 
The most commonly used structure when modelling disease transmission in the prison setting has 
been to simply represent prison as a single compartment with a constant inflow and outflow of 
inmates as depicted in Figure 1. Gani [418,419], Ching et al [420] and Brauer and van den Driessche 
[421] have used it to study fundamental properties of generic epidemics in a system defined by a 
constant flow of susceptible and infected individuals. More recently Kajita et al [422] applied it to 
investigate an outbreak of MRSA in the Los Angeles County jail and Legrand et al [423] used it to 
estimate the potential impact of different strategies to control TB transmission in Rio de Janeiro 
state prisons.  
 
Figure 1 . Model diagram representing the transmission dynamics of MRSA in a jail.  
Source: Kajita et al 2007 [422]. The jail is represented through flows in and out of the different infection stages. No track is 
made of previously imprisoned individuals. 
 
More complex structures that represent both the prison setting and the community have been 
developed to study the potential impact of screening or vaccination interventions in prison. Tuli and 
Kerndt (2009) [424] developed a model to investigate the cost effectiveness of an STI screening and 
treatment intervention among MSM in Los Angeles County Men’s jail. The model structure is shown 
in Figure 2. They represented MSM outside and inside jail allowing them to investigate the impact of 
different assumptions regarding sexual behaviour and treatment in these two settings.   
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Figure 2. Model diagram representing STI transmission among MSM in and out of prison from Tuli and Kernt [424].  
The prison and the outside are represented by separate compartments allowing movement between the two. Although 
this incorporates recidivism to a certain extent by allowing individuals to come back to prison it does not take track of 
those who have been in prison. (The structure is used twice to represent two different sexual activity classes). 
 
Sutton et al. [425] developed a model to investigate the impact of a Hepatitis B vaccination 
programme in prisons in England and Wales and then extended this work [426] to compare the 
effectiveness of different vaccination strategies. In that study, explicitly representing individuals with 
previous exposure to prison was important as a proportion would have been vaccinated in a 
previous incarceration. Their model, presented in Figure 3 was also stratified by IDU status with 
different imprisonment rates attributed for IDUs and non-IDUs, further accounting for differentials 
in exposure to the vaccine among this population as a result of more frequent imprisonment. 
 
Figure 3. Model  diagram representing the movement between different imprisonment states including “never 
imprisoned”, “currently imprisoned” and “previously imprisoned” from Sutton et al. [425]  
This not only differentiates between the prison and the outside but separates individuals who have been exposed to the 
prison setting allowing a more precise representation of recidivism and of its impact on the epidemic. The model also 
includes different IDU states and allows movement between these. 
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Mathematical techniques that do not incorporate the dynamics of infections have also been used to 
investigate the contribution of the inmate population to the incidence or the prevalence of 
particular infectious diseases in the total population. These have incorporated population movement 
in prison to calculate estimates. Hartley et al. [427], proposed a metric which they called 
“Epidemiologic weight” to estimate the contribution of prison to incident MRSA carriage in a 
population. This took into account the mean length of stay in prison. Hammett et al (2002)  [428] 
estimated the burden of HIV, hepatitis C and TB among inmates in the U.S. in 1997 by calculating the 
number of infected individuals that pass through the system in that year and dividing in over the 
total number of infected individuals in the population. This exercise was repeated recently to update 
the estimate of the share of HIV infections borne by inmates in 2006 [429]. To calculate the number 
of unique individuals that go through the correctional system in one year several entry and release 
mechanisms have to be taken into account. These are illustrated in Figure 4. 
 
Figure 4. Diagram representing the different routes of entry and release from jail and prison in the U.S. correctional 
system by Spaulding et al. [429]  
Note: This is not a dynamic model but it illustrates the complexity in estimating the number of unique individuals that go 
through the system in a given time period.  
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1.4 Aims 
In the previous chapter we characterised the inmate population in Lurigancho in terms of 
demography, incarceration patterns and HIV associated risk behaviours and we investigated causal 
pathways leading to HIV infection among this population. This analysis generated questions about 
the timing of infection among inmates and the role played by the prison on their risk of infection. It 
also suggested that significant changes in behaviour had taken place between 2000 and 2005 and as 
HIV prevalence also declined over this period, the possibility of a causal association between these 
was considered. Additionally, less obvious but perhaps more fundamental questions are implicitly 
attached to the results from these analyses: how do the sexual behaviour patterns observed 
translate into HIV transmission at the population level taking into account population movement in 
the prison? Could a large epidemic be hidden behind the high turnover rates observed in 
Lurigancho?   We aimed to investigate these issues using a mathematical model of HIV transmission 
among Lurigancho inmates and their visitors. The objectives were to: 
 Characterise the HIV epidemic among inmates in Lurigancho in terms of: 
o Magnitude 
o Groups at risk 
 Understand the role played by the prison on the epidemic 
 Determine whether the decline in prevalence observed between 2000 and 2005 can be 
attributed to declines in risk behaviour. 
2 Methods 
Three deterministic compartmental models of HIV transmission among Lurigancho prison inmates 
and their visitors were developed and parameterised. These mainly differed in their representation 
of the prison demography. The first used the basic “single box” structure described above. This 
reproduced total prevalence adequately but did not allow investigating the effect of prison exposure 
on prevalence patterns, leading us to consider a more complex representation of prison 
demography. The second model used the structure proposed by Sutton et al. but further 
disaggregated inmates into different offender types depending on their frequency of incarceration 
and their sentence length. Although it allowed studying and comparing the epidemic between 
groups with different exposure to prison it averred difficult to parameterise and its outputs were not 
directly comparable to available data making it unpractical. A third structure was therefore 
considered which mirrored time in prison and recidivism in a straightforward way and reconciled 
with available data. Models 1 and 2 are described in appendix and the prevalence and incidence 
curves obtained as well as the overall fit to the data are presented as an illustration of their basic 
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functioning. Model 3 is presented below and was used to carry out the full epidemiological analysis 
of HIV in Lurigancho.  
Model 1 was double-programmed and solved numerically using the Runge-Kutta 4 –step algorithm 
in Berkeley Madonna and a custom-made Euler routine in Matlab. Model 2 and 3 were programmed 
and solved numerically using a custom-made Euler routine in Matlab. 
2.1.1 Summary of model 3 structure 
Model 3 simulated HIV transmission in a population stratified by sexual behaviour, time in prison 
and number of incarcerations. HIV was transmitted through sex between inmates or between 
inmates and female visitors. Infected individuals were assumed to progress through 5 stages: acute 
infection, chronic infection, pre-AIDS or ART treatment and AIDS. The inmate population was divided 
into 5 groups of inmates and 4 groups of female visitors including FSW. These groups were 
characterised by their mixing patterns, the total number of partnerships per year, the number of sex 
acts per partnership, and the use of condoms with each of these partners. Entry into each of these 
groups was assumed to remain constant through time and therefore to be independent of 
differential mortality rates. To focus on trends in prevalence and incidence as a function of prison 
exposure, time in prison was represented using a monthly structure allowing progression through 
risk behaviours according to length of stay. The number of incarcerations was explicitly modelled as 
separate compartments representing individual incarcerations and the outside periods in between 
up to the 5th incarceration. Prison population growth was also modelled to fit the observed 
population size through time in Lurigancho. Uncertainty in parameter values (especially those 
determining sexual behaviour) was considered through the use of a frequentist process which 
allowed parameters to vary and identified parameter sets that produced outputs coherent with 
demographic as well as epidemic data. The analyses were carried out using the selected parameter 
sets and the mean of all runs was presented along with the 95% uncertainty intervals. Table 1 below 
provides a definition of terms used along the model description and results’ section which might 
take a different meaning from the standard. 
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Term Definition 
Inside Individuals in the incarceration stages 
Outside Individuals in the outside stages in between incarcerations 
Inmate 
Individuals who have been incarcerated at least once. Those who are in the outside 
stages in between incarcerations are also referred to as "inmates" 
System 
Entire model. More precisely it refers to individuals in the incarceration AND outside 
stages 
Prison 
demography 
Changes in size and composition of the prison population over time that are 
determined by patterns of incarceration and reoffending as well as sentence length 
Delinquency 
Duration of time during which individuals who have been in contact with the prison 
system remain in the delinquency environment and are therefore subject to coming 
back to prison   
New entries 
In the model, inmates can enter the prison through reoffending (i.e. progression from 
an outside stage to an incarceration stage) or through the entry rate. The latter are 
referred as "New entries" as they are new to Lurigancho. However, the model accounts 
for these being previously incarcerated in other prisons so they are distributed in the 
different incarceration stages at entry  
Table 1. Definition of terms used to describe the model methods and results 
2.1.2 Natural history of infection 
HIV natural history was described as a progression through six stages as shown in Figure 5 and 
detailed in equation 1 to 6: 1=susceptible, 2=acute infection (3 months duration and high 
transmission probability), 3=latent infection (8 years duration, low transmission probability), 4=pre-
AIDS (1 year, high transmission), 5=AIDS (1 year, no transmission) and 6= ART treatment (12 years, 
very low transmission). The state variables are given by ),(, tpX
s
ri  s is the infection-status,  i 
designates the  ‘sexual behaviour group’, r  is the incarceration stage or period outside prison in 
between incarcerations, p is the month in prison since entry during the current incarceration or the 
month outside prison since coming out of prison and t is the time elapsed in the simulation. ϭ2 
designates disease progression from acute to chronic infection, ϭ3 from chronic to pre-AIDS or 
treatment depending on treatment coverage δ at time t, ϭ4 from pre-AIDS to AIDS , ϭ6 from 
treatment to AIDS and ϭ5 from AIDS to death. μ designates the background mortality rate, θ 
designates the population turnover in each sexual behaviour group i and Ϛ designates the exit rate 
from prison or from the outside stages r for each sexual behaviour group i. λi,r is the force of 
infection by sexual behaviour group i and prison or outside stage r. χ is the progression through risk 
behaviours with time in prison which will be defined below. 
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Figure 5. Flow diagram representing the natural history of HIV infection among Lurigancho inmates.  
A number of inmates E enter prison each month and are distributed into their corresponding sexual behaviour group i 
according to κ. A proportion Ωi is chronically infected with HIV. The model assumes a higher prevalence at entry among 
transgender sex workers. After becoming infected at a rate λi,r individuals move through 5 stages characterised by different 
durations and transmission probabilities at a rate σ. A proportion δ receives treatment before entering the pre-AIDS stage. 
Aside from progression to another infectious stage, they can also exit each stage due to background mortality μ, release 
from prison Ϛ or population turnover ϴ. The latter only applies to FSW who exit sex work after a period of time. 
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In the absence of data on treatment among Lurigancho inmates upon release, progression to 
treatment, coverage and adherence were assumed to be independent of prison status (being inside 
or outside). Treatment was modelled using the general population data available for Peru and 
presented in Chapter 3 with the exception that treatment started being available in 2005 (rather 
than 2004) in Lurigancho.  
Progression to treatment was assumed to follow the chronic stage based on the Peruvian treatment 
guidelines. The chronic stage was estimated to last on average 8 years which is shorter than 
assumed in our previous model to account for the high mortality rates observed among HIV positive 
inmates in prison, partly associated to the high TB prevalence in this population. Coverage δ was 
assumed to increase linearly from 2005 to reach 48% in 2007, keep rising up to 80% in 2010 and stay 
constant thereafter. Patients were assumed to be 12 times less likely to transmit HIV while on 
treatment than during latent infection. Patients with AIDS were assumed to have no risk of 
transmitting HIV due to a cessation of sexual activity. The probability of HIV transmission during a 
sex act was determined according to the stage of infection of the infected individual, to the sex of 
the susceptible individual and in case of sex between men, to his sexual positioning during anal sex. 
The parameter values for the history of infections are given in Table 2.  
Parameters Symbol Prior Value       
mode [min-max] 
Reference  
Average transmission rate of HIV per sex act  β
3
 0.001[0.0005-
0.002] 
[430] 
Start of the epidemic ϖ 1975 [318] 
Time for prevalence at entry to reach current levels  ξ [15-30] Assumption 
Current prevalence at entry Ω 0.013 [375] 
Relative transmission rate per:    
receptive vaginal sex act  βi,i' 1 Baseline  
insertive vaginal sex act  βi,i' 0.5 [7]  
insertive anal sex act  βi,i' 3 [7,431] 
insertive or receptive anal sex act (versatile) βi,i' 10 [7,319,431]  
receptive anal sex act  βi,i' 15 [319] 
Relative infectiousness in:    
acute phase infection  β
2
 27 [11] 
latent phase infection  β
3
 1 [11] 
pre-AIDS phase infection   β4 7·2 [11] 
AIDS phase infection  β5 0 [11] 
ART virally-suppressed phase infection β6 0·08 [11,320] 
Mean duration of:    
acute phase infection  1/σ2 3 months [11,320] 
latent phase infection 1/σ3 8 years [11,320] 
pre-AIDS phase infection with elevated viral load 1/σ4 10 months [11,320] 
AIDS phase infection before death  1/σ5 9 months [11,320] 
late ART viral suppression phase infection 1/σ6 12 years [320,321] 
Mean ART coverage of those in need (CD4<200)  δ 0·48(0-0.8) [313,322] 
Table 2. Parameterisation of the natural history of infection.  
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Parameters allowed to vary in the fitting procedure are highlighted in grey and the range of variation is given within the 
Prior Value column. When the mode is given, the triangular distribution was used to sample values; otherwise the uniform 
distribution was used. 
 
2.1.3 Sexual behaviour 
To describe the inmate population’s sexual behaviour we used data from the sentinel surveillance 
survey in 2000.  Inmates were divided into 5 groups based on answers to the question: “In the past 3 
months have you had sex with:  cohabiting partner, female friend, FSW, another man” as described 
in the previous chapter. The index i is used to designate the ‘sexual behaviour group’: 
 1=Men who do not have sex (corresponding to men who reported no partner in the past 12 
months). These were assumed to never have sex from the moment they enter the system. 
 2=Men who only have sex with their wife (MOSW), who constituted nearly 35% of 
respondents in 2000 
 3=Men who have Casual Heterosexual Sex (MCHS), these include men who report sex with a 
female friend and/or a FSW and who might also report sex with their wife 
 4=Bisexual men (Bi), who report having sex with another man and at least one of the three 
possible female partner types  
 5=Transgender Sex Workers (TSW). The last category was not determined through the 
previous question but through work carried out by MSF in Lurigancho that identified the 
inmates belonging to the “Comunidad Virgen de la Puerta” (CVP) as very vulnerable to HIV 
infection [82]. They are difficult to identify in the sentinel surveillance studies as very few 
men report a high number of partners and some of these report having a wife which does 
not correspond to the profile of transwomen. Since they constitute a small group of people 
(about 40 coming through the prison in a year), it is possible that they were randomly 
missed in the sampling process but they could have refused to participate.    
4 groups of visitors, corresponding to the female partners of inmates were created based on this 
information:  
 6=Wives of Men who Only have Sex with their Wife (Wives MOSW)  
 7=Wives and friends of Men who have Casual Heterosexual Sex (Wives MCHS)  
 8=Wives of bisexual men  (Wives bisexual) 
 9=FSW who enter the prison on female visiting days (FSW) 
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2.1.3.1 Distribution per sexual behaviour group 
The distribution of people per risk behaviour at entry was based on the 2000 data restricted to first 
offenders who had been in Lurigancho for less than 3 months (to obtain an adequate sample size). 
The number of women in the system was assumed to be two thirds of the number of inmates 
(corresponding to 60% of inmates and 40% of women in the system) based on the fact that one third 
of inmates reported being single. The proportion in each group of women was based on the 
definition of their male partner: all MOSW were assumed to have a wife so the numbers in these 
two groups were equal. Half of MCHS were assumed to have a wife as a considerable number 
reported having sex with female friends only or FSW. The same assumption was applied to calculate 
the number of wives of Bisexual men. The number of FSW was based on information from the HIV 
programme in Lurigancho that estimates there are less than 100 FSW visiting Lurigancho.  
2.1.3.2 Sex acts per partnership 
2.1.3.2.1 Stable partner 
Information on number of sex acts per partnership was not available so assumptions were made 
based on the number of visit days and on previously reported information on sexual activity with 
specific partner types. In Lurigancho there are 2 visit days for women: Wednesdays and Saturdays. If 
stable female partners visit and have sex once on both days each week this would result in 104 sex 
acts per year. This is probably a high bound as it is unlikely that women always manage to visit on 
both days and although inmates are allowed to take visitors to their cell, there is a limited number of 
beds and if we apply the organisation observed in other Latin American prisons, these spaces are 
often rented meaning that having sex can represent an expenditure.  One sex act per week was 
considered a more reasonable estimate (52 per year). As a comparison, the average number of sex 
acts per year reported by cohabiting partners in Peru is 77 [316].  
2.1.3.2.2 Sex worker 
Concerning commercial sex, we assumed these are one time encounters with a maximum of 2 acts 
per encounter, so the number of sex acts per commercial partnerships was set at 2.  
2.1.3.2.3 Casual partner 
For casual/occasional partners we assumed an average of 10 sex acts per partnership.  All parameter 
values for the parameterisation of sexual behaviour in the model are provided in Table 4. 
2.1.3.3 Number of partners and condom use 
The number of partners per year for each of the groups was based on their answer to the question: 
“how many sexual partners have you had in the past 12 months” as presented in the previous 
Chapter. Contact patterns between groups are determined by the mixing matrix described below 
and illustrated in Figure 6.  
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Condom use between different groups was approximated by using the questions “Did you use a 
condom last time you had sex with your stable partner/casual partner?” among those who only 
report one type of partner in the past 3 months as described in the previous Chapter. It is likely that 
condom use was much lower early in the epidemic as condoms started being heavily marketed with 
the onset of the HIV epidemic. Condom use values were therefore assumed to be very low at start 
and to increase linearly from 1985 to 2000 due to information campaigns around HIV/AIDS and 
general increase in the availability of condoms during this period to reach the values observed in 
2000. From 2000 to 2009 (MSF period) the slope of the increase in condom use was used to 
represent changes in behaviour and fit the model. In both time periods condom use was assumed to 
increase at the same rate among all sexual behaviour groups.  
2.1.3.4 Mixing matrix 
The mixing matrix, defined by ρi,i’, is the probability that a person in group i forms a partnership with 
a person in group i’. By definition, among men who only have sex with their wife (MOSW) all their 
partnerships are formed with their wife, so ',ii  is set at 1 for i’ corresponding to wives of MOSW 
and 0 for all other groups. It was assumed that stable partners of inmates were monogamous so 
',ii  was set at 1 for i’ corresponding to their partner and 0 for all other groups. TSW were assumed 
to only have sex with bisexual men, as given the nature of their identity they very rarely have sex 
with women or between them. Men who have casual sex with women shared their partnership 
between their stable partner and FSW. Bisexual men were assumed to have sex with their stable 
partners, FSW, TSW and between each other.The mixing matrix is illustrated in figure 6 below. 
 
Figure 6. Diagram representing patterns of partnership formation between inmates and visitors with different sexual 
behaviours.  
MOSW: Men who only have sex with their wife/cohabiting partner; MCHS: Men who have Casual Heterosexual sex; 
Bisexuals: men who have sex with men and women; TSW: Transgender sex workers; No sex: men who never have sex; 
FSW: Female sex workers who visit the prison; the wives/cohabiting partners of inmates are modelled as separate groups 
depending on the sexual activity of their partner. Mixing in the model is determined by the insertive partners 
corresponding to MOSW, MCHS and bisexuals (although these are assumed to be versatile when they have sex with other 
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bisexual men). The direction of the arrow goes from the insertive to the receptive partner. Double ended arrows represent 
versatility in sexual positioning during anal sex. Only the parameters defining the behaviours of other groups are shown in 
the model for clarity. Ci corresponds to the number of partners per year in group i and pi,i’ corresponds to the proportion of 
partnerships among group i that happen with group i’ 
 
It was assumed that the demand for sex was driven by men playing the insertive role during vaginal 
or anal sex. To balance the number of partnerships formed between the groups, the total number 
and proportion of partners that receptive individuals had in each group Ci and ρi,i’  respectively was 
inferred from the number of partners they had in group i’. As shown in equation 7, the number of 
partners for female visitors (wives and FSW) was therefore calculated based on the number of 
partners reported by men and on men’s sexual mixing matrices. In the same way, the number of 
partners of TSW was calculated based on the demand from Bisexual men. 
G1=odd numbers inside prison= {g=1,3,5,7,9} 
G2=even numbers outside prison= {g=2,4,6,8} 
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The frequency of male to male sex in Lurigancho and most prisons is unknown. One of the theories 
regarding the modification of sexual behaviour while in prison is the so called “situational 
homosexuality”, where men that would not have sex with other men in their usual environment do 
it in prison because of unavailability of female partners[69]. If this was the most common profile 
among MSM in prison, a minority of their sex acts would happen with other men. Exclusive 
homosexuality on the other hand, is described as a true preference for same-sex sex. If this was the 
most common profile among MSM in prison, a majority of sex acts would happen with other men. 
Additionally, the frequency of sexual coercion in prison will also influence mixing patterns between 
men. To allow for flexibility between these two extremes, the mixing matrix for MSM was 
constructed so that the “homosexuality degree” could be varied. Situational homosexuality (SH) was 
defined as 80% of partnerships occurring with women (wife and FSW) and exclusive homosexuality 
(EH) was defined as 80% of partnerships occurring with men (Bisexual men and TSW).  The mixing 
matrix combines these two profiles with the degree of homosexuality being determined by ε (ε=1 
corresponding to the exclusive homosexuality and ε=0 corresponding to the situational 
homosexuality) as shown in Figure 7 and equation 8 where ρi,i’ is the proportion of partnerships in 
group i formed with group i’.  All values for the mixing matrix are provided in Table 3.
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  Figure 7. Type of homosexuality determining the parameterisation of mixing patterns among bisexual men in 
Lurigancho.  
(8)          )1( ',',', iiiiii SHEH    
 
Table 3. Mixing matrix between sexual behaviour groups.  
The proportion of partnerships formed with each partner type is given for each sexual behaviour group by row. For 
bisexual men, these could vary between two extreme scenarios: Exclusive homosexuality (EH) and Situational 
homosexuality (SH). 
 
2.1.3.5 Force of infection 
The rate of progression from susceptible to infected, determined by the force of infection (FOI) 
through sexual contact depends on: the number partnerships iC , the proportion of partnerships 
formed with each of the sexual behaviour groups ',ii , the number of sex acts occurring within that 
partnership ( ',ii ), the infection-status and stage of infection of the partner and the fraction of sex 
acts in which a condom is used ( ',ii ) as shown in equation 9.
s
ii ',  
is the probability of HIV 
transmission per sex act for each stage of infection and for the type of sex occurring in that 
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particular partnership (insertive/receptive vaginal or anal sex). As no information was available 
regarding sexual behaviour outside prison it was assumed that the relative differences between 
groups was maintained but the magnitude of the transmission was allowed to vary through 
multiplying the FOI inside prison by a constant named “outside_level” as shown in equation 10. 
Bisexual men were assumed to be versatile when they had sex with other bisexual men and to be 
exclusively insertive when they had sex with TSW. TSW were therefore assumed to be exclusively 
receptive. Although an effort was made to capture heterogeneity in transmission depending on 
infectious status, type of contacts and condom use with different partners, deterministic models 
work with averages and so they can only provide an approximation of the true force of infection.  
G1=odd numbers inside prison= {g=1,3,5,7,9} 
G2=even numbers outside prison= {g=2,4,6,8} 
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Parameter Symbol Prior Value      
Mode [min-max] 
Reference 
Fraction of inmates who:    
do not have sex κ1 0.006[0.003-0.012] SS 2000  
are MOSW κ2 0.27[0.19-0.35] SS 2000 
are MCHS κ3 0.27[0.20-0.35] SS 2000 
are Bisexual κ4 0.05[0.005-0.11] SS 2000 
are Trans Sex Workers κ5 0.009[4.5e-4-0.03] [82,375] 
are wives of MOSW κ6 0.26[0.23-0.28] By definition 
are wives of MCHS κ7 0.10[0.08-0.12] Assumption 
are wives of Bisexual men κ8 0.03[0.02-0.05] Assumption 
are FSW κ9 0.004[0.002-0.02] [375] 
Number of partners among:    
men who do not have sex C1 0 By definition 
MOSW C2 1.3[0.7-2.6] SS 2000 
MCHF C3 3[1.5-6] SS 2000 
Bisexual men C4 3.4[1.7-7] SS 2000 
Number of sex acts with:    
sex workers ω5,i and ω9,i [1-4] Assumption 
stable partner ω6to8,i  [12-96] Assumption 
casual partners ω4,4 [5-15] Assumption 
Fraction of partnerships formed by:            
MOSW with wife ρ2,6 1 By definition 
MCHS with wife ρ3,7 0.34 Assumption 
MCHS with FSW ρ3,9 0.66 Assumption 
Bisexual men with wife EH/SH ρ4,8 0.05/0.2 Assumption 
Bisexual men with FSW EH/SH ρ4,9 0.15/0.6 Assumption 
Bisexual men with Bisexual men EH/SH ρ4,4 0.2/0.05 Assumption 
Bisexual men with TSW EH/SH ρ4,5 0.6/0.15 Assumption 
TSW with Bisexual men ρ5,4 1 Assumption 
MOSW with MOSW  ρ6,2 1 By definition 
MCHS with MCHS ρ7,3 1 By definition 
Bisexual men wives with Bisexual men ρ8,4 1 By definition 
Degree of situational homosexuality ε [0-1] Extreme scenarios 
Condom use with:    
Stable partner (in 1985) θ6to8,2to4 0.04[0.01-0.06] SS 2000 
TSW (in 1985) θ5,4 0.08[0.02-0.1] SS 2000 
FSW (in 1985) θ9,3to4 0.12[0.03-0.14] SS 2000 
Bisexual men (in 1985) θ4,4 0.06[0.015-0.08] SS 2000 
Condom change factor from 1985 to 1999  Condom_Ch1 5.5 SS 2000 
Condom change factor from 1999 to 2009 Condom_Ch2 1.58*[0-6] SS 2000-2005 
Factor for acceleration of risk behaviour progression Prison_effect [0-3] SS 2000 (calibration) 
Factor for change of FOI outside prison Outside_level 1*[0-15] extreme scenarios 
Table 4. Parameterisation of sexual behaviour.  
Parameters allowed to vary in the fitting procedure are highlighted in grey and the range of variation is given within the 
Prior Value column. When the mode is given, the triangular distribution was used to sample values; otherwise the uniform 
distribution was used. * indicates that the log normal distribution was used for sampling and the number preceding it 
refers to the median as opposed to the mode. SS 2000: sentinel surveillance survey 2000. 
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2.1.3.6 Progression through risk behaviours 
The multivariable analysis looking at predictors of risk behaviours indicated that time in prison and 
number of incarcerations were independent risk factors for some risk behaviours.  Results from 
these analyses are presented in Chapter 4 and summarised in Table 5. Although most associations 
follow the same direction in the 2000 and 2005 datasets, significance was not always reached for the 
same variables.  
  
FSW 
Sex with 
men 
Unprotected sex 
last casual 
Sexual 
abstinence 
Previous 
incarcerations 
2000 (↑)  (↑)  ↑* (↑) 
2005 ↑** ↑** ↑** ↓* 
Time in prison 
2000 ↑***  ↑***  ↓* - 
2005 ↑**  (↑)  (↓) ↑*** 
 
 
 
 
Table 5. Estimated effect and significance of the number of incarceration and the length of stay in prison on the 
prevalence of risk behaviours among inmates from multivariable analyses chapter 4.  
p values are reported as follows:  ˜= borderline significant, *<0.05, **<0.01, ***<0.001. Brackets represent effects that 
were significant in the univariable analysis but lost significance after adjustment for other variables. 
 
To incorporate this in the model, the information had to be reconciled in a tangible way.  Taking a 
simplistic view, the results suggest that the more inmates are in contact with the prison context the 
more they engage in behaviours that may put them at risk of HIV. Because we needed to reproduce 
the movement of the prison population in a precise way to answer our research questions, both 
time in prison and the number of incarcerations were incorporated in the model. We implemented a 
PDE model to represent time in prison (described in the next section) which we used to model the 
progression of inmates through risk behaviours as a function of their exposure to prison. The 
multivariable analysis suggested that those reporting no sexual partners in the past 12 months were 
more likely to be older men, who had separated or lost their partner, who had been in prison for 
longer and who were more likely to test positive for syphilis antibodies (which can be a marker of 
past risk behaviours). Based on these findings, inmates were assumed to progress through the 
different groups of sexual behaviour following an increased risk gradient or to stop having sex as 
shown in Figure 8 and equation 12. Men who only have sex with their wives change their behaviour 
at a rate η2,2 and a proportion starts having casual sex with FSW while the remaining stops having 
sex. These are expressed in terms of rates η2,3 and η2,1  respectively in Figure 8 in agreement with the 
model implementation. In the same way, MCHS progressed at a rate η3,4  and η3,1 to having sex with 
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men and FSW and to stop having sex respectively. Bisexual men progress to selling sex to men at a 
(very slow) rate η4,5 or stop having sex at a (higher) rate η4,1. TSW stop having sex at a rate η5,1. These 
rates have a baseline value η* which magnitude is allowed to vary by a constant named 
“prison_effect” as shown in equation 11. The progression to higher risk behaviours only occurs 
among those who are inside prison. 
Wives of inmates in each of the groups progress as the same rate as inmates to simulate continuity 
in the partnership. To reproduce partnership dissolution, when inmates progress to not having sex, 
women exit the population. Again, couples are no modelled explicitly here so this is an 
approximation. The values for the progression rates are given in Table 6. 
 
Figure 8. Diagram describing the progression through the different sexual behaviour compartments with time in prison.  
As inmates spend longer in prison they are assumed to engage in riskier sexual behaviours or to stop having sex. This is 
represented by a progression to the sexual behaviour group implying an additional level of risk or to the “no sex” group 
respectively according to rates ηi,i’ (the first index corresponds to the individuals progressing, the second to the group they 
are progressing to). Wives of inmates are assumed to progress at the same rate to approximate the couple contruct. When 
inmates progress to not having sex, wives exit the population. 
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Sexual behaviour group Rate of progression through sexual behaviour groups 
Description Index η1 η2 η3 η4 η5 η6 η7 η8 η9 
No sex 1   -1/60 -1/60 -1/60 -1/60         
MOSW 2   1/15               
MCHS 3   -1/20 1/15             
Bisexual 4     -1/20 1/20           
TSW 5       -1/30 1/60         
Wife MOSW 6           1/15       
Wife MCHS 7           -1/20 1/15     
Wife bisexual 8             -1/20 1/20   
FSW 9                   
Table 6. Values for the rate of progression through risk behaviours based on manual calibration.  
Positive values correspond to inmates exiting their sexual behaviour group and negative ones correspond to inmates 
entering a new group. For each group, these must sum to 1. The colours show that these rates are equal for inmates and 
wives. 
2.1.4 Prison demographics 
The two determinants of prison exposure are the time spent in prison and the frequency of 
incarcerations. We aimed to reproduce reality as accurately as possible while keeping the model 
structure relatively simple. Additionally, we aimed to develop a model that conformed to the data 
available both in terms of its parameterisation and its outputs. From the sentinel surveillance survey, 
information on time spent in prison during the current incarceration and on the number of previous 
incarcerations was available. This is the standard information collected in prison surveys. Based on 
this we developed a model that allowed tracking both time spent in Lurigancho during the current 
incarceration and the number of incarcerations. 
2.1.4.1 Time in prison 
Compartmental models work with exponential rates and these do not simulate time in an accurate 
way. The time spent by individuals in a compartment will be on average 1 over the progression rate 
but some will be there for a very short time while others will be there for longer, following the 
exponential curve. To tackle this issue, a partial differential equation model was implemented 
allowing variables to change in function of time as well as time in prison. This was approximated by 
including a third dimension representing the month in prison. p is the month in prison since entry 
during the current incarceration or the current month outside prison since coming out of prison. 
Individuals are moved into the following month in prison p+1 at each time step dt (which 
corresponds to one month) as shown in Figure 9. When inmates exit prison they go to the first 
month outside prison and when they go back into prison they enter the first month in prison during 
the current incarceration as shown in equations 15 to 26, meaning that the clocks are re-started 
every time inmates exit or enter prison and therefore total cumulated time in prison over several 
incarcerations is not tracked in the model. Based on data from the sentinel surveillance the vast 
  
233 Chapter 5: Characterisation of the HIV epidemic in Lurigancho through mathematical modelling 
majority of inmates remain in prison for less than 20 years during a particular incarceration, so this is 
set as the maximum sentence length corresponding to 240 compartments (20*12).  
2.1.4.2 Recidivism 
To accurately represent recidivism each incarceration was modelled as a separate compartment, 
individuals exit prison and a proportion φ progresses to a compartment representing a period 
outside prison before going to the following incarceration stage as shown in Figure 9. According to 
the sentinel surveillance data, over 90% of inmates have been incarcerated less than 5 times in their 
lifetime. The recidivism dimension was therefore divided into 9 compartments representing 5 
incarcerations and the outside periods in between. r is the incarceration stage or period outside 
prison in between incarcerations (1=First incarceration; 2=First period outside; 3=Second 
incarceration, 4=Second period outside, 5=Third Incarceration, 6=Third period outside, 7=Fourth 
incarceration, 8=Fourth or more periods outside, 9= Fifth or more incarcerations). Reoffenders 
progress to the compartment r+1 with one exception: in order to take into account very frequent 
offenders, individuals can go back and forth between the 5th incarceration compartment and the 
outside period preceding it as shown in equations 21 to 26. The data did not indicate important 
differences in sentence length depending on the number of previous incarcerations. The exit rate Ϛ 
was then assumed to be equal for all incarceration stages and was calibrated to match the average 
time spent in prison reported by inmates in the two sentinel surveillance studies. There was an 
increase in sentence length between 2000 and 2005 as average time spent in prison in the current 
incarceration went from 1.8 to 2.4 years respectively. The model assumes, based on the age profile 
of inmates that delinquency (or other behaviours potentially leading to incarceration) only lasts for a 
certain period of time which was assumed to be no longer than 25 years on average. The duration in 
the outside stages was calculated based on total duration in delinquency and the average sentence 
length. The proportion of inmates that remain in the system (i.e. that reoffend) after each 
incarceration decreases as the number of incarcerations increases.  As shown in equations 13 and 
14, new entries were distributed in the different sexual behaviour groups according to κ based on 
the distribution observed among first offenders that had been in prison for less than 3 months in the 
2000 sentinel surveillance data. They were also distributed in the different incarceration stages 
according to ψ to account for inmates that had been incarcerated elsewhere before. Finally, a 
proportion Ωi of the new entries in each sexual behaviour group κi was assumed to be infected and 
entered the chronic infection stage (entry prevalence). Apart from new entries it was necessary to 
reintroduce individuals lost due to AIDS related death  t
,
5
,
ri
riX  or that exit the population after 
having been in an incarceration or outside stage for over 20 years  
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Figure 9. Diagram representing the movement of the inmate population and their visitors through time and number of 
incarcerations.  
The first panel represents the full structure: each column represents an incarceration stage or a period outside in between 
incarceration r. Inmates (and their visitors) enter the first incarceration stage and spend some time in prison p represented 
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by the rows of the structure. Each row represents a different month in prison or outside and allows tracking the time spent 
by individuals in a specific stage. The longer they spend in a stage the lower they get in the structure. When they exit 
prison they enter the first month of the corresponding period outside, going back to the top of the structure and the same 
happens when they return to prison. This is shown in more detail the lower panel: A number of inmates and visitors E 
enters prison at each time step dt and these are distributed in the different incarceration stages according to ψr to account 
for inmates who have been in other prisons before. At each time step dt they progress to the following time in prison 
compartment p+1, which they exit at a rate ζi,r , assumed to take a single value for all incarceration stages and another for 
all the outside periods. A proportion φr, corresponding to reoffenders, enter the compartment p1 of the period outside 
following that incarceration stage. When they exit the outside stage, all go back into prison.  
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Data on entry prevalence was available from the routine screening system from 2006 and 
prevalence among first offenders who had been in prison for less than 3 months was obtained from 
the two sentinel surveillance surveys to have earlier estimates. Total prevalence at entry was 
assumed to linearly increase until it reached 1.3%. This is defined as 
i
i max in equation 27.  The 
time needed to reach this value (i.e. to the epidemic to take off) was determined by a parameter ξ 
which was allowed to vary between 15 and 30 years and so the prevalence at entry increased 
linearly from the start of the epidemic in year ϖ to year ϖ+ξ. Prevalence at entry Ωi was assumed to 
be equal among all groups except TSW (κ=5) for whom it was estimated to reach 40% after the 
epidemic take off as shown in equation 28. Prevalence in the other groups was then calculated as 
the residual of total prevalence and prevalence among TSW as shown in equation 29 but it was 
assumed to reach levels no lower than 0.4% once total prevalence had reached 1.3%, corresponding 
to current estimates of prevalence in the general population. This meant that under some parameter 
sets, entry prevalence among TSW could be lower than 40% after epidemic take off. 
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To allow for the system to reach equilibrium, the simulation was started in 1964 corresponding to 
the opening of Lurigancho. As the total population in the model includes stable partners of inmates 
as well as FSW, the starting population was set at 2550 with 1500 of these corresponding to inmates. 
At time 0, all individuals are put into the first month of the first incarceration stage according to ϑr as 
shown in equation 31. It is likely that some of these inmates had been incarcerated before in other 
prisons but given that we do not have data to inform this we decided to reduce the number of 
assumptions and allow the system to reach an equilibrium that fits the patterns observed. The only 
imprisonment scenario not represented here is being incarcerated in another prison in between 
incarcerations in Lurigancho.  All individuals were assumed to be susceptibe to HIV at the start of the 
simulation as show in equations 31 to 36. 
(30)          , riri    
   
 
 
 
 
  (36)          00,1
(35)          00,1
(34)          00,1
(33)          00,1
(32)          00,1
(31)          00,1
6
,
5
,
4
,
3
,
2
,
,
1
,






tpX
tpX
tpX
tpX
tpX
tNtpX
ri
ri
ri
ri
ri
riri 
 
 
 
 
 
  
238 Chapter 5: Characterisation of the HIV epidemic in Lurigancho through mathematical modelling 
2.1.4.3 Integrating changes in population size 
As described in the previous Chapter the population size of Lurigancho has been changing over time, 
Figure 10 is given as a reminder. The model was fitted to these estimates.  
 
Figure 10. Number of inmates in Lurigancho through time 
 
In a closed system and if entry rate E is constant, the prison population size at equilibrium P is equal 
to: 
                                                 
Where S is the sentence length at each incarceration stage and ϕ is the proportion reoffending after 
each incarceration stage. Equation 37 assumes that all entries arrive into the first incarceration 
stage. However, Lurigancho receives reoffenders who have previously been incarcerated in other 
prisons. The proportion entering each incarceration stage is defined by a parameter ψ: 
                                                                   
                                            (38) 
In Lurigancho, entry rate was not constant throughout time. However, the population size curve can 
be cut into two straight lines, from 1964 to 2000 and from 2000 onwards. Therefore, entry rate also 
changes with time following a straight line and it is possible to calculate its value at each time point 
by determining entry rate at the extremities of the straight lines and obtaining the slope of the lines 
as shown in equations 40 and 41. 
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The number of new entries per month (E) was then calculated as a function of the average sentence 
length (S), the proportion reoffending (φ) at each incarceration stage and the prison population at 
equilibrium, ensuring that it reproduced the observed population growth. The parameters describing 
prison demography are listed in Table 7 below. 
 
Parameter Symbol Prior Value      
Mode [min-max] 
Reference 
Prison Demographics       
Start of simulation   1964 MSF report 
Population at start Nt=0 2550 MSF report 
Life expectancy 1/μ 45 World Bank/SS 
Fraction of new entries for whom it is the:    
1st incarceration ψ1 [0.5-0.9] SS 2000 
2nd incarceration ψ3 [0.02-0.25] SS 2000 
3rd incarceration ψ5 [0.01-0.19] SS 2000 
4th incarceration ψ7 [0.006-0.15] SS 2000 
5th+ incarceration ψ9 [0.02-0.23] SS 2000 
Fraction who reoffend after the:    
1st incarceration φ1 [0.2-0.33] SS 2000 
 
2nd incarceration 
φ3 [0.17-0.25] SS 2000 
3rd incarceration. φ5 [0.1-0.17] SS 2000 
4th incarceration. φ7 [0.08-0.125] SS 2000 
5th+ incarceration φ9 [0.08-0.125] SS 2000 
Average sentence length before 2000  S1 2[1.8-2.2] SS 2000 
Average sentence length after 2000 S2 2.8[2.4-3] SS 2000 
Duration of criminal career DE 18[16-25] Assumption 
Turnover of the FSW population τ9 1/5 Assumption 
Table 7. Parameterisation of the prison demography.  
Parameters allowed to vary in the fitting procedure are highlighted in grey and the range of variation is given within the 
Prior Value column. When the mode is given, the triangular distribution was used to sample values; otherwise the uniform 
distribution was used. SS: sentinel surveillance. 
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2.1.5 Model Calibration 
  
2.1.5.1 Determining parameter variation ranges 
To fit the model, allowing for uncertainty around parameter values, a frequentist approach was 
taken. Parameters describing sexual behaviour as well as the demography of the prison population 
were allowed to vary within a range and following a distribution. Of the natural history of infection 
parameters only two parameters were sampled: the basic transmission probability and the time 
needed to reach current prevalence at entry levels. The parameters allowed to vary are highlighted 
in grey in tables 6, 7 and 10 and their range and distribution are given. Conditionality between 
parameters determining the proportion of individuals in each sexual behaviour group and 
incarceration stage at entry was addressed by building trees ensuring that the sum was always equal 
to 1. When point estimates were available from data, parameters were allowed to vary around 
these. When no data was available a manual calibration was used to inform the ranges.  
2.1.5.2 Sampling parameter values 
Parameter values were sampled using Latin Hypercube Sampling (LHS), a technique described in 
Chapter 3, which evenly covers the distribution space and allows obtaining parameter sets 
corresponding to different combinations of parameter values. For all parameters, the uniform 
distribution was chosen when there was no prior information available and the triangular 
distribution was used when a point estimate was available. The log normal distribution was used for 
the multiplication factors for condom change and force of infection outside in order to test 
hypotheses as described further in the analysis section.  The model was run with 10,000 different 
parameter sets.  
2.1.5.3 Selecting plausible parameter sets 
Rejection was based on demographic criteria:  
o proportion of inmates in each incarceration stage  
o proportion of inmates in each time in prison category 
o number of entries per month at four time points 
o average time spent in prison at two time points 
Sexual behaviour criteria:  
o proportion of people in each sexual behaviour group 
Epidemic criteria:  
o total prevalence among inmates at several time points 
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Selected runs are therefore considered consistent with the dynamics of the prison population and of 
the epidemic as observed from the available data. Prior limits for each of these outputs are listed in 
Table 8 below. The reasoning used to determine the lower and higher bounds for each prior limit are 
given in the table. The analyses were carried out with all runs and the mean and 95% uncertainty 
intervals are presented. 
Parameter year Lower 
bound 
Higher 
bound 
Determination of bound 
values Prison demography        
Fraction of inmates in 1st inc. 2000 0.55 0.70 
15% around point estimate 
Fraction of inmates in 2nd inc. 2000 0.1 0.25 
Fraction of inmates in 3rd inc. 2000 0.05 0.20 
Fraction of inmates in 4th inc. 2000 0.02 0.17 
Fraction of inmates in 5th inc. 2000 0.02 0.17 
Fraction of inmates in <1y time cat. 2000 0.25 0.45 20% around point estimate 
Fraction of inmates in 1-4y time cat. 2000 0.4 0.65 25% around point estimate 
Fraction of inmates in 4+y time cat. 2000 0.02 0.20 18% around point estimate 
Number of new entries per month 
2005 200 350 
150 around point estimate 2006 200 350 
2008 300 450 
2009 300 450 
Mean time in prison 2000 1.6 2.4 -0.2/+0.6 point estimate 
2005 2.2 2.6 +/- 0.2 point estimate 
Sexual behaviour        
Fraction no sex 2000 0.000 0.050 Broad variation around point 
estimate to account for 
misreporting but keeping 
order of magnitude 
Fraction MOSW 2000 0.3 0.5 
Fraction MCHS 2000 0.3 0.5 
Fraction Bisexual men 2000 0 0.15 
Fraction TSW 2000 0 0.05 
Epidemic        
Total prevalence among inmates 
2000 0.01 0.08 Low: account for non-
response/ High: HIV 
programme estimate 
SS 95% CI halved and doubled 
HIV programme 95% CI 
halved and doubled 
2005 0.006 0.034 
2010 0.007 0.040 
2012 0.009 0.050 
Table 8. Prior limits for the rejection of runs  
 
2.2 Analysis 
The analysis followed the three main questions driving this study: characterisation of the epidemic in 
Lurigancho in terms of magnitude and groups affected, elucidation of the role played by the prison 
system in the epidemic, investigation of the potential impact of MSF on the epidemic. A basic 
evaluation of the model’s performance and sensitivity to uncertainty in parameter values was 
carried out before addressing the questions to verify that the model reproduced the sentinel 
surveillance data adequately. Selected results were compared to available data from the HIV 
programme in Lurigancho to validate the findings.  
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2.2.1 Evaluating model fit and validation 
The outputs for the distribution and HIV prevalence by incarceration stage, time in prison category 
and sexual behaviour group was expressed as the mean from all selected runs and 2.5 and 97.5 
percentiles to fully represent uncertainty.  To identify parameters dominating the selection of 
parameter sets, thedistributions of all parameters allowed to vary before and after the selection 
process were plotted and compared.  
The sensitivity of the model to uncertainty in parameter values was evaluated by estimating the 
strength in association between the parameters allowed to vary in the LHS and incidence and 
prevalence in 2010. Partial Rank Correlation Coefficients (PRCC) were calculated for each parameter. 
As all parameters vary simultaneously, it is possible to estimate the independent effect of each while 
controlling for all other parameters. Non parametric tests of ranked data are needed to carry out 
sensitivity analyses when the PDFs of the parameters are not normally distributed and when the 
outcome is not a linear function of the input variables [327], which is often the case with infectious 
disease models and true for this particular model. This method was proposed by Kendall and Stewart 
in 1979 [327] and describes the strength of the independent statistical relationship between each 
input parameter and the output and calculates its significance through a Student’s t‐test.  
A validation of the results was carried out by comparing the total number of new infections, AIDS 
cases and patients starting ART treatment among inmates generated by the model to independent 
data available from the HIV programme in the prison.  
 
2.2.2 Characterisation and magnitude of the epidemic 
 
The main aim was to characterise the epidemic among Lurigancho prison inmates. The plausible 
prevalence and incidence curves obtained from the epidemic selection procedure were presented, 
as well as mean prevalence and incidence per sexual behaviour groups, incarceration stages and 
time in prison categories to illustrate potential heterogeneities in risk according to these variables. 
The magnitude of the epidemic was evaluated by exploring incidence at different time points and 
estimating the maximum incidence among inmates that would still be consistent with available 
prevalence estimates.  
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2.2.3 Effect of the prison setting on transmission: estimating of transmission 
levels outside as compared to inside prison 
 
As the data did not provide information on sexual behaviour outside prison, an important unknown 
was the risk of HIV transmission outside and whether this was higher or lower than in prison.  As in 
theory, transmission in prison has the potential to be higher than outside due to higher community 
prevalence and less access to prevention measures or “safe partners”, the null hypothesis was that 
the force of infection would be higher inside than outside prison. To test this, the force of infection 
outside prison was kept identical than inside prison for each of the sexual behaviour groups and was 
multiplied by a constant that could take values ranging from 0 to over 10. For sampling this 
parameter, the log-normal distribution was used in order to have the same probability of sampling 
values below and above 1. If the median of the values corresponding to the selected runs was 
significantly different from 1, it would suggest transmission outside prison in different from 
transmission inside prison.  
2.2.4 Estimation of the potential impact of MSF prevention efforts on the 
epidemic 
 
MSF were present in Lurigancho from 1999 to 2009. During this time, they raised awareness about 
HIV/AIDS, made testing more accessible, provided STI treatment and distributed condoms among 
other prevention activities. Although a formal programme evaluation is not possible in this case, the 
2000 sentinel surveillance survey (which actually started being collected at the end of 1999) can be 
used as baseline data for both sexual behaviour and HIV prevalence. A comparison of the results 
from the 2000 and 2005 surveys suggested there had been a significant decrease in the prevalence 
of most risk behaviours and HIV prevalence decreased from 2.6 to 1%.  It is not possible to attribute 
the decrease in risk behaviours to the MSF interventions because there is no measure of exposure to 
the intervention in the questionnaire. Also, the decrease in prevalence might be due to the natural 
dynamics of the epidemic.  The model was used to test the evidence that changes in behaviour 
affected the natural course of the epidemic.  
Behaviour was assumed to remain constant throughout the simulation and was parameterised using 
2000 data.  Possible changes in behaviour were simulated by changing the general trend in condom 
use from 1999 to 2009.  We assumed that condom use would have continued to increase after 1999 
independently of MSF following the slope of increase in condom use that happened from 1985 to 
1999 (shown in the red dashed line in Figure 11). This is quite a conservative assumption as it is 
possible that this increase would have levelled off after 1999 (grey dashed line) or even decreased 
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after 1999. For the increase in condom use to follow the same slope it would have had to increase 
1.58 fold from 1999 to 2009.  
 
 
Figure 11. Diagram representing assumptions for the trends in condom use.  
Note: The null hypothesis assumed a constant increase in condom use after 1999 (red dashed line) 
 
The factor for condom use change was sampled using a log normal distribution that ensured the 
same probability of sampling values below and above 1.58. If the median of the values 
corresponding to the selected runs was significantly different from 1.58, it would suggest an increase 
in condom use higher than observed between 1985 and 1999 was needed to obtain the observed 
levels of prevalence.  
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3 Results 
 
The model was run with 10 000 parameter sets and 431 runs were selected, corresponding to a 96% 
rejection rate.  
3.1 Evaluating model fit 
3.1.1 Comparison of model outputs to sentinel surveillance data 
 
Figure 14 shows the mean and 95% uncertainty intervals of a selection of model outputs and the 
corresponding point estimate and 95% confidence interval from the data. Prior limits used to select 
model runs are also shown. The fit to the demographic variables is very good. The proportion in each 
incarceration stage obtained from the model closely matches data from 2005, with the mean model 
outputs corresponding or closely approximating the point estimates from the surveillance data. In 
2000 there were fewer inmates in the second incarceration stage than in the third. This does not 
agree with the model dynamics which will always result in fewer people reaching further 
incarceration stages (unless sentence length was assumed to increase with incarceration stage). The 
model tends to over-estimate the proportion of people who have been in prison for less than a year 
and to under-estimate the proportion of those who have been in for 1 to 4 years. Regarding the 
distribution per sexual behaviour, it closely matches data from 2000 used to parameterise the 
model. In 2005 there was a shift in the distribution per sexual behaviour with many more inmates 
reporting not having had sex in the past 12 months and less inmates reporting casual heterosexual 
sex. This was not included in the model parameterisation and is reflected in the fit. 
The fit of the model to prevalence values was less good; however uncertainty around these 
estimates was much broader. Observed prevalence in 2000 increased with the number of 
incarcerations by two to three fold compared to prevalence among new offenders. The model failed 
to reproduce this pattern in most runs although the overlap between the uncertainty and 
confidence intervals indicates that some runs were consistent with the data.    
The fit was better regarding prevalence by time in prison category although the model did not 
reproduce the much higher prevalence levels observed among inmates who had been in prison for 
over four years in 2000. Again, the uncertainty interval’s higher bound overlapped with the data’s 
95%CI. Transmission levels might have been much higher in the 90’s resulting in high prevalence 
levels among people who were still in prison 5 years later. Condom levels are assumed to be lower 
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earlier in the epidemic but this does not seem to be enough to produce much higher infection rates 
among “senior inmates”.  
The fit to the prevalence among sexual behaviour groups is close for most groups although the 
model systematically underestimated prevalence among those who do not have sex. These are 
assumed not to have sex during their entire duration in the system and so prevalence in this group is 
dependent on new HIV infected inmates entering and on HIV infected inmates progressing from 
other sexual behaviour groups into this group. There is no progression out from the no sex group. 
Allowing some turnover might reproduce trends better. In 2000, one of the predictors for HIV 
infection was not having had partners in the 12 past months (see chapter 4). This suggested inmates 
either knew their status and were avoiding sex (or at least reporting so) or that most were too ill to 
have sex (there was no treatment available until 2005 in Peru for most people). This was not 
captured by the model as movement to risk groups is based on sexual behaviour and not on 
infection status.  
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Figure 12. Comparison of data from 2000 and 2005 sentinel surveillance surveys to the model outputs in regards to 
proportion and prevalence in each incarceration stage, time in prison category and sexual behaviour group.  
Point estimates and 95%CI of the data are shown in red and the hight of the bars represents the mean value obtained from 
the model while the 95% uncertainty intervals are shown in dark grey. The thik black lines correspond to the prior limits 
determining the rejection of runs  
 
3.1.2 Information obtained from the epidemic selection process 
 
In order to explore the influence of the selection process on the choice of parameter values, the 
prior and posterior distribution of the parameters allowed to vary were plotted (see Figure 13 and 
Figure 14) and correlations between them were calculated. The model does not provide much 
information on parameters describing sexual behaviour. The rejection of runs due to implausible 
behavioural parameters was based on prevalence among inmates inside prison for a few time points 
from 2000 onwards. It is possible that the bounds around these prior limits were not discriminative 
enough or that differences in prevalence caused by the different combinations of behavioural 
parameters happened earlier in the epidemic, where no prior limits were imposed due to lack of 
information. This is possible because high levels of condom use after 2000 might take over the effect 
of other behavioural parameters.  Also, as the only selection criterion regarding the epidemic was 
total prevalence (as opposed to prevalence in each group) there was no influence on the role played 
by each of the groups. This choice was made to investigate whether reported behaviours in each of 
the groups reproduced the prevalence patterns observed. Many combinations of epidemics 
happening in each of the groups could result in the same total prevalence. The multiplication factor 
for progression through risk behaviour with time in prison only took values inferior to 1.3 despite 
being allowed to vary between 0 and 3. This suggests that to have the distribution of risk behaviours 
observed, progression cannot happen too rapidly or to a very high extent.  
The model was more informative in regards to demographic parameters. It suggested that to obtain 
the observed patterns in reoffending numbers no less that 65% of inmates new to Lurigancho had to 
be first offenders. Average sentence length after 2000 must have been at least 2.65 years and total 
time in delinquency is maximum 21 years. 
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Figure 13. Prior and posterior distributions of the parameters describing the sexual behaviour from the 431 selected run.  
Note: The prior distribution is shown in red and the posterior in blue.
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Figure 14.  Prior and posterior distributions of the parameters describing the prison demography from the 431 selected runs.  
Note: The prior distribution is shown in red and the posterior in blue 
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3.1.3 Sensitivity analysis 
In order to estimate the sensitivity of the modelled epidemic to uncertainty in parameter values, 
strength of the association between the parameters and prevalence among inmates in 2005 was 
calculated using the PRCC method (Table 9). As the parameter ranges were defined based on 
previous studies or on assumptions when no information was available, some parameters will have 
more uncertainty than others to start with, which will affect the results. However, this analysis helps 
us identify the most uncertain parameters that have the greatest impact on the main output. To 
aknowledge this limitation we only report correlation coefficients and not their corresponding p-
values as these might be uninformative. 
The parameters that were most strongly associated with the output were the basic transmission 
probability β, the number of sex acts with stable partners, the degree of situational homosexuality 
and the factor for condom change between 1999 and 2009.  Both β and the condom change factor 
have a generalised effect on the epidemic as they change transmission among all groups.  The 
number of sex acts among stable couples had a broad variation range and was applied to the 
majority of the population. The degree of situational homosexuality determines the frequency of 
mixing between bisexual men and TSW and although they represent a small proportion of the total 
population, the higher levels of transmission and partner change rates characterising this population 
have an effect on the overall epidemic. The number of partners among bisexual men, the proportion 
of TSW, the levels of condom use between bisexual men and with TSW and the number of sex acts 
with TSW were also significantly associated with  prevalence in 2005, confirming that sexual contact 
patterns between these two groups have a strong impact on the results. Studies specifically looking 
at these that pay careful attention to potential biases would be useful to reduce uncertainty 
regarding the contribution of male to male sex in prisons.  
The number of partners among MOSW and MCSH as well as the number of sex acts in occasional 
partnerships also had a relatively strong correlation with prevalence and so did prevalence at entry. 
The latter contributes importantly to overall prevalence in prison as there is a rapid turnover of the 
population and the number of entries in high, so it is an important indicator to be measuring. The 
factor of change for the force of infection outside was associated with prevalence; this reflects the 
fact that we did not have information on sexual behaviour outside prison. Of the prison 
demographic variables, only the proportion of inmates reoffending after the first incarceration was 
strongly associated with the outcome. Keeping inmates in the system for longer contributes to 
higher levels of prevalence. 
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Parameters PRCC 
HIV transmission rate per sex act  0.68 
N. sex acts stable partner 0.68 
Situational homosexuality degree 0.47 
N. partners bisexuals 0.45 
Condom change: 1999 to 2009 -0.45 
N sex acts with sex worker 0.39 
N. partners MCHS 0.28 
Condom use with TSW -0.27 
Factor change  FOI outside  0.23 
N. partners MOSW 0.23 
Time for prevalence at entry to 
reach current levels  
-0.22 
Proportion TSW 0.21 
N. sex acts with casual partner 0.19 
Fraction recidivists after 1st inc. 0.14 
Condom use with stable partners -0.13 
Condom use between bisexuals -0.12 
Condom use with FSW 0.08 
Proportion MOSW -0.07 
Proportion MCHS -0.06 
Fraction recidivists after 3rd inc. -0.05 
Fraction recidivists after 2nd inc. -0.05 
Fraction recidivists after 4th inc. 0.05 
Proportion wives of Bisexuals 0.05 
Fraction of new entries:4th inc. 0.05 
Fraction of new entries:5th+ inc. 0.05 
Fraction of new entries:1st inc. 0.04 
Proportion who have no sex 0.04 
Fraction recidivists after 5th inc. 0.04 
Average sentence after 2000  -0.03 
Proportion FSW 0.03 
Fraction of new entries:3rd inc. 0.03 
Fraction of new entries:2nd inc. 0.02 
Proportion wives of MOSW 0.02 
Duration criminal career 0.02 
Proportion wives of MCHS -0.01 
Average sentence before 2000 -0.01 
Factor for acceleration of risk 
behaviour progression 
-0.01 
Proportion bisexual 0.00 
Table 9. PRCC between parameters allowed to vary and prevalence among inmates in 2005 presented in descending 
order of strength. 
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3.1.4 Validation: correspondence between model outputs and data from the 
prison’s HIV programme 
 
Data on inmates receiving HIV treatment and HIV care was available from the HIV programme (Table 
10). These indicators provided an independent source of reference to evaluate whether the numbers 
obtained from the model were plausible.  The number of inmates receiving HIV counselling each 
year from 2000 to 2010 sums up to 1717. Considering inmates spent about 2.8 years in Lurigancho it 
would result in 613 different HIV positive inmates. This agrees with the number of diagnosed cases 
by the programme from 2000 to 2010 (636). The mean number of HIV positive inmates going 
through the system from 2000 to 2010 included is 569 [95% uncertainty interval: 467-1042]. This is 
close but lower than the total number of diagnoses in this period. However it does not take into 
account infections that entered the system before 2000 and that might have been diagnosed later 
on. 
Year HIV patients starting 
ART 
HIV + receiving counselling HIV positive 
tests 
2000 - 81 34 
2001 - 100 39 
2002 - 108 51 
2003 - 123 50 
2004 - 135 50 
2005 16 161 78 
2006 29 179 72 
2007 27 197 60 
2008 38 213 87 
2009 31 226 70 
2010 40 194 45 
Total 181 1717 636 
Table 10. Summary of some of the indicators available from the HIV programme in Lurigancho [375].  
Note: HIV patients starting ART are all different individuals starting treatment each year; the number of HIV + inmates 
receiving counselling corresponds to the total inmates seen each year and these can be counted several times in different 
years. The number of HIV positive tests corresponds to new diagnoses in Lurigancho. 
  
Figure 15 shows the total number of AIDS cases from the beginning of the epidemic to December 
2010 for each of the runs selected. Estimates range from 127 to 760 with a mean number of 234 
cases [95% uncertainty interval: 135-518]. This is close to the number of inmates that have started 
ART in prison (181). However not all AIDS patients in the model have received ART since it only 
started being available in 2005. When we plot the number of inmates that have started ART from 
the beginning of the epidemic to December 2010, this is much smaller (from 45 to 123) with the 
mean being 62 [95% uncertainty interval: 46-105]. 
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Figure 15. Distribution of number of AIDS cases and patients starting ART going through the system (inside and outside 
prison) from the beginning of the epidemic to December 2010 from the 431 selected parameter sets. 
 
The model might be underestimating the number of HIV cases that have gone through the system, 
although the difference between the data and the model output is small. The gap is larger when 
looking at the number of ART patients, as the estimate from the HIV programme is outside the 95% 
uncertainty intervals obtained from the model. ART treatment coverage in the model was estimated 
to increase linearly to reach 48% in 2007 and then to increase to 80% and remain constant 
wherever. As the vast majority of inmates are tested at entry since 2006 and HIV positive inmates 
are followed by the programme thereafter, ART coverage in the prison might be closer to 100% and 
the time needed to reach coverage might have been shorter. Also, in the model HIV positive inmates 
are assumed to start ART before the pre-AIDS stage which corresponds to a CD4 count of about 200 
cells/mm3. Since 2010, the guidelines in Lurigancho recommend treatment initiation at 300 
cells/mm3. Unfortunately this information became available very recently and could not be 
incorporated in the analysis. These two issues combined with a slight underestimation of HIV cases 
contribute to low numbers of patients on ART in the model. Overall, the model adequately 
reproduces the data obtained from the HIV programme. 
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3.2 Characterisation of the epidemic 
 
The selected parameter sets produced the prevalence curves shown below (Figure 16). We observe 
two main types of possible epidemics: a larger epidemic type which peaked in the late 1980’s 
reaching prevalence values above 2% and up to 8% and remaining between 2 and 4% in the late 
2000’s. The second type corresponds to a smaller epidemic which grew slowly to reach 1 to 2% 
prevalence in 2000 and stabilised at this level. In all scenarios prevalence is estimated between 1 
and 4% after 2010. Having information on prevalence prior to 2000 would allow discriminating 
between these two broad epidemic patterns, thereby reducing uncertainty. The peaks observed 
around 2000 and 2012 are due to changes in assumptions regarding the prison demographics 
(sentence length increases from 2000 and no new inmates enter between mid-2009 and mid-2011). 
 
Figure 16. HIV prevalence among prison inmates inside prison for the 431 selected parameter sets.  
Red stars represent the data points from the two sentinel surveillance surveys and from HIV programme data after 2005. 
The black lines correspond to the prior limits used to determine the rejection of runs. 
 
Figure 17 shows the mean prevalence per risk behaviour obtained from the selected runs.  The 
highest prevalence is observed among TSW peaking at about 32% in 2000 and stabilising at 27% 
after 2010, followed by prevalence among bisexual men peaking at about 5% in the early 90’s and 
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decreasing thereafter. Among the other groups, prevalence is stable and lower at about 1%.  
 
Figure 17. Mean HIV prevalence among each sexual behaviour group obtained from the 431 selected parameter sets. 
Prevalence by incarceration stage and time in prison are plotted in Figure 18. Until 2000 there is 
some heterogeneity between groups with 2nd and 3rd time offenders experiencing higher prevalence 
than 1st and 4th and 5th time offenders and with inmates who had been in prison for 4 years or longer 
also presenting higher prevalence. These differences become thinner after 2000, probably due to 
increases in condom use. 
  
Figure 18. Mean HIV prevalence by incarceration stage and time in prison category obtained from the 431 selected 
parameter sets 
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3.3 Magnitude of the epidemic 
 
3.3.1 Insights from incidence outputs 
 
The relatively low prevalence levels observed in Lurigancho might be hiding a large epidemic which 
would be covered by a high turnover of the population or other dynamic processes specific to this 
prison. To investigate this question incidence estimates obtained from the simulation were explored 
in detail. Incidence may have reached values of over 4% in the 1980’s but most scenarios indicate it 
has remained below 1% from the year 2000 (Figure 19). Most runs predict incidence values just 
below 0.5% which is close to that estimated for the general population in Peru in 2010 by the Modes 
of transmission model (0.3%) and higher than that estimated by Spectrum along the years which has 
remained below 0.1%. Figure 20 shows that incidence has been below 1% in all groups except 
among TSW and bisexual men for whom it reaches 9% and 2% respectively in the late 1980’s. 
Incidence among TSW stabilises at 1% after 2010 and remains below 1% for bisexual men. 
 
  
Figure 19. HIV incidence among prison inmates inside prison for the 431 selected parameter sets 
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Figure 20. Mean HIV incidence among each sexual behaviour group obtained from the 431 selected parameter sets. 
The distribution of total incidence (inside and outside) at different time points illustrating the early, 
later and current stages of the epidemic was plotted. Figure 21 suggests incidence might have been 
higher early in the epidemic but it has been stable at very low levels for about a decade. The 
variation range is much broader in 1990 reflecting the lack of prior information to guide the 
selection of epidemic fits for this period. In contrast the range for 2010 is very narrow. 
 
Figure 21. Distribution of total HIV incidence among inmates obtained from selected runs in A. 1980 B. 2000 and C. 2010 
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The epidemic was then explored in terms of absolute numbers. The total number of new infections 
occurring among inmates inside and outside prison from the beginning of the epidemic to January 
2012 in each of the selected runs was plotted (Figure 22). This varies from 22 to 3075, with most 
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runs predicting less than 500 new infections. These correspond to inmates being infected after 
entering the system. Another source of infections in the model is that of new inmates entering 
Lurigancho when they were already infected. The distribution was also plotted and the model 
suggests between 735 and 1070 inmates entered the prison having already contracted HIV.  Adding 
these two sources of infection gives an estimate of the total number of HIV infected inmates going 
through the system during the epidemic. This goes from 760 to 4150 with a mean of 1374 [95% 
uncertainty interval: 866-2882] cases. These are relatively small numbers when we compare them to 
the total number of inmates that have been through the prison in the past 37 years (the mean 
number of entries was approximately 90,000). However, it represents 5.7% [95% uncertainty 
interval: 3.1%-17%] of the 24,309 HIV cases reported in the department of Lima up to January 2012 
[242].  Approximately half of these have been reported in Lima City [432], so cases in Lurigancho 
would represent over 10% of the total number of cases. Even considering 50% under-reporting they 
would still represent 5% of cases in Lima, suggesting this is an important setting for detection. 
 
 
Figure 22A. Distribution of selected runs for the number of new infections occurring inside and outside prison after entry 
to the system , B. Number of inmates that entered the system when already HIV positive, C.  Total number of HIV 
positive inmates that have gone through the system (C) from the beginning of the epidemic to January 2012. 
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3.3.3 Could the observed prevalence levels be reproduced through the entry 
of infected inmates only? 
 
Interestingly, the vast majority of these infections were formed by inmates that were infected 
before entering the system. This suggests the prevalence trend observed could correspond to the 
number of HIV positive entries over the total inmate population rather than to the result of a 
dynamic epidemic.  To test this, the model was run fixing the probability of transmission β to 0 
(infectious process turned off) and the prevalence was plotted against prevalence bounds. As seen in 
Figure 23, when no infections are occurring in the system the prevalence curve fits within the 
bounds for most runs.  
 
Figure 23. HIV prevalence among inmates inside prison when there is no transmission in the system (inside or outside) 
for the 431 selected parameter sets.  
The dark thin lines correspond to the prior limits used to determine the rejection of runs during the original fitting 
procedure. All runs would have been selected based on the last three priors and some would have been rejected based on 
the 1
st
 prior. 
 
3.3.4 What is the maximum incidence consistent with prevalence and 
demographic data? 
 
To provide more precise information on the scale of the epidemic we determined the threshold 
value of incidence among inmates for which the observed prevalence levels at particular time points 
are still consistent. This would be the maximum incidence coherent with the data and prison 
demographic patterns. The 431 selected parameters sets were ran with ascending values of the 
transmission probability beta (0%, 0.5%, 1%, 2%, 4% and 6%) and the corresponding incidence and 
prevalence values at specific time points were recorded. Results are presented in Figure 24. 
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Incidence values above 1% in 2005 and 0.8% in 2010 are inconsistent with the prevalence values 
observed, suggesting incidence has remained below 1% in the past 5 to 10 years.  
 
Figure 24. Relationship between prevalence in prison and incidence in prison (varied through the basic transmission 
probability β).  
The 431 parameter sets where ran with different values of β and prevalence at two time points was recorded: 2005 in red 
and 2010 in blue. The dashed lines represent the upper bounds of the prior limits for prevalence at these two time points. 
The left panel gives an overview of the relationship between incidence and prevalence in Lurigancho and the right panel is 
a close up of the area below the prior limits allowing to visualise the maximum incidence consistent with the prevalence 
values observed. 
 
3.4 Estimating transmission levels outside: are these higher than inside? 
 
As the data did not provide information on sexual behaviour outside of prison, the force of infection 
outside was assumed to be equal than inside for each sexual behaviour group and allowed to vary 
through an “outside transmission factor” parameter that remained constant through the simulation. 
The median was 0.92, meaning that the selection process slightly favoured runs with lower 
transmission outside. Figure 25 shows the prior and posterior distribution of the outside 
transmission factor. These are very similar suggesting that, based on the available data, there is no 
evidence for a higher or lower transmission inside prison as compared to outside, once there has 
been contact with the prison system.  
In order to exclude the possibility that parameters sets that resulted in high transmission inside and 
low transmission outside or inversely were systematically selected, the correlation between the 
outside transmission factor and beta was calculated. There was no strong correlation between these 
parameters. As re-offenders only represent a small proportion of new entries, their contribution to 
the number of new infections is probably not as important. 
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Figure 25. Prior (red) and posterior (blue) distribution of the outside transmission factor from the 431 selected 
parameter sets. 
 
3.5 Could the decline in prevalence observed after 2000 have happened 
without a decrease in risk behaviours (potentially associated with the 
MSF intervention)? 
 
This question was explored through varying the slope of the general trend in condom use from 1999 
to 2009, corresponding to the period MSF were present in Lurigancho. It was assumed that condom 
use would have kept increasing at the same rate as before 1999 in the absence of an intervention 
which corresponded to increasing condom use by 1.58 folds between 1999 and 2009.  
The median value for this parameter was 1.67, so slightly higher than the prior median. The prior 
and posterior distributions of the condom change factor are shown in Figure 26.  Again, a visual 
inspection of these distributions indicates there is no case for further investigation.   
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Figure 26. Prior (red) and posterior (blue) distribution of the condom change factor from the 431 selected parameter 
sets 
The impact of condom use on the epidemic was investigated in more detail by measuring prevalence 
in 2005 under two different scenarios for condom use: scenario 1 assumed condom use kept 
increasing until 2009 following the increase observed from 1985 to 1999 (corresponding to a factor 
of 2.7); scenario 2 assumed condom use had stayed constant after 1999 (corresponding to a factor 
of 1). As observed in Figure 27, under scenario 1 there is very little variation in prevalence with 75% 
of runs resulting in prevalence values under 2% in 2005. Under scenario 2, there is more variation 
but median prevalence is still below 2%. The small difference in prevalence observed between these 
two scenarios suggests this indicator conferred little power to test the impact of changes in condom 
use. Instead it might have been more appropriate to use incidence.  Figure 28 shows the mean 
incidence over time obtained from all selected fits for the two scenarios presented above, the 
baseline results and a third scenario where condom use was set at zero for the entire epidemic. It is 
possible to appreciate from this plot that condom use has had an important impact in controlling the 
epidemic and that a constant increase in condom use after 2000 brings the epidemic down to very 
low incidence levels. Interestingly, our baseline results stand in between the two assumptions 
regarding condom use after 2000, suggesting there was an increase in condom use but may be not 
as sharp as the on assumed between 1985 and 2000. 
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Figure 27. Boxplots showing the variation in HIV prevalence among inmates in 2005 depending on different assumptions 
regarding condom use.  
Scenario 1: condom use increases until 2009 following the same slope observed from 2000 to 2005. Scenario 2: condom 
use remains constant at 2000 levels for the remaining time.  
 
Figure 28. Mean incidence among inmates inside prison under different assumptions regarding condom use as compared 
to baseline results.  
Blue: mean from baseline results; Green: condom use increases until 2009 following the same slope observed from 2000 to 
2005; Yellow::condom use remains constant at 2000 levels for the remaining time; Red: condom use is assumed to be 0 
throughout the epidemic. 
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4 Discussion 
 
4.1 Findings and interpretation 
An epidemiological analysis of HIV in Lurigancho was carried out through the development of a 
mathematical model simulating transmission between inmates and their visitors and representing 
the demography of the prison population in a precise, yet straightforward manner. The results 
suggest the relatively low prevalence trends observed in Lurigancho for the past two decades are the 
reflection of low incidence levels. It is likely that incidence was higher before 2000 as parameter sets 
that resulted in high levels of transmission in the 1990’s fitted the data better; however, there is no 
information available to confirm this deduction. This would also be consistent with the higher 
prevalence levels observed among reoffenders and inmates with long sentences in 2000 but not in 
2005. The analyses suggest that incidence in Lurigancho is most likely below 1% and probably closer 
to 0.5%.  
In fact, the epidemic is mostly sustained by infections coming from outside and increases in 
incidence in prison would be rapidly reflected on prevalence. This finding is consistent with the 
hypotheses resulting from the HIV causal pathways analysis presented in the previous Chapter. 
Inmates arrive to Lurigancho at a mean age of 30 and it is estimated that the mean age at infection 
in Peru is 22 [241]. The findings argue for the maintenance of the current screening system in place 
in Lurigancho which offers testing at entry to all inmates. In this way, the prison acts as a sieve to 
identify infected inmates and direct them to care. Based on the model’s outputs, it was estimated 
that over 10% of HIV cases reported in Lima (City) from the start of the epidemic have gone through 
Lurigancho, further highlighting the importance of this prison as a setting for HIV detection and care.   
Although it could be expected that prisons are fertile grounds for HIV transmission it is accepted in 
the U.S. that the vast majority of infections occur outside prison [159]. It is likely to be the case for 
Lurigancho and considering the expansion in testing, prevention and treatment that the health 
services in Lurigancho have undergone, it would be worrying to observe high rates of new infections 
occurring in the prison.  
The potential impact of these prevention efforts, in particular those carried out by MSF between 
1999 and 2009,  was investigated by testing whether the lower prevalence levels observed in recent 
years as compared to 2000 could have happened without an increase in condom use superior to the 
one assumed from 1985 to 1999. The analysis did not provide evidence for a steeper increase in 
condom use after 2000. However, the conditions set to test this hypothesis might have been too 
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harsh to detect a significant effect. Firstly, assuming that condom levels would have kept increasing 
at such a steep rate in the baseline scenario might be unrealistic. Secondly, the prior limits on total 
prevalence that determined the rejection of runs was quite broad and therefore small changes in 
prevalence would have been difficult to detect. When comparing incidence over time under 
different scenarios with regards to condom use, the scenario assuming an increase in condom use 
after 2000 was more consistent with observed data showing that prevalence has been between 1 
and 2% in the past decade. This increase has probably not been as sharp as that assumed between 
1985 and 1999. Additionally, the scenario assuming no condom use through the epidemic resulted in 
much higher incidence levels suggesting condom use has been important in controlling the epidemic 
among Lurigancho inmates.  
While total prevalence and incidence levels are relatively low, some groups experience a much 
higher burden of infection. TSW and bisexual men were found to be most affected by the epidemic. 
Prevalence at entry among TSW was assumed to be very high at 30 to 40% but this group still 
experienced the highest incidence by far due to high susceptibility to HIV during receptive anal sex 
and high partner change rates. Bisexual men are exposed to HIV mostly through sex with TSW as 
condom use with FSW is high and prevalence among stable partners is low. TSW in Lurigancho 
receive counselling once per week to address HIV/STI prevention issues but also to help them 
overcome low self-confidence and other problems experienced by this population. Additionally, they 
are tested for HIV every three months. It would be useful to study the information available from 
testing among this group over time as it might allow estimating incidence in this group directly and 
therefore more accurately.  
Another issue that was explored was the potential for higher transmission in prison than outside 
among inmates who reoffend (so comparing transmission in Lurigancho and in the outside stages 
between incarcerations). The analysis did not provide evidence for a significant difference between 
these two settings. As the observed epidemic could be reproduced through prevalence at entry only, 
the levels of transmission in the system did not affect the selection of runs to a great extent unless 
this was exceedingly high. Additionally, the proportion of the total population in the outside stages is 
relatively small and the time spent outside is assumed to be short. However, since prevalence at 
entry is above 1% it is likely that transmission outside is relatively high in order to sustain these 
levels among young inmates. More attention should be given to this high prevalence at entry to 
Lurigancho, it is not clear from the data whether inmates new to Lurigancho become infected before 
their first ever incarceration or after (as some will have been incarcerated in other prisons before). 
At the moment the model assumes the same prevalence at entry for first and subsequent offenders 
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but it would be useful to stratify the data obtained from the screening programme by reoffending 
status.  
In the previous Chapter it was found that the current behavioural questionnaire applied during VCT 
did not allow identifying the source of infection. Developing an instrument that provides information 
on the timing, location and possible source of infection would be a valuable undertaking. As a 
majority of inmates in Lurigancho come from pockets of poverty around Lima and Callao, actively 
bringing prevention services to these areas might be a solution.  
4.2 Representation of prison demography 
In addition to the exploration of the HIV epidemic in Lurigancho, another issue that was of particular 
interest and that is relevant to the study of HIV transmission in prisons in general, was the 
representation of the prison demographics. The structure used to carry out the analysis resulted 
from a process of trial and error that could be synthesised in two main models. These were given in 
appendix to keep the focus on the main questions but some relevant points that emerged from the 
process are discussed below. 
The three models broadly represented sexual behaviour and the natural history of infection in the 
same way but differed in their representation of the prison demography. The first model assumed 
homogeneity in sentence length among inmates and did not incorporate recidivism. However, as 
theoretically recidivism and heterogeneity in sentence length could have an impact on the epidemic 
dynamics, it seemed important to explore these issues further. Although most inmates spend less 
than two years in Lurigancho, sentences can go up to 20 years and even longer in some particular 
cases. In addition, about one third of inmates are reoffenders which is a considerable proportion.  
Model 2 intended to capture these heterogeneities through stratifying the inmate population into 
four offender groups representing one time offenders, regular offenders, frequent offenders and 
long sentences. This captured differences in incarceration patterns and represented special cases 
regarding sentence length. The model also differentiated the first incarceration from subsequent 
incarcerations and represented the time spent in the community between incarcerations. The 
advantage of this model is that it controls for the effect of recidivism and differential sentence 
length and it allows studying the potential impact of exposure to the prison system on the likelihood 
of infection. However, it is not straightforward to parameterise as the definition of regular 
offenders, frequent offenders and long sentences are somehow subjective and the outputs are not 
directly comparable to available data. This structure might be overly specified for modelling a single 
prison. Nevertheless, it could be useful when representing a network of prisons or a correctional 
system composed of different types of establishments. As an example, the frequent offenders’ 
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category could represent jails; the regular offenders’ category could represent medium security 
prisons while the long sentences’ category could simulate maximum security prisons. The “one time 
offenders” category could represent police stations for overnight arrests or other relevant settings. 
It is especially important to represent differences in incarceration patterns if these are also 
correlated with probability of infection. In what concerns IDUs, they have higher incarceration rates 
and a higher probability of hepatitis B infection. As mentioned earlier in this chapter, this type of 
model structure makes assumptions about inmates’ characteristics: ie. reoffenders are more likely to 
be IDU, and this might be the right approach as the environment or individual situation of inmates 
will determine their frequency and type of contact with the prison system. Alongside, these may also 
determine their sexual risk behaviours. This structure would therefore be useful when high levels of 
heterogeneity in incarceration patterns are observed such as in a correctional system or when 
looking at specific populations at high risk of infection and incarceration such as IDU.  
The final model made fewer assumptions about the characteristics of inmates and represented 
prison demography in a more complete way. Interestingly, this closely reproduced the distribution of 
inmates by reoffending category and time in prison when making simple assumptions about the 
average length and the proportion reoffending.  
Here, the probability of having a long sentence or of reoffending many times is random and 
determined by the overall system characteristics rather than by individual characteristics. It views 
the movement of the prison population as a natural process. This structure was chosen to carry out 
the full analysis because it represented the prison demography accurately and it was straightforward 
to parameterise and to interpret. However, it is worth noting that the three models produced very 
similar results in terms of the HIV epidemic suggesting the simplest structure might be sufficient to 
study HIV in Lurigancho. As transmission levels are relatively low inside it might not be necessary to 
track inmates through time and to differentiate them in subsequent incarcerations. In the context of 
this study it allowed us to build a clear interpretation of epidemic trends and provided more 
confidence around the outputs. Another point that should be mentioned is the relevance of 
stochastic models for the study of epidemics in the prison context due to the relatively small size of 
the populations modelled. This would have been an option for this study and it would be possible to 
make the current model stochastic. However, as the aim was to investigate how the reported 
behaviours translate into epidemic potential in this context and to explore broad questions about 
the mechanisms driving the observed epidemic patterns, a deterministic approach was considered 
appropriate to produce such tool. Individual based models can also be useful in the study of 
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epidemics among populations with very heterogeneous sexual behaviours such as prison inmates. In 
this case, the data available was insufficient to justify taking such an approach. 
4.3 Strengths and limitations 
To our knowledge this is the only mathematical modelling study investigating the HIV epidemic in a 
Latin American prison. It therefore provides a first impression of the main characteristics of the 
epidemic in this particular setting. Generalisation to other prisons in the region is not directly 
possible as the epidemic in each prison will be dependent on the background epidemic in the 
country or town and especially on inmates’ characteristics (prevalence at entry and sexual 
behaviour). However, this model can be parameterised and adapted to study the epidemic in other 
prisons provided that there is data available. Since the model was built based on sentinel 
surveillance data rather than on a specific study, it is more likely that other countries will have the 
necessary information.  
The model is also novel in terms of its precision in the representation of the prison demography.  In 
this case it allowed producing stronger conclusions about the epidemic but this would be especially 
useful in contexts where the prison environment has a great effect on transmission such as among 
IDUs or in prisons where prevention methods are not available and sex between inmates is frequent.  
Although the model parameterisation drew on several data sources (2 rounds of sentinel 
surveillance, National Penitentiary Institute statistics, HIV programme in the prison), the earliest 
information available was from the year 2000. Sexual behaviour was assumed to be constant 
throughout the simulation and levels of condom use were used in an attempt to control for 
improvements in prevention as the epidemic progressed. However, it is possible that the profile of 
inmates changed along the years and that risk was much higher or lower as a result of this. These 
changes could be due to changes in the organisation of the prison itself (accepting inmates charged 
with serious crimes rather than common crimes for instance) or to the country’s socio-economic 
situation at the time. Lurigancho was one of the prisons that withheld individuals charged for 
terrorist activities during the shining path period. If these represented an important proportion of 
the inmate population it might have affected the patterns in sexual behaviour (discipline and order 
were important values of the shining path and sexual behaviour might have been restrained among 
its members). Particular sexual habits or events such as group rapes might also be happening in 
Lurigancho that we are not capturing in the model. On the same lines, injecting drug use is not 
incorporated in the model. This is assumed to be quite rare in Lurigancho but we rely on self-report. 
The epidemic selection procedure partly accounts for these issues as an important range of 
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scenarios regarding the demography and the sexual behaviour of the population are investigated 
and uncertainty in the outputs was represented throughout the analysis.  
4.4 Conclusive remarks 
In conclusion by faithfully reproducing demographic patterns including population growth, turnover, 
reoffending and heterogeneity in sentence length, this model allows having more certainty on the 
epidemic projections. The results suggest infections rates have been low in Lurigancho at least in the 
last decade and it is estimated that about 1374 [95% uncertainty interval: 866-2882] HIV cases have 
gone through the prison from the beginning of the epidemic. This corresponds to an average of 37 
cases per year which is far from negligible. Lurigancho represents an opportunity to identify 
infections and direct them to care. The model was shown to be consistent with data from the 
programme that was not used for the parameterisation or fitting procedure suggesting it captures 
the epidemic in this setting. It was developed with the intention to produce a tool that will allow 
investigating questions related to programmatic decisions, changes in the penitentiary system or in 
the epidemic itself. Changes in the screening system is probably one of the most relevant questions 
currently as the funds available from the Global Fund have been used and keeping such high testing 
coverage might not be feasible in the future. Investigating the potential impact of decreases in 
coverage and comparing different alternative screening systems would be a useful undertaking.  
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Chapter 6: Formulating a conceptual framework of 
HIV risk among prison inmates and designing a 
questionnaire to test it  
1 Introduction 
Studies investigating HIV among prison inmates have mostly focussed on obtaining prevalence 
estimates and identifying proximate determinants associated with infection. They rarely collect 
information comparing behaviours inside and outside prison and are limited in their scope, providing 
little insight into the full sexual history of inmates and the contexts in which these occur. While they 
provide the basic information needed by governments and HIV programmes to undertake a rapid 
assessment of the situation they can only have a limited impact.  Individual risk factors might inform 
us on the mechanism of infection but only understanding the motivations and circumstances leading 
to that behaviour will allow conceiving better adapted and more effective prevention interventions. 
The social background of prison inmates, touched upon in relation to several issues along this thesis, 
is very particular and can influence sexual and drug using behaviours through many pathways that 
most likely work synergistically. Identifying the differences between infected and uninfected inmates 
is a starting point to reconstructing the causal pathways for infection. As pointed by Garnett [433] in 
his editorial entitled Theory Is Critical in Understanding the Risks of Acquiring HIV, “by going beyond 
the usual risk factors” and exploring “a wide range of potential risks” it is possible to identify 
determinants of infection specific to a population. As discussed in Chapter 4, the risk factors 
investigated in the sentinel surveillance study among prison inmates in Peru in 2000 and 2005, did 
not identify potential causal pathways for infection among Lurigancho inmates. This is likely due to a 
lag between the timing covered by the questions and the actual time of infection but also to the 
limited number of questions included. The latter point is almost invariably a limiting factor and a 
solution employed to overcome the time limit in some studies has been to apply a longer version of 
questionnaire to only a small fraction of the sample or to carry out qualitative work in addition to 
the questionnaire.  
 
Mixed methods studies have been extensively used in disciplines such as education or health care 
satisfaction and have been increasingly encouraged in the field of HIV research. The term “mixed 
methods” is generally defined as “the collection, analysis and interpretation of both quantitative and 
qualitative data within a study” [434].  The qualitative component is often used to explore the 
subject in order to identify themes to be addressed in the quantitative component. Alternatively, the 
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qualitative component can also be used to investigate the results from the quantitative component 
and find explanations or simply to expand the findings.  
In this study we have combined the use of qualitative methods with literature searches covering a 
range of disciplines to inform the design of a structured questionnaire to identify determinants of 
HIV infection among prison inmates, with an emphasis on the social and underlying determinants 
within a Latin American context.  The objectives of this work were to: 
  Identify and describe potential determinants of HIV infection among prison inmates  
 Construct a framework to understand the position and relation of these determinants in the 
pathway of risk  
 Develop a structured questionnaire to gather information on these and test the framework 
2 Methods 
We used two main streams of data to formulate a framework of HIV risk among prison inmates in 
the region: qualitative information obtained during explorative work carried out for the 
development of a large scale study investigating the health profile of prison inmates in Mexico City, 
with particular attention to HIV and STI, and information obtained from a literature review. Based on 
this, we developed a structured questionnaire to test the hypotheses implicit in the framework. 
2.1 Qualitative work 
In response to audits and reports from the Mexican human rights commission [435]and other 
organisations denouncing the sub-standard life conditions in the prisons of Mexico City, the 
government funded a large scale study to evaluate and improve the health of inmates.  The National 
Institute of Public Health in Mexico (INSP) was commissioned to take on this project.  Our 
involvement was based on our expertise in the field of HIV/STI modelling. During the collaboration 
period we focussed on identifying determinants of HIV infection among this population in order to 
inform potential model structures (i.e. decide on specific groups and behaviours to be included in 
models). The study was broad and covered not only several diseases but also different strata of the 
health provision framework, namely treatment and care, screening and diagnosis, and prevention. 
The different study components are described below and illustrated in Figure 1. 
 
 The treatment component consisted in improving the health care provided to HIV positive 
inmates at the HIV clinic of the Santa Martha prison (where all HIV positive inmates access 
treatment) and to monitor and evaluate the changes in patients’ adherence to treatment 
and health resulting from this intervention. 
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 The diagnostic component consisted of a comprehensive health screen:  HIV, Hepatitis B and 
C, syphilis, herpes, tuberculosis and diabetes as well as a lipid profile coupled with blood 
pressure and anthropometric measurements (height and weight). A sub-sample of 
participants would complete a structured interview including questions on socio-
demographic background, sexual and drug using behaviours, eating habits and violence; self-
administered through the use of Audio Computer Assisted Self Interview (ACASI).  
 The prevention component aimed to design, implement and evaluate HIV and STI prevention 
interventions using specific approaches for particular subpopulations including women and 
young inmates.  
 Finally the sexual offenders’ component aimed to design, implement and validate a 
classification tool that identified types of sexual offenders based on their likelihood of 
rehabilitation and recidivism; as well as on possibilities for treatment.  
The project was at the interface between a public health intervention and a research study, as all 
inmates would be offered testing for a range of health conditions and would be referred to the 
prison’s health services for treatment. The mathematical modelling study fed into the diagnostic 
component as it would inform the design of the questionnaire and would use the results of the 
survey to develop and parameterise the models. In the longer term, the models would be used to 
guide the design of prevention interventions and evaluate their impact.  
 
 
Figure 1 Diagram representing the different components of the Mexico prisons’ study and their interactions.  
The lower boxes with red borders correspond to the components that we were responsible for. 
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Between December 2008 and February 2010, for an overall period of 4 months, I worked on site as 
part of the INSP’s team. I produced the first draft of the study protocol and formulated the first 
version of the questionnaire. In particular, this consisted in making background research on the 
different study components, liaising with other collaborators and attending all meetings to gather 
information to be included in the protocol. This allowed me to take part in qualitative work covering 
a range of issues relevant to the study design (ethics, logistics, and acceptability) as well as the study 
subject (epidemiology of selected diseases among the inmate population). We had meetings and 
interviewed individuals with particular expertise or life experience covering a range of issues 
important to the study design. Each conversation provided useful insights relevant to different 
stages of the Mexico City prisons project and to this particular study. 
2.1.1 Interviews with experts 
Ethics: We consulted a lawyer specialised in the medical field and a representative of the Mexico City 
human rights commission to discuss ethical issues relative to confidentiality, HIV status disclosure 
and the conditions imposed by the penitentiary system to receive treatment.  We concluded that a 
secure mechanism had to be put in place to ensure confidentiality of the results and that the 
penitentiary system had to be prepared for lawsuits  from part of inmates who wanted to receive 
treatment without being transferred to Santa Martha. Inmates should have the right to treatment 
independently of the prison where they are held, and the HIV programme would have to plan for 
this eventuality to ensure the delivery of treatment in other prisons. 
Logistics: We met prison directors and prison healthcare workers to discuss the feasibility of the 
project and the capacity of the health services in the different prisons. These welcomed the study’s 
initiative but expressed concern about the insufficient capacity of the health services to provide care 
to an additional number of inmates as a result of the study.  
Facilities and services: We evaluated the HIV treatment and monitoring situation of HIV positive 
inmates with the head of the main HIV hospital in Mexico City and defined the improvements to be 
implemented. The health facilities in Sta Martha required an HIV specialist to adequately monitor 
patients’ health and adherence to treatment which was found to be very low. Strategies to improve 
adherence would be put in place and investigated. 
 
 
2.1.2 Interviews with key informants  
We carried out interviews with key informants during the planning phase of the project. I took notes 
during these and wrote a report later on that same day to complete and organise the information 
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recorded in the notes.  The findings cannot be formally reported due to concerns in ethics but are 
reflected in the results.  
Prison guards’ perspective: An informal interview with two members of the security staff of the HIV 
positive inmates’ ward took place in Santa Martha prison in March 2009 and was led by Stefano 
Bertozzi. The interview lasted for approximately half an hour. It revealed serious issues around fear 
of HIV among the prison staff, mostly related to poor knowledge about the virus and how it is 
transmitted. These also commented on their work conditions and difficulties. 
Family perspective: An informal interview with two mothers of HIV positive inmates took place at the 
main HIV clinic in Mexico City (Clinica Condesa) in March 2009 and was led by the head of the HIV 
programme in Mexico City. This lasted for approximately an hour. The aim was to gain insight on the 
potential impact of HIV diagnosis among inmates for their family members, to find out about the 
circumstances under which they learned their son’s HIV status and to obtain information on the type 
of healthcare they were receiving in the prison. The two mothers shared their son’s stories providing 
insight into the wider environment of HIV positive inmates. 
HIV positive inmates’ perspective: Informal interviews with 4 HIV positive inmates took place in 
Santa Martha Prison in March 2009 during the hours of consultation with the HIV specialist that had 
been working in the prison two days per week as part of the project. Two inmates were seen 
separately and two asked to be interviewed together as they were a couple. Each interview lasted 
for approximately an hour and a half. The aim was to obtain information on the general feeling 
inmates could have about the study and to investigate potential incentives to increase participation 
among other issues relevant to the study acceptability. However, the interviewees spoke very freely 
about anything they wanted to share and so the interviews proved to be a rich source of 
information. 
2.2 Literature review 
To confirm, complement and broaden the findings from the qualitative work, a variety of sources 
were searched.  
2.2.1 Sociological studies 
Due to the extreme modifications that prisons impose on the environment and condition of 
individuals, they have been a subject of interest among sociologists. As these studies generally 
employ qualitative methods, they can provide great insight into the elements governing the life of 
those who live behind bars. Two books reporting the findings of studies carried out in the Reclusorio 
Norte in Mexico City and in several South American prisons respectively were especially relevant to 
our research: 
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-Panópticos y Laberintos. Subjetivación, deseo y corporalidad en una cárcel de hombres (2007), by 
Rodrigo Parrini Roses [179]. 
In his study, Parrini investigated gender, identity and sexuality in the context of a men’s prison. He 
carried out 15 in depth interviews and recruitment was initially done through the guards following a 
list of criteria and then through recommendations from the interviewees, word of mouth and by 
directly asking inmates passing by. Issues approached were the condition of confinement, the 
experience of time and space in prison, the social hierarchy in prison, death in prison and within the 
subject matter, the meaning of masculinity for the inmates, conjugal visits and intimacy, prostitution 
and the body as capital, seduction and homoerotism. 
-La construcción social de la realidad carcelaria (2000), by José Luis Pérez Guadalupe [436]. 
This study investigated the informal social organisation that emerges in prisons in the absence of 
one established by the authorities, but more generally as a natural process to ensure the functioning 
of everyday life. This is investigated from the points of view of the prisons’ architecture and how this 
is modified by inmates to suit their needs and rules; the hierarchical system both within delinquency 
and in prison; the norms and values of the prison culture; and the characteristics of fights and their 
resolutions. The investigator used both in depth interviews and ethnographic observation carried 
out over different time periods in 5 prisons in Peru (Lurigancho 1986-1994), Chile (Ex-Penitenciaría 
de Santiago 1994-1995), Argentina (Cárcel de Villa Devoto 1965-1966), Brazil (Casa de Detención de 
Sao Paulo 1975-1976) and Bolivia (Cárcel de San Pedro 1993-1994). 
2.2.2 Testimonies 
Testimonies from ex-prison inmates, prison staff and family members of current or ex-prison 
inmates are mostly found on the internet and their reliability is difficult to trace. Therefore we 
decided to include this type of data but restricted it to two examples as an illustration. The main 
testimony chosen is a well-known book describing prison life in Latin American prisons:  
Estacao Carandiru, Sao Paulo, Brazil (1999), by Drauzio Varella [437]. 
This book is an account of life in Carandiru prison as witnessed by Drauzio Varella who worked as a 
doctor there for 13 years (1989-2002). He describes the day to day in the prison and paints a picture 
of inmates’ lives and values mostly through recounting stories that these shared with him during 
that time. 
We also used a much less widespread collection of testimonies in the context of a prevention 
intervention in prisons in Mexico and Honduras: Historias de VIHda. Testimonios desde el encierro 
(2005) which was published by the Human Rights commission of Mexico City [438]. 
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2.2.3 Literature searches 
Three searches were carried out in the peer reviewed literature in June 2012. All the publications 
were screened based on the title and the remaining articles were screened based on the abstract. 
Any study considered relevant was included. In total 56 articles were read.  
 a pubmed search using the terms: “determinants AND (HIV OR AIDS OR (sexually AND 
transmitted AND infection) OR (risk AND behaviour)) AND prison*” identified 57 
publications.  
 
 A search using “Determinante AND VIH AND prisión” in LILACS (the main database gathering 
Latin American scientific peer reviewed literature) was expanded to “VIH AND cárcel OR 
prisión” resulting in 59 publications. These were an eclectic mix of papers, of which few 
centred on HIV/AIDS. The themes most frequently studied were mental illness and 
associated behaviours among this population and especially among sexual offenders, drug 
use and traffic, crime and violence, prevalence of infectious diseases and their prevention 
(particularly TB), medical doctors’ responsibilities and experiences, changes in law and their 
impact and the role of prisons and society in the wellbeing of delinquents. Several studies 
tested the validity of survey instruments to identify specific psychological disorders or 
investigated the beliefs and emotions of inmates through qualitative methods. Case reports 
of particular medical conditions observed among inmates were common. Studies among 
adolescent delinquents were over-represented. The vast majority of articles originated from 
Brazil and other countries represented were Colombia, Mexico, Nicaragua, Peru, Argentina 
and Chile. 
 An additional search in LILACS using “prisión OR cárcel OR penal OR penitenicario” resulted 
in 646 studies. This allowed broadening the universe of the search to other fields that 
provide an insight on the situation and characteristics of inmates in Latin America without 
HIV necessarily being the main focus. The area most represented was psychology/psychiatry. 
Sociology and law as well as epidemiology/public health were also represented. This search 
allowed the identification of additional studies investigating drug use, its measurement and 
correlates. A few studies investigating the social and family background of inmates were also 
considered relevant and others dealing with specific issues such as the perception of 
inmates’ health among prison guards were selected. 
 
Notes were taken from the qualitative work reports, and from the books and papers included in the 
search. Each source was analysed separately to extract potential determinants leading to 
vulnerability to HIV. All these were listed, compared and grouped when they referred to similar 
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issues. In this way, a number of recurrent themes became apparent and although these are most 
generally interlinked an endeavour was made to synthesise this information. Our focus was on 
identifying conditions or situations particular to the prison context that could lead to HIV infection; 
however, it became obvious along the analysis that risks present in the community cannot be 
ignored and are often associated with outcomes in prison. In the same way, the experience of 
incarceration will affect risk upon return to the community. The analysis was therefore divided into 
“Community” and “Prison” themes. The themes identified were examined following the general 
concept of the proximate determinants framework developed by Boerma and presented in Chapter 
4 and of the social determinants framework proposed by Poundstone [387], which hypothesise that 
there are several layers of influence leading to HIV infection. Frameworks developed by other 
researchers in the field of HIV and STIs were used to inform and complement our framework 
[117,387,439,440,441].   
3 Results 
The different issues affecting risk both in the community and in prison identified from the qualitative 
work and the literature searches are described below and are categorised as structural, social and 
underlying determinants. Each theme encompasses a variety of determinants that may be at 
different points along a path to HIV or even act through different paths. These paths are not 
described in detail and have been synthesised in a conceptual framework of HIV infection among 
inmates presented in Figure 3. In the same way, the influences and synergies between the 
determinants are mentioned in the text but more clearly defined in Figure 3. 
3.1 Community 
 
3.1.1 Structural determinants 
We propose that structural factors including poverty but more importantly socio-economic 
inequalities and unemployment generate financial needs and frustrations that favour the 
involvement in delinquency and other risky situations. The social exclusion, marginalisation and 
discrimination directed towards the lower, uneducated social classes and individuals with a sexual 
orientation different to the heterosexual also contribute to reducing opportunities, creating 
insecurities and resentment and affecting access to health care [117,441]. These situations are 
eventually conducive to risky sexual behaviours. 
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3.1.2 Social determinants 
 
3.1.2.1 Low access to health care 
For those who live in deprived neighbourhoods, on the outskirts of the city, access to health care is 
rendered difficult by the absence or inefficiency of public transport to reach health centres 
[442,443]. In Canada, among those who have already been in contact with the police, area 
restrictions have been shown to hinder access to treatment and harm reduction services [443]. 
There is little exposure to health promotion activities and so health and especially prevention are 
not as highly valued as in wealthier contexts. Stigma and marginalisation also hinder access to 
health, especially when considering drug users and transgender women [86,444]. A study carried out 
among heroin addicts found that they had a low perception of health problems and that they only 
accessed treatment when they had suffered from an overdose or had had episodes in A&E [444]. A 
lack of exposure to STI prevention interventions and more generally to information about these 
infections will hamper the adoption of preventive behaviours. When considering drug users, the lack 
of access to treatment and harm reductions services can prolong the duration, intensity and risks 
associated with drug use (and especially with IDU). 
3.1.2.2 Dysfunctional family environment 
Several patterns were observed in the description of inmates’ family environment and childhood: 
economic hardship, mono-parental families, numerous siblings, domestic violence, sexual abuse and 
alcohol and substance abuse by the parent(s) were the main issues emerging [445,446,447,448,449]. 
All these did not always coexist nor were they necessary factors for incarceration but they did 
appear to have a strong role in the process. Orphanhood or abandonment result in children being 
taken care of by other family members who may already be struggling with their own children and 
may be unable to deal with an additional financial burden [438]. Living with other family members or 
step-parents seems to increase the risk of sexual abuse [448]. These situations result in low levels of 
family support and even in the more positive cases (mostly observed when the carers are the 
grandparents), the children can accumulate insecurities and deficiencies that are often manifested 
during the adolescence [446,450,451]. A variety of situations including both external (financial need, 
maltreatment) and internal (rebellion, anger) drive adolescents to the streets in a more or less 
permanent form [449]. 
3.1.2.3 School dropout 
Lower levels of school attendance, higher levels of repeating and early school dropout are frequent 
among inmates[447].  In a study exploring the childhood and adolescence of inmates at the State 
Penitentiary of Maringa in Brazil, all reported having started working informally when they were 
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children to contribute to the family’s earnings [445]. As the financial pressures incurred by the family 
take over, studying is viewed as dispensable [445]. School dropout has been found to be associated 
with delinquency and substance use during adolescence [452,453].  
3.1.2.4 Neighbourhood, Gang membership and values 
The neighbourhood has been recognised as a setting for risk generation in social epidemiology 
[387,439,440]. The segregation and social isolation of individuals with low socio-economic 
background and fewer opportunities promotes risky behaviours through normative influences and 
clusters the sexual network aiding the transmission of STIs [387]. In particular, gang membership or 
involvement in mafia organisations can be common in deprived neighbourhoods as these will often 
provide the opportunities, support and recognition missing from the system [442,454]. Gang 
membership and more generally socialisation in risky neighbourhoods often lead to the 
experimentation of alcohol and increasingly addictive drugs [455,456,457]. Bravery, toughness, 
impulsiveness, fearlessness are valued qualities in the delinquency environment and in the context 
of sex this brings consequences including the risk of exposure to HIV. Gang membership was found 
to be associated with having had sex, having caused a pregnancy (unprotected sex), having multiple 
concurrent partners and having had sex under the influence or with a partner who was under the 
influence of alcohol or drugs among a sample of 14 to 18 year old detained adolescents in Georgia, 
U.S. [458,459]. In their study in the province of Concepcion Chile, Rioseco and colleagues [447] 
found that 90% of adolescent delinquents aged between 14 and 17 had had sex compared to 22% 
among non-delinquent adolescents. Of these some had between one and three children. Teenage 
pregnancies are common among young delinquents and generally imply new financial 
responsibilities that lead to more serious delinquency. Visiting FSW becomes possible with more 
availability of money, contributing to increasing the number of sexual partners and the exposure to 
networks with higher prevalence.  
3.1.3 Underlying determinants 
3.1.3.1  Drug use 
Drug use generally starts at an early age among inmates and prevalence is high [460]. Drug use has 
consistently been shown to increase sexual risk behaviours and has been identified as an 
independent risk factor for STIs and HIV among street youth and prison inmates [168,406].Drug 
addiction is also a central driver of delinquency, imprisonment, mental health problems and 
homelessness which can potentially exacerbate the risk of STIs [444,460]. In Latin America, crack has 
become widely used in the delinquency environment. It is cheaper than heroine and other drugs, 
extremely addictive, and produces intense but ephemeral pleasure[460]. Addiction leads to 
increased financial need and almost inevitably debt. Debt in this environment is a vicious circle: 
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interest rates are very high and so are the consequences of failure to respect the agreement. Some 
resort to sex work as another means to obtain resources and their crimes become less organised, 
more desperate and more violent, increasing the risk of being incarcerated. Homelessness is 
common among severely addicted individuals.  
3.1.3.2 Homelessness and unstable housing 
Homelessness and unstable housing have been associated with increased risk of HIV and STIs among 
a range of populations and age groups. Marshall et al have extensively investigated the risk of HIV 
and STIs among a sample of street involved youth in Vancouver, Canada. Homelessness was 
significantly associated with inconsistent condom use among this population while unstable housing 
(living in hostels and shelters) was associated with having multiple partners [461]. This is an issue 
that came out in the accounts of inmates from Carandiru, although the underlying reasons for 
unstable housing might have been different in these two populations. Carandiru inmates were 
constantly moving to avoid being found by the police and this involved sleeping with women and 
FSW they met during the night or with whom they had on-going affairs [437]. Being searched by the 
police was also found to be a correlated with having multiple partners among street involved youth 
in Vancouver [443]. Both individual mobility and living in a place where the turnover of people is 
high facilitate meeting new sexual partners. Living in the street is likely to result in rushed sex where 
condom use is more difficult. Also, among people who live in the street, protection against STIs 
through the use of condoms might be at the end of the list of priorities as they have much greater 
and immediate worries to face.  
3.1.3.3 Mental Health 
Mental health problems are frequent among inmates. The quality of the relationship with parents 
and especially with the father are known to be crucial for the psychological development of the child 
[460]. Not feeling cared for affects the construction of one’s identity and the perception of others 
[446]. Low capacity to empathise is often seen among delinquents as well as high prevalence of anti-
social behaviours. In the study comparing detained adolescents to adolescents enrolled in a school 
with matching socio-economic characteristics, the former were much more likely to suffer from 
psychological pathologies (64% vs 18%) and had lower levels of intellectual development [447]. 
These characteristics facilitate involvement in drugs and delinquency, forming a feedback loop. In 
fact, 12% and 16% suffered from alcohol and cannabis dependence vs 1% and 2% in the control 
group. Mental health problems can translate in a difficulty to form stable relationships and therefore 
in higher sexual partner change rates. In particular sexual offenders were found to have higher 
prevalence of mental retardation and to suffer from substance abuse [462]. 
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3.1.3.4 Pre-existing Sexual orientation 
Having same sex sexual orientation in a context where educational level is low and traditional values 
are reinforced (machismo, homophobia) will exacerbate the marginalisation experienced and might 
also affect family relationships [406].  
3.1.3.4.1 Sex with men 
It is hypothesised that a majority of men who report having sex in prison have had sex with a man 
previously, in the community [155,191]. The profile of MSM among the inmate population is very 
diverse. A recurrent issue among prison inmates reporting sex with men in Latin American countries 
is the history of sexual abuse by another man during their childhood. The perpetrators mentioned 
are often uncles or cousins and those who have a history of living in the street when they were 
young also report rape. These continue having male partners later on in their life and some enter sex 
work. Same sex sexual orientation has been found to be an important predictor of survival sex 
among street involved youth in Vancouver and also to be associated with a higher number of clients 
and inconsistent condom use [463]. Among HIV positive inmates in Latin America, being seduced by 
older men offering important quantities of money and travel/holidays in return for sexual acts is a 
frequently shared recollection. The account often includes the mention of pills being taken by the 
costumer/protector in question, with some specifying these being ARVs [438]. The repetition of this 
particular story puts in doubt its veracity and it is possible that this is a preferred explanation for 
their infection over admitting regular involvement in survival sex. Mental retardation or learning 
disabilities also seems to be a factor for being pulled into sex work or into relationships with men 
who give them protection, especially once in prison.  
3.1.3.4.2 Transgender women 
There are generally transgender women In Latin American prisons. Due to the stigma and social 
rejection that they endure as well as to severe mental health issues, it is very difficult for 
transgender women in this region to lead a standard life. As described in Chapter 1, transgender 
women face a variety of disadvantages and challenges: emotional problems, self-hatred and family 
rejection and low opportunities to progress in the professional world and be solvent economically. 
These recur to sex work and/or delinquency to make a living [70].  
3.1.3.5 Previous incarceration: the feedback loop 
Having been incarcerated will reinforce certain paths to risk present in the community. The time 
following release from prison is a particularly vulnerable period as it represents the recovery of 
autonomy and can result in an urgency to make up for the privation lived in prison, including the lack 
of sex. Multiple partnerships and sex with FSW upon release from prison have been suggested to be 
mediated through the dissolution of intimate relationships during incarceration by creating a need 
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for sexual and emotional fulfilment and by removing an important source of support leading to 
negative emotional outcomes such as depression [403,464]. The hypothesised pathway proposed by 
Khan et al. is shown in Figure 2 below. 
 
Figure 2. Proposed pathways through which dissolution of stable partnerships during incarceration lead to risky sexual 
behaviours as described in Khan et al [403]. 
The immediate period post-release has also been found to be crucial for those who formerly injected 
drugs as this practice is strictly controlled in most prisons. In fact, the risk of dying from an overdose 
has been shown to be greatest during the first two weeks post release among ex-offenders 
[465,466]. Incarceration can cause the loss of friends, partners and family [467] and can also affect 
the ability to form new relationships as being exposed to a constant state of oppression, alert and 
mistrust results in isolation and low self-esteem [467]. In the absence of social support, being 
released can encompass homelessness and economic hardship.  
By reinforcing networks with the delinquency environment in prison, ex-offenders are likely to have 
a greater involvement with gangs and drug mafias upon release further encouraging delinquency 
[467].  
Being an ex-convict is charged with a range of negative connotations aggravating the marginalisation 
and rejection experienced by these individuals, contributing to unemployment and lack of 
opportunities completing the full circle back to the structural determinants of risk [406]. 
For inmates who have children, their incarceration will have an impact on their family life, 
economically as well as emotionally; setting the grounds for a new generation of deprived children.  
 
3.2 Prison  
The risks in the prison will be very different depending on the prison’s population size, living 
conditions, regulations and personnel capacity (staff to inmate ratio) among others. Some studies 
suggest that there is very little sexual activity occurring in prisons [191]. While there are conditions 
that may decrease sexual risk behaviours in prison, the social organisation of this setting also favours 
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the emergence of power differentials and vulnerabilities that can lead to risk. As the objective of this 
work was to identify potential determinants of HIV infection among prison inmates we investigated 
these. 
We have focussed here on the medium security prisons of Latin America where the number of 
inmates is often high and generally surpasses the prison capacity; where access to visitors is mostly 
unrestricted and where the vigilance/surveillance by the authorities is undermined by insufficient 
staff numbers and pervasive corruption. In this specific context, where the prison can be a miniature 
replica of the outside world, the risks incurred by inmates can be quite similar than in the 
community. One fact that will remain true invariably is that those who were fragile outside will 
remain so inside.  
3.2.1 Structural determinants 
Alongside the socio-economic issues mentioned in the community section, the political and legal 
contexts will drive incarceration patterns putting certain groups at higher risks of being prosecuted 
than others [387]. In particular, laws regulating drug possession and consumption will have an 
impact on incarceration patterns of drug users. The growing presence of the “war on drugs” in 
several Latin American countries is affecting the size and composition of the prison population 
through higher incarceration rates and a higher proportion of drug users among inmates [387]. 
Likewise, changes in the drug markets can directly modify HIV risk among inmates. In Carandiru for 
instance, IDU was common in the late eighties and prevalence was high among inmates (17.3%) 
[468]. Later on, crack started becoming more fashionable, partly because of interventions in the 
prison persuading the inmates to avoid injection, partly because crack was entering the general 
drugs market at the time [468]. Prevalence in 1994 decreased to 13.7%. Situations of civil unrest or 
armed conflicts will also influence the characteristics of the prison population. In the 1990’s in Peru 
members of the shining path (a Maoist organisation in Peru which started an internal conflict in Peru 
in 1980 that would last for over 10 years) were over-represented in prisons, more recently in 
Colombia members of the FARC (Revolutionary Armed Forces of Colombia) have had an influential 
presence in some prisons. These often follow a very strict discipline and might be less likely to 
engage in risk behaviours [454]. In other settings the prison population might be a reflection of the 
social marginalisation of specific ethnic groups (black Africans in U.S. [170], indigenous communities 
in Australia [469]) and again their exposure to HIV will vary accordingly. 
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3.2.2 Social determinants 
3.2.2.1 Resistance 
Factor et al (2011) [441] hypothesise that rather than passively experiencing the health outcomes 
associated with their socio-economic status, individuals in deprived or marginalised situations will 
actively lead a riskier lifestyle to confront the system. In their work they employ the concept of the 
minority versus the dominant group. As the minority does not feel integrated into society and rather 
experiences resentment against it, it will confront it (either consciously or not) through violating the 
law and by going against the behaviours encouraged by society. In this frame of thought drink-
driving, smoking, drug use, vandalism are all expressions of resistance against the system. Inmates 
are probably one of the most visible minorities rejected (and physically removed) by society. 
Sentiments of anger and victimisation are often expressed by inmates in reference to society and 
impulsivity and risk taking are characteristic of this population. It is therefore sensible to consider 
the theory of resistance as one of the possible contributors of the negative health outcomes 
(including HIV and STIs) among prison inmates.   
3.2.2.2 Deficient health care services and low access 
Low access to health care in the community is common among individuals involved in delinquency. 
However, the prison context imposes very particular constraints to both the quality and the access 
of health care that deserve special attention [470]. Firstly, the capacity of health services in prisons is 
generally insufficient due to the lack of medical staff and budget to put towards adequate diagnostic 
and treatment tools. Medical staff is often described as discouraged by the work conditions and low 
salaries, in agreement with findings from Chapter 1 [189]. Secondly, the access to health services in 
prisons is conditioned by the guards. Allowing inmates to exit their cells to be taken to a different 
part of the establishment poses security issues and therefore threatens the guards’ main 
responsibility. In a study carried out among guards in a Brazilian prison, these report prioritising 
security over health issues and only taking inmates to the health services if symptoms are visible 
[471]. Guards describe inmates as clever and astute and faking illness can be a distraction [471]. A 
more subtle reason for restricting access to health is the fear of appearing weak to the eyes of 
inmates [471]. Guards must be seen as authoritarian and intransigent to be respected and keep 
control over their ward. In the same lines, as access to health services is a privilege granted by 
guards, these prefer to use it as a tool to negotiate. For multiple reasons, the nature of the 
relationship between inmates and guards creates a bottleneck for their access to care. In some 
prisons, the intervention of family members requesting an appointment can help but in most cases 
the time lag from symptoms to care is lengthy [470]. At the societal level, this is considered part of 
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the punishment deserved by those who have infringed the law and there is therefore little pressure 
put on the authorities to improve the health of inmates [470]. 
However, in some places (mainly U.S., Australia and Spain) prisons are used as a setting for detection 
of infections (HIV in particular) and will represent the first opportunity to get tested and directed to 
treatment for many inmates. In progressive settings, where the role of the prison in the re-education 
and re-integration of inmates is considered, services such as counselling, mental health support, 
drug addiction treatment and harm reduction are offered to inmates. 
3.2.2.3 Hierarchy 
The prison culture is heavily hierarchical and the position in the pyramid will determine the risk of 
abuse and involvement into sex work. The social hierarchy in prison acts at many levels, from the 
allocation of space in the cell to the decision to punish or kill another inmate.  
3.2.2.3.1 Cell 
Within the cell, the position in the hierarchy often depends on the time spent in that cell. The 
inmate with the longer stay will generally be the leader and will organise the others to ensure the 
running of the cell [179]. The newest inmates are generally in charge of cleaning and other physically 
demanding tasks [179,472]. The position in the hierarchy is reflected in the sleeping arrangements 
with the leader sleeping in a bed and new inmates sleeping on the floor and often next to the toilet 
[437]. New inmates can pay their way up in the hierarchy and those with high resources will get a 
cell of their own. In Carandiru, the cells were a property of the inmates and among habituated 
delinquents these would be sublet to friends upon release until they came back. Inmates with no 
resources to buy a cell would have trouble finding a place to sleep but also to have access to meals 
given by the authorities as these were distributed in the cells [82,437]. This type of organisation 
generates vulnerabilities as inmates in a fragile position will need to offer services in exchange of a 
space. Being “cell-less” in prison implies similar risks as being homeless in the community. 
3.2.2.3.2 Housekeeping 
The day to day running of the prison also happens within a hierarchical structure: in Lurigancho, 
“delegados” are in charge of the different areas (sport, security, education, catering etc.) [436]. 
These are elected by the inmates and generally exhibit leadership skills. In Carandiru a group of 
inmates named the “housekeeping” would be in charge of the cleaning, cooking and food 
distribution in each ward. This group of inmates would also be chosen, live together and were in a 
position of power as a strike or riot from the housekeeping would jeopardise the equilibrium of the 
most basic needs. It is likely that inmates who hold these types of positions are less vulnerable to 
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abuse but also to depression and probably drug addiction as they lead a more active and structured 
life behind walls. 
3.2.2.3.3 Social order 
At a higher and less visible level, every ward or section will be supervised by a highly respected 
inmate. The heads of sections are renowned and influential delinquents who might already have 
exerted power in their neighbourhood while outside or who might have long standing experience of 
the prison [436]. The criteria to reach such status appear to change over time following the 
evolution of the crime scene in the country [436].  In the event of fights within the ward, he will be 
consulted and his permission will be needed to take action. When problems arise between wards, 
the heads of each ward gather and discuss [437]. These important figures remain anonymous to the 
authorities. 
3.2.2.4 Network 
3.2.2.4.1 Gang Membership 
As for the heads of section, the position of inmates within the prison will be dependent on their 
network outside prison or on their exposure to prison. Those who come from neighbourhoods 
where delinquency is common will have higher chances of knowing other inmates at entry or even 
to have some of their family members in prison. These will be protected by their social network and 
will be less vulnerable than those who have had no contact with the delinquency environment 
before. Ruiz (2007) [473] found that inmates who had greater awareness of gangs’ norms had a 
lower prevalence of emotional problems. However, those who were involved in a delinquent 
network outside will also bring their rivalries inside.  
Additionally, the values of bravery, carelessness associated with masculinity mentioned before might 
be intensified in the prison context. It is well known that prisons are an interface for exchange and 
learning between delinquents [472]. Lurigancho prison, which was the focus of the two previous 
Chapters, is known as “the high school of crime” [376]. It catalyses the reinforcement and formation 
of criminal networks as well as the transmission of values and norms of the delinquency 
environment, pushing inmates to get involved in riskier situations [472]. 
3.2.2.4.2 Visitors 
Another important source of support in prison are visitors. In material terms, these will cover the 
basic needs of inmates through bringing food, clothes, medication as well as other things requested 
by inmates to improve their living conditions. These will often also bring money to pay for their 
needs or for debts they might have acquired. Visitors also represent a source of emotional support 
and care, a link with the outside and normality, a motivation to keep going and recover their 
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freedom. This is evident from the discourse of inmates in the Capixaba prison in Brazil [474]. Inmates 
who receive no visitors will be more prone to depression and addiction [475].  In particular inmates 
who have intimate visitors are less likely to seek sex from sex workers as described in Chapter 1 and 
confirmed in Chapter 4. 
3.2.2.4.3 Religious communities 
Involvement in a religious community was found to be a central element in the accounts of some 
inmates and in descriptions of the prison population. The church and other religious bodies often are 
the only organisations to provide support to inmates and for some it is their only link to the 
community. In fact, one of the articles identified in the LILACS search was an interview to a priest in 
charge of the prison pastoral for the state of Sao Paolo, where he condemned the system for feeding 
a cycle of poverty among the deprived sectors of the population [442].  In Carandiru, the largest 
religious community was the “Assembleia de Deus”, they all lived together and had an extremely 
disciplined routine punctuated by prayer and meditation. According to the testimonies included, 
inmates who enter these communities/sects while in prison are often those who are at the verge of 
collapsing. Inmates who have been close to dying or who have lost it all, often a result of drug 
addiction, tend to recur to religion. The promise of redemption and of a better life offered by 
religion is sometimes the only source of hope left. This transformation was observed among one of 
the inmates interviewed in Mexico and in one of the four interviewees at the Capixaba prison [474]. 
Additionally, in his book Varella mentions that inmates who were in danger of prosecution by other 
inmates in prison such as sexual offenders or drug users who had not been able to pay their debts 
also faked conversion and join this community for protection [437]. We hypothesise that HIV 
prevalence could be higher among these religious communities as a result of past risk behaviours 
but current risk taking behaviour and HIV incidence to be lower.  
3.2.3 Underlying determinants 
 
3.2.3.1 Drug use 
The prevalence and intensity of drug use increase in prison as a result of a multiplicity of factors that 
encourage its use. As an example, for every additional year spent in prison among inmates in Rio de 
Janeiro, the odds of cocaine use were found to increase by 13% [476]. Access is facilitated through 
their widespread availability and use is encouraged by dealers. Drugs provide a fictitious way out 
from the situation of reclusion, deprivation and inactivity imposed by the prison environment. As the 
mental health of inmates is weakened, addiction takes over bringing a range of problems. The 
repercussions of having a debt are exacerbated in prison as there is no way to escape and there is 
more pressure for the dealer to show no forgiveness in case of failure to pay as the rumour will 
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quickly travel and endanger his business [437]. IDU in particular is widespread in prisons in countries 
or areas where this practice is present and is almost invariably identified as a risk factor for HIV 
infection [166]. As described in Chapter 4, the use of non-injected drugs has also been found to be 
associated with HIV risk among inmates. 
3.2.3.2 Coerced sex and situational homosexuality 
Although, as seen from the above examples, there are a variety of reasons why inmates might have 
had sex with men before entering prison; there are specific circumstances in prison that can result in 
inmates experiencing sex with men for the first time. Additionally, the lack of feminine presence in 
the everyday life of the prison creates a void, and therefore, having a same sex sexual orientation 
acquires additional significance especially among those who exhibit a feminine side and transwomen 
in particular. These are viewed as the substitute for women and are expected to provide sexual 
services [179]. 
3.2.3.2.1 Sexual offenders 
Probably the most widely held belief is that sexual offenders/rapists, get raped themselves by other 
inmates when they enter prison. Although this certainly happens it is probably not as systematic and 
widespread as could be imagined. Firstly, the crime for which inmates are charged is normally kept 
confidential, so unless the information is provided by the accused himself, by another inmate or by a 
member of the prison staff (which is a professional fault), other inmates should not know about the 
criminal history of sexual offenders. Secondly, because this practice is known, sexual offenders are 
sometimes held in a separate ward to protect them from the other inmates [437]. Thirdly, the 
punishment can take other forms of physical violence that do not involve rape. Notwithstanding, this 
is a reality in prison as suggested by testimonies and reports in qualitative and quantitative studies 
[472]. Victims of rape are at high risk of HIV/STI infection, especially when there are multiple 
perpetrators as the rate of exposure is large and violent sex can increase the susceptibility through 
causing wounds. If the victim is himself HIV positive, group rape can be a particularly efficient path 
for transmission. Surprisingly, there have been very few studies looking at HIV/STI prevalence among 
sexual offenders. Considering their sexual exposure, it could be expected that it is higher than 
among the general population and it is important information to estimate the risk of HIV/STI 
infection among victims of rape. Only two studies that specifically investigated this were identified: 
Giotakos et al. [477] measured HIV and HBV and HCV prevalence among a sample of rapists and 
child molesters in Greece. None was found to be HIV positive and 13% and 6.5% were found to be 
HBV and HCV positive respectively which was substantially higher than the general population.  
Modestini et al. [478] offered HBV testing to 153 inmates in a UK prison and of the 45 who accepted 
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testing, one (2.2%) was found to be positive. While the national prevalence is around 0.3% [479], it is 
hard to draw conclusions from this study. 
3.2.3.2.2 Other victims of rape or abuse 
Very young men, especially if attractive, are at higher risk of being sexually abused or pulled into sex 
work. According to Parrini’s findings, “Chamacos” (kids) are considered as substitutes for virgin 
women because they have generally never had sex with other men, following the construct of 
homosexuality in the region described in Chapter 1 [179]. They are therefore inexperienced and can 
be manipulated during sex. These young men often become addicted to drugs during their stay in 
prison and find in sex work a source of money to pay for their dose or for their debts.  Weaker 
inmates in general (either as a result of addiction or financial need) will be more subject to giving 
sexual services. Oral sex was found to be the most commonly reported sexual service exchanged in 
prison. It is essential to consider this when asking about sex in this setting as failure to do so might 
result in an over-estimation of anal sex between inmates.   
3.2.3.2.3 Perpetrators 
While we have hypothesised that powerful inmates are at less risk of abuse, they may also be more 
likely to be perpetrators of rape and abuse or to provide protection to other inmates against sex. 
They might also be in a better economic position to buy sex from FSW. Power might therefore not 
necessarily be associated with lower risk of HIV/STI infections and so investigating its impact is of 
special interest. Powerful inmates that exert their dominance through coerced sex might act as 
efficient spreaders of infection. 
3.2.3.3 Mental health 
Incarceration is described as one of the most traumatic events that can be experienced by an 
individual. It represents an interruption in the individuals’ lifetime, involving being physically 
removed from their home, work and relationships [416,449] to enter a hostile environment of 
constant supervision, fear and deprivation. These conditions can only aggravate existing 
psychological problems and are likely to cause new ones. The first weeks of incarceration have been 
found to be the most difficult in several studies, as suggested by the rates of suicide during this 
period [473]. In a sample of inmates in Colombia with variable lengths of stay, 20% were found to be 
at risk of suicide which was correlated with higher levels of depression and hopelessness [480]. 
Suffering from mental health problems such as learning disabilities in prison increases the likelihood 
of abuse.  
3.2.3.4 Time in prison and recidivism 
Time in prison and recidivism determine exposure to the prison system and therefore have an 
influence on most of the issues presented in this section. As described above, at the cell and prison 
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level, time in prison will be an important criterion for the position in the hierarchy. Alongside, both 
time in prison and recidivism will have an impact on the social network of inmates. Recidivism in 
particular can be the reflection of a deeper involvement in the delinquency environment and might 
imply a stronger network both inside and outside prison. In contrast, a long time in prison does not 
necessarily reflect this as a single serious crime will result in a long sentence. However, a long time in 
prison will result in familiarisation with the system and possibly social integration.  
Regarding sexual partners, a long time in prison may result in the need to resort to sex with FSW or 
other inmates among those who do not have sexual partners visiting them. Prolonged confinement 
affects mental health and can cause depression and hopelessness, which can in turn impact drug 
using behaviours. Finally, a long time in prison results in a more permanent adoption of the realities 
imposed by the system such as the loss of autonomy and of behaviours that facilitate life in prison 
such as isolation and mistrust. These will hinder the reintegration of inmates when they go back to 
the community. 
3.3 Framework description 
In Figure 3, the four different layers of risk (proximate, underlying, social and structural) are 
represented by boxes embedded within each other. The structural and social determinants of risk 
present in the community act through drivers including financial need, resistance and peer pressure 
shown in the large grey arrow and lead to a variety of underlying determinants that influence each 
other as shown by the thin black arrows and that eventually lead to incarceration. The prison 
context is represented by a separate blue box describing the structural, social and underlying 
determinants specific to this environment. The large light orange arrow represents the pathway 
through which the social profile of inmates defined by age, contact with the prison system, social 
network, position in the hierarchy will influence their risk of using drugs, engaging into sex work, 
experiencing coerced sex or rape, leading to specific proximate determinants of HIV risk.  Aside from 
the risks imposed by the prison environment, incarceration acts through reinforcing risk in the 
community after release. This is shown by the dark orange arrows coming out of the incarceration 
box. Interventions implemented in prison to reduce risk behaviours and help inmates controlling 
drug addiction and mitigate mental health problems can help reversing this vicious circle of risk. The 
pathway will be different depending on the circumstances and while some will travel along the long 
route to risk, others will be born in it. Street kids grow homeless, transgender women will almost 
invariably be exposed to sex work, individuals with mental health problems will be more vulnerable 
to drug use and might enter the risk circle faster while more steps will stand between children born 
in a poor family in the rural areas and the delinquency environment.   
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Figure 3. Proposed framework for HIV acquisition among prison inmates with a particular emphasis on the Latin 
American setting.  
This is divided into the structural, social, underlying and proximate determinants of risk and differentiates the prison (in the 
blue box) from the outside. The gears represent the synergy between the different underlying determinants of risk both 
outside an inside prison while the thin arrows describe particular relationships between them (same-sex sexual orientation 
for instance, has been found to lead to low health seeking behaviours due to the fear of being humiliated). The underlying 
determinants present outside prison, and especially delinquency, lead to incarceration as shown by the orange arrow. The 
large light orange arrow within the incarceration box shows how the social determinants influence underlying 
determinants. Prevention and harm reduction activities in the prison (orange box) can help preventing or moderating these 
underlying determinants. The thin orange arrows coming out of the incarceration box show how incarceration can fuel the 
determinants of risk outside prison at different levels, thereby promoting risk behaviours and increasing the risk of being 
incarcerated again. 
 
3.4 Questionnaire 
3.4.1 Structure 
Based on the information gathered, a structured questionnaire was designed to obtain information 
on identified issues that may shape the inmates’ risk profile. This is included in appendix but the 
general structure is described in Table 1. The questionnaire was divided in two main sections: inside 
and outside prison to obtain information on the risks implied by these two settings. Risks are likely 
to be different inside and outside and through this thesis we have been faced to the lack of 
information on sexual and drug using behaviours outside prison. In medium security prisons, the 
average sentence length is rarely longer than 5 years and many inmates will be incarcerated for only 
a few months. Additionally, the average age at first entry can be further years apart from the age at 
first sex meaning that the first years of sexual activity, often characterised by higher risk behaviours, 
occur outside prison for many. Consequently, most of inmates’ sexual life happens outside the 
prison walls and it is essential to gather information on behaviours and their determinants in this 
setting. While this work focusses on understanding the role of prisons in modulating HIV risk, the 
difficulty in answering this question is partly due to the lack of “baseline” data on sexual behaviours 
outside to be used for comparison. It is difficult to obtain directly comparable information on 
behaviours inside and outside due to time differentials (between the time spent outside and inside 
for each individual and between individuals). An example of this would be the study by Gough and 
Edwards (2009) investigating risk behaviours inside and outside prison among inmates in Belize  
[191]. They ask about behaviours in prison over the past 12 months, while in the outside prison 
section the time scale used is either “the last two years” or “ever”. We have endeavoured to design 
the questionnaire in a way that the information describing behaviour inside and outside prison is 
comparable. Nonetheless, the focus of this questionnaire is on gathering information that can 
provide answers about the role played by the prison in modifying sexual behaviours and to identify 
circumstances that can increase risk in prison and that could be used in the design of prevention 
intervention. Similarly, building profiles of inmates at higher risk based on this information should 
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also allow directing these interventions. The questions included cover the social, underlying and 
proximate determinants presented in the framework and focus on gathering information on the 
potential pathways for risk described in the blue “incarceration box. In the right column of Table 1 
we have briefly reminded the hypotheses underlying these questions. 
Table 1. Basic questionnaire structure to investigate determinants of risk among prison inmates (outside prison section) 
 
 
 
Outside prison 
Questionnaire structure Main associations investigated 
1)      Socio-demographic indicators and living 
arrangements 
 
Marital status, children, place of residence, type of 
accommodation, ever been homeless 
Poor/rough neighbourhood→gang membership 
Homelessness→sexual risk behaviours/abuse 
2)      Childhood and schooling  
Family type (monoparental, number of members), 
economic hardship, domestic violence, sexual abuse, age 
of leaving family home 
Dysfunctional family  
→school dropout→ gang membership →earlier 
engagements in risky behaviours 
→Sexual abuse 
Economic hardship→ gang membership 
School dropout, attainment, age at 1
st
 job, type of 
employment 
3)      Drug use  
Age at start, type of drugs used, frequency, debt 
→higher sexual risk behaviours 
→engagement in sex work to finance drug habit 
4)      Sexual activity  
Age at first sex, number and type of partners (lifetime/ 
last 6 months) 
Proximate determinants resulting from different 
pathways proposed 
Condom use  
Paid for sex, sold sex, same sex partners (ever/ past 6 
months) 
 
5)      Access to health care  
Distance to nearest centre, vaccinations, frequency and 
reasons for visits, HIV test. 
Bad access to care→ lower practice of prevention 
behaviours 
6) Mental Health  
Apply instrument to screen for mental health problems 
such as the Personality Assessment Inventory [52] and 
the Weschler Adult Intelligent scale (WAIS) to detect 
mental retardation [16].  
Mental health problems 
→ engagement in risky sexual behaviours 
→vulnerability to sexual abuse 
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Table 1. continued. Basic questionnaire structure to investigate determinants of risk among prison inmates (inside 
prison section) 
 
3.4.2 Administration mode  
The choice of administration mode for this questionnaire needs to be carefully considered. It 
contains questions concerning sensitive topics including drug use and coerced sex which are likely to 
be difficult to report in the prison setting. As the need for information on risky behaviours such as 
sharing of injecting equipment and unprotected sex became greater due to the expansion of the HIV 
epidemic, the application of alternative methods for interviewing grew. Self‐Administered 
Questionnaires (SAQ) proved to be efficient in increasing the report of illicit drug use in different 
settings and it was later found to increase the report of partner numbers among women and to 
reduce it among men compared to face-to-face interviews (FTFI). One of the methods being 
increasingly used is the Audio Computer Assisted Self Interview (ACASI) method. This method has 
been shown to increase the report of stigmatised behaviours such as alcohol and illicit drug 
Inside prison 
Questionnaire structure Main associations investigated 
1)      Criminal history  
Incarcerations: age at first, number, length of stay 
for each 
Measure exposure to the prison context and determine 
delinquency profile of inmates (first/frequent offenders) 
Type of crime→ status among other inmates Type of crime 
2)      Network  
Acquaintances, family in this prison, visitors, 
membership to a group, religious community, loss 
of social support, partnership dissolution 
Network within prison→ protection from abuse 
Visitors→ financial and moral support→ protection from abuse 
Religious community → past risk behaviours 
Prison exposure→ loss of social support/partnership 
dissolution→ engagement in risky behaviours 
3)      Position in hierarchy  
Cell: number of inmates in current cell, sleeping 
conditions (i.e. proximity to toilet) 
Cell 
→no cell=high risk of sexual abuse 
Previous cells and reasons for moving →overcrowded=conducive to sex 
Prison: activities, responsibilities (ex. Delegado), 
perception of oneself (respected, invisible, weak) 
→sleeping space=reflective of position in hierarchy 
Activities 
→better placed in the hierarchy, better psychological state→ 
less engagement in risk behaviours/less risk of abuse 
4)      Drug use  
Drugs used, frequency, debt Exposure to prison→ Increased drug use (especially for NIDU). 
5)      Sexual activity  
Number and type of partners Proximate determinants. 
Patterns likely to be different from outside: allow for 
comparison 
Paid for sex, sold sex, coerced sex (past 6 months/ 
since entry) 
Sexual orientation 
6)      Access to health care and HIV testing  
 Bad access to care→no STI prevention/treatment/Awareness  
7)      Mental health/ Current emotional state  
Apply instrument to measure current emotional 
state 
Prison exposure→depression/psychological problems→drug 
use and risky sexual behaviours 
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consumption, abortion, violence and stigmatised sexual practices [481,482,483]. Abortion was one 
of the first sensitive issues for which the use of self‐applied questionnaires was proven to increase 
the report. It was known that this procedure was underreported because the numbers obtained 
from surveys did not match the records available from the clinics.  The rapid development of 
informatics and the decline in computer prices allowed the use of technology in the survey field. 
Tourangeau and Smith [481] carried out a study comparing CAPI (Computer‐Assisted Personal 
Interview) which follows the same principle of PAPI (Paper‐Assisted Personal Interview) with the 
difference that a computer is used to enter the answers. They found that the self‐interviews resulted 
in increased reports of number of partners among women and of oral and anal sex, marijuana and 
cocaine use among all participants. In Peru, CASI has been used in parallel to face to face interview 
to investigate the prevalence and incidence of self-induced abortion [484]. The estimates obtained 
were relatively high and higher than previously obtained in demographic health surveys [484]. There 
was 91.3% agreement between the two methods which could be expected considering each 
participant responded to the same questionnaire twice but the authors did not specify whether one 
method resulted in higher reporting rates. Apart from reducing social desirability bias it is also 
thought to allow minimising data entry errors as the database is built as the participant goes through 
the questionnaire and it also eliminates the potential variability between interviewers.  
A potential problem inherent to self‐administered questionnaires (SAQ) is that they require a certain 
level of literacy. This issue is circumvented using ACASI because the questions and answers are 
recorded and read to the participant as they are displayed on the screen. The use of touch screens 
can circumvent the difficulties of typing answers on the keyboard [485]. This instrument has been 
applied to Mexican migrant populations, both in rural Mexico and in Atlanta as well as among 
adolescents from disadvantaged households in Mexico. More recently, Phillips and colleagues [486] 
reviewed the capacity of innovative methods (i.e. not requiring an interviewer) over FTFI to elicit the 
report of stigmatized or sensitive behaviours in low and middle income countries. The authors stated 
that the superiority of innovative methods (mostly ACASI) over FTFI was not observed across 
outcome measures but was dependent on the setting (country, rural/urban) and the population’s 
characteristics (gender, level of education), suggesting piloting the instrument in the prison against a 
traditional FTFI might be a valuable undertaking for this study. On the other hand, the report of 
forced sex was the only outcome for which innovative methods clearly increased the report, 
independently of other factors. As this is one of the key questions to be evaluated with our 
questionnaire, Phillips’ findings encourage the use of this type of methods for the purpose of our 
study. Finally, ACASI was the method used in the Mexico prisons’ study, and information on the 
acceptability and feasibility of this method should become available soon.  
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4 Discussion 
 
We have identified potential determinants of risk among inmates through qualitative work and a 
literature search covering a broad range of fields and have organised them within a conceptual 
framework of risk representing the structural, social, underlying and proximal contexts of inmates 
thereby proposing pathways of risk. Based on this preliminary work, we developed a structured 
questionnaire to gather information of these potential determinants and test the hypotheses 
brought forward in the framework.  
 
We interviewed a range of informants linked to the prison environment either through their job, 
their family members or by being incarcerated themselves, to identify potential determinants and 
circumstances leading to vulnerability to HIV infection among the inmate population of Mexico City. 
The information obtained was verified and complemented through searches including sociological 
studies, testimonies and peer reviewed literature with a focus on Latin American research. We 
investigated risk in the community and in prison. Incarceration appears to be a common event in the 
delinquent’s life and the practices and values encountered in the street are brought into the prison. 
The determinants found to influence risk both inside and outside prison were drugs, which occupy a 
central role in shaping risk among this population, mental health, sexual orientation, social network 
(influences/support) and access to health care. However, the conditions imposed by the prison 
context modify these risks and create other vulnerabilities, requiring a separate analysis.    
The themes identified were organised into a social determinants framework of HIV infection in order 
to construct potential pathways to infection. From the interviews carried out in Mexico City and the 
testimonies consulted it can be inferred that inmates infected with HIV in the Latin American region 
have a very high risk profile generally involving a combination of drug addiction, homelessness and 
multiple male sexual partners. Both having a same sex sexual orientation and growing in a deprived 
neighbourhood were social determinants leading to the aforementioned underlying determinants. 
This would explain why, in the majority of cases, HIV positive inmates enter prison for the first time 
already carrying infection as we inferred from the modelling work in the previous chapter.  In prison, 
the social network and the previous exposure to the prison environment were the social 
determinants influencing vulnerability to drug use and psychological problems, leading to sex work 
and abuse. Synthesising the information helps visualise the relations between determinants and 
compare their relative importance: the multiple influences exerted by drug use make it an obvious 
target for prevention interventions among this population. The framework therefore helps 
identifying points of leverage. In the same way, it can also highlight issues that will impact on the 
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success of interventions. The role played by the sentiments of resistance and rebellion against 
society in promoting delinquency and risk taking might also result in a rejection of interventions. It 
might therefore be necessary to revisit prevention strategies and take this in consideration when 
planning both the message and how to approach this population with an intervention. Finally, the 
framework also contextualises and explains some of the situations encountered in the accounts of 
inmates such as the return to prison only a few days or weeks after release. Although they provide 
specific reasons for this such as falling back into drugs; by looking at this issue from a broader 
perspective we find that it is the result of several factors working in tandem: the reinforcement of 
the delinquent network inside, the loss of support in the community, the compensation for the 
privation experienced inside. Putting together the material obtained from the qualitative work with 
processed information stemming from the studies allows a more comprehensive interpretation of 
the findings. 
However, the method used to formulate this framework also carried important limitations. Firstly, it 
covered a heterogeneous range of sources studying different populations that varied in terms of age 
(adolescent offenders versus older inmates), level of involvement in delinquency (street youth, 
juvenile offenders, recidivists, and sexual offenders), geography (South and Central American 
countries, Mexico but also Canada and the U.S.), setting (smaller versus larger facilities) and time 
(from the 1980’s to date). It is well established that risk is context specific [440] and it is possible to 
observe from the sources studied that this changes over time. Finally, and as mentioned before in 
this thesis, the determinants of HIV among the prison population will depend on the background 
epidemic in the country. Where prevalence is low like in Mexico and Peru, HIV positive inmates will 
exhibit very high risk profiles, while in countries with a higher prevalence, there is no need of such 
an accumulation of risk factors to be infected (same as for epidemics in the general population). 
Nonetheless, despite the many sources of variation present in this study it was encouraging to 
observe that findings emerging from the qualitative work and testimonies were often confirmed in 
studies across countries and time. Seeing individual situations obtained from testimonies and from 
our own experience engaging with inmates, their family and prison personnel reflected in the body 
of literature considered suggests a certain level of validity and provides confidence in the findings.  
 
By covering a wide range of fields, we captured risk determinants from the different aspects that 
form an individual’s life. This is one of the study’s strengths as it provides a holistic picture of risk 
and helps thinking about potential interventions in a more realistic way. For instance, although 
tackling homelessness would probably reduce the engagement in risky sexual behaviours, if 
addiction is not treated it is unlikely to make a substantial difference. However, the disadvantage of 
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broadening the scope of the study is that some issues were only treated superficially. The mental 
health of inmates is a complex and thoroughly investigated subject. A more in depth search would 
be required to link particular manifestations of mental health problems with HIV risk in this context. 
Further along this route, not only mental health problems but basic personality characteristics will 
influence risk taking behaviours and impulsiveness. Although this was touched upon in this work it 
deserves more attention. Same applies to most subjects approached in this study, but an in depth 
investigation of each issue would represent a huge undertaking. Collaborating or consulting research 
specialised on the key aspects affecting inmates: drug use, mental health, urban violence and 
delinquency would greatly improve the quality of this study. 
 
The framework presented here requires testing. The aim of a majority of studies included was not 
the evaluation of HIV risk. Therefore, we made inferences as to what could influence risk.  Clearly 
stating the hypotheses behind the framework and systematically reviewing the literature to identify 
studies that might already have tested them, is the first stage to be completed. For instance, the 
partnership dissolution pathway to risk has been tested by Khan et al. [464]. The framework should 
then be tested on a defined study population through applying a questionnaire. For this purpose, we 
developed a structured questionnaire addressing the different themes identified. This should be 
used as a guide rather than a ready to use instrument as it should be adapted to the context in 
which the investigation will take place. Similarly, although an endeavour was made to use simple 
language and manage sensitivities, this questionnaire will need to be piloted with representative 
members of the population. Some of the questions included in the instrument have already been 
applied in the Mexico City prisons study [183]. It would be possible to assess their acceptability 
based on the response rate obtained. In the same way, it would be possible to test some of the 
hypotheses implied in the framework. Obtaining accurate responses from surveys represents a great 
challenge, especially in an environment such as prisons where inmates might fear that the 
information shared will bring deleterious consequences. Additionally, many of the behaviours 
investigated here (such as coerced sex or sex work) are charged with high sensitivity and inmates 
might be unwilling to disclose them. Ensuring that the participants understand and believe in the 
confidentiality of the study is the first step to tackle the former issue. The questionnaire should be 
completed away from the presence of prison personnel. Anonymity of the responses must also be 
insisted upon when obtaining the participant’s informed consent. The use of methods that enhance 
the impression of anonymity such as ACASI should be considered. However, their superiority should 
not be assumed by default as it has been shown that the effect of these interviewing methods varied 
by setting. In fact, discussions with the HIV programme staff at Lurigancho have suggested that 
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inmates might actually prefer talking to a member of staff that they already know and trust than to 
an anonymous interviewer [375]. In an HIV testing campaign carried out in 2005 in Lurigancho, 
inmates preferred to be seen by the health promoters and HIV programme staff of Lurigancho than 
by interviewers coming from the University San Marcos [375]. These issues need to be investigated 
before launching into the study and the questionnaire must be piloted with a small group of inmates 
to remove questions that might cause particular discomfort. Additionally, including a qualitative 
component to the study either through the use of semi-structured or in depth interviews would be a 
valuable addition to the proposed study as it would provide a sense of whether the findings 
obtained from the structured questionnaire can be trusted, it would help interpreting the results 
and probably expanding the findings. 
 
This work constitutes the foundation for a study aiming at identifying determinants of HIV infection 
among prison inmates in Latin American settings, although it could be adapted to other contexts. 
The background investigation included qualitative interviews as well as testimonies, sociological 
studies and peer reviewed literature from scientific databases representative of both international 
and Latin-American research. The information was analysed and synthesised through the 
development of a social determinants framework of HIV infection proposing pathways for infection 
and highlighting connections and interactions between different determinants. A structured 
questionnaire was built from this analysis and suggestions as to how to implement it were 
formulated. We hope that this will provide guidance to researchers planning to investigate the 
epidemiology of HIV in this population. 
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Chapter 7: Discussion 
The aim of this thesis is to strengthen the evidence for the need of prevention among key 
populations in Latin America and to improve our understanding of these epidemics in the view to 
achieving a better quality response. In Figure 1 we present the HIV epidemic as the ultimate 
outcome of a chain of events spanning over different levels of influence which can be broadly 
classified as relating to the population or the individual. The field has progressively expanded from 
investigating the behaviours immediately preceding infection to considering the contexts in which 
these occur and the social and structural factors shaping them. This is a simple conceptualisation of 
the breadth of research that should be considered when thinking about the response in HIV and we 
have indicated where the work carried out in this thesis stands within this frame.  
 
Figure 1 .  Summary of the studies in this thesis within the broader HIV research field.  
Upper section: The epidemic is the endpoint of a chain of events whereby infection of an individual is the result of behaviours, which 
happen within vulnerability contexts such as imprisonment, that are determined by broader social and structural factors. In this way, 
population level determinants affect individuals’ behaviours that interact with demography, the natural history of infection and the risk of 
being exposed to an infected individual to determine spread of infection at the population level. The epidemic patterns produced will in 
turn impact on the risk of exposure of an individual as shown by the blue arrow. Feedback loops between the socio-structural 
determinants and the vulnerability contexts are also represented by blue arrows: detrimental conditions will lead to being in vulnerability 
contexts which are often illegal resulting in punitive responses which exacerbate vulnerability. Bottom section: the arrows indicate the 
direction of the questions approached in the analyses with respect to the chain of events described in the upper part: In Chapter 2 and 3 
we used information on behaviour to generate epidemic patterns. Two of the analyses in chapter 4 did not have infection or epidemic 
patterns as an outcome and either described behaviours or investigated associations between these and vulnerability contexts. Chapter 5 
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used the information on behavioural patterns to generate an epidemic and reconcile it with prevalence data. The causal pathways analysis 
in chapter 4 used information on infection to identify the behaviours and contextual factors preceding it. Chapter 6 investigated 
associations between the different elements in the chain to produce hypotheses about pathways for infection. As it used information from 
HIV positive and negative individuals, the research was bi-directional. 
 
The right half of the figure refers to the sexual and drug using practices of individuals, which interact 
with the natural history of HIV and other STIs as well as with demographical factors to generate an 
epidemic. This will feed back into the infection process by determining the risk of exposure to an 
infected individual. These dynamic processes are complex and mathematical models have been used 
to understand them and guide the response. In this work, we have carried out three analyses using 
models that answer different questions about the epidemic and that are representative of the main 
uses of modelling in the field: prediction of epidemic patterns, estimation of intervention impact and 
hypothesis testing to understand the epidemic.  
1 Predicting incidence patterns in the short term 
An issue faced by all countries to a greater or lesser extent in the limited availability of resources. A 
better understanding of the epidemic allows allocating these resources more efficiently to achieve a 
greater impact on transmission. Thirty years into the epidemic, data on several populations have 
accumulated and putting them together to better characterise the epidemic is a first step to 
improving the response. We used the UNAIDS Modes of Transmission (MoT) model to predict the 
distribution of new infections in the next year by mode of exposure in three countries in the region: 
Mexico, Peru and Dominican Republic. Prevalence tells us about the extent to which the epidemic 
has established in a population, being the reflection of past incidence and mortality trends 
[223,224]. Current incidence, on the other hand, trends inform us on where new infections are 
occurring which is the basic information needed for prevention planning. We found that in Mexico 
and Peru over 50% of new infections would occur among MSM confirming the heightened 
vulnerability of this population to the epidemic and its pivotal role in the effort to control it. Perhaps 
less expectedly, the contribution of MSM to the number of new infections was also substantial in 
Dominican Republic with over a third of new infections predicted to occur among this population.  
This highlighted the importance of maintaining the focus on key populations despite greater 
prevalence levels among the general population and suggested that the term “mixed” rather than 
“generalised” might be more appropriate to describe this particular epidemic and to set the grounds 
for prevention programmes. Rather than producing accurate estimates of incidence and its 
distribution, the MoT provides an overview of these patterns and it is within this mind frame that 
the results should be interpreted. We aimed to provide a strong sense of these limitations by 
developing a simple scoring algorithm to evaluate the quality of the data used to inform the model 
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(when this was available) and explained how the structural assumptions of the model can affect the 
validity of the outputs. The uncertainty module which was developed to illustrate some of these 
limitations is unlikely to provide an accurate representation of the true uncertainty.  Nevertheless, 
we believe that this is a useful tool that provides a framework to systematically review and question 
the validity of the information available in a country and which output is meaningful to policy 
makers, potentially leading to a more appropriate allocation of resources. The lessons learnt in this 
work should be considered when applying this model elsewhere. As much as possible the 
uncertainty in the inputs must be minimised and the interpretation must be done in the light of 
other information sources that can validate and complement the results.  
2 Estimating the potential impact of a prevention intervention at the 
population level 
To provide specific guidance regarding the design and implementation of prevention interventions, 
more specified models are required, that incorporate heterogeneity in behaviours and HIV/STI 
prevalence. MSM are the group at highest risk of infection in most of Latin America, as well as in 
high income countries including the U.S., Australia and in Western Europe and epidemics among this 
population are being increasingly reported in Africa and China [281]. Although high condom use has 
been reached in some settings, especially where the gay community has been active and where laws 
do not criminalise homosexuality, high incidence is still observed in many settings and this appears 
to be increasing in others, likely as a result of prevention fatigue and behavioural disinhibition 
resulting from the availability of treatment [281]. The use of ARVs to prevent infection has been put 
forward as a potential additional prevention intervention. In particular, oral pre-exposure 
prophylaxis (PrEP) has been shown to be effective in preventing infection among high risk MSM in a 
RCT [287]. While trials tell us about the effect of an intervention on an individual’s risk of infection, 
they do not inform us on its impact once implemented on a large scale and in the long term. 
Mathematical models are useful tools to tackle these questions as they incorporate the dynamics of 
infection and population demography. An important question is how relevant these novel ARV-
based prevention interventions are to middle income settings such as those found in Latin America. 
Should they be considered or ruled out?  
We investigated this question in the context of the MSM epidemic in Lima, Peru because the HIV 
prevalence and associated behaviours of this population have been well documented through the 
years and because the information obtained from the trial was representative of this population as 
the majority of the participants were recruited in Peru [287]. We developed a mathematical model 
of HIV transmission among this population based on an extensive review of the literature and 
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discussions with experts and identified issues which we felt could not be ignored. PrEP is an 
intervention that prevents individuals from acquiring infection. It is therefore essential, in order to 
accurately estimate its potential effect, to incorporate factors that will determine the risk of 
acquisition, especially if these are heterogeneous within a population. Sexual positioning in anal sex 
not only affects an individual’s risk of infection but also has an impact on population spread. Since 
one of the key advantages of mathematical models in investigating the impact of interventions, is 
that they simulate the secondary effects of preventing infection, this modality of MSM sexual 
behaviour had to be incorporated in the model. We also considered the visibility of populations to 
ensure the findings were relevant to programmatic needs. The groups included represent four 
distinct types of MSM: the relatively visible MSM whose social life might revolve around or at least 
include other MSM and who will therefore attend bars and places where these gather; hidden MSM 
who might be married and who stay on the margins of the gay scene; male sex workers who can be 
found by identifying places or means (such as the internet) for commercial sexual transactions are; 
and transwomen who are a clearly defined population and might also gather and sell sex in specific 
places. While others have assumed risk among MSM to be determined by their age or number of 
partners when investigating the impact of PrEP among MSM [343,366,367], we believe that the 
differences in identity and sexual role are crucial in defining the risk of MSM in Lima and should be 
included in PrEP models in other settings where such issues apply. In fact, recent work by Mitchell et 
al. incorporates sexual role when modelling the impact of PrEP among MSM in India where identities 
and behaviours of MSM have also been shown to have great variations[487].  
Using this model, we investigated the impact of programmatic factors including coverage and 
prioritisation as well as issues dependent on the participants such as adherence and changes in 
behaviour. We found that PrEP might be cost effective in this setting, which is consistent with the 
high vulnerability of infection observed among this population as described in the introduction and 
confirmed through the application of the MoT. Prioritisation of the groups at highest risk and a low 
coverage would maximise its impact, in agreement to the large variations in risk identified between 
groups. However, it would be unaffordable at a large scale (considering the size of the MSM 
population in Lima) and therefore should be used as an additional tool to be combined with other 
prevention interventions. It is likely that PrEP will be given to individuals corresponding to specific 
risk and adherence profiles and demonstration studies will be needed to better inform these 
decisions. A whole range of issues that were not investigated in this work will influence the success 
of a PrEP intervention starting from reaching MSM that are willing to participate and ensuring their 
regular contact with the programme to monitor their infection status. 
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The findings were in broad agreement with those from studies investigating the same question in 
the U.S. setting [343,365,366,367], although it is important to keep in mind that the success of HIV 
interventions is context specific [488]. Serosorting provides a good example to illustrate this 
[42,489]. This practice, which consists in having unprotected sex only with partners of the same HIV 
serostatus, has been adopted as a prevention strategy by the MSM community in several cities 
across the U.S. and in Australia. No information on the potential impact of this “spontaneous 
intervention” on transmission at the population level was available and mathematical models were 
used to investigate it. In one study investigating its impact among MSM in Seattle it was found to be 
effective [490] while in another among MSM in South Wales Australia it was found to be detrimental 
[491], confirming the importance of investigating questions at the local level. However, although 
these two studies appeared contradictory at first glance, the results were driven by differences in 
testing rates in each setting. It was concluded that if more than 20% of MSM are unaware of their 
status, serosorting should not be recommended as a prevention strategy [42].  
While results are context specific, there are likely fundamental conclusions that can be drawn from 
the different modelling studies. Interpreting findings from modelling studies in the light of similar 
studies can enhance their value by explaining them better and the process can also be used to 
improve the quality of future modelling studies.  In this view, we have undertaken a review of the 
modelling work investigating the potential effectiveness of PrEP to synthesise this information and 
identify conditions in which PrEP would be useful as well as modalities that would allow maximise its 
impact. This type of exercises can be hampered by the difficulty in comparing models that are based 
on different assumptions and which results are expressed using different metrics (this is especially 
relevant in cost effectiveness analyses). The field is currently moving towards better communication 
between modelling teams through initiatives such as the HIV modelling consortium that fosters 
collaboration between modellers to address specific issues [42,492]. There is also increased 
recognition of the need for more transparency and perhaps more simplicity in the articulation of 
modelling results, especially when these are to be used by researchers from other disciplines and by 
policy makers [488]. Reviews that dissect models and explain the implications of the structural 
assumptions made as well as of the choice in parameter values such as the one by Baggaley and 
Fraser [493] on modelling “universal test and treat”, are a good example of how mathematical 
models can be taken out of their black box and made accessible to non-modellers.  Stronger outputs 
from modelling studies should hopefully contribute to accelerating the implementation of actions 
essential to controlling the epidemic. For example, modelling has produced part of the evidence 
supporting the large scale implementation of Needle Exchange Programmes (NEPS) for IDU which is 
now taking place in several countries[494]. PrEP is at a much earlier stage in the prevention research 
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timeline and there are still many questions to be answered before being able to provide solid 
recommendations. 
3 Understanding prevalence trends 
Other key populations have been much less well characterised than MSM and therefore the 
epidemic among these is similarly less well understood. This is particularly true for prison inmates, in 
part because they are an eclectic population that share the reality of being incarcerated but that 
otherwise, once outside the prison walls, do not represent a well-defined group of individuals. 
Additionally, they are often at the bottom of the list of priorities for governments and funders. The 
prisons of Latin America are overcrowded and the safety of inmates is not ensured by the authorities 
due to shortages in staff numbers [177]. As prison inmates have been shown to exhibit high risk 
behaviours in other parts of the world and prisons are settings conducive to coerced sex among 
other types of risky sexual encounters [397], it was deemed important to investigate the epidemic 
among this population. The composition of the prison population will depend on the country’s legal 
and political context as well as on the illegal drug market. The conditions inside the prison will 
depend on the security type, overcrowding and health care services in place. Therefore we decided 
to focus on one prison for which there was a substantial amount of data available. We described the 
surveillance system in the Lurigancho prison in Lima, Peru and showed basic indicators of the 
epidemic obtained by the HIV programme inside the prison. These suggested relatively low HIV 
prevalence levels and improvements in the prognosis of HIV patients since the availability of ART 
treatment in the prison in 2005.  We then used two rounds of HIV/Syphilis surveillance data to 
describe the inmate population in terms of age, civil status, prison history and sexual and drug using 
behaviours. We found that this is a young population with an elevated prevalence of risk behaviours 
including illicit drug use, sex with FSW and with men). The analysis indicated significant declines in 
both risk behaviours and HIV prevalence in 2005. We went further into characterising specific risk 
profiles through building multivariable logistic regression models and identified inmates who 
reported sex with men as particularly risky compared to those who reported sex with FSW. This 
analysis informed the development of a series of mathematical models simulating the transmission 
of HIV among Lurigancho inmates and their visitors. This was prompted by the need to better 
understand the prevalence trends observed and their consistency with the sexual behaviours 
reported. We wanted to investigate whether the former could be masking high incidence levels 
through the high population turnover in the prison. Indeed, not only the composition but also the 
size of the prison population can fluctuate greatly over relatively short periods of time as seen in 
Lurigancho. The variations in population size as well as patterns of recidivism and sentence length 
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can shape the epidemic within walls.  We therefore carried out the analysis using a PDE (partial 
differential equation) model which represented the movement of the prison population by explicitly 
incorporating recidivism and by tracking the time spent in prison during each of the incarcerations 
and the periods spent outside in between these. We found that rather than amplifying transmission, 
the prison is likely to be acting as a setting for HIV detection and referral to treatment through the 
routine opt-out screening system in place for inmates at entry, the testing campaigns occurring 
periodically and the specific programmes following populations at higher risk. Prevalence trends in 
Lurigancho are driven by the continuous entry of already infected individuals and incidence rates in 
the prison above 1% would be inconsistent with the prevalence trends observed. Although these 
findings might seem obvious in retrospect, we would not have been able to state them with 
confidence without the development of a model accounting for the different processes shaping 
prevalence in the prison. 
These are encouraging results in regards to the efforts made by the HIV programme in Lurigancho 
and they suggest that the current screening system in place at entry is a useful intervention. Based 
on our findings over 10% of the HIV cases identified in Lima so far have gone through the doors of 
Lurigancho. Under these conditions, further than preventing transmission within prison, screening 
and counselling programmes in these settings also contribute controlling the epidemic in the wider 
world. Their success outside walls is however dependent on the continuity of care being ensured 
upon release.  
However, two issues deserve more attention than we have been able to give them in this work due 
to the unavailability of data when the analyses were carried out. In the model, we did not explicitly 
include the potential transmission resulting from rape or other forms of coerced sex in the prison. 
This is an important limitation because it is often the hidden behaviours that increase vulnerability 
to HIV. The questionnaire used by the prison HIV programme during HIV testing contains one 
question about rape. Now that some of the data is available in electronic format, we will extract the 
prevalence of reporting rape and will explore associations between this event and HIV infection as 
well as other characteristics. It might be possible to obtain a profile for the risk of being raped 
depending on age, crime charged for, exposure to prison, sexual orientation and behaviours as well 
as drug use that could be used to prevent rape within the prison’s premises.  
Another issue that is worth investigating further is the potential change in behaviours among HIV 
positive inmates as a result of learning their status and receiving counselling. This will require having 
data for HIV positive inmates at two time points: entry (through the screening questionnaire) and 
later (through the testing campaigns).  The sample size might be small as HIV positive inmates that 
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are aware of their status rarely participate in campaigns. As suggested before, including one 
question to the currently used questionnaire in Lurigancho asking about knowledge of status would 
at least allow comparing behaviours among positives aware and unaware of their status.  
Finally increasing our knowledge on sexual and drug using behaviours outside prison is crucial to 
understanding infection among these men and the data from those answering the questionnaire 
when testing at entry can provide some insight. A comparison of behaviours inside and outside 
prison should also be possible through comparing data from screening at entry to data obtained 
from the campaigns. This will help validate our results suggesting that transmission inside is not 
higher than outside. 
While the analyses carried out inform us on the risk behaviours of inmates in Lurigancho and on how 
these translate in terms of population spread of HIV, the issues considered here provide a restricted 
picture of the pathways leading to infection among this population. We intended to identify 
potential pathways by applying the Boerma and Weir’s proximate determinants framework [382] to 
the sentinel surveillance data for both years and were not able to identify proximate determinants 
that could explain infection. Instead, the behaviours associated with HIV infections where 
characteristic of either prevention as a result of status awareness or cessation of sexual activity as a 
result of symptoms.  This reflected the limitations of this type of data to inform on incidence 
patterns. As mentioned in the context of the MoT work, prevalence data does not tell us who and 
how is currently getting infected. Additionally, the time scale of the questionnaire did not allow 
investigating lifetime risk behaviours which are relevant considering that inmates are on average 10 
years older than the estimated average age at infection in Peru. Finally, these types of studies 
require the use of very short instruments and so the scope of research is often restricted to 
individual behaviours. We believe it is essential when investigating the epidemic among prison 
inmates, to go beyond these behaviours and turn to the left half of the epidemic process to identify 
the social and structural circumstances that lead to infection among this population.  
4 Social and structural determinants of infection 
As pointed by Kippax [495], sexual behaviours happen in a context and are determined by traditions 
and values as well as financial circumstances and for this reason they should be considered as 
“practices” rather than behaviours. While the former can take a limited number of forms 
(anal,oral,vaginal,insertive,receptive sex), the latter can take an infinity of forms (set in the context 
of sex work, marriage, one night stand, coercive environment)  and will have an impact on the risk of 
infection. With the aim of obtaining information on the social and structural elements influencing 
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risk of infection, we undertook the development of a structured questionnaire covering central 
themes. With this purpose, we combined information obtained from qualitative investigations 
among relevant informants in Mexico City with literature searches to construct a conceptual 
framework of infection among prison inmates in Latin America that would serve as the basis to 
design the questionnaire. The search incorporated findings from studies in the U.S. and Canada and 
is likely to be relevant to other populations of inmates. We found that that while there are 
circumstances that can exacerbate risk in prison, these will probably affect those that already were 
in a vulnerable position outside. Prisons can act as a setting for helping individuals in a precarious 
state recover some stability (which they very rarely do). However, it is much earlier that 
interventions must take place in order to prevent reaching such desperate states. Neighbourhoods 
were identified here (and by many other researchers) as settings for the production of risk and 
violence. The “broken window” hypothesis has been tested in several places to prove the perhaps 
obvious association between and the neighbourhood conditions and the risk of acquiring STIs 
[496,497]. This stipulates that independently of poverty, a degraded environment where buildings 
and cars are abandoned and vandalised, trash is left in the streets can promote social isolation and 
affect the social norms that ensure the order and stability in a community leading to similar 
carelessness regarding sexual and drug using behaviours [496,497]. Structural interventions that 
address the incarceration problem at the legal level can tackle overcrowding and the problems 
associated to it, while interventions at the community and neighbourhood level (such as preventing 
school dropout, providing better job opportunities, offering better health services and access to 
activities such as sport or workshops to learn practical skills in the community) are likely to result in 
positive outcomes not only in regards to HIV but also in regards to drug use, homelessness, sex work 
and other consequences of growing up in a difficult and violent environment.  
An issue that has been raised regarding these interventions is that they are likely to go underfunded 
or totally unfunded based on cost-effectiveness analyses [498]. Prisons are in fact one example 
illustrating a much wider debate in the field of HIV. Acting upstream of the pathway leading to HIV is 
generally more expensive than delivering a behaviour change intervention to a group of individuals 
and although it provides collateral benefits these are not accounted for in the cost effectiveness 
analyses because these are normally based on a single outcome (HIV infections averted) [498]. 
Spending the HIV budget to achieve outcomes that are not directly accountable in terms of 
controlling the epidemic is therefore considered as non-essential. The UNAIDS investment 
framework is based on maximising resources by allocating them to the interventions that will result 
in the strongest impact on the epidemic[499].  However, a financial participation from the other 
sectors benefiting from such an intervention would solve this issue [498]. Cost benefit analyses, 
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which can incorporate multiple outcomes, rather than cost effectiveness analyses have been 
proposed as a better tool to approach this issue and to encourage collaboration between different 
sectors in dealing with social issues [498]. 
Further work will involve testing this conceptual framework, first by carrying out a systematic 
literature search looking for studies that might have already tested for specific associations 
proposed in the framework and subsequently by implementing a case control study to apply the 
questionnaire to HIV positive inmates and matched HIV negative inmates.  
5 Generalisability of the results 
The results of this thesis cover only a few countries, and aside from the MoT work, they describe in 
detail  the context specific epidemic at a the city level or  prison level, prompting the question of 
how generalisable they are to the Latin American region or even to other cities in Peru or other 
prisons in Lima.  This is probably the most important paradox in the HIV field whereby global 
estimates are constantly being produced, regional trends presented and generalisation made while 
the importance of considering the local epidemic and its contextual factors is invariably reminded 
[488]. The former comes from the need to achieve an understanding on the epidemic and this 
requires defining it and visualising it as a whole. However, epidemics do occur at the micro level and 
especially among key populations, as these are characterised by great heterogeneity in behaviours 
and often represent relatively closed networks; which actually makes them more suitable to 
modelling studies [489].  This work intended to provide a rigorous appraisal of issues that are 
considered important to plan an adequate response among specific populations. We investigated 
one question at the country level and obtained a general picture of incidence patterns in each of 
these. While we observed differences between the countries it is, in some cases, difficult to say 
whether these are “noise” or “signal” due to the important uncertainties inherent to the process but 
also precisely because we use national data. In the other chapters we focussed on smaller scale 
epidemics in order to produce sounder results. The results obtained from the PrEP study might be 
generalizable to MSM populations with similar prevalence and behaviour trends in countries with a 
similar economic background.  In the same way, the Lurigancho study will be generalizable to prisons 
with similar standards of care, prison demography and HIV prevalence and behavioural patterns 
among inmates.  But perhaps more importantly, the questions asked and the process followed to 
develop the methods and carry out the analyses are themselves generalizable and we believe more 
studies of this type in the region would benefit mounting a better response to the HIV epidemic. 
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Figure 1. Snapshot of MoT spreadsheet for Dominican Republic 
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Figure 2. Snapshot of MoT spreadsheet for Mexico 
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Figure 3. Snapshot of MoT spreadsheet for Peru
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Table 1. Parameter values and sources for the MoT for Dominican Republic
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Table 2. Parameter values and sources for the MoT for Mexico 
REF. 
in 
MoT 
VARIABLE Estimate Year  SOURCE 
B-2 
Adult 
population 
58,913,000 2005 
CONAPO. Calculation based on: National population on the 1st of 
January by age and sex  2005-2051. 
(15-49 years)     
http://www.conapo.gob.mx/index.php?option=com_content&vi
ew=article&id=36&Itemid=234  
B-3 
HIV Prevalence 
(15-49) (%) 
    HIV prevalence among 15 to 49 in 2009 is 0.37%,  
0.37% 2009 
CENSIDA. El VIH/SIDA en México 2009. Visita en línea: 
http://www.censida.salud.gob.mx/descargas/2009/VIHSIDAenM
exico2009.pdf  
N-4 
% Circumcised 
men 
  
  
  
20% 
  
  
  
2000/2003 
In two studies with different sub-populations (men getting the 
vasectomy and military men) prevalence was 31.7% y 7.5% 
respectively. The average (20%) was taken.  
Between January 2003 and September 2004 among 779 men 
who requested a vasectomy in 27 public clinics in 14 states of 
Mexico. 
Circumcised men made up 31.7% of our study population. A 
strong and significant inverse association was found between 
HPV positivity and being circumcised (OR 5 0.2, 95% CI: 0.1–0.4). 
Pag. 1936. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, 
Cruz-Valdez A, Diaz V, Schiavon R, Hernandez P, Kornegay JR, 
Hernandez-Avila M, Franceschi S. Prevalence and determinants 
of human papillomavirus infection in men attending vasectomy 
clinics in Mexico. Int J Cancer 2006;119:1934–9. Published online 
17 May 2006 in Wiley InterScience 
From July 2000 to July 2003, we sought to identify determinants 
of HPV infection, acquisition, and persistence in 1,030 healthy 
military men in Mexico. Baseline-only cohort (n = 694), 
circumcised (self-reported) 52 (7.5%); pag. 1711. Lajous M, 
Mueller N, Cruz-Valdéz A, et al. Determinants of Prevalence, 
Acquisition, and Persistence of Human Papillomavirus in Healthy 
Mexican Military Men. Cancer Epidemiol Biomarkers Prev 
2005;14:1710-1716. Published online July 19, 2005. 
    
Injecting drug users 
B-9 % Male IDU 
0.147% 1985-2005 
Aceijas C, Stimson G, Hickman M, Rhodes T. Global overview of 
injecting drug use and HIV infection among injecting drug users. 
AIDS 2004, 18:2295-2303. 
C-9 % Female IDU 
  
1985-2005 
It is considered that the number of women who inject drugs has 
been increasing in the last few years, therefore it was assumed 
that the proportion of IDU who were women was of 20%. 
  
Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost 
SD; for Proyecto ElCuete. Using Respondent-Driven Sampling in a 
Hidden Population at Risk of HIV Infection: Who Do HIV-Positive 
Recruiters Recruit? Sex Transm Dis. 2009 Aug 21. 
0.04% and 
  2008 
G-9 HIV Prevalence  
5% 
2008 
Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost 
SD; for Proyecto ElCuete. Using Respondent-Driven Sampling in a 
Hidden Population at Risk of HIV Infection: Who Do HIV-Positive 
Recruiters Recruit? Sex Transm Dis. 2009 Aug 21. 
I-9 STI prevalence  
15% 
2006/2008 
Steffanie A. Strathdee, Remedios Lozada, Robin A. Pollini, 
Kimberly C. Brouwer, Andrea Mantsios, Daniela A. Abramovitz, 
Tim Rhodes, Carl A. Latkin, Oralia Loza, Jorge Alvelais, Carlos 
Magis-Rodriguez, Thomas L. Patterson, for Proyecto El Cuete. 
Individual, Social, and Environmental Influences Associated With 
HIV Infection Among Injection Drug Users in Tijuana, Mexico. J 
Acquir Immune Defic Syndr 2008;47:369–376. 
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J-9 
Number of 
injection 
partners per 
year 
2.6 
2006/2008 
Steffanie A. Strathdee, Remedios Lozada, Robin A. Pollini, 
Kimberly C. Brouwer, Andrea Mantsios, Daniela A. Abramovitz, 
Tim Rhodes, Carl A. Latkin, Oralia Loza, Jorge Alvelais, Carlos 
Magis-Rodriguez, Thomas L. Patterson. Individual, Social, and 
Environmental Influences Associated With HIV Infection Among 
Injection Drug Users in Tijuana, Mexico. J Acquir Immune Defic 
Syndr 2008;47:369–376. 
K-9 
Number of acts 
of exposure per 
partner per 
year 
80   
Shares syringe 4 times per week for 52 weeks  = 208 times per 
year, distributed between 2.6 sharing partners = 80 times per 
year with each partner. Calculations based on info obtained 
from:  
Steffanie A. Strathdee, Remedios Lozada, Robin A. Pollini, 
Kimberly C. Brouwer, Andrea Mantsios, Daniela A. Abramovitz, 
Tim Rhodes, Carl A. Latkin, Oralia Loza, Jorge Alvelais, Carlos 
Magis-Rodriguez, Thomas L. Patterson. Individual, Social, and 
Environmental Influences Associated With HIV Infection Among 
Injection Drug Users in Tijuana, Mexico. J Acquir Immune Defic 
Syndr 2008;47:369–376. 
  2006/2008 
L-9 
% acts 
protected 
    
9% shares 75% of times (mid-point between every time and 50% 
of times), so protected 25% of times. 41% never shares (or at 
least never receives), so protected 100% of times. The remaining 
50% share sometimes, to stay conservative we asume they share 
40% of times (just under 50%) so they are protected 60% of 
times. 
Percent of injections protected= (9%*25% + 41%*100% + 
50%*60%) * 100 = 73.25% 
Calculation base don info from: Steffanie A. Strathdee, Remedios 
Lozada, Robin A. Pollini, Kimberly C. Brouwer, Andrea Mantsios, 
Daniela A. Abramovitz, Tim Rhodes, Carl A. Latkin, Oralia Loza, 
Jorge Alvelais, Carlos Magis-Rodriguez, Thomas L. Patterson. 
Individual, Social, and Environmental Influences Associated With 
HIV Infection Among Injection Drug Users in Tijuana, Mexico. J 
Acquir Immune Defic Syndr 2008;47:369–376.  
73.30% 2006/2008 
    
Partners of IDU 
B-10 
% stable 
partners of 
male IDU 
0.04% 
  
It is assumed that 57% of IDUs have a stable female partner 
(percent of cohabiting men nationally) and that 50% of these are 
IDU, already included in female IDU, so the proportion of stable 
female partners of IDU is: 57%*50%*0.0015.  
C-10 
% stable 
partners of 
female IDU 0.04% 
  
It is assumed that female IDU have at least 1 male partner per 
year. 
G-10 HIV prevalence  1%   
There is no Information available in Mexico. It is assumed that 
prevalence in this group is equivalent to that in clients of FSW. 
J-10 
Number of 
sexual partners 
1   
There is no Information available in Mexico. It is assumed that 
they have the same behaviour as the low risk population and that 
their only risk is to be a partner of an IDU.  
K-10 
Number of acts 
of exposure per 
partner per 
year 
34   
Sexual activity among IDU is lower than in the general 
population. It is assumed that they have half the number of sex 
acts than in the low risk group. 
L-10 
% of sex acts 
protected 
29% 2007 
SS/Centro Nacional para la Prevención y el Control del VIH/SIDA. 
Encuesta a Poblaciones Vulnerables, datos a nivel nacional al 31 
de diciembre de 2007. CENSIDA, México. 
Female Sex workers 
C-11 
% of women 
who are female 
sex workers 
  
0.64% 
  
We use the average of the estimated obtained from Argentina, 
Colombia and Venezuela in: Talbott JR (2007) Size Matters: The 
Number of Prostitutes and the Global HIV/AIDS Pandemic. PLoS 
ONE 2(6): e543. doi:10.1371/ 
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The most accepted hypothesis among experts in CENSIDA is that 
there are 200,000 FSW: Torres MP (Ed). Mujeres, adolescentes y 
niñas mexicanas: una mirada comprensiva en torno al VIH y el 
SIDA. Epidemiología, prevención, atención y mejores prácticas en 
México. Serie Ángulos del SIDA (Volumen 10) México: CENSIDA, 
INMUJERES, INSP, 2010. 
G-11 
HIV prevalence  
(%) 
2% 2005 
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
I-11 
STI prevalence 
(%) 
25% 2004/2006 
Steffanie A. Strathdee, Brent Mausbach, Remedios Lozada, Hugo 
Staines-Orozco, Shirley J. Semple, Daniela Abramovitz, Miguel 
Fraga-Vallejo, Adela de la Torre, Hortensia Amaro, Gustavo 
Martínez-Mendizábal, Carlos Magis-Rodríguez, Thomas L. 
Patterson. Predictors of Sexual Risk Reduction Among Mexican 
Female Sex Workers Enrolled in a Behavioral Intervention Study. J 
Acquir Immune Defic Syndr. 2009 May 1; 51(Suppl 1): S42–S46. 
J-11 
Number of 
sexual partners 
per year  
200 2005 
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
K-11 
Number of acts 
of exposure per 
client of FWS 
per year 
1.5   
The assumption is 1.5 acts per client based on: Rodríguez C, 
Bravo-García E, Gayet C, Rivera P, De Luca M. El VIH y el Sida en 
México al 2008. Hallazgos, tendencias y reflexiones. Censida, 
Serie Ángulos del Sida núm. 9. México, 2008. 
L-11 
Percent of sex 
acts protected 
(%) 
    
Three surveys obtain values around 90%, but condom use with 
occasional partners is lower (55%) so the estimate was lowered 
to 85%. 
  
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
85% 2005 
    
Clients of FSW 
B-12 
Percent of men 
that are clients 
of FSW (%) 
    
Between 5 and 7% in Latin America, considering confidence 
intervals we assumed 7.5%. 
  
Carael M, Slaymaker E, Lyerla R, Sarkar S. Clients of sex workers 
in different regions of the world: hard to count. Sex Transm Infect 
2006;82(Suppl III):iii26–iii33. 
7.50% 
previous to 
2006 
    
G-12 
HIV prevalence 
(%) 
0.60% 2005 
Gayet, Cecilia, Carlos Magis et al. (2007). Prácticas sexuales de las 
poblaciones vulnerables a la epidemia de VIH/SIDA en México. 
SS/Centro Nacional para la Prevención y el Control del VIH/SIDA y 
Facultad Latinoamericana de Ciencias Sociales. México D.F. 
I-12 
STI prevalence 
(%) 
8% 2000 
Conde-González CJ, Valdespino JL, Juárez-Figueroa LA,Palma O, 
Olamendi-Portugal M, Olaiz-Fernández G, Sepúlveda J. 
Prevalencia de anticuerpos anti-treponémicos y características 
sociodemográficas en población mexicana adulta en el año 2000. 
Salud Publica Mex 2007;49 supl 3:S412-S420. 
J-12 
Number of FSW 
partners per 
client per year 
    
In Tijuana, Clients visit FSW on average 25 times per year. 
However, some clients visit the same FSW more tan once. 
(average: 1.5 times). At the national level we assume 17 different 
FSW per client per year with a frequency of visit per FSW of 1.5 
times (17*1.5 = 25.5 visitas). 
  
Patterson TL, Goldenberg S, Gallardo M, Lozada R, Semple SJ, 
Orozovich P, Abramovitz D, Strathdee SA. Correlates of HIV, 
sexually transmitted infections, and associated high-risk 
behaviors among male clients of female sex workers in Tijuana, 
Mexico. AIDS, 2009 Aug 24;23(13):1765-71. 
17 2008 
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K-12 
Number of acts 
of exposure per 
year 
1.5   
It is assumed that a client visits the same FSW 1.5 times per year 
on average. 
L-12 
% protected 
sex acts  
    
Three surveys obtain values around 90%, but condom use with 
occasional partners is lower (55%) so the estimate was lowered 
to 85%. 
85% 2005   
    
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
Partners of clients of FSW 
C-13 
% of women 
that are 
partners of 
FSW’s clients 
    
Assumed to be equal than in the general population: 57% 
cohabiting 
  
Encuesta Nacional de la Dinámica Demográfica. ENADID 2009. 
CONAPO, INEGI, INSP, SSA. 2010.  
4% 2009 
    
G-13 
HIV prevalence 
(%) 
0.30%   
Higher bound of prevalence in the general population (0.3%) also 
corresponds to half the prevalence among clients which is one of 
the assumptions used by UNAIDS when information is missing for 
this input. 
J-13 
Number of 
partners per 
year  
1   We assume the same behaviour as in the low risk group. 
K-13 
Number of acts 
of exposure per 
partner per 
year  
69 2003 
We assume the same behaviour as in the low risk group. ENSAR 
2003 shows that the average number of sex acts per month is 5.8 
which corresponds to 69 per year. 
    The 2003 National Reproductive Health Survey (ENSAR). 
L-13 
Percent 
protected sex 
acts (%) 
    
According to ENADID 2006, 7.6% of the 68.3% of women in union 
who use contraceptive methods use condoms: 68%*7.6%=5%. 
  
Encuesta Nacional de la Dinámica Demográfica. ENADID 2006. 
CONAPO, INEGI, INSP, SSA. 2007. 
5% 2006 
    
Men who have Sex with Men 
B-14 
Percent of men 
who are MSM 
3.50%   
Mid point between 2% and 5%. Suggested by UNAIDS in 
countries that do do have information. El valor surge del análisis 
presentado en: Diamond M. Homosexuality and Bisexuality in 
Different Populations. Archives of Sexual Behavior, Vol. 22, No. 4, 
1993. 
G-14 
HIV prevalence 
(%) 
    
Cross-sectional studies obtain a prevalence of 10%, but increased 
to 11% to take into account TTT (transexuals, transgenders and 
tranvestites) who have a 20% prevalence and were no part of the 
samples.  Although they represent a small number they have an 
impacto on the MSM prevalence. 
  
Gayet, Cecilia, Carlos Magis et al. (2007). Prácticas sexuales de las 
poblaciones vulnerables a la epidemia de VIH/SIDA en México. 
SS/Centro Nacional para la Prevención y el Control del VIH/SIDA y 
Facultad Latinoamericana de Ciencias Sociales.  
11% 2005 
    
I-14 
STI prevalence 
(%) 
    
HIV/STI's detection Centres in Mexico City are open for general 
population who voluntarily attend to be tested free of charge. 
1,430 men having sex with other men attended this clinic from 
January 2000 to December 2001. Average number of sex partners 
in last six month, 6; anti-HIV-1, 15.4% (217); anti- T. pallidum (S) 
3.9% (55). 
  
Cruz-Palacios C, Ramos-Alamillo U, Villegas L, Varela C, Martínez 
J, Hernández-Tepichin G, Teran-Toledo X. Risk practices for STI's 
3.90% 2000/2001 
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among MSM in Mexico City. Int Conf AIDS. 2002 Jul 7-12; 14: 
abstract no. D11368. 
J-14 
Number of 
partners per 
year  
    
9 is the average from the cross-sectional studies (2001 and 2005) 
when the question was correctly formulated. 
  
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
9 2001 
  and 2005 
K-14 
Number of acts 
of exposure per 
partner per 
year 
4.5   
It was assumed that on average they have less sex acts tan teh 
general population because they have a higher partner change 
rate Se asume que en promedio sostienen menor cantidad de 
actos sexuales: 40.5 acts/ 9 partners= 4.5 acts per partner. 
L-14 
Percent of 
protected sex 
acts (%) 
    
FLACSO/CENSIDA/FHI survey in 2005: 80.6% condom use with 
occasional partner. Survey carried out by CENSIDA in 2003 
showed 90%. Mid-point value was taken considering that 
condom use levels have increased due to prevention 
programmes. 
  
Magis-Rodríguez C, Bravo-García E, Gayet C, Rivera P, De Luca M. 
El VIH y el Sida en México al 2008. Hallazgos, tendencias y 
reflexiones. Censida, Serie Ángulos del Sida núm. 9. México, 
2008. 
85% 2005 
    
Partners of MSM 
B-15 
% of women 
who are stable 
partners of 
MSM 
    Between 8% and 30% of MSM report a female partner: 
Cáceres et al. Epidemiology of male same sex behaviour and 
associated sexual health indicators in low and middle income 
countries: 2003-2007 estimates. STI 2008:84.  
  
The upper bound was used.  
Gayet, Cecilia, Carlos Magis et al. (2007). Prácticas sexuales de las 
poblaciones vulnerables a la epidemia de VIH/SIDA en México. 
SS/Centro Nacional para la Prevención y el Control del VIH/SIDA y 
Facultad Latinoamericana de Ciencias Sociales. México D.F. 
    
1.05% 2003/2007 
    
    
G-15 HIV prevalence 2%   
No Information available in Mexico. It was assumed that they had 
the same prevalence as FSW. 
J-15 
Number of 
partners per 
year 
1   
We assume the same behaviour as in the low risk group: 1 
partner per year (ENADID 2006). 
K-15 
Number of acts 
of exposure per 
partner per 
year 
69 2006 
We assume the same behaviour as in the low risk group: 69 acts 
per year (ENADID 2006). 
L-15 
Percent of sex 
acts protected  
(%) 
    
We assume the same behaviour as in the low risk group, 
According to ENADID 2006, 7.6% of the 68.3% of women in union 
who use contraceptive methods use condoms: 68%*7.6%=5%. 
  
Encuesta Nacional de la Dinámica Demográfica. ENADID 2006. 
CONAPO, INEGI, INSP, SSA. 2007. 
5% 2006 
    
Casual Heterosexual Sex 
B-16 
% of men who 
practice casual 
heterosexual 
sex (CHS) 
18.50% 
1992/1993 
2003 and 
2006 
15% of cohabiting men reported having an extra-conjugal visit.  
  
Julie Pulerwitz, ScD, Jose-Antonio Izazola-Licea, MD, ScD, and 
Steven L. Gortmaker, PhD.Extrarelational Sex Among Mexican 
Men and Their Partners’ Risk of HIV and Other Sexually 
Transmitted Diseases. American Journal of Public Health, October 
2001.  
  
57% of men live in union and 25% of men are virgin. 100%-57%-
25%= 18% of men have sex outside union. This does not 
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necessarily mean that they have multiple partners but it is the 
only information available. Of those in union, it was considered 
that 20% have extraconjugal relationships (to take into account 
that the Pulerwitz study is not recent). CHS=18%+(57*20%)= 
29.4% 
Among men who have CHS we have clients, MSM and IDU, 
therefore: 
CHS = 29.4% - 7.5% (clients) - 3.5% (MSM )- 0.15% (IDU) = 
18.25% 
    
 
C-16 
% of women 
who practice 
casual 
heterosexual 
sex (CHS) 
    Same thought process followed for women: 
    
Women that practice CHS =100%-57% (in union) - 33.5% (no 
risk)= 9.5% 
11.67   
It is estimated that 5% of women in unión have extra-conjugal 
sex  
    CHS= 9.5% +(57*5%) – FSW – IDU 
    CHS= 1.00 – 0.57 –  0.335 + 0.0285 – 0.0066 – 0.0004 = 0.1165 
G-16 
HIV prevalence 
(%) 
0.20%   
No Information available in Mexico. It was assumed that it was 
equivalent to 1/3 of the prevalence observed among clients of 
FSW. 
I-16 
STI prevalence  
(%) 
    
Herpes is a very prevalent infection among the general 
population especially in poor urban centres, but prevalence 
descreases in rual areas and in medium or high income areas. It is 
considered that on average prevalence would be around 4%.  
  
Risk behaviors of 15–21 year olds in Mexico lead to a high 
prevalence of sexually transmitted infections: results of a survey 
in disadvantaged urban areas Juan-Pablo Gutierrez, Stefano M 
Bertozzi, Carlos J Conde-Glez and Miguel-Angel Sanchez-Aleman. 
BMC Public Health 2006, 6:49. Herpes prevalence is approx. 12% 
and chlamydia prevalence is 8% 
4% after 2000 
    
      
J-16 
Number of 
partners per 
year 
1.93   
The average number of sexual partners in the last year is higher 
among men than women (2.2 vs. 1.5). Presentation: SEXUALIDAD 
Y VIH/SIDA: PRÁCTICAS DE LOS JÓVENES EN MÉXICO. By Jorge 
Valencia 2007. 
    
As the same value is used for men and women a weighted 
average was calculated = 1.93 parejas 
K-16 
Number of acts 
of exposure per 
partner per 
year  
35.8   
We assume the same behaviour as in the low risk group: 69 acts 
per year (ENADID 2006), distributed by the average number of 
partners per year: 69 / 1.93 
L-16 
Percent of sex 
acts protected 
  
  
2003 
and 
2006 
Among those men who reported having more than one sexual 
partner, 77.8% of those aged 20-24 reported using a condom 
during their last sexual intercourse, versus 14.3% in the case of 
older men (ENSAR 2003). 
The average between the value for Young people and adults was 
used: 46%. 
  
Rivera-Reyes
 
MdP, Paredes-Orozco G. Sexual HIV Prevention: 
Condom Use and HIV Detection in Mexico. AIDS XII International 
Conference 2008, México. 
36% 
  
  
Partners of people who engage in Casual Heterosexual sex 
B-17 
Percent of men 
who are stable 
partners of CHS 
women 
4.67   
It is assumed that 40% of women who practice CHS also have a 
stable partner. 
    40% x % of women who practice CHS = 4.67% 
C-17 
Percent of 
women who 
    
It is assumed that 40% of men who practice CHS also have a 
stable partner. 
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are stable 
partners of CHS 
men 
7.30%   40% x % of men who practice CHS = 7.30% 
G-17 
HIV prevalence 
(%) 
    There is no information available in Mexico. 
0.20%   
It was assumed that it was equivalent to 1/3 of the prevalence 
observed among clients of FSW. 
J-17 
Number of 
partners 
1 2006 
We assume the same behaviour as in the low risk group: 1 
partner per year (ENADID 2006). 
K-17 
Number of acts 
of exposure per 
partner per 
year 
69 2006 
We assume the same behaviour as in the low risk group: 69 acts 
per year (ENADID 2006). 
L-17 
Percent of 
protected sex 
acts 
5% 2006 
We assume the same behaviour as in the low risk group, 
According to ENADID 2006, 7.6% of the 68.3% of women in union 
who use contraceptive methods use condoms: 68%*7.6%=5%. 
Low Risk Group 
B-19 
% of men who 
have a low risk 
behaviour 
    
Low risk men=57%-(57*20%)=45.6% - partners of members of 
high risk groups 
40.89% 2009   
    
= 57% - (57%*20%) – partners of female IDU – partners of female 
CHS = 40.89% 
C-19 
% of women 
who have a low 
risk behaviour 
    
Low risk women=57%- (57*5%)= 54.15 - partners of members of 
high risk groups 
41.49% 2009   
      
G-19 
HIV 
prevalence(%) 
0.10% 2005   
    Prevalence among pregnant women = 0.1% 
I-19 
STI prevalence 
(%) 
    
On average a prevalence of 5% was found among pregnant 
women and 1.5% among fertile men. A weighted average was 
calculated which is similar to the prevalence of syphilis 
antibodies. 
  
Conde-González CJ, Valdespino JL, Juárez-Figueroa LA,  Palma O, 
Olamendi-Portugal M, Olaiz-Fernández G, Sepúlveda J. Anti-
Treponema pallidum seroprevalence and sociodemographic 
characteristics in Mexican adult population, 2000. Salud Publica 
Mex 2007;49 suppl 3:S412-S420. Prevalence anti-T pallidum 
antibodies: 3% (active syphilis: 0.3%) 
  
Cravioto MC, Matamoros O, Villalobos-Zapata Y, Peña O, García-
Lara E, Martínez M, Castelo J, Sifuentes-Osornio J. Prevalence of 
antibodies against Chlamydia trachomatis and Neisseria 
gonorrhoeae in Mexican populations. Salud Publica Mex 2003;45 
suppl 5:S681-S689. Pregnant women: Gonorrhoea 4.5%, 
Chlamydia 3.6%. In the same study several other studies are cited 
which report estimates of chlamydia prevalence among pregnat 
women between 4 and 10%. Men in fertile age: prevalence of 
gonorrhoea and chlamydia: 1.5% 
    
2.69% 2000 
    
    
J-19 
Number of 
partners 
1 2006 1 partner per year (ENADID 2006). 
K-19 
Number of sex 
acts per 
partner per 
year 
69 2006 69 acts per year (ENADID 2006). 
L-19 
Percent of sex 
acts protected  
5% 2006 
We assume the same behaviour as in the low risk group, 
According to ENADID 2006, 7.6% of the 68.3% of women in union 
who use contraceptive methods use condoms: 68%*7.6%=5%. 
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Table 3. Parameter values and sources for the MoT for Peru 
Risk group Estimate Date SOURCE 
Total population (15-49 
años) 
14,514,191 2007 INEI, XI Censo de Población y VI de Vivienda 2007. Perfil 
sociodemográfico del Perú. 
HIV prevalence among 
adults 
0.5 (0.3–0.6) 2008 UNAIDS. Peru HIV and AIDS estimates. 
Injecting drug users (IDU) 
Percentage of IDU in 
adult population 
    
  
Men Prevalencia de 
vida: 0.033% 
2006 DEVIDA, III Encuesta Nacional de consumo de drogas en población 
general de Perú 2006. 
Women Prevalencia de 
vida:  
0.00% 
HIV prevalence 13.00% 1994-
1995 
Bradley M, et al. Global epidemiology of injecting drug use and 
HIV among people who inject drugs: a systematic review. Lancet. 
2008;372:1733-45.  
STI prevalence 3.15% (sífilis) 2003-
2004 
Clark JL, et al. Prevalence of HIV, herpes simplex virus-2, and 
syphilis in male sex partners of pregnant women in Peru. BMC 
Public Health. 2008;8:65. Syplilis prevalence is 1.5%. 
NIMH collaborative HIV/STD prevention trial group. STD and HIV 
prevalence and risk factors in concentrated and generalized HIV 
epidemic settings. AIDS. 2007;21(suppl 2):S81-S90. STI prevalence 
ratio for IDU is 2.1. 
By applying the prevalence ratio of 2.1 to the 1.5% prevalence, the 
estimate obtained is 1.5%*2.1 = 3.15% 
Average number of 
partners per year 
2 1997-
2000 
Ouellet L, et al. HIV risk practices among needle exchange users 
and nonusers in Chicago. J Acquir Immune Defic Syndr. 
2004;37(1):1187-96. 
Average number of acts 
per partner per year 
(injections) 
95 2004 Folch C. Factores asociados a la práctica de compartir jeringuillas 
usadas entre usuarios de droga por vía parenteral reclutados en la 
calle. Med Clin (Barc). 2006;127(14):526-32. 
Proportion of times 
sterile equipment is 
used 
80% 2004 Folch C. Factores asociados a la práctica de compartir jeringuillas 
usadas entre usuarios de droga por vía parenteral reclutados en la 
calle. Med Clin (Barc). 2006;127(14):526-32. 
    2000-
2001 
Ferreira AD, et al. Profile of male brazilian injecting drug users who 
have sex with men. Cad Saude Pub. 2006;22(4)849-60. 
IDU sexual partners 
Percentage of partners 
of IDU 
      
  
Assumption. IDU have the same prevalence of union than in the 
general population(52.9%according to 2007 Census). 
Men 0   
Women 0.017% 2007 
HIV prevalence 2.50% 1996-
1997 
Alarcon J,  et al. Determinants and prevalence of HIV infection in 
pregnant Peruvian women. AIDS. 2003; 17:613-18. 
 
2.5% is the prevalence among women who reported their partner 
to be an IDU or not to know. 
Average number of 
partners per year 
1 2004-
2006 
DHS: Perú Encuesta Demográfica y de Salud Nacional. ENDES 
Continua 2004-2006. 
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 7.45% 2004-
2006 
DHS. Condom use at last sex with husband 
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Female Sex Workers 
Percent women who 
are sex workers 
0.49% 2002 UNAIDS. Sex work and HIV. UNAIDS Technical Update. June 2002. 
HIV prevalence 0.90% 1999 - 
2002 
Montano S, et al. Prevalences, genotypes and risk factors for HIV 
transmission in South America. J Acquir Immune Defic Syndr. 
2005;40(1):57–64. 
 
Weighted average: (1.6*0.3 + 0.6*0.7 - Lima y provinces 
respectively). 
 
PREVEN 2002: 0.69%. (personal communication Dr. César 
Cárcamo) 
STI prevalence Gonorrhoea – 
1.80% 
Chlamydia – 
14.4% 
Syphilis – 1.46% 
Tricomona – 
7.29% 
2002 PREVEN 2002 (personal communication Dr. César Cárcamo) (only 
provinces) 
 Chlamydia prevalence used in MoT: 15% 
  Gonorrhoea – 
3.7% 
Chlamydia – 
12.8% 
Syphilis – 4.1% 
Tricomona – 
4.1% 
1994-
1995 
Sanchez J, et al. Prevention of sexually transmitted diseases (STDs) 
in female sex workers. Sex Transm Dis. 2003;30(4):273-79. 
 
Lima/Callao. 15% for any STI 
Average number of 
partners per year 
843 2002 PREVEN 2002 (personal communication Dr. César Cárcamo): 843 
partners based on 21 partners per week, in 40 weeks (accounting 
for menstraul periods and illness/holidays) 
Average number of acts 
per partner per year 
1   Assumption: one act per client on average. 
Percent condom use 80.6% 1994 Trujillo L, et al. Sexual practices and and prevalence of HIV, HTLV-
I/II, and Treponema pallidum among clandestine female sex 
workers in Lima, Perú. Sex Transm Dis. 1999;26(2):115-18.  
  2003 Miller G, et al. Clients of female sex workers in Lima, Peru. A 
bridge population for STD/HIV transmission? Sex Transm Dis. 
2004;31(6):337-42.  
    Average between Trujillo (75.3%) and Miller (85.8%). 
  2003 Similar to Gutiérrez J et al. Uso inconsistente del condón entre 
trabajadoras sexuales en Ecuador: resultados de una encuesta de 
comportamientos Salud Pública de México 2006;48(2):104-12. 
82% of FSW reported consistent condom use with clients 
Clients 
Percentage of FSW 
clients 
15.8% 2002 PREVEN 2002 (Personal communication Dr. César Cárcamo) 
  1996-
1997 
Alarcon J,  et al. Determinants and prevalence of HIV infection in 
pregnant Peruvian women. AIDS. 2003; 17:613-18. 
12% is the midpoint between 4.4% and 19.6% 
    2003 Miller G, et al. Clients of female sex workers in Lima, Peru. A 
bridge population for STD/HIV transmission? Sex Transm Dis. 
2004;31(6):337-42.  
 
Reference to Caceres (10% in the last year) 
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HIV prevalence 0.76% 2005 DGE - sentinel surveillance (2005), prevalence in pregnant women: 
0.27%. Informe preliminar DGE. 
Alarcon et al: prevalence ratio of 2.8 among women who report 
that their partner visits FSW or that they don't know 
Estimate: 0.27% x 2.8 = 0.76% 
    2002 PREVEN 2002 (Personal communication Dr. César Cárcamo). 
Prevalence is 0.45% outside Lima. 
STI prevalence 3.3% (sífilis) 2003-
2004 
Clark JL, et al. Prevalence of HIV, herpes simplex virus-2, and 
syphilis in male sex partners of pregnant women in Peru. BMC 
Public Health. 2008;8:65. syphilis prevalence is 1.5%. 
Alarcón J. Determinants and prevalence of HIV and syphilis in 
pregnant women in Lima, Perú. Tesis, University of Washington. 
Prevalence ratio of 2.2 among pregnant women who reported 
their husband visited FSW. 
Estimate: 1.5%*2.2 = 3.3% 
    2003 Miller G, et al. Clients of female sex workers in Lima, Peru. A 
bridge population for STD/HIV transmission? Sex Transm Dis. 
2004;31(6):337-42. Chlamydia prevalence: 2%. 
    2002 PREVEN 2002 (Personal communication Dr. César Cárcamo): 
Chlamydia prevalence among clients of FSW who have 
unprotected sex 3.6% 
Average number of 
partners per year 
26   26.140 
Average number of acts 
per partner per year 
1   Number of FSW x Number of sex acts / Number of clients 
 
     35 560         x                    843                   /      1 146 621 
Percent condom use 80.6% 1994 Trujillo L, et al. Sexual practices and and prevalence of HIV, HTLV-
I/II, and Treponema pallidum among clandestine female sex 
workers in Lima, Perú. Sex Transm Dis. 1999;26(2):115-18.  
  2003 Miller G, et al. Clients of female sex workers in Lima, Peru. A 
bridge population for STD/HIV transmission? Sex Transm Dis. 
2004;31(6):337-42.  
    Average between Trujillo (75.3%) and Miller (85.8%). 
  2003   
  2002 PREVEN 2002 (personal communication Dr. César Cárcamo): 75% 
of heterosexual men who are clients of FSW use condoms 
(provinces) 
Partners of clients 
Percent women who 
are partners of FSW 
clients 
6.35% 2007 Assumption: Clients of FSW have the same prevalence of union 
than in the general population (52.9% according to 2007 Census). 
HIV prevalence 0.64% 2005 DGE - sentinel surveillance (2005), prevalence among pregnant 
women 0.23%. 
Alracon et al, prevalence ration of 2.8 among women who report 
that their partner visits FSW 
estimate: 0.23 x 2.8 = 0.64 
Average number of 
partners per year 
1 2004-
2006 
DHS 2004-2006.  
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 7.45% 2004-
2006 
DHS 
Men who have sex wth men 
Percent men who are 6.00% 2002 PREVEN 2002 (personal communication Dr. César Cárcamo). 
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MSM     Cáceres C, et al. Estimating the number of men who have sex with 
men in low and middle income countries. Sex Transm Infect. 
2006;82(Suppl 3):iii3-9. MSM in the past year: between 1% and 
8%. 
HIV prevalence 5.16% 2002 Notifications of HIV cases and  among MSM from DGE (1983-2007) 
adjusted for mortality and 50% under-reporting to obtain 
numerator and PREVEN (6% men are MSM) and population census 
2007 to obtain denominator. 
STI prevalence 6.00% 2002 PREVEN 2002 (personal communication. César Cárcamo). 
Chlamydia 
  2002-
2003 
Lama J, et al. Association of herpes simplex virus type 2 infection 
and syphilis with human immunodeficiency virus infection among 
men who have sex with men in Peru. J Infect Dis. 
2006;194(10):1459-66. Higher prevalence but high risk MSM 
Average number of 
partners per year 
2.7 2000-
2001 
Clark JL, et al. Prevalence of Same-Sex Behavior and Associated 
Characteristics among Low-Income Urban Males in Peru. PLoS 
ONE. 2007;2(8): e778. 
PREVEN 2002 (personal communication Dr. César Cárcamo),  2.47 
partners in the last year. 
Average number of sex 
acts per partner per 
year 
12   PREVEN 2002 (personal communication Dr. César Cárcamo), 11.56 
acts per partner per year 
Percent condom use   2000-
2001 
Clark JL, et al. Prevalence of Same-Sex Behavior and Associated 
Characteristics among Low-Income Urban Males in Peru. PLoS 
ONE. 2007;2(8): e778. 
 90.4% (casual partners) y 61% (stable partners). Mid-point: 75.6% 
    1996-
2002 
Sanchez J, et al. HIV-1, Sexually Transmitted Infections, and Sexual 
Behavior Trends Among Men Who Have Sex With Men in Lima, 
Peru. J Acquir Immune Defic Syndr. 2007; 44(5):578-85.Clark JL, et 
al. 
  70%   Value between 68.04% and 75.6% (70%). 
Female partners of MSM 
Percent women who 
are partners of MSM 
1.14% Public
acione
s 
entre 
2003 y 
2007 
Cáceres C, et al. Epidemiology of male same-sex behaviour and 
associated sexual health indicators in low- and middle-income 
countries: 2003-2007 estimates. Sex Transm Infect. 2008;84(Suppl 
1):i49-i56. 
 
 19% (Mid-point between 8% and 30%) of MSM have a female 
partner. 6% x 19% = 1.14% 
HIV prevalence 1.61% 2005 DGE - sentinel surveillance (2005), prevalence among pregnant 
women 0.23%. 
Alarcon et al., prevalence ratio is 7 among women who report that 
their partner has sex with men 
Por eso la estimación es 0.23 x 7 = 1.61 
Average number of 
partners per year 
1 2004-
2006 
DHS 
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 7.45% 2004-
2006 
DHS 
Casual Heterosexual Sex 
Percent of adults who 
engage in CHS 
      
Men 21.02%   DHS 2008 
Women 11.00% 2004-
2006 
DHS 2004-2006 
HIV prevalence 0.270% 2005 DGE - sentinel surveillance (2005), prevalence among partners 
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STI prevalence 12% 2000 Thompson D, et al. Sexually transmitted diseases in a family 
planning and an antenatal clinic in Peru: limitations of current 
practices and analysis of the use of potential markers, pH testing, 
and Whiff testing. Sex Transm Dis. 2000;27(7):386-92. 
12% among women.  
Average number of 
partners per year 
1 2004-
2006 
DHS 
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 27.26% 2004-
2006 
DHS 
Partners of people who have CHS 
Percent of adults who 
are partners of people 
who engage in CHS 
      
Men 5.87% 2007 Proportion of CHS women x 0.534 according to census 
Women 11.12% 2007 proportion of CHS men x 0.529 according to census 
HIV prevalence 0.270% 2005 DGE - sentinel surveillance (2005), prevalence among partners 
Average number of 
partners per year 
1 2004-
2006 
DHS 
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 7.45% 2004-
2006 
DHS 
Low risk heterosexual sex 
Percent adults who are 
at low risk 
      
Men 26.84%   Residual from other groups 
Women 37.17%   Residual from other groups 
HIV prevalence 0.250% 2005 DGE - sentinel surveillance (2005), average between prevalence 
among pregnant women 0.23% and their partners 0.27% 
STI prevalence 9% 2007 PREVEN 2007 (Personal communication Dr.César Cárcamo), men 
and women in Lima and provinces, between 18 and 29 years (CT 
6.50%, TV 2.12%, Syphilis 0.26%, GC 0.15%) 
  1996 
/2001 
Thompson D, et al. Sexually transmitted diseases in a family 
planning and an antenatal clinic in Peru: limitations of current 
practices and analysis of the use of potential markers, pH testing, 
and Ehiff testing. Sex Transm Dis. 2000;27(7):386-92. 
Assuming prevalence among men to be one third that among 
women: 12.1% for women and 4% for men, average 8%. 
NIMH Collaborative HIV/STD prevention Trial Group. Sexually 
transmitted disease and HIV prevalence and risk factors in 
concentrated and generalized HIV epidemic settings. AIDS. 
2007;21(Suppl 2): S81-S90. 
Prevalence among women 10.3% and among men 5.8%. 
Average number of 
partners per year 
1 2004-
2006 
DHS 
Average number of acts 
per partner per year 
77 2000 Stover J, et al. Empirically-based conversion factors for calculating 
couple-years of protection. Evaluation Review 2000;24(1):3-46. 
Percent condom use 7.45% 2004-
2006 
DHS 
No risk 
Percent adults who are 
at no risk 
      
Men 29.73% 2008 DHS 2008 
Women 33.00% 2004-
2006 
DHS 
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Trial version of MoT model for Dominican Republic including Non-Injecting Drug Users, 
transgender women and women with no formal education 
The DR was particularly interesting because recent surveys had identified groups with high HIV 
prevalence that did not correspond to the populations considered by the MoT model as they did not 
share an obvious mode of transmission. These were “women with no education” with a prevalence 
of 3.7% and non-injecting drug users (NIDU) with a prevalence of 8%. Transwomen were also 
considered to require special attention as the last behavioural survey (2008) among this population 
found prevalence of 17% among this group. Several stakeholders were involved in the MoT process 
in DR, including members from the civil society and NGOs. As there was a strong shared will to 
include these groups in the model to give them visibility and attract resources towards prevention 
services for them, a trial version of the model was built to allow it. This followed the basic concept of 
the MoT model which characterises groups by their mode of transmission. NIDU get infected not 
through the use of drugs but through risky sexual behaviours. To represent this population, MSM 
and clients of FSW were divided in non-drug users and drug users. This entails the assumption that 
NIDU are either MSM or clients of FSW which is an over-simplification but as their prevalence was 
high and they represented a small proportion of the population, it was considered reasonable to 
distribute them between the two groups at highest risk. Female NIDU were not considered here as 
their reported number was negligible. No modifications to the model were made to explicitly 
represent transwomen and women with no education. In regards to Transwomen, data was 
insufficient to parameterise the model, as was the case for women with no education; and their 
infection could have several sources: being a stable partner of MSM, clients of FSW, IDU, men who 
engage in CHS or working as a sex worker (in a less formal context). In order to estimate their 
contribution to the number of new infections, a simple inference was made: the number of new 
infections among MSM was multiplied by the proportion of men who are transwomen and by the 
ratio in prevalence observed between transwomen and MSM. The same method was followed to 
calculate the contribution of women with no education, with the total number of women being the 
reference.  
The additional inputs needed to parameterise the model are presented in table 1. The HIV and STI 
prevalence among NIDU obtained from the BBS survey 2008 was used to parameterise both the 
NIDU MSM and NIDU Client groups. Prevalence among non-drug users was adjusted so that total 
prevalence combining drug users and non-drug users corresponded to the total prevalence in these 
groups. The frequency of condom use among NIDU clients was modified to correspond to the value 
reported by NIDU in the survey and it was adjusted among other clients to obtain the same total as 
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in the original model. This change was not made for the NIDU MSM as there was no information on 
condom use with men.  
Data on women with no education was obtained from the DHS survey 2007.  No reliable estimate of 
the proportion of men that are transwomen was available for DR. In the BBS survey 2008, about 8% 
of all MSM were transwomen. However, this is most likely a consequence of the sampling strategy. 
Instead, we used a study from Olyslager et al which estimates that between 0.02 and 0.2% of men in 
the U.S. are transgender. As variations in this estimate had a great influence on the total 
contribution of transwomen the full range was considered in the results.  
MSM Parameter value Reference 
Proportion of MSM that are NIDU 30.00% BBS 2008 
HIV Prevalence among NIDU MSM 8.00% BBS 2008 
Adjusted HIV prevalence among other MSM 5.30% Calculated 
STI prevalence among NIDU MSM 10.60% BBS 2008 
Adjusted STI prevalence among other MSM 3.00% Calculated 
Clients     
Proportion of clients that are NIDU 12.50% Calculated* 
HIV prevalence among NIDU clients 8.00% BBS 2008 
Adjusted prevalence among other clients 1.40% Calculated 
STI prevalence among NIDU clients 10.60% BBS 2008 
Adjusted STI prevalence among other clients 2.50% Calculated 
Condom use among NIDU clients 65.00% BBS 2008 
Adjusted condom use among other clients 83.00% Calculated 
Women with no education     
Proportion of women with low educational level 4.30% DHS 2007 
Relative risk of infection (based on prevalence ratio) 4.50 DHS 2007 
Transwomen     
Proportion of Men that are Trans 0.02%-0.2% Olyslager et al. 2007 
Relative risk of infection (based on prevalence ratio) 2.8 BBS 2008 
   *Residual of total proportion of men reporting using drugs in the last 3 months (DHS 2007) and proportion of 
MSM that reported using drugs (BBS 2008) Table 1. Parameter table for additional inputs required to include Drug Users, Trans and women 
with no education in the MoT for DR. 
This simple representation of the NIDU population suggested that over 11% of new infections 
occurred among this population, of which 9.77% were among MSM as shown in Figure 1. This is 
dependent on the assumption that above 50% of NIDU have sex with men, which was based on the 
proportion of MSM reporting drug use and might be an overestimate. Nevertheless between 15 and 
30% of NIDU in the 2008 BBS survey report selling sex, depending on the region and it is likely that 
an additional fraction has sex with men outside the context of commercial sex. The contribution of 
this group to the number of new infections will be very much dependent on whether they have sex 
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with men or not and considering their high prevalence it is likely that a substantial proportion 
engage in same-sex sex.  
Based on the estimate of the proportion of women who have no education and on their relative risk 
of infection, it was estimated that approximately 6.6% of new infections would occur among this 
group. These women might share a predominant risk factor for infection; however it is more likely 
that infections in this group result from a mix of exposures and directing prevention based on 
educational level might prove an efficient way of reaching women at risk. 
The potential contribution of Transwomen to incidence varied importantly depending on the size 
estimate of this population, going from 0.43 to 4.3% when the proportion of men that were 
Transwomen was estimated at 0.02% and 0.2% respectively. In either case, this is very high in 
proportion to the size of the population. This highlights the importance of having a reliable estimate 
of the number of Transwomen in DR and elsewhere. 
 
Figure 1. Distribution of new infections by sexual behaviour in DR, including NIDU and inferring the potential 
contribution of Transwomen and women with no education to the total number of new infection. Note:the 
bars in blue sum to 100%, the bars in red show an estimate of the proportion of new infections that occurr 
among transwomen (who are included in the MSM group) and of women with no education (who are 
distributed across all female groups).  
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ESTIMACIÓN Y ANÁLISIS DE LA INCIDENCIA DE VIH 
EN POBLACIÓN ADULTA DEL PERÚ: RESULTADOS DE LA 
APLICACIÓN DEL MODELO MATEMÁTICO MoT
Jorge O. Alarcón1,a, Mónica Pun2,a, César Gutiérrez1,a, Álvaro Whittembury1,a, Romina Tejada1,b, 
Luis Suárez2,a, Gustavo Rosell3,b, Annick Bórquez4,c, Paloma Cuchi5,a
RESUMEN
Objetivos. Estimar la incidencia de VIH en la población adulta del Perú, 2010, y analizar su distribución según 
comportamientos de riesgo. Materiales y métodos. Se aplicó el modelo de ONUSIDA según modos de transmisión 
(MoT). Los datos fueron obtenidos de la revisión detallada de 59 documentos (1984 – 2008). También se analizó bases 
de datos nacionales para obtener datos específicos. La selección final de los datos fue validada por el grupo técnico 
y un grupo de expertos. Después de la consulta con expertos, se corrigieron los valores y se realizó un análisis de 
incertidumbre. El modelo fue ajustado a la prevalencia nacional del 2009 (0,45%). Resultados. La incidencia estimada 
para el 2010 fue de 0,03%, (4346 nuevas infecciones). El 84% de nuevas infecciones se concentra en grupos de 
mayor riesgo: hombres que tienen sexo con hombres (55%) y personas que tienen sexo casual heterosexual (6,2%). 
El 16% restante corresponde a la población heterosexual de bajo riesgo. La transmisión heterosexual es el 43% 
de nuevos casos, y dentro de estos el 18% corresponde a parejas femeninas de sujetos de alto riesgo. Solo 2,2% 
de casos está relacionado al trabajo sexual femenino y 1,0% a usuarios de drogas inyectables. Conclusiones. El 
modelo proporciona una estimación de la incidencia y su distribución entre los grupos de riesgo según el modo de 
transmisión, consistente con los reportes de casos de VIH. El modelo permite crear escenarios para ayudar a la toma 
de decisiones y formulación de políticas, así como para vigilancia y planificación de la prevención y control.
Palabras clave: VIH; Modelos matemáticos; Técnicas de estimación; Incidencia (fuente: DeCS BIREME).
ESTIMATION AND ANALYSIS OF HIV INCIDENCE IN THE ADULT 
POPULATION IN PERU: RESULTS OF THE APPLICATION OF THE 
MoT MATHEMATIC MODEL 
ABSTRACT
Objectives. To estimate HIV incidence in the adult population of Peru, 2010, and analyze its distribution based on 
risk behavior. Materials and methods. The UNAIDS model was applied based on the modes of transmission (MoT). 
The information was obtained from the review detailed in 59 documents (1984 – 2008). National databases were 
also analyzed to obtain specific data. Final selection of data was validated by the technical group and a group of 
experts. After consultation with experts, values were corrected and an uncertainty analysis was conducted. The model 
was adjusted to 2009 national prevalence (0.45%). Results. Incidence estimated for 2010 was 0.03%, (4346 new 
infections). 84% of new infections concentrate on higher risk groups: men who have sex with men (55%) and people 
who have casual sex with heterosexuals (6.2%). The remaining 16% corresponds to low-risk heterosexual population. 
Heterosexual transmission accounts for 43% of new cases, 18% of which corresponds to female partners of high 
risk individuals. Only 2.2% of cases is related to female sexual work and 1.0% to injection drug users. Conclusions. 
The model provides an estimation of the incidence and its distribution among risk groups according to the mode of 
transmission, consistent with the HIV case reporting. The model creates scenarios to help decision making and policy 
formulation, as well as surveillance and planning of prevention and control.
Key words: HIV; Mathematical models; Estimation techniques; Incidence (source: MeSH NLM).
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INTRODUCCIÓN
En el Perú se cuenta con información sobre la 
prevalencia de VIH/SIDA, particularmente de los grupos 
de mayor riesgo; sin embargo, hay pocos estudios 
acerca de su incidencia por las dificultades para 
estimarla (particularidades de la historia natural, costo y 
tiempo de dichos estudios).
La incidencia es el mejor indicador para conocer el curso 
de la epidemia, identificar los puntos de intervención 
y prever los recursos para una prevención efectiva. 
Entre las alternativas para estimar la incidencia (1,2) lo 
que más se ha usado es la elaboración de modelos 
matemáticos, siendo necesario contar con información 
confiable sobre prevalencia y asumir supuestos de la 
supervivencia y tasas de transmisión (3-5). Sin embargo, 
estas estimaciones no proporcionan información 
acerca de los comportamientos de riesgo y, por ende, 
no permiten dirigir los esfuerzos de prevención hacia 
los grupos más vulnerables. Frente a esta necesidad, 
el año 2001 el grupo de referencia en estimaciones, 
modelamiento y proyecciones de ONUSIDA desarrolló 
el modelo de modos de transmisión (MoT) (6) que 
permite estimar los casos incidentes de VIH del año 
próximo según diferentes comportamientos de riesgo 
a partir de datos de prevalencia, siendo sus ventajas el 
ser relativamente sencillo de aplicar y demandar menor 
cantidad de datos comparado con otros. La información 
obtenida (nuevas infecciones por comportamiento de 
riesgo a corto plazo) permite formular un mensaje 
claro y conciso para la prevención. El modelo se ha 
aplicado en varios países, está disponible junto con el 
manual para su aplicación en el portal de ONUSIDA 
(http:/www.unaids.org) y ha sido descrito en otros 
artículos (7,8).
En Perú, las primeras predicciones de la tendencia 
de la epidemia del VIH fueron hechas el año 2000, 
utilizando el programa EPIMODEL (6); en los últimos 
años se han empleado otros modelos como Spectrum y 
EPP. Esto permitió, en su momento, estimar el número 
de personas viviendo con el VIH, número de casos 
incidentes anuales, número de personas que requerirán 
tratamiento antirretroviral de gran actividad (TARGA) 
y la magnitud de la mortalidad por SIDA. Los datos 
empleados en estas aplicaciones fueron obtenidos de 
la vigilancia centinela, notificación de casos de VIH/
SIDA, atenciones en los centros de referencia de ETS 
(CERETS) y datos poblacionales del Instituto Nacional 
de Estadística e Informática (INEI), entre otras fuentes. 
En este trabajo se estima la proporción de nuevas 
infecciones a corto plazo por modo de transmisión, 
obtenido a través de la aplicación del MoT al Perú, 
usando como fuentes la información generada por el 
sistema de vigilancia, los reportes de atenciones de los 
servicios hospitalarios y ambulatorios y por los estudios 
realizados entre 1983 y 2008.
MATERIALES Y MÉTODOS
MODELO DE MODOS DE TRANSMISIÓN 
El MoT es un modelo probabilístico estático basado en 
el teorema de Bernoulli, que calcula la proporción de 
nuevas infecciones por comportamiento de riesgo a 
corto plazo a partir del número promedio de contactos 
y de la prevalencia de VIH de estos contactos. Requiere 
identificar grupos con comportamientos de riesgo 
específicos y conocer su tamaño, prevalencia actual de 
VIH e ITS, frecuencia de exposición y protección, y la 
Ecuación 1: Ii = Si [ 1- { pi’Bi’[1-βi’i´ ]
α
i,i’
(1-ν
i,i’
) + pi’(1-Bi’)[1-βi’i]
α
i,i’
 (1-ν
i,i’
)  +  (1-pi’) }
n
i ]                 
          pareja VIH/ITS +               pareja VIH +            pareja VIH -
I: incidencia en el grupo i; S: número de individuos susceptibles en este grupo; p’: prevalencia de VIH de la pareja; B: prevalencia de 
ITS de la pareja; β: probabilidad de transmisión de VIH; β’: probabilidad de transmisión de VIH en presencia de una ITS; α: número de 
relaciones sexuales por pareja; v: proporción de relaciones sexuales protegidas por uso de condón; n: número de parejas.
Ecuación 2: Ii = Si [ 1- { pi[1-βi’i]
α
i,i
 (1-ν
i,i
)  + (1-pi) }
n
i ]                                                 
   contacto VIH +           contacto VIH –
I: incidencia en el grupo i; S: número de individuos susceptibles en este grupo; p’: prevalencia de VIH en compañeros que comparten 
jeringas; β: probabilidad de transmisión de VIH; α: contactos por compañeros; v: uso de jeringas estériles; n: número de compañeros.
Figura 1. Ecuación estándar del modelo que calcula la incidencia de nuevas infecciones por VIH adquiridas a través de contacto 
sexual entre las personas con una conducta de riesgo específica y sus parejas (ecuación 1) o por vía parenteral (ecuación 2).
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probabilidad específica de transmisión según el modo 
de exposición. 
La estimación de la incidencia de VIH por transmisión 
sexual y parenteral (en UDI) en cada grupo i se obtiene 
de las ecuaciones 1 y 2 (Figura 1). Los grupos incluidos 
en el modelo y los contactos entre estos considerados 
por el modelo están en la Anexo 1 (disponible solo en 
la versión electrónica). La transmisión por inyecciones 
médicas y transfusiones sanguíneas se calcula con la 
misma ecuación de la transmisión parenteral en UDI, 
pero se considera que los contactos provienen de la 
población total y no de un solo grupo.
El número de nuevas infecciones por transmisión 
sexual en un grupo es igual al número de individuos 
susceptibles en ese grupo por 1, menos la probabilidad 
de no infectarse (1-β) después de α actos sexuales de 
los cuales (1-v) no son protegidos, con cada una de 
las parejas que pueden ser: VIH e ITS positivas, o VIH 
positivas pero ITS negativas o VIH negativas. Estos tres 
tipos de parejas suman: pB+ p(1-B)+ (1-p)=1.
El efecto de las ITS se incorpora en la probabilidad de 
transmitir la infección por VIH, pero no en la de adquirirla, 
suponiendo que el riesgo de transmitir VIH por personas 
ITS positivas es cuatro veces mayor (9,10). 
El efecto de la circuncisión se incorpora modificando 
directamente la probabilidad de transmisión de mujer 
a hombre por 60% por la proporción de hombres 
circuncidados (11). Esta probabilidad se aplica a todos los 
actos sexuales entre hombres y mujeres, por ende se 
supone que la proporción de circuncidados es igual en 
todos los grupos de hombres del modelo.
Los grupos considerados en el modelo son usuarios 
de drogas inyectables (UDI) y sus parejas sexuales, 
trabajadoras sexuales (TS), sus clientes y las parejas 
sexuales de estos, los HSH y sus parejas sexuales 
estables mujeres, las personas que tienen sexo 
casual heterosexual y sus parejas estables, las 
personas que tienen sexo heterosexual de bajo riesgo 
(monógamos) y las personas sin riesgo de infectarse 
por vía sexual o compartir jeringas. Se considera 
que cada grupo únicamente se infecta por un tipo 
de exposición (Anexo 1). Los UDI por ejemplo, solo 
se infectan por compartir jeringas, aunque también 
tengan parejas sexuales. 
FUENTES  DE DATOS
Los datos fueron recolectados de los archivos 
proporcionados por la Dirección General de Epidemiología 
(DGE) y de la búsqueda sistemática en PubMed y LILACS, 
empleando los términos VIH, ETS/ITS, Perú y los relativos 
a comportamientos de riesgo. Se revisó 59 documentos 
(1984 - 2008), extrayendo los datos por una ficha ad hoc: 
población estudiada, periodo y ámbito de estudio, vía 
de transmisión, nivel de riesgo e indicadores utilizados 
como prevalencia e incidencia. También se analizaron 
para obtener datos específicos la ENDES 2004-2006 
(12) y 2008 (13), el Censo Nacional 2007 (14) y la Encuesta 
Nacional de Consumo de Drogas 2006 (15). La selección 
final de datos fue validada por el grupo técnico y un grupo 
de expertos.
SELECCIÓN DE LOS DATOS
El modelo se ajustó a la prevalencia nacional del 2009 
(0,45%) (16) y a una población de 14 514 191 personas 
entre 15 y 49 años (14). Para los casos de las parejas 
femeninas de HSH, UDI, clientes de TS y personas 
que practican sexo casual heterosexual, se asignó una 
pareja sexual por año (12), 77 actos sexuales por pareja 
por año (17) y 7,45% de uso de condón (12). Se siguieron 
los siguientes criterios para la inclusión de datos: 
Hombres que tienen sexo con hombres (HSH) y sus 
parejas: los HSH representaban el 6% de la población 
masculina según los estudios de Cárcamo et al. 
(comunicación personal antes de la publicación del 
estudio PREVEN) (18) y Cáceres et al (19), asignándoles 
una prevalencia de 5,16% (14,20,21), ajustada al número 
de muertes y subregistro. No se empleó los datos de 
Baral et al. (22) (12,2%) debido al sesgo de selección en el 
metanálisis. La prevalencia de ITS se estimó en 6% (18). No 
se consideraron los datos de Lama et al. (22) por ser una 
población HSH de alto riesgo. Se asumió 2,7 parejas por 
año (18,23) con doce actos de exposición por pareja por 
año (18) y 70% de actos protegidos (23, 24).
Se consideró que el porcentaje de parejas femeninas 
de HSH fue 1,14% de la población femenina (el 19,0% 
de HSH reporta pareja femenina estable (25)). Se asignó 
una prevalencia de 1,6% (multiplicación del valor de 
vigilancia centinela (0,23%) (26) y un OR de siete (27). 
Usuarios de drogas intravenosas (UDI) y sus parejas: 
la prevalencia de vida de drogas intravenosas en 2006 
fue 0,03% en varones y ningún caso en mujeres (15). No 
existen datos nacionales de prevalencia de VIH para 
este grupo por lo que se usó el reporte de Mathers 
et al. (28) de 13%. Se estimó una prevalencia de ITS en 
3,15% (29) (prevalencia de sífilis de 1,5%) y el OR de 2,1 
para la presencia de cualquier ITS (30). Se consideraron 
dos parejas de inyección por año (31) y 95 actos de 
intercambio de agujas con cada pareja de inyección 
por año (32) y un total de 190 actos de exposición por 
año (33). 
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Bajo el supuesto que los varones UDI tienen el mismo 
número de parejas sexuales femeninas que la población 
masculina general (52,9%) (14), la proporción de parejas 
sería de 0,02% de la población general y la prevalencia 
de VIH 2,5% (27). 
Trabajadoras sexuales (TS): las mujeres TS se estimaron 
en 0,5% (34) de la población femenina. La prevalencia de 
VIH se estimó en 0,9% (35) y de ITS 15,0% (18,36). Se estimó 
que cada TS en promedio tiene 843 parejas sexuales 
por año (18) y se asumió un acto sexual por cliente al año, 
con 80,6% de actos sexuales protegidos (37-39). 
Clientes de TS y sus parejas: el porcentaje de clientes 
de TS se calculó en 15,8% (18,27,38). La prevalencia de 
VIH se estimó en 0,76% (prevalencia de vigilancia 
centinela (26) (0,27%) multiplicada por OR de 2,8 (27)). 
Del mismo modo, se estimó la prevalencia de ITS en 
3,3% (29,40). La estimación resultante fue compatible con 
datos previamente descritos (18,38). El número promedio 
de parejas al año de los clientes de TS se calculó en 
26, según la fórmula: (número de TS x número de actos 
sexuales)/número de clientes; se mantuvo el supuesto 
de un acto sexual por pareja por año y de un 80,6% de 
actos sexuales protegidos. 
Se asumió que la proporción de parejas de los clientes 
de TS es 8,4% de la población femenina, suponiendo 
que los clientes de TS tienen parejas en una proporción 
similar a la población masculina (14), y que la prevalencia 
de VIH es la misma que la informada en la vigilancia 
centinela (26) multiplicado por un OR de 2,8 (27). 
Personas que tienen sexo casual heterosexual (SCH): 
se consideró SCH cuando se tiene relaciones sexuales 
con una persona con la que no se cohabita, no es 
regular o tiene múltiples parejas (41). La proporción de 
hombres en este grupo fue de 21,0% (13) y de mujeres 
de 11,0% (12,31). Se les asignó una prevalencia de VIH 
similar a la de la población general (26) y para ITS de 
12,0% (42). Se consideró que tienen 1,5 parejas sexuales 
por año (promedio de hombres y mujeres) (12,13), 39 actos 
sexuales por pareja por año (50% de actos sexuales con 
una pareja estable) (28) y uso de condón del 27,2% (12). 
Las parejas varones representaron el 5,8% y las parejas 
mujeres el 11,2% de la población general, valores 
obtenidos de multiplicar el número de mujeres y hombres 
que practican SCH por 0,54 y 0,53 respectivamente 
(porcentaje de unidos) (14). Se les asignó una prevalencia 
de VIH igual a la de sus parejas (26).
Personas sin riesgo: los varones sin riesgo de VIH 
representaban el 29,7% (13) y las mujeres 33,0%(12), 
equivalente al porcentaje de hombres no unidos y 
mujeres que nunca han tenido relaciones sexuales o 
que han tenido relaciones sexuales hace un año o más.
Heterosexuales de bajo riesgo: personas casadas o con 
pareja estable no incluidas en los otros grupos; representó 
el 26,8% de hombres y 37,1% de mujeres. Se asignó una 
prevalencia de VIH de 0,25% (26) y de ITS de 9,0% (18). 
Transfusiones sanguíneas: se asumió que el 0,5% de 
la población femenina y masculina han recibido en 
algún momento de su vida una transfusión, dado que 
la prevalencia de hemofilia y otras enfermedades que 
requieran transfusiones es muy baja. Se asignó una 
prevalencia de 0,25% (26) y se consideró que el 100% de 
unidades de sangre son tamizadas eficientemente para 
VIH (43). 
Datos adicionales: finalmente, se estableció que el 5,7% 
de hombres adultos es circuncidado (44). Se asumió que 
toda la población en algún momento de su vida ha recibido 
alguna inyección médica, por lo que estarían incluidos en 
los otros grupos, con una prevalencia de VIH igual que la 
población general (26) y una protección del 95%.
VALIDACIÓN CON EXPERTOS NACIONALES
 
Se realizó una reunión para la validación interna del 
modelo a la que se invitó a expertos en el tema, (MINSA, 
universidades y sociedad civil). Se presentaron los 
fundamentos del modelo y los datos ingresados. Se 
discutió la confiabilidad de dichos datos, el uso de otras 
fuentes y se entregó un formulario con la relación de los 
datos y se pidió que en caso necesario proporcionaran 
referencias para obtener una mejor estimación. 
ANÁLISIS DE INCERTIDUMBRE
Tomando en cuenta que el MoT requiere una cantidad 
de datos importante para su parametrización, es difícil 
contar con toda la información necesaria. Por ello, ciertos 
parámetros se basan en inferencias, en datos de otros 
países o en supuestos. Además, aunque se cuente con 
información nacional, los estimados inevitablemente 
tienen cierta incertidumbre. Se asignó un porcentaje 
de variación a cada parámetro (0 al 100%). Todos los 
parámetros varían, excepto el número de parejas en el 
grupo de bajo riesgo y en las parejas de miembros del 
grupo de riesgo (por definición es uno). El tamaño de 
los grupos que son parejas de miembros de grupos de 
riesgo no varía directamente sino que se le asigna una 
proporción fija del tamaño del grupo de riesgo.
Se hizo un muestreo de tipo Monte Carlo, de manera 
que cada parámetro variara simultánea, aleatoria e 
independientemente a cada corrida del modelo. Para 
que la población total sumara al 100% y la prevalencia 
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Tabla 1. Hoja de cálculo MoT parametrizada con datos de Perú.
Comporta-
miento de 
riesgo
Población con 
conductas de 
riesgo (%) N.° * Prev. VIH (%)
Número 
VIH + Prev. ITS (%)
Parejas 
por año
(N°)
Actos de 
exposición 
por pareja 
y año
(N°)
Actos 
prote-
gidos
(%)
Probabilidad 
de transmisión 
por exposición 
con riesgo
Inciden-
cia
Distri-
bución 
% de la 
inciden-
cia
Inciden-
cia por 
100 000
Hombres Mujeres con ITS Sin ITS
Uso drogas 
inyectables 
(UDI)
0,033 0,00 2 402 13,00 312 3,15 1 190 80,00 0,0100 86 1,98 3 590
Parejas UDI 0,00 0,017 1 241 2,50 31 NA 1 77 7,45 0,002 0,0008 9 0,22 762
Trabajadoras 
sexuales (TS) 0,49 35 560 0,90 320 15,00 843 1 80,60 0,002 0,0008 39 0,89 108
Clientes TS 15,80 1 146 621 0,76 8 714 3,30 26 1 80,60 0,002 0,0008 58 1,33 5
Parejas de 
clientes TS 8,358 606 563 0,64 3 882 NA 1 77 7,45 0,003 0,0008 276 6,36 46
Hombres que 
tienen sexo 
con hombres 
(HSH)
6,00 435 426 5,16 22 468 6,00 2,7 12 70,00 0,040 0,0100 2,389 54,97 549
Parejas 
femeninas de 
HSH
1,140 82 731 1,61 1 332 NA 1 77 7,45 0,003 0,0008 270 6,22 327
Sexo casual 
heterosexual 
(SCH)
21,02 11,00 2 323 722 0,27 6 274 12,00 1,5 39 27,26 0,002 0,0008 274 6,29 12
Parejas SCH 5,87 11,12 1 233 240 0,27 3 330 NA 1 77 7,45 0,003 0,0008 241 5,54 20
Sexo hete-
rosexual de 
bajo riesgo
21,54 34,88 4 094 310 0,25 10 236 9,00 1 77 7,45 0,003 0,0008 694 15,97 17
Sin riesgo 29,73 33,00 4 552 376 0,20 9 105 0,0 0 0 0 0,00 0
Inyecciones 
médicas** 100,00 100,00 14 514 191 0,25 NA 1 1 95,00 0,0040 10 0,23 0
Transfusiones 
sanguíneas** 0,50 0,50 72 571 0,25 NA 1 1 100,00 0,9000 0 0,00 0
Población 
adulta total 100 100 14 514 191 0,45 66 004 4 346 30
*: Estimado de personas con comportamiento de riesgo ** No se consideran conductas excluyentes; Prev: prevalencia; NA: no aplica.
total correspondiera a la estimada en el modelo original, 
el tamaño y la prevalencia del grupo de bajo riesgo se 
calcularon como el remanente de los otros grupos. Para 
seleccionar sets de parámetros que resultaran en una 
estimación de la incidencia plausible, se aplicó como 
filtro el rango de nuevas infecciones estimadas con el 
modelo Spectrum de ONUSIDA. Se repitió el proceso 
hasta obtener 1000 corridas que produjeran un número 
de nuevas infecciones dentro de este rango. El rango de 
incertidumbre obtenido corresponde a los percentiles 2,5 
y 97,5 del número total de nuevas infecciones obtenidas 
en las 1000 corridas.
RESULTADOS
Los resultados de la estimación se presentan en la Tabla 
1. La incidencia de VIH en la población adulta entre 15 y 
49 años para el 2010 se estima en 0,03% (4346 nuevas 
infecciones). Sin considerar a los UDI y a sus parejas, los 
grupos de mayor riesgo son los HSH, las parejas femeninas 
de los HSH y las TS. La distribución proporcional de estas 
infecciones según grupo de riesgo se presenta en la 
penúltima columna de la Tabla, observando que  84,0% 
de las nuevas infecciones se concentra en población de 
mayor riesgo, destacando los HSH (55,0%); le siguen en 
importancia el grupo de personas que tienen SCH (6,2%). 
El 16,0% restante corresponde a nuevas infecciones en 
la población heterosexual de bajo riesgo. 
La transmisión heterosexual ocurre en el 43,0% de 
nuevos casos; 18,0% corresponde a parejas femeninas 
de sujetos de alto riesgo (clientes de TS, HSH, UDI y 
SCH), 16,0% en población femenina y masculina de 
bajo riesgo, 6,2% en personas que tienen SCH y solo 
2,2% en grupos vinculados al trabajo sexual femenino 
(TS y sus clientes). Finalmente los UDI contribuyen con 
el 1,0% de nuevas infecciones. 
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Figura 2. Límites de incertidumbre alrededor de la distribución de nuevas infecciones por VIH según modo de transmisión en Perú.
HSH: hombres que tienen sexo con hombres; HSC: heterosexuales que realizan sexo casual; UDI: usuarios de drogas endovenosas.
Los valores y límites de incertidumbre para cada grupo 
están en la Figura 2. Pese a la amplitud de los intervalos, 
es claro el predominio de los HSH.
DISCUSIÓN 
La incidencia estimada por el modelo (0,03%) es 
consistente con una epidemia concentrada, como la 
que afecta al país y cercana a los datos de notificación 
nacional. Sin tomar en cuenta los UDI y sus parejas, la 
población de HSH es la de mayor incidencia y representa 
el 55% (intervalo de incertidumbre: 38-70%) del total de 
casos nuevos estimados, no obstante ser el 6% de la 
población adulta.
Los otros grupos de incidencia elevada contribuyen en 
menor proporción al total de casos nuevos, por tener 
menor incidencia que los HSH y representan una 
proporción pequeña de la población. Los UDI, que tiene 
la incidencia más alta, constituirían el 1% de los casos 
nuevos. En el Perú casi no se reportan casos de VIH con 
este hábito, y el hábito mismo está muy poco extendido. 
Es posible incluso, que este valor sea consecuencia de 
una sobrestimación tanto de la proporción de usuarios 
de este tipo de drogas como de la probabilidad de 
transmisión en el país. 
En el caso de las TS ocurre algo similar. Tienen una 
incidencia elevada, aunque bastante menor que los 
HSH, pero solo representan el 0,8% de los casos 
nuevos estimados. Esto es consistente con el hecho 
que los estudios realizados en este grupo encuentran 
que la prevalencia es baja y un elevado uso de condón, 
probablemente debido a las múltiples intervenciones 
de prevención. Por el momento, este resultado debilita 
el argumento de considerar a las TS como población 
puente para la transmisión del VIH de HSH a personas 
heterosexuales, pudiendo ser tal vez la población 
bisexual la que este desempeñando dicho papel en 
el país. Sin embargo, hay que tomar en cuenta que el 
modelo no considera el contacto entre TS y HSH y que 
algunos datos de los estudios de prevalencia en esta 
población son incompletos. No hay que perder de vista, 
según el modelo, que la incidencia en este grupo es alta 
(casi cinco veces superior a la de la población de bajo 
riesgo), hecho que puede ser importante para el futuro 
desarrollo de la epidemia.
Es diferente la situación en la población heterosexual 
de bajo riesgo, que con una incidencia mucho menor 
contribuye con el 16% de los casos nuevos, puesto que 
representan casi el 30% de la población, que contrasta 
con el 6% que se atribuye a la población de HSH pero que 
por su elevada incidencia contribuye significativamente 
al total de casos incidentes estimados para el año 2010.
En suma, el modelo proporciona una estimación 
de la incidencia global y específica por grupos de 
riesgo aceptable, que será de mucha utilidad para la 
priorización de las actividades preventivas, ofreciendo 
sustento a diversas estrategias de intervención. Por 
ejemplo, si se toma en cuenta que casi la mitad de 
los casos nuevos corresponden a HSH, que a su vez 
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se estiman son el 6% de la población adulta de 15 a 
49 años, es razonable pensar que las acciones de 
prevención en este grupo pueden ser más eficientes 
y producir un impacto importante en el curso de la 
epidemia en el país. Si a esto se suma el hecho de que 
el 18% de nuevas infecciones se presentarán en parejas 
estables de grupos de riesgo, es recomendable extender 
y fortalecer las actividades preventivas a estas parejas 
y a la población general. Actividades sencillas como 
mejorar los mecanismos de información para promover 
la consejería y la prueba voluntaria permitirían prevenir 
en gran parte nuevas infecciones en estos grupos. 
También es recomendable mantener una constante 
vigilancia epidemiológica en TS, considerando que si 
bien contribuyen poco a los casos incidentes, tienen una 
elevada incidencia y, por tanto, un constante riesgo de 
sufrir la infección y trasmitirla. 
Una de las ventajas del modelo es su simplicidad, ya 
que usa datos de prevalencia existentes; ventaja que 
resalta si lo comparamos con otros métodos para 
obtener incidencia, como son los estudios de cohortes 
y el uso de pruebas de laboratorio para diagnosticar 
infecciones recientes. También el modelo puede 
aplicarse a las regiones del país, y así contribuir a la 
planificación regional. Adicionalmente, el modelo puede 
ser usado en la construcción de distintos escenarios 
bajo determinados supuestos, de modo que se pueda 
evaluar el impacto de posibles intervenciones en 
salud pública sobre la incidencia de la infección por 
VIH. Finalmente, el modelo es perfectible y puede ser 
validado con la información recogida por los sistemas de 
vigilancia para el año estimado.
No obstante las bondades del MoT, no deja de tener 
limitaciones. Las proyecciones y extrapolaciones 
de casos de VIH/SIDA en general dependen de la 
disponibilidad de datos confiables, ideal que es difícil 
alcanzar sobre todo en el caso de los datos regionales. 
Esto se expresa, en este estudio, en los amplios rangos 
de incertidumbre hallados. Por ejemplo, muchos de 
los estudios consultados se realizaron en muestras 
pequeñas o poco representativas de los subgrupos 
respectivos; se observó, además, un importante 
subregistro de los casos de VIH/SIDA; tampoco se contó 
con prevalencias a nivel nacional ni datos actualizados, 
a falta de los cuales se emplearon fuentes que podrían 
tener sesgo de selección como la hoja de monitorización 
de los CERITSS. Lamentablemente, la información 
proporcionada por los sistemas de vigilancia también 
tiene sesgos relacionados con el acceso a las pruebas, 
el acceso al sistema de salud y a la variabilidad en el 
tiempo que transcurre desde que ocurre la infección 
hasta que se realiza el diagnóstico del VIH (45). 
Además, el modelo no toma en cuenta diferentes niveles 
de riesgo dentro de un mismo grupo; tampoco toma en 
cuenta el traslape entre diferentes comportamientos de 
riesgo, fenómeno que puede tener un efecto importante 
sobre la dinámica de la epidemia. Otra limitación es 
la no inclusión de la proporción de personas viviendo 
con el VIH que reciben TARGA, y esto puede tener un 
impacto importante en la transmisión (46). Finalmente, 
las estimaciones de incidencia son válidas solo para un 
año, siendo difícil repetir el cálculo de manera anual, 
tanto por la obtención de la información actualizada 
como por su sistematización para los fines del modelo. 
Un tiempo prudencial que se ha recomendado para las 
estimaciones es cinco años, pues hay que considerar 
que la dinámica de la infección y la composición de los 
grupos de riesgo pueden cambiar, sea por saturación o 
cambios de comportamiento. 
El presente estudio representa la primera experiencia 
nacional de estimación de la incidencia para casos 
de VIH según modos de transmisión. Se presentaron 
diversas dificultades en la construcción del mismo, 
principalmente debido a la falta de datos completos; a 
pesar de ello, el modelo proporciona una estimación 
de la incidencia y su distribución entre los grupos de 
riesgo según el modo de transmisión, consistente con 
la distribución de los reportes de casos captados por 
el sistema de vigilancia. Las dificultades encontradas 
plantean la necesidad de implementar adecuados 
sistemas de vigilancia, que recoja los datos necesarios 
para hacer estimaciones más confiables. También 
es necesario desarrollar investigaciones puntuales 
que permitan contar con mejor información sobre la 
incidencia de VIH en el país. Finalmente, se debe 
estimular el tamiz en población masculina, donde se 
tiene menor información sobre la prevalencia de VIH; 
al igual que continuar con actividades en población 
general como el tamizaje voluntario en MEF. 
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Understanding the modes of transmission model of new HIV infection 
and its use in prevention planning
Kelsey K Case,a Peter D Ghys,b Eleanor Gouws,b Jeffrey W Eaton,a Annick Borquez,a John Stover,c Paloma Cuchi,d 
Laith J Abu-Raddad,e Geoffrey P Garnettf & Timothy B Hallettaon behalf of the HIV Modelling Consortium
Introduction
In the current global financial climate, it is more important 
than ever that effective resource allocation for the control of 
human immunodeficiency virus (HIV) infection is based on 
informed, strategic decision-making. Planning HIV preven-
tion programmes requires up-to-date information on the 
likely sources of new infections and mathematical modelling 
provides a framework for understanding epidemic patterns 
and for highlighting priority areas for prevention. Various 
models of HIV epidemics, in particular the modes of transmis-
sion (MOT) model recommended by the Joint United Nations 
Programme on HIV/AIDS (UNAIDS),1 are used to increase 
understanding and to assist national planning.2–10
When constructing a model, it is important to include 
adequate detail to address the questions posed. Superfluous 
detail reduces the transparency of the model and can make it 
more difficult to estimate model parameters reliably, whereas 
excluding important details can lead to erroneous conclusions. 
The MOT model was developed in 2002 and was designed to 
focus on identifying who is at risk of infection rather than on 
the broad categorization of the type of epidemic (i.e. low-level, 
concentrated, generalized or hyperendemic).11 Its aim was to 
provide better information for strategic planning of disease 
prevention.
Unlike models that are region-specific (e.g. the Asian Epi-
demic Model)12 or country-specific (e.g. the Actuarial Society 
of South Africa model,13 used primarily in South Africa but 
also in other countries in southern Africa), the MOT model 
was designed to be easy to use and can be applied in any epi-
demic setting. It differs from other approaches, such as the 
Estimation and Projection Package14 curve-fitting approach 
embedded within the Spectrum modelling software,15 which 
estimates and projects HIV prevalence and incidence from 
surveillance data and does not aim to take mechanisms of 
infection into account.
Use of the MOT model at the country level was recom-
mended in 2008 as part of a synthesis process supported by 
UNAIDS and the World Bank Global HIV/AIDS Monitoring 
and Evaluation Team in southern and eastern Africa,16,17 con-
sistent with the UNAIDS “know your epidemic, know your 
response” strategy.18 This approach emphasizes the importance 
of understanding, at the local level, which subpopulations are 
most at risk of HIV infection and which risk behaviours may 
facilitate transmission and of using this information to tailor 
national responses.
When evaluating the performance of a model that is 
widely used to assist countries in decision-making, it is impor-
tant to consider the perspective and experience of individuals 
involved in the modelling process, including those involved 
in developing and implementing the model, those who rely 
on the model results for decision-making and the normative 
agencies that help support the modelling process. In April 
2011, the HIV Modelling Consortium (participants are listed 
in the acknowledgements section) gathered together stake-
holders involved in different stages of the modelling process 
to review both the methods used for estimating sources of 
HIV infection and the MOT process.19 The impetus for this 
manuscript originated from discussions at this meeting; one 
outcome of the meeting was a manuscript that described the 
strengths and limitations of the MOT process.
Our intention was to strengthen future use of the MOT 
model by reviewing its principle features in detail and by sum-
marizing feedback from previous applications. Specifically, we 
Abstract The modes of transmission model has been widely used to help decision-makers target measures for preventing human 
immunodeficiency virus (HIV) infection. The model estimates the number of new HIV infections that will be acquired over the ensuing 
year by individuals in identified risk groups in a given population using data on the size of the groups, the aggregate risk behaviour in each 
group, the current prevalence of HIV infection among the sexual or injecting drug partners of individuals in each group, and the probability 
of HIV transmission associated with different risk behaviours. The strength of the model is its simplicity, which enables data from a variety 
of sources to be synthesized, resulting in better characterization of HIV epidemics in some settings. However, concerns have been raised 
about the assumptions underlying the model structure, about limitations in the data available for deriving input parameters and about 
interpretation and communication of the model results. The aim of this review was to improve the use of the model by reassessing its 
paradigm, structure and data requirements. We identified key questions to be asked when conducting an analysis and when interpreting 
the model results and make recommendations for strengthening the model’s application in the future.
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aimed to clarify the model paradigm, 
to review the model structure and data 
requirements and to propose questions 
that can be used to guide interpretation 
of the model results.
Modes of transmission 
model
The MOT model uses information on 
the current distribution of prevalent 
infections in a population and assump-
tions about patterns of risk behaviour 
within different risk groups to calculate 
the expected distribution of new adult 
HIV infections in the following year 
in terms of the mode of exposure. The 
inputs to the model, which are based 
on a comprehensive review of available 
epidemiological and behavioural infor-
mation, are:
•	 the proportion of the adult male and 
female population that belongs to 
each of several risk groups, which are 
precisely defined by each country, 
including: sex workers and their cli-
ents, injecting drug users, men who 
have sex with men, individuals with 
multiple heterosexual sex partners in 
the last year, the spouses of individu-
als with higher-risk behaviour and 
individuals in stable heterosexual 
relationships (i.e. generally married 
or cohabiting couples with one mo-
nogamous heterosexual partner in 
the last year; these individuals were 
previously referred to as “low risk”);
•	 the prevalence of HIV infection and 
of a generic sexually transmitted in-
fection (STI) within each risk group;
•	 the average number of sexual or in-
jecting partners per year and the 
average number of exposures per 
partner, taking into account the av-
erage level of protective behaviour 
(e.g. condom use or the use of clean 
needles), for individuals in each risk 
group;
•	 the probability of HIV transmission 
per exposure act in each risk group, 
taking into account the effect of STIs 
and the prevalence of male circumci-
sion.
The model estimates the number of 
new adult HIV infections that will occur 
over the ensuing year in each risk group 
from the number of HIV-susceptible 
individuals, the number of contacts 
each had with HIV-positive individuals 
and the probability of HIV transmission 
associated with each type of contact. 
Taken together, this provides an estimate 
of the distribution of new infections in 
adults according to the population risk 
structure defined by each country.
By the end of 2012, over 40 coun-
tries with a diverse range of HIV 
epidemics will have completed or begun 
an MOT analysis (Table 1, available 
at: http://www.who.int/bulletin/vol/-
umes/90/11/12-102574). The results of 
model analyses conducted in sub-Saha-
ran Africa (Fig. 1) show that the major-
ity of new infections were expected to 
occur in the general heterosexual popu-
lation, either in serodiscordant couples 
or as a result of having multiple sexual 
partners. Although there is substantial 
uncertainty, the estimated proportion of 
new infections that occur in men who 
have sex with men and in injecting drug 
users in many countries in this region 
is larger than acknowledged before the 
advent of the MOT framework.
Benefits 
The MOT analysis forms part of a multi-
stage process that typically includes: (i) a 
comprehensive review and synthesis of 
epidemiological and behavioural data; 
(ii) use of the MOT model to estimate 
the distribution of new infections; (iii) a 
review of existing or proposed HIV pre-
vention planning and resource alloca-
tion for treatment and prevention; (iv) a 
comparison of resource allocation and 
the modelled distribution of sources of 
infection, and (v) a national stakeholder 
consensus meeting to discuss the model 
results and formulate key recommenda-
tions. This process provides a framework 
for countries to interpret and evaluate 
their data, to assess data availability 
and quality, and to identify gaps in data 
collection. It can help consolidate 
knowledge of the current situation, but 
can also expose gaps in information 
about specific risk behaviours. In addi-
Fig. 1. Sources of new HIV infections estimated by the modes of transmission model in 
sub-Saharan Africa, 2008–2010
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tion, the model results could be used to 
raise awareness for groups that may not 
previously have received enough atten-
tion, to highlight areas for improvement 
in prevention and to identify areas for 
further research. Although the concept 
of the MOT analysis has gained broad 
support, important questions have been 
raised about the simplicity of the model, 
its use of data and how the results are 
interpreted.
Limitations 
The limitations of the MOT model and 
its assumptions can be divided into 
three categories relating to the model 
structure, the data used in the model and 
the interpretation of the results.
Model structure
The MOT model is a static model rep-
resenting risk in a single year. It has a 
simple structure that does not incorpo-
rate many of the complexities of HIV 
epidemiology. It assumes that the popu-
lations in each risk group are mutually 
exclusive and that the risk of infection 
is homogenous within each group. This 
means, for example, that all men who 
have sex with men are assumed to have 
the same risk of infection. Moreover, 
the assumption of homogeneity would 
not capture details such as the clients 
of sex workers only visiting a particular 
type of sex worker or an injecting drug 
user sharing injecting equipment only 
within a specific cluster. These factors 
could influence the model results if there 
are important differences among those 
classified as belonging to the same risk 
group. However, the model offers the 
flexibility to disaggregate a subpopula-
tion if there is enough evidence of het-
erogeneity in risk and sufficient data are 
available to characterize the different 
subgroups within a subpopulation, but 
generally suitable data are not available.
In the model, individuals must be 
assigned to a single risk group and are, 
consequently, assumed to be at risk of 
infection from only one source. Those 
at risk of infection from more than one 
source are classified according to the 
behaviour associated with the highest 
probability of HIV transmission. For 
example, a sex worker who also injects 
drugs is classified as an injecting drug 
user. This assumption implies that elimi-
nating that source of risk will avert infec-
tion. An analysis that looked at the effect 
of modifying the model structure to 
allow for an individual’s risk of infection 
from more than one source found that 
assuming a single source could result 
in overestimating the potential impact 
of interventions targeting that source.20 
Conversely, the effect of interventions 
targeting a less risky behaviour could 
be underestimated if the size of the risk 
group is underestimated because that 
behaviour ranks lower in the hierarchy 
of risk. For example, the model assumes 
that sex workers who are also injecting 
drug users and who would be classified 
as such would not benefit from a suc-
cessful intervention among sex workers.
The probabilities of HIV transmis-
sion for different exposure acts and 
the parameter used to modify these 
probabilities when an STI is present 
are derived from published data, sys-
tematic reviews and meta-analyses of 
observational studies.21–23 While these 
sources represent the best available evi-
dence, they may not capture potential 
variability of transmission in different 
geographical settings.23,24 Additionally, it 
is assumed that there is no variation in 
transmission probability by stage of HIV 
infection and the model does not allow 
temporal patterns of sexual contacts, 
such as concurrent sexual partnerships, 
to influence transmission. Previous 
MOT analyses have not allowed for the 
effect of antiretroviral therapy on trans-
mission, but this has been incorporated 
in the latest revision of the model.
In the model, the size of the “low-
risk” or “stable heterosexual” subpopula-
tion is sometimes calculated as a residual 
after the sizes of other groups are entered 
to ensure the summed size of the groups 
matches the total population size. This 
creates a dependency between the sizes 
of the different risk groups, so that, if the 
summed size of the high-risk groups is 
underestimated, the importance of the 
low-risk group will be overestimated. 
Thus, poor data quality for a single risk 
group can result in biased estimates and 
misinterpretation of the relative impor-
tance of the low-risk group.
While the MOT model calculates 
the cumulative number of incident 
cases of HIV infection in 1 year, it does 
not capture secondary HIV transmis-
sion arising from onward transmission 
within that year. Further, the MOT 
model assumes that the population is 
closed and defined by country borders 
and a defined age range. The estimates 
obtained are for new HIV infections 
that arise within a country and do not 
account for exogenous HIV exposures, 
which may contribute to a considerable 
fraction of HIV infections in some coun-
tries, in the Middle East and northern 
Africa, for example.25,26 As epidem-
ics mature, the contribution of older 
adults, outside the age range of 15 to 49 
years that is typically used in the MOT 
model, to new HIV transmissions may 
increase.27 The model can be adapted 
to incorporate older age groups if data 
are available.
Data inputs
The MOT model requires detailed, up-
to-date information on the size of risk 
groups and on the prevalence of HIV 
infection and of other STIs and precise 
descriptions of sexual behaviour in each 
risk group. Often this exceeds the data 
available, particularly when describing 
hidden or stigmatized populations, 
but also when describing the general 
population in countries where national 
survey data are not available. Standard 
survey instruments do not collect spe-
cific information on the detailed inputs 
required by the MOT model and most 
other models, including the average 
number of sex acts per partnership, 
injecting behaviour and the prevalence 
of HIV and STI in each risk group. It is 
unlikely that all the information needed 
to characterize a specific group can be 
obtained from a single study. Instead, 
estimates are often based on data from 
several sources that were collected at 
different times within a prespecified 
period, typically 5 years, using different 
study designs.
The quality of the model results 
depends on the quality of the input data 
and the MOT model is highly sensitive 
to the size of subpopulations28 and to 
behaviour within risk groups. Although 
guidelines exist for estimating popula-
tion size,29 the methods used are often 
complex and of uncertain precision, 
particularly for hidden or hard-to-reach 
populations such as men who have sex 
with men in Africa.30 Consistently de-
fining the risk of HIV infection is not 
straightforward in certain populations, 
for example, women who occasionally 
sell sex in informal settings but do not 
self-identify as sex workers. These fac-
tors contribute to the use of different 
estimation methods, producing substan-
tially varying population size estimates 
which could affect the model results.31
The patterns of risk behaviour 
ascribed to high-risk groups may be 
subject to bias in self-reported mea-
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sures of behaviour. National household 
surveys, such as the Demographic 
and Health Survey, are often used as 
a source for sensitive information on, 
for example, individuals who engage in 
casual heterosexual sex or the clients 
of sex workers. Increasing evidence 
suggests that higher-risk behaviour 
may be substantially underreported in 
these surveys.32–34 Other sources of HIV 
prevalence and behavioural data for 
hard-to-reach, hidden or stigmatized 
populations may not be representative. 
Such data generally come from surveil-
lance or behavioural studies in capital 
cities or urban centres (often via conve-
nience samples) and may be difficult to 
extrapolate to national-level estimates.
Nevertheless, it is important to 
recognize that the MOT model requires 
fewer data than many dynamic models, 
which have the same data limitations, 
but still aims to capture the mechanisms 
of infection.
Interpreting and communicating 
results
The major misunderstanding of the 
model results comes from a misappre-
hension of the question addressed by the 
model analysis. The model calculates the 
estimated distribution of new infections 
in 1 year; it does not take into account 
the number of secondary infections that 
will result from new infections in a risk 
group. It is important to distinguish 
between identifying among whom new 
infections are predicted to occur in the 
short term, which the model does, and 
the types of risk behaviour that sustain 
the epidemic (i.e. the epidemic driv-
ers).31 For example, although a large 
proportion of new HIV infections may 
occur among individuals in serodiscor-
dant, stable, monogamous partnerships, 
the index HIV-positive partners in these 
couples may have previously acquired 
the infection through higher-risk be-
haviour, such as commercial sex. Cur-
rently, both partners would be classified 
as part of the low-risk population, but 
the essential driver of HIV transmis-
sion between the partners is previous 
sexual contact within commercial sex 
networks. This is an important dis-
tinction, particularly when the model 
results are used for planning preven-
tion programmes, which may then 
underallocate resources for prevention 
in commercial sex settings. Allocating 
resources for prevention to match the 
predicted distribution of new infections 
identified in the MOT analysis implicitly 
focuses prevention efforts on reducing 
the risk of acquisition among susceptible 
individuals. However, in some cases, 
it may be more effective or efficient to 
target prevention efforts towards the 
individuals who contribute most to 
onward transmission.31
One difficulty with the commu-
nication of the results of the MOT 
model is that concise pie or bar charts 
(Fig. 1) do not represent uncertainties 
in input data, which can be substantial. 
Users of the MOT model can conduct 
a simple uncertainty analysis based 
on specifying plausible ranges for key 
input variables. Then, a large number 
of parameter combinations from the 
specified plausibility bounds are in-
dependently and uniformly sampled 
and outputs are calculated for each 
combination of parameters. During 
this process, the prevalence of HIV 
infection in the total population is 
maintained by adjusting the size of the 
low-risk group and the prevalence in 
that group. While this method gives 
some notion of how uncertainty in in-
put data could affect the model outputs, 
it does not take into account systematic 
bias or correlated errors between model 
inputs. The results can also vary sub-
stantially depending on the plausible 
ranges specified by the user and the 
use of plausibility ranges for model pa-
rameter values does not take account of 
the intrinsic uncertainty caused by the 
simplified model structure. In addition, 
use of the low-risk group as a “catch-all” 
for maintaining internal consistency 
neglects the fact that countries with 
good surveillance of HIV infection in 
the general population may have more 
robust data on the low-risk group than 
on less surveyed, high-risk groups.
Nevertheless, even simple demon-
stration of how uncertainties in certain 
model inputs translate into uncertainties 
in outputs is helpful. Representation of 
uncertainty is a strength and an impor-
tant consideration in decision-making. 
If recommendations do not change 
when uncertainty is taken into account, 
decision-makers can have more confi-
dence in the use of the model results. 
However, if the implications are more 
ambiguous, decisions about resource 
allocation based on the model results 
should reflect this and priority should 
be given to improving knowledge about 
parameters that contribute most to 
uncertainty.  Box 1 lists questions that 
should be considered when conducting 
an MOT analysis and interpreting the 
model results. Responses to these ques-
tions can help in forming a cautious, 
nuanced analysis of the model results 
that will ultimately strengthen its con-
tribution to decision-making.
The way forward
Mathematical modelling can be used to 
inform health policy and focus decision-
making on key issues, for example, in the 
design and allocation of resources for 
HIV prevention programmes. However, 
translating model outputs into policy 
decisions should be done carefully 
and within the local context. In addi-
Box 1. Questions to ask when conducting a modes of transmission analysis and 
interpreting the results of the modes of transmission model
•	 How complete is and what is the quality of the data available for model inputs and model 
validation?
•	 How robust are data on the size of population subgroups, particularly subgroups that may 
be stigmatized?
•	 Could the size of key population subgroups at an increased risk of HIV infection be 
underestimated or overestimated?
•	 Could risk behaviour (e.g. number of sexual partners or sex acts) or protective behaviour 
(e.g. use of clean needles or condoms) be underestimated or overestimated?
•	 Could the number of new infections in a high-risk group or the low-risk group be 
underestimated or overestimated as a result of the way the model represents these groups?
•	 Is it possible to have a substantial contribution of new infections from outside the borders 
of the geographical region or outside the age group under study that are not captured?
•	 Are the model results consistent with other epidemiological information?
•	 Are the uncertainties in model inputs and the limitations of the model structure fully reflected 
in the communication of the results?
•	 How should estimates of the distribution of new infections in the short term be used?
HIV, human immunodeficiency virus.
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tion, the results need to be interpreted 
considering the underlying structure of 
the model, the sensitivity of outputs to 
variations in model parameters and the 
potential deficiencies in data quality or 
availability. Recently, UNAIDS devel-
oped a toolkit to help countries assess 
the availability, completeness and qual-
ity of the epidemiological data before 
application of the MOT model.
Box 2 contains a list of recommen-
dations for improving the use of the 
MOT model. Viewing the modelling 
exercise as a process rather than an 
endpoint and using it as a tool to iden-
tify key data needs and to understand 
which aspects of the data or the model 
structure affect results will ensure more 
constructive use of the model. This will 
enable those advising policy-makers 
on the basis of modelling to help dis-
tinguish between decisions that can be 
recommended robustly and decisions 
on which the model is unable to provide 
clear guidance. A way to increase con-
fidence in the model findings is to test 
whether the model can be corroborated 
with other independent data or epide-
miological information.
One strength of the MOT model is 
that it has been designed to acknowl-
edge and evaluate potential sources 
of infection in a range of settings. In 
some countries with particularly strong 
epidemiological surveillance, country-
specific models or modified versions 
of the MOT that expand the model 
structure to disaggregate subpopulations 
and incorporate multiple sources of 
risk20 may offer a better balance between 
model complexity and data availability 
and provide more actionable informa-
tion, but will require additional effort, 
expense and time to develop.
Looking at new infections over 
1 year may not highlight the underlying 
factors that drive an epidemic and, if the 
contribution of high-risk groups to the 
epidemic is underestimated in static, 
short-term modelling, then a portfolio 
of interventions based on these results 
may be sub-optimal for long-term con-
trol.28 Comparing the short-term predic-
tions of the MOT model with dynamic 
transmission models could suggest how 
decision-making may have differed if it 
was based on determinants of long-term 
epidemic spread. One such comparison, 
in two distinct epidemics, illustrated 
how the MOT model can overestimate 
the contribution of low-risk groups and 
underestimate the contribution of com-
mercial sex, thereby underestimating 
the longer-term preventive potential of 
targeted interventions for commercial 
sex workers.35
Moving forward, the current MOT 
process can be strengthened by bet-
ter understanding of the limitations 
of the model and the data, by some 
modifications to the model structure 
and assumptions, and by careful and 
considered interpretation and applica-
tion of its results. ■
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Box 2. Recommendations for improving the use of the modes of transmission model for 
estimating the source of new HIV infections
Synthesize and triangulate available data. Conduct a comprehensive review of all data available 
on HIV infection, STIs, size estimates for risk groups, and sexual and injecting behaviours before 
beginning the MOT analysis to identify the best available data for model input parameters. 
Attempt to build a coherent picture of the epidemiology of HIV infection through synthesis 
and triangulation of the different data sources available.
Emphasize the use of the MOT model as a process. If no other modelling results or data are available 
for comparison or if the model is insufficiently informed, use the model as a process rather than 
a means of deriving hard outcomes. Complete the analysis as a way of evaluating the data 
available with less emphasis on generating an end result and more focus on understanding 
gaps in knowledge about the epidemic, behaviour, the different risk groups, the validity and 
reliability of the data available and the gaps in data collection.
Improve the consideration given to data quality. It is important that the data used are representative. 
Good quality data are essential for estimates of the size of the risk groups in a population and 
the prevalence of HIV infection in each group. Biases in population estimates in one group can 
lead to biased estimates about the contribution of other groups.
Adopt a bottom-up approach. Identify the data available to parameterize the model and identify 
the questions to be answered before tailoring the model to the local level. Where epidemiological 
information indicates that there are key distinctions in risks of infection within groups or patterns 
of mixing between groups, consider representing this in the model, if sufficient data are available.
Validate the model results. Compare the results of the MOT model with epidemiological evidence 
and with findings from data synthesis and triangulation. Explain any differences. The model 
results may be compared with surveillance data, survey data, case reports and results from other 
models, including dynamic transmission models.
Establish minimum conditions for conducting the MOT analysis. Define minimum data requirements 
and identify the conditions under which it is advisable to carry out an analysis using the MOT 
model. The analysis is intended to increase understanding of an HIV epidemic but some countries 
may already have robust surveillance and empirical data and a good understanding. Conversely, 
too much data may be missing for the analysis to be considered worthwhile.
Strengthen the uncertainty analysis. Allow for correlated errors in input data. Extend the uncertainty 
analysis to examine, where possible, the influence of key modelling assumptions on, for example, 
patterns of mixing between groups and heterogeneities in risk within groups. Ensure that 
uncertainty estimates are reflected in the presentation of results.
Be clear about what the model results mean. The MOT model estimates the distribution of new 
HIV infections in the short term, which does not necessarily reflect the most important drivers 
of the epidemic.
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صخلم
يقوتلا طيطتخ في اهمادختساو ةديدلجا يشربلا يعانلما زوعلا سويرف ىودع نايسر جذومن طمانأ مهف
 ةيغب  عساو  قاطن  لىع  ىودعلا  نايسر  جذومن  طمانأ  مادختسا  مت
 ىودع  يقوتل  ةيمارلا  يربادتلا  فادهتسا  في  رارقلا  عانص  ةدعاسم
 ددع  جذومنلا  ردقيو  .)HIV(  يشربلا  يعانلما  زوعلا  سويرف
 اهبستكيس يتلا يشربلا يعانلما زوعلا سويرفل ةديدلجا ضارملأا
 في ةددحلما رطخلل ةضرعلما تائفلا في لياتلا ماعلا رادم لىع دارفلأا
 كولسلاو ،تائفلا مجحب ةينعلما تانايبلا مادختساب يننيعم ناكس
 ليالحا راشتنلاا لدعمو ،ةئف لك في ةمكاترلما رطاخلما لىع يوطنلما
 ةقلاعلا  في  ءانرقلا  ينب  يشربلا  يعانلما  زوعلا  سويرف  ىودعل
 دارفلأا  نم  نقلحا  قيرط  نع  تاردخلما  نوطاعتي  نم  وأ  ةيسنلجا
 يشربلا يعانلما زوعلا سويرف ىودع نايسر ةيلماتحاو ،ةئف لك في
 ةوق  لثمتتو  .رطامخ  لىع  ةيوطنلما  ةفلتخلما  تايكولسلاب  ةطبترلما
 رداصم  نم  تانايبلا  صلاختسا  حيتت  يتلا  هتطاسب  في  جذومنلا
 يعانلما  زوعلا  سويرف  ةئبوأ  تماس  ديدتح  نع  رفسي  امم  ،ةددعتم
 قلق  يرثأ  ،كلذ  عمو  .لضفأ  وحن  لىع  عقاولما  ضعب  في  يشربلا
 في  دويقلا  نأشبو  ،جذومنلا  ةينب  اهنمضتت  يتلا  تاضاترفلاا  نأشب
 يرسفت  نأشبو  ،تلاخدلما  تاترماراب  قاقتشلا  ةحاتلما  تانايبلا
 ينستح ضارعتسلاا اذه فده ناكو .هنع غلابلإاو جذومنلا جئاتن
 تابلطتمو هتينبو هلكيه مييقت ةداعإ للاخ نم جذومنلا مادختسا
 ءارجإ  دنع اهحرط ررقلما  نم ةيسيئر  ةلئسأ  ديدحتب  انمقو .هتانايب
 لجأ  نم  تايصوتلا  رادصإو  جذومنلا  جئاتن  يرسفت  دنعو  ليلتح
.لبقتسلما في جذومنلا قيبطت زيزعت
摘要
理解艾滋病毒感染新传播方式的模式模型及其在防治规划中的使用
传播模式模型已被广泛用来帮助决策者确定防止艾滋病毒
（HIV）感染的措施。该模型使用群体规模、每个群体中
的总计风险行为、每个群体中个人的性或注射毒品伙伴之
间的HIV感染的当前流行度和不同风险行为相关的HIV传播
可能性的数据来估计在给定人口中识别出的高危人群中的
个体在次年的新发HIV感染数。模型的优点在于它的简单
性，这样就能将各种来源的数据综合，在某些环境中得
到对HIV流行的更好表征。然而，人们对支持模型结构的
假设、获取输入参数的可用数据的限制和模型结果的解释
和沟通提出疑虑。本综述的目的是通过重新评估其范例、
结构和数据的要求来改善模型的使用情况。我们确定了进
行分析和解释模型的结果时要问的关键问题，并提出了加
强模型未来应用的建议。
Résumé
Comprendre le modèle des modes de transmission des nouvelles infections par le VIH et son utilisation dans les plans de 
prévention
Le modèle de modes de transmission a été largement utilisé pour aider 
les décideurs à cibler les mesures empêchant l’infection par le virus 
d’immunodéficience humaine (VIH). Le modèle estime le nombre de 
nouvelles infections par le VIH au cours de l’année suivante, contractées 
par des individus appartenant aux groupes à risque identifiés d’une 
population donnée, en utilisant des données sur la taille des groupes, 
le comportement à risque global de chaque groupe, la prévalence 
actuelle de l’infection par le VIH entre partenaires sexuels ou d’injection 
de drogues de chaque groupe, et la probabilité de transmission du VIH 
associée aux divers comportements à risque. La force du modèle réside 
dans sa simplicité, permettant de synthétiser des données provenant 
d’une variété de sources, ce qui donne une meilleure caractérisation de 
l’épidémie du VIH dans certains contextes. Toutefois, des problèmes ont 
été relevés concernant les hypothèses qui sous-tendent la structure du 
modèle, les limites des données disponibles pour obtenir les paramètres 
d’entrée, ainsi que l’interprétation et la communication des résultats 
du modèle. L’objectif de la présente étude était d’améliorer l’utilisation 
du modèle en réévaluant son paradigme, sa structure et ses exigences 
en termes de données. Nous avons identifié les principales questions 
à poser lors de l’analyse et de l’interprétation des résultats du modèle, 
et nous faisons des recommandations visant à renforcer l’application 
du modèle à l’avenir.
Резюме
Понимание форм модели передачи новой ВИЧ-инфекции и ее использование в планировании 
предупреждения заражения
Формы модели передачи широко используются для помощи 
ответственным органам в планировании мер по предотвращению 
заражения вирусом иммунодефицита человека (ВИЧ). 
Модель оценивает число новых ВИЧ-инфекций, которые 
будут приобретены в течение последующего года лицами в 
установленных группах риска в данной популяции, с помощью 
данных о численности групп, совокупному рискованному 
поведению в каждой группе, текущей распространенности ВИЧ-
инфекции среди сексуальных партнеров или употребляющих 
инъекционные наркотики в каждой группе и вероятности 
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передачи ВИЧ-инфекции, связанной с различным рискованным 
поведением. Преимуществом данной модели является ее 
простота, которая позволяет объединить данные, полученные 
из различных источников, что дает лучшее представление 
об эпидемиях ВИЧ в определенных условиях. Тем не менее, 
возникли вопросы в отношении допущений, лежащих в основе 
структуры модели, ограниченности доступных данных для 
формирования входных параметров, а также интерпретации 
и представления результатов моделирования. Целью данного 
обзора являлось улучшение использования модели посредством 
повторной оценки ее парадигм, структуры и требований к 
данным. Нами были определены ключевые вопросы, которые 
необходимо ставить при проведении анализа и интерпретации 
результатов модели, а также предложены рекомендации по 
совершенствованию применения модели в будущем.
Resumen
Entender el modelo de los modos de transmisión de las infecciones nuevas por VIH y su uso en los planes de prevención
El modelo de los modos de transmisión se ha empleado de manera 
generalizada para ayudar a los responsables de la toma de decisiones 
a dirigir las medidas para la prevención de la infección por el virus de 
la inmunodeficiencia humana (VIH). El modelo calcula el número de 
infecciones por VIH nuevas adquiridas durante el año subsiguiente por 
individuos en grupos de riesgo identificados en una población dada 
empleando datos acerca del tamaño de los grupos, el comportamiento 
de riesgo conjunto en cada grupo, la prevalencia actual de la infección por 
VIH entre las parejas sexuales o personas que comparten jeringuillas para 
el consumo de drogas de los individuos de cada grupo y la probabilidad 
de trasmitir el VIH asociada a los diferentes comportamientos de riesgo. El 
punto fuerte del modelo es su sencillez, que permite sintetizar datos de 
fuentes variadas, de lo que resulta una caracterización más exacta de la 
epidemia del VIH en algunos entornos. No obstante, han surgido dudas 
acerca de las suposiciones que subyacen a la estructura del modelo, las 
limitaciones de los datos disponibles para derivar de ellos parámetros 
de entrada y la interpretación y comunicación de los resultados del 
modelo. El objeto de este examen fue el de mejorar el uso del modelo 
volviendo a examinar su paradigma, su estructura y los requisitos de los 
datos. Identificamos los puntos clave que deben cuestionarse durante 
la realización de un análisis y la interpretación de los resultados del 
modelo y formulamos recomendaciones para consolidar la aplicación 
del modelo en el futuro.
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Table 1. Countries using the modes of transmission model to estimate the source of 
new HIV infections, by region, 2005–2013
Region and country Year model analysis 
completed
   Year model analysis started or 
planned to start
Sub-Saharan Africa
Angola 2012–2013
Benin 2009
Burkina Faso 2009
Côte d’Ivoire 2009
Democratic Republic of the 
Congo
2012–2013
Ethiopia 2012
Ghana 2009
Kenya 2005 and 2008
Lesotho 2008
Malawi 2012–2013
Mozambique 2008
Nigeria 2009
Rwanda 2009
Senegal 2009
South Africa 2010
Swaziland 2008
Uganda 2008
United Republic of Tanzania 2012
Zambia 2008
Zimbabwe 2011
Middle East and northern Africa
Djibouti 2012
Islamic Republic of Iran 2011
Morocco 2010
Tunisia 2012
Latin America and the Caribbean
Brazil 2012
Costa Rica 2012
Dominican Republic 2009–2010
El Salvador 2012
Guatemala 2012
Guyana 2012
Jamaica 2012
Mexico 2012
Nicaragua 2012
Panama 2012
Peru 2009
Eastern Europe and central Asia
Armenia 2011
Belarus 2012
Georgia 2012
Republic of Moldova 2011
Asia and Pacific
Indonesia 2011
Myanmar 2011
Nepal 2011
Philippines 2011
Thailand 2005
HIV, human immunodeficiency virus.
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Comparing best fit to other selected parameter sets 
We explored the degree of uncertainty associated with the epidemiological assumptions. We 
calculated the number of infections averted for both the low and high coverage (5% and 20%) 
scenarios under all prioritisation strategies, using the iPrEX adherence profile and 92% efficacy 
assumption for each of the selected parameter sets. The resulting distributions for the 449 selected 
runs and for the best 50 fits according to log-likelihood are shown in figure 2 and details on the 
median and 95% percentiles are provided in table 1. The number of infections averted used in the 
analysis for each scenario corresponds to the red lines. In general, we see that although the range of 
infections averted is broad, the distributions broadly follow a normal shape meaning that most 
results concentrate around the mean. The fit chosen falls close to both the median for all selected 
runs and for the 50 best fits for the some and high prioritisation scenarios for a low coverage. It falls 
close to the lower bound of the distribution for the uniform prioritisation scenario for a low 
coverage and for all the prioritisation scenarios for a high coverage, suggesting we might be under-
estimating the potential impact of these strategies. However, the main result remains unchanged 
with more infections being averted when the intervention is prioritised to MSW and transwomen. 
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Figure 2 - Uncertainty around the number of infections averted for a ten year intervention for all  
coverage scenarios and all prioritisation strategies Note: Red lines: best fit 
 
 
  
Number of infections averted over 10 years 
Coverage Prioritisation 
All selected runs 
Median (2.5-97.5 
percentile)                        
50 best fits 
Median (2.5-97.5 
percentile)                                       
Analysis 
value 
Low (5%) 
Uniform 1409 (953-1636)  1384 (983-1579)  971 
Some 2589 (1444-4274) 2434 (1394-3836) 2317 
High 2537(1170-4221) 2351 (1102-3716) 2519 
 Uniform 5525 (3649-6458) 5382 (3799-6155) 3738 
High (20%) Some 5921 (4594-7202) 5995 (4839-7170) 4871 
 High 7223 (5314-9250) 7473 (5558-9162) 6368 
Table 1- Median number of infections averted over 10 years for the low coverage (5%) scenario 
under each prioritisation strategy for all selected runs and the 50 best fits compared to the best fit 
used in the analysis. 
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Finally, we investigated the potential implications of restricting our analyses to the 10 years of the 
intervention in terms of the number infections averted. Since it is possible that those who did not 
get infected while they were taking PrEP, get infected subsequently, we ran the analysis for an extra 
60 years after the end of the intervention (corresponding to the life expectancy in the model). We 
found that the number of infections averted is greater when looking further into the future, 
suggesting averting infections during the 10 years of the intervention results in averting secondary 
infections later on. Results for the low coverage, all prioritisation strategies, under the IPrEX 
adherence scenario and assuming 92% efficacy are shown in table 2. 
 
 
  
Number of infections averted 
  
10 year 
intervention 
10 year 
intervention      
+ 60 years 
Prioritisation 
scenario 
Uniform 971 1965 
Some 2317 4560 
High 2519 5115 
 
Table 2 – Number of infections averted for the low coverage (5%) scenario under each 
prioritisation strategy when restricting the analysis to the intervention period and when projecting 
60 years into the future. Legend: under the IPrEX adherence scenario and assuming 92% efficacy 
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Calculation of dangerous PrEP years 
 
The calculation of dangerous PrEP years (corresponding to the use of PrEP while infected) was 
carried out for the low coverage, high prioritisation scenario as it is expected to be the one where 
most infections will occur as a proportion of the number of people receiving PrEP due to the high 
incidence among Trans and sex workers. There are 3 paths to using PrEP while infected: having a 
false negative test at recruitment, being in the window period of detection at recruitment and 
getting infected while on PrEP (because of low adherence or lack of efficacy of the product).  
 
The number to be tested Tk is calculated in function of prevalence in each group (Yk/Nk) to recruit 
90% and 11% of susceptible Trans and sex workers respectively (equation 1). The number of PrEP 
users that will be mistakenly recruited due to testing error kYFN will be dependent on prevalence in 
each group and on the probability of getting a false negative test, given by FNp  (equation 2). This is 
estimated at 0.003 as the sensitivity of HIV test is 99.7%.  The number of PrEP users that will be 
recruited during the window period for detection kYWP will be dependent on the number of 
susceptibles kkX  , on incidence k and on duration of the window period which was estimated to 
last for 1 month (1/12th of a year) (equation 3). Finally, the number that will get infected while on 
PrEP will be dependent on the number of susceptibles,  on incidence, on the effectiveness of PrEP 
given by , based on the functional effectiveness  for the IPrEX adherence scenario  and on the 
duration of the intervention D (equation 4). The total number of person years on PrEP while infected 
per 1,000 person years on PrEP is dependent on the number of men who were mistakenly recruited 
(either because of testing error or of recent infection) and on time to the 1st check-up after 
recruitment C, on the number of men who became infected while on PrEP and on the interval 
between two tests (equation 5). The values used for this exercise are given in table X and the 
equations are given below. 
 
A few simplifications were made to do this exercise: whereas the model accounts for a scale up 
period of the intervention, it was assumed that PrEP coverage started at 5% and all results were 
based on this initial population. In the model, individuals exit the programme once infected and new 
individuals are recruited to maintain coverage at 5%. This would result in more infections for the 
same total number of PrEP years. In order to account for this, the same calculations were carried out 
using the total number of infected individuals, to simulate a second wave of recruitment. 
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Values for 2012 (start of intervention) 
 
Trans Sex workers 
Total population of MSM & Trans 151791 
  Proportion of the population 
 
4.6 11.3 
Total number N 6952 17137 
Prevalence Y/N 0.38 0.17 
Total number susceptible X 4310 1574 
Coverage Ϛ 90% 11% 
Incidence in 2012 λ 0.066 0.029 
Time to the 1st check after PrEP initiation (months) C 1 1 
Interval between tests (months) I 3/6 3/6 
Proportion false positive tests pFN 0.003 0.003 
Duration of the intervention (years) D 10 10 
PrEP effectiveness   0.51 0.51 
Table 3. parameter values for calculation of number of PrEP-PY taken while infected in a high 
prioritisation, low coverage scenario. 
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1. Calculation of DALYs averted per HIV infection averted  
 
 
Variables symbol no ART ART Variables symbol Pre AIDS  
(no ART) 
Pre AIDS 
(ART) 
AIDS  
(no ART) 
AIDS 
(ART) 
a. Assumptions: [0.03,1,0.04] – with discounting and age weighting  
Age weighting modulation factor  K 1 1   1 1 1 1 
Age weighting constant  C 0.1658 0.1658   0.1658 0.1658 0.1658 0.1658 
Discount rate R 0.03 0.03   0.03 0.03 0.03 0.03 
Constant from the age weighting  
function  
Β 0.04 0.04   0.04 0.04 0.04 0.04 
  E 2.72 2.72  e 2.72 2.72 2.72 2.72 
Age at death  A 36.75 48.75 Age at onset of disability a 24.92 24.92 36.00 48.00 
Standard expectation of life at age a L 33.75 21.75 Duration of disability L 11.08 23.08 0.75 0.75 
     Disability weight D 0.135 0.135 0.505 0.167 
YLL (at age 36.75 or 48.75)   23.44 15.01 YLDs   1.89 3.17 0.53 0.14 
Discount rate R 0.03 0.03       
YLL (at age 24.92)  16.44 7.34       
b. Assumptions: [0.03,0,0] – with discounting and no age weighting  
Age weighting modulation factor  K 0 0  K 0 0 0 0 
Age weighting constant  C 0.1658 0.1658  C 0.1658 0.1658 0.1658 0.1658 
Discount rate R 0.03 0.03  r 0.03 0.03 0.03 0.03 
Constant from the age weighting  
function  
Β 0 0  β 0 0 0 0 
  E 2.72 2.72  e 2.72 2.72 2.72 2.72 
Age at death  A 36.75 48.75 Age at onset of disability a 24.92 24.92 36.00 48.00 
Standard expectation of life at age a L 33.75 21.75 Duration of disability L 11.08 23.08 0.75 0.75 
     Disability weight D 0.135 0.135 0.505 0.167 
YLL (at age 36.75 or 48.75)   21.22 15.98 YLDs   1.27 2.25 0.37 0.12 
Discount rate R 0.03 0.03       
YLL (at age 24.92)  14.88 7.81       
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c. Assumptions: [0,1,0.04] – with no discounting and age weighting  
Age weighting modulation factor  K 1 1  K 1 1 1 1 
Age weighting constant  C 0.1658 0.1658  C 0.1658 0.1658 0.1658 0.1658 
Discount rate R 0 0  r 0 0 0 0 
Constant from the age weighting  
function  
Β 0.04 0.04  β 0.04 0.04 0.04 0.04 
  E 2.72 2.72  e 2.72 2.72 2.72 2.72 
Age at death  A 36.75 48.75 Age at onset of disability a 24.92 24.92 36.00 48.00 
Standard expectation of life at age a L 33.75 21.75 Duration of disability L 11.08 23.08 0.75 0.75 
     Disability weight D 0.135 0.135 0.505 0.167 
YLL (at age 36.75 or 48.75)   35.26 19.90 YLDs   2.22 4.32 0.53 0.15 
d. Assumptions: [0,0,0] – with no discounting and no age weighting  
Age weighting modulation factor  K 0 0  K 0 0 0 0 
Age weighting constant  C 0.1658 0.1658  C 0.1658 0.1658 0.1658 0.1658 
Discount rate R 0 0  r 0 0 0 0 
Constant from the age weighting  
function  
Β 0 0  β 0 0 0 0 
  E 2.72 2.72  e 2.72 2.72 2.72 2.72 
Age at death  A 36.75 48.75 Age at onset of disability a 24.92 24.92 36.00 48.00 
Standard expectation of life at age a L 33.75 21.75 Duration of disability L 11.08 23.08 0.75 0.75 
     Disability weight D 0.135 0.135 0.505 0.167 
YLL (at age 36.75 or 48.75)   33.75 21.75 YLDs   1.50 3.12 0.38 0.13 
 
Table 4 – Detailed calculation of DALYs averted per HIV infection averted in Peruvian male adults [346,352,353,354] 
YLLs: years of life lost; YLDs: years of life lived with disability. 
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2. Additional results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Population impact of PrEP with respect to changes in condom use.A. “uniform” scenario. B. “some 
prioritisation” scenario.  
Legend: This figure assumes there is no correlation between adherence and risk compensation. In green: low coverage 
scenario: 5%; in blue: high coverage scenario: 20%. Reference is no change in condom use.  
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Figure 4. Cost-effectiveness of PrEP with respect to changes in condom use: Downstream ARV costs averted not 
included.A. “uniform” scenario. B. “some prioritisation” scenario.  
Legend: This figure assumes there is no correlation between adherence and risk compensation DALY, disability-adjusted life 
year. iPrEX adherence profile used for these scenarios. In green: low coverage scenario: 5%; in blue: high coverage 
scenario: 20%. The cost-effectiveness thresholds shown (red lines on the figure) correspond to: 1. World Bank: cost-
effective intervention <US$745/DALY averted; 2. World Bank: highly cost-effective intervention <US$149/DALY averted. 
 
 
Figure 5. Cost of PrEP with respect to changes in condom use for a high prioritisation strategy.A. Downstream ARV costs 
averted included at US$1,000/PY-ARV. B. Downstream ARV costs averted included at US$3,500/PY-ARV.  
Legend: This figure assumes there is no correlation between adherence and risk compensation. DALY, disability-adjusted 
life year. iPrEX adherence profile used for these scenarios. In green: low coverage scenario: 5%; in blue: high coverage 
scenario: 20%. The cost-effectiveness thresholds shown (red lines on the figure) correspond to: 1. World Bank: cost-
effective intervention <US$745/DALY averted; 2. World Bank: highly cost-effective intervention <US$149/DALY averted. 
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Figure 6. Cost-effectiveness of PrEP with respect to changes in condom use: Downstream ARV costs averted included at 
US$1,000/PY-ARV. 
A. “uniform” scenario. B. “some prioritisation” scenario. Legend: This figure assumes there is no correlation between 
adherence and risk compensation. DALY, disability-adjusted life year. iPrEX adherence profile used for these scenarios. In 
green: low coverage scenario: 5%; in blue: high coverage scenario: 20%. The cost-effectiveness thresholds shown (red lines 
on the figure) correspond to: 1. World Bank: cost-effective intervention <US$745/DALY averted; 2. World Bank: highly cost-
effective intervention <US$149/DALY averted. 
 
 
Figure 7. Cost-effectiveness of PrEP with respect to changes in condom use: Downstream ARV costs averted included at 
US$3,500/PY-ARV. 
A. “uniform” scenario. B. “some prioritisation” scenario. Legend: This figure assumes there is no correlation between 
adherence and risk compensation. DALY, disability-adjusted life year. iPrEX adherence profile used for these scenarios. In 
green: low coverage scenario: 5%; in blue: high coverage scenario: 20%. The cost-effectiveness thresholds shown (red lines 
on the figure) correspond to: 1. World Bank: cost-effective intervention <US$745/DALY averted; 2. World Bank: highly cost-
effective intervention <US$149/DALY averted. 
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Distribution  Scale up  Coverage  Total PY  Cost/DALY (1)  Total cost (1)  Cost/DALY (2)  Total cost (2)  
Uniform  Two years  0.46  597,165  [938-1,741]  [212,985,781-
395,121,146]  
[-207-596]  [-46,873,703-
135,261,661]  
Uniform  Five years  0.57  625,155  [1,017-1,857]  [230,871,816-
421,543,582]  
[-94-773]  [-20,735,759-
169,936,008]  
Some 
prioritisation  
Two years  0.40  
(0.26/0.38/
0.63/0.63)  
521,040  [772-1,478]  [173,846,982  
-332,765,071]  
[-373-333]  
[-83,878,936-
75,039,153]  
Some 
prioritisation  
Five years  0.54  
(0.51/0.51/
0.7/0.7)  
591,730  [963-1,780]  [212,785,304-
393,263,226]  
[-182-635]  
[-40,217,470-
140,260,451]  
High  
prioritisation  
Two years  0.34 
(0.27/0.22/
0.9/0.9)  
433,810  [568-1,155]  [127,939,027-
260,250,303]  
[-577-10]  
[-130,069,542-
2,241,734]  
High  
prioritisation  
Five years  0.49  
(0.42/0.41/
0.9/0.9)  
535,155  [826-1,564]  [182,992,144-
346,281,992]  
[-319-419]  [-70,546,066-
92,743,783]  
Table 5. Scenarios to achieve one third of new infections averted over ten years. Downstream ARV costs averted 
included at US$1,000 and 3,500/PY-ARV. 
Legend: Total PY, total number of person-years on PrEP over ten years; Cost/DALY: cost in US$ per disability-adjusted life 
years; Total cost: total cost of PrEP intervention over ten years. (1) Includes downstream ARV costs averted included at 
US$1,000/PY-ARV. (2) Includes downstream ARV costs averted included at US$3,500/PY-ARV. The range observed in 
this column and in the Total cost column represents the variation observed in the costs per PREP-year. Coverage in the 
uniform distribution strategy is equal in all subgroups (MMSW – men that mostly have sex with women, MMSM – men that 
mostly have sex with men, sex workers, and transwomen at higher risk). The coverage showed in both strategies involving 
prioritisation (some and high) are given as overall population coverage and in brackets, the coverage in each subpopulation 
(MMSW/MMSM/sex workers/transwomen at higher risk).  
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infection, has demonstrated effectiveness in preventing acquisition in a high-risk population of men who have sex with men
(MSM). Consequently, there is a need to understand if and how PrEP can be used cost-effectively to prevent HIV infection in
such populations.
Methods and Findings:We developed a mathematical model representing the HIV epidemic among MSM and transwomen
(male-to-female transgender individuals) in Lima, Peru, as a test case. PrEP effectiveness in the model is assumed to result
from the combination of a ‘‘conditional efficacy’’ parameter and an adherence parameter. Annual operating costs from a
health provider perspective were based on the US Centers for Disease Control and Prevention interim guidelines for PrEP
use. The model was used to investigate the population-level impact, cost, and cost-effectiveness of PrEP under a range of
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Introduction
The use of antiretroviral (ARV) medicines for prevention of
acquisition or transmission of HIV is currently a focus of policy
discussions. The use of ARV drugs in HIV-uninfected individuals
to prevent HIV acquisition—pre-exposure prophylaxis (PrEP)—is
one of the alternatives being considered as a potential tool in the
HIV prevention arsenal [1]. In 2010, the results of the first phase
III clinical trial of PrEP were published: the Pre-Exposure
Prophylaxis Initiative (iPrEx) study was a multinational trial of
daily oral tenofovir/emtricitabine to prevent acquisition of HIV
among high-risk men who have sex with men (MSM) [2]. It
showed that this regime was safe and reduced the risk of HIV
acquisition by 44% [2]. Consequently, the World Health
Organization, the US Centers for Disease Control and Prevention,
the British Association for Sexual Health and HIV, and the South
African HIV Clinicians Society have published interim guidance
on PrEP [3–6] recommending its use as part of a programme of
comprehensive HIV prevention. Recently the US Food and Drug
Administration approved the use of ARV drugs (tenofovir/
emtricitabine, brand name Truvada) for use as PrEP among
men and women [7]. Consultations are taking place to inform
public health policy-makers in the development of clinical and
service guidelines regarding PrEP. Additionally, adding momen-
tum to this fast-moving field, PrEP was also found to be effective in
preventing acquisition of HIV among heterosexual men and
women in sub-Saharan Africa in some studies [8,9]. However,
FEM-PrEP, a trial recruiting heterosexual women in South Africa,
Tanzania, and Kenya was closed prematurely last year when the
data review committee stated that it would not be able to
demonstrate an effect of PrEP [10]. Two further trials have tested
the efficacy of 1% tenofovir gel, with somewhat inconsistent
results. The CAPRISA 004 trial found a reduction in women’s risk
by 39% [11], while the VOICE trial’s gel arm was stopped early
after finding the product safe but not effective [12]. There is,
therefore, a need to understand if and how PrEP could cost-
effectively prevent HIV infection in specific populations within the
current context of expanding access to treatment.
Although trials can demonstrate effectiveness in reducing an
individual’s chance of acquiring HIV, they do not show the extent
to which a PrEP intervention would reduce the spread of HIV at
the population level. Questions remain about how to optimally
implement PrEP when multiple forms of delivery, prioritisation,
and scale-up are possible in the context of other HIV prevention
interventions. In response, we have built and analysed a
mathematical model of the HIV epidemic among MSM and
transwomen (male-to-female transgender individuals) in Lima,
Peru. Mathematical models provide a framework to examine the
potential impact of interventions that may inform policy develop-
ment [13]. The HIV epidemic in Lima, Peru, is concentrated
among MSM, comparable to most of Latin America and multiple
high-income settings [14]. As such, it provides a ‘‘test case’’ for
which there are high-quality behavioural and epidemiological data
to adequately specify a mathematical model. Moreover, the
majority of iPrEx participants were recruited in Peru, allowing us
to include representative information on potential PrEP use. Our
analysis aims to provide information to assist the process of
translating recent trial results into cost-effective programmes.
Methods
In this paper, we present the potential benefits and costs of a
hypothetical PrEP intervention using a deterministic, compart-
mental model to represent the sexual transmission of HIV
amongst MSM and transwomen in Lima, Peru. Our aim was to
investigate the impact of a feasible intervention and to determine
the most efficient strategies for its roll out in this population. In
particular, we looked at the impact of coverage, adherence, and
prioritisation on both health benefits and costs to the health
system.
Lima has a diverse MSM population, which we defined as men
or transwomen who have reported a sexual partnership with a
man in the last 12 mo. To represent HIV spread in the model, we
defined four interacting groups: men who mostly have sex with
women (MMSW), men who mostly have sex with men (MMSM),
sex workers, and transwomen at higher risk (including transsex-
uals and transvestites who have a large number of partners on
average). These categories are intended to represent a broad
spectrum of sexual identities, orientations, and behaviours
encompassing variation in numbers of partners, types of
partnerships formed (stable, casual, commercial), condom use,
and sex work (defined as the exchange of anal sex for money,
drugs, gifts, or favours). Our subgroup definitions followed the
classification commonly used in research studies in Peru [14].
Some groups were further subdivided into mutually exclusive
compartments according to their sexual positioning in anal sex
(insertive, receptive, or versatile, i.e., practicing both insertive and
receptive anal sex), resulting in a total of nine groups (Figure 1;
more information on the group definitions can be found in Text
S1). To estimate the distribution of MSM into the different risk
groups, we reviewed studies describing the proportion of MSM
reporting sex with a woman in the last year and/or the
proportion of MSM self-identified as heterosexuals or bisexuals
(for MMSW), as homosexuals/gay (for MMSM), and as
transgender, transvestite, or transsexual. To estimate the propor-
tion of sex workers, we subtracted the proportions of MMSW,
MMSM, and transwomen from the total. We then compared this
estimate against reported proportions of MSM involved in sex
work during the last year [15–20]. Frequency of partnership
formation was based on reported number of sexual partners from
published studies and unpublished data from studies of trans-
women (transwomen study funded by amfAR) [21] and MSM
(CPOS study; C. Caceres and E. R. Segura, unpublished data).
Stable, casual, and commercial partnerships were defined by
frequencies of sex acts. For the versatile group, the total number
of sex acts was divided into a proportion of insertive or receptive
acts. Condom use was estimated from reported condom use data
at last sex act for different partnership types. If data were
available for both the insertive and receptive partners, the
probability of using a condom was determined by the receptive
partner. Receptive partners have a higher probability of infection
than insertive partners, and condom use thus has a higher impact
on the receptive partner. HIV prevalence in Lima among the
general population is low, and therefore the risk of transmission
to MSM and transgender people from other sources was not
included (tables detailing contact patterns by type of partnership,
HIV prevalence by group, group distributions, and demographic
and behavioural parameters used in the model can be found in
Text S1).
Following previous work, the natural course of HIV infection
was represented as four phases of disease progression defined by
duration and infectiousness: acute infection, latent phase, pre-
AIDS, and AIDS (see Text S1) [22–25]. A proportion of
individuals initiate antiretroviral treatment (ART) rather than
progress to pre-AIDS, depending on the coverage level. ART is
assumed to reduce infectiousness and extend survival [26].
Cost-Effectiveness of PrEP in MSM Populations
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Three sources of information were used to calibrate the model:
reported behaviour, HIV natural history, and data on prevalence
and incidence for MSM and transwomen subpopulations in Lima
(from the Peruvian Ministry of Health and published studies; these
sources and values are detailed in Text S1). We used a quasi-
Bayesian procedure to combine these sources of information and
account for uncertainty around parameter estimates [27,28]. This
procedure consists in allowing certain parameters to vary within a
specified prior distribution reflecting the uncertainty of the
estimates. The parameters allowed to vary describe the risk
distribution in the population and risk behaviours (presented in
Text S1). These are specific to each setting and are most
vulnerable to bias in the sampling method and to reporting bias.
The sampling of parameter values was carried out using Latin
hypercube sampling [29]. Each model run is the result of a
different combination of parameter values. Prior limits on
prevalence are defined in order to select plausible runs, and then
the best fitting set of parameters is determined using the log
likelihood (details on prior limits chosen are given in Text S1). Of
10,000 runs performed, 449 were selected and are shown in
Figure 2, together with the best fit based on prevalence data for the
four subgroups (MMSW, MMSM, sex workers, and transwomen
at higher risk) and the overall population. This best fit was then
used for the primary analyses. To ensure it was representative of
the most likely epidemiological scenario, we explored the
uncertainty due to the epidemiological assumptions and compared
the results obtained using the parameter set corresponding to the
best fit to those from all other runs selected in the Bayesian
process. The distribution of infections averted obtained from all
selected runs and the 50 best fits are presented in Text S1 and
compared to the estimates obtained from the best fit for the most
relevant scenarios.
Assumptions about the Pre-Exposure Prophylaxis
Intervention in the Model
PrEP effectiveness in the model is assumed to result from the
combination of a reduction in susceptibility to HIV infection
during a PrEP-protected sex act (‘‘conditional efficacy’’ parameter)
and a proportion of sex acts protected (adherence parameter). We
aimed to reflect a daily regimen of PrEP and an overall
effectiveness equivalent to that of the iPrEx trial, 44% (95% CI
15–63) [2]. In a retrospective analysis of data from the iPrEx trial,
for those with detectable levels of drug in their blood samples, HIV
incidence was reduced by 92% (95% CI 40–99). We interpreted
these findings to show an efficacy of PrEP that varies with
individual-level adherence, in accordance to results presented
recently in which biological determinants did not explain the
differential efficacy observed in the iPrEx trial [30]. We refer to
this parameter as a ‘‘conditional efficacy’’ in the model to reflect
an assumption of high intrinsic efficacy of PrEP (equivalent to
92%) but large population-level heterogeneity in adherence
behaviours. Therefore, we divided PrEP-users into three adher-
ence groups using point estimates: good (95%), average (45%), and
poor (15%). The proportion in each group was altered to reflect
three adherence profiles: the ‘‘iPrEx adherence’’ profile, for which
the proportions were as observed in the trial, and the ‘‘less
adherence’’ and ‘‘more adherence’’ scenarios. The adherence
profile in the ‘‘more adherence’’ scenario corresponds to the
hypothesis being tested in the open label extension of the iPrEx
trial looking at a possible increase in use of the study drug by
participants due to the participants’ knowledge of receiving an
active drug that provides some protection against HIV infection.
For all scenarios, when both the conditional efficacy and
adherence profiles are combined, the functional effectiveness
calculated reproduces the effectiveness observed in the iPrEx trial,
Figure 1. Model representation of sexual mixing and sexual positioning among MSM and transwomen. Insertive (Ins) and receptive
(Rec) men always take the insertive and receptive role during anal sex, respectively. Versatile (Ver) men take either the insertive or the receptive role
during anal sex. Arrows indicate sexual partnerships being formed between individuals within groups—the width shows the number of partnerships,
and the direction illustrates sexual positioning (from insertive towards receptive). For each category, insertive men will form partnerships only with
receptive men or versatile men (the latter in a receptive role); versatile men will form partnerships with insertive men, versatile men, or receptive men,
depending on their role per sex act; receptive men will form partnerships only with insertive men or versatile men (the latter in an insertive role).
doi:10.1371/journal.pmed.1001323.g001
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44% (95% CI 15–63) [2]. Table 1 shows the assumptions made for
conditional efficacy and adherence, as well as the resulting
functional effectiveness for each profile.
We constructed two scenarios for overall scale-up of PrEP
programmes: (i) ‘‘low coverage’’ and (ii) ‘‘high coverage’’,
whereby 5% and 20% of uninfected individuals use PrEP,
respectively. In both scenarios, scale-up begins in 2012, and
coverage is reached in 5 y and maintained thereafter for an
additional 5 y. We quantified the contribution of each subpop-
ulation to the number of future HIV infections and the relative
impact of PrEP if used in each group separately to identify key
points for an intervention. We looked at the impact of distributing
a fixed amount of PrEP (25,000 person-years, corresponding to a
10% resource allocation of the national prevention programme to
PrEP [31]) to each group in isolation. PrEP could then be
distributed evenly to all MSM and transwomen (‘‘uniform
coverage’’), or certain key groups could be prioritised for PrEP
allocation (‘‘prioritisation’’). Prioritised scenarios could result in
‘‘some prioritisation’’, where a higher coverage is achieved in key
populations such as the transwomen at higher risk and sex worker
groups (but no more than 50% coverage) than in MMSW and
MMSM, or in ‘‘high prioritisation’’: once 90% of the transwomen
at higher risk group receives PrEP, the residual amount (to
achieve 5% or 20% overall coverage) is divided among the three
other populations, prioritising sex workers over MMSW and
MMSM. Table 2 shows the coverage assumptions of PrEP for
each scenario.
Cost-Effectiveness Calculations
We estimated the annual operating costs of providing a
hypothetical PrEP intervention to individuals, from a health
provider perspective, based on the US Center for Disease Control
and Prevention interim guidelines for PrEP [3]. In accordance
with these clinical recommendations, we included costs for the
following procedures: HIV testing before starting PrEP, HIV
testing every 3 mo during use of PrEP, HIV confirmatory testing if
an individual is found positive, one creatinine/blood urea nitrogen
test per year during PrEP use, outreach and counselling services,
and condom and lubricant promotion and provision. The
estimation includes additional costs for human resources, but it
does not include costs related to HIV treatment after infection,
resistance testing, or testing and treatment of other sexually
transmitted infections. We included a 5% extra cost to allow for
the creation of an enabling environment at the project level,
programme management costs, or monitoring and evaluation costs
at the project level [32]. This 5% mark-up was chosen based on
the budget reported for management, monitoring, and evaluation
of HIV programmes at the national level [31]. We did not include
Figure 2. Selected model runs and best fit based on prevalence data for four subgroups and the overall population. Grey shading
represents selected runs; red lines represent the best fit. The runs were selected based on bounds (black bars) defined from prevalence data (blue x’s)
for four subgroups and the overall population.
doi:10.1371/journal.pmed.1001323.g002
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indirect costs such as potential earning forgone by patients or
carers. We present all costs as unadjusted market prices, specific to
Peru [31,33,34], and calculated for 10 y (i.e., the duration of our
simulated intervention).
We estimated the unit cost of a PrEP intervention to be between
US$525 and US$830, of which the main component was the cost
of PrEP drugs (over two-thirds of the total estimate). The cost of
drugs used for PrEP was set to be between US$420 and US$600
per year based on cost data provided by Gilead (for one bottle
[1 mo] supply: Viread, US$30, and Truvada, US$45, plus a 10%
to 15% distributor mark-up per bottle) [33].
For the cost-effectiveness analysis, our principal epidemiological
outcome was cost per disability-adjusted life year (DALY) averted.
PrEP implementation scenarios were assessed against a ‘‘no PrEP
intervention’’ scenario. Total number of DALYs averted was then
calculated using the number of infections averted in each scenario.
The uncertainty due to the epidemiological assumptions was
represented by adding credible intervals in our primary analysis.
These credible intervals correspond to the model runs estimating
the maximum and minimum impact of PrEP, in terms of
infections averted per person-year on PrEP. The estimated
number of DALYs associated with one HIV infection averted
was calculated as the sum of the number of years of life lost and the
number of years lost due to disability using published methods
[34,35]. These calculations included weights for Peruvian life
expectancy, age, future time, and disability. Duration of disability
was calculated on the basis of local clinical data for HIV-positive
patients presenting to care [36], and the disability weights for
HIV-related conditions were obtained from the Global Burden of
Disease study [37]. We estimated approximately 12.3 discounted
DALYs averted per infection averted, including access to ART for
80% of infected individuals. When we excluded the age weighting
function, we estimated 11.5 discounted DALYs averted. This is the
equivalent of 27.09 (and 27.12 when we exclude the age weighting
function) DALYs averted per infection averted if no discounting is
assumed, comparable to other estimates in the HIV literature
[38,39]. All details of costs and DALY estimate calculations are
given in Text S1. Future costs, savings, and health gains were
discounted at a rate of 3%. See Figures S3, S5, S6, S7, S10, and
S11 and Table S1 for a sensitivity analysis of all our results if
downstream costs of treatment averted are included in the
evaluation. The cost of ART for this analysis varied from
US$1,000 [40] to US$3,500 [38].
Currently, there is a subjective selection of cost-effectiveness
thresholds in the literature [41]. We refer to two threshold systems
commonly used. The World Health Organization Choosing
Interventions That Are Cost-Effective (WHO-CHOICE) initiative
considers an intervention to be (1) very cost-effective, if its cost is
less than the gross domestic product (GDP) per capita
(,US$5,401) per DALY averted; (2) cost-effective, if it costs
between one and three times the GDP per capita (US$5,401 to
US$16,203) per DALY averted; or (3) not cost-effective, if it costs
Table 1. Scenario definitions: impact of PrEP by adherence and functional effectiveness.
Efficacy/Adherence Adherence
iPrEx Adherence More Adherence Less Adherence
Conditional efficacy 0.92 (0.4–0.99) 0.92 (0.4–0.99) 0.92 (0.4–0.99)
Adherence 1a 0.95 0.95 0.95
Adherence 2a 0.40 0.40 0.40
Adherence 3a 0.15 0.15 0.15
Proportion in adherence group 1 0.50 0.60 0.30
Proportion in adherence group 2 0.00 0.10 0.10
Proportion in adherence group 3 0.50 0.30 0.60
Functional effectiveness 0.52 0.62 0.35
All values are proportions. Functional effectiveness is a function of the probability of transmission, the intrinsic efficacy, the adherence to PrEP, and its distribution,
affecting only unprotected sex acts, which in turn are dependent on the number of partners, average condom use, and number of sex acts per partner (all values
derived from iPrEx data [2]).
aAdherence 1, 2, and 3 refer to the proportion of doses taken consistently by an individual. The proportion in each adherence group is the population distribution (the
number of people in each adherence group). This reflects the data reported in the iPrEx study: a distribution of participants by ranges of adherence. We included a point
estimate within those ranges.
doi:10.1371/journal.pmed.1001323.t001
Table 2. Scenario definitions: impact of PrEP by coverage and
prioritisation.
Distribution Subgroup Coverage
Low Coverage
(5%)
High Coverage
(20%)
Uniform coverage Overall 0.05 0.2
MMSW 0.05 0.2
MMSM 0.05 0.2
MSW 0.05 0.2
Trans 0.05 0.2
Some prioritisation Overall 0.05 0.2
MMSW 0 0.46
MMSM 0 0.09
MSW 0.26 0.5
Trans 0.5 0.5
High prioritisation Overall 0.05 0.2
MMSW 0 0.22
MMSM 0 0.04
MSW 0.11 0.9
Trans 0.9 0.9
All values are proportions. MSW, men sex workers; trans, transwomen at higher
risk.
doi:10.1371/journal.pmed.1001323.t002
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more than three times the GDP per capita (.US$16,203) per
DALY averted. The GDP values are those estimated for Peru in
2010 [34,42]. The second threshold system we used involves more
conservative cutoff points suggested by the World Bank in 1993 for
middle-income countries [43]: ,US$100 per DALY averted to
reflect a highly cost-effective intervention, between US$100 to
US$500 for a cost-effective intervention, and .US$500 for an
intervention to be considered not cost-effective. These World Bank
cutoff points were considered in the analysis inflated to their 2010
equivalents—,US$149 for a highly cost-effective intervention and
,US$745 for a cost-effective intervention.
Analysis
We quantified the impact, cost, and cost-effectiveness of
different patterns of PrEP use across the population, identifying
dependencies on PrEP conditional efficacy, coverage, scale-up
period, prioritisation of key groups, and adherence. The impact of
risk compensation, i.e., where those on PrEP reduce condom use,
was investigated. We then used the model to find intervention
scenarios that would result in reducing the number of new
infections by one-third, representing a relevant planning target for
Lima.
Results
Key Groups to Prioritise among MSM and Transgender
People
To establish an appropriate set of strategies for using PrEP, it is
important to identify which groups to prioritise. Individuals who
might be a priority could be determined by (1) the number of
similar people and the ease of reaching them, (2) their own risk of
HIV, and (3) their relative contribution to onward transmission. In
Lima, the majority of MSM are MMSM (approximately 70%) and
MMSW (approximately 15%), but both groups experience a
relatively low risk of infection (2.5% and 1.0% modelled incidence
in 2010, respectively). Transwomen at higher risk (approximately
5%) and sex workers (approximately 10%) are smaller groups, but
are at higher risk of infection (7.3% and 3.1% modelled incidence
in 2010, respectively). A fixed amount of PrEP (25,000 person-
years) would allow covering 60% of transwomen at higher risk,
20% of sex workers, 3% of MMSM, and 16% of MMSW over
10 y. Allocated only to transwomen at higher risk or sex workers,
25,000 person-years of PrEP would be expected to avert,
respectively, 4.7% or 3.4% of infections over 10 y in the whole
population, whereas the same amount of PrEP allocated to
MMSW or MMSM would avert fewer infections: 0.9% or 1.2%,
respectively (Figure 3). For these reasons, in this epidemic context,
strategies that prioritise transwomen at higher risk and sex workers
could be expected to have higher impact for the same cost,
including amongst those not taking PrEP, because of the
prevention of downstream infection.
Potential Impact of PrEP Programmes as a Function of
Adherence, Coverage, and Prioritisation Strategies
We estimated the impact of a PrEP intervention over 10 y
under a range of implementation strategies. Figure 4 shows the
number of infections averted over 10 y (number of infections
averted per 1,000 person-years on PrEP and the proportion of
infections averted over 10 y are shown in Figures S1 and S2). For
a modest programme of 5% PrEP coverage, over 8% of infections
could be averted with an adherence level equivalent to the one
observed in the iPrEx trial and with prioritisation (high
prioritisation scenario) of the groups most likely to become
infected. Prioritising PrEP to sex workers and transwomen rather
than achieving a uniform coverage increases the impact of
interventions. This is particularly the case when overall coverage
is low. For example, for an iPrEx adherence profile, with a
coverage of 5%, the number of infections averted with a uniform
coverage strategy (970 [range 394–1,060]) more than doubles by
prioritising PrEP in a high prioritisation scenario (2,519 [range
1,086–2,713]). Increased individual adherence to PrEP increases
its estimated impact at the population level. With higher coverage
levels, the impact of PrEP interventions is greater but the relative
benefit is reduced (the numbers of infections averted per year of
PrEP decreases). This is because, in the high coverage scenario,
person-years of PrEP become relatively less efficiently allocated to
individuals with low risk.
Cost-Effectiveness of PrEP interventions
The cost per DALY averted was quantified for PrEP
interventions assuming the iPrEx profile of adherence (Figure 5,
top panel). Across all scenarios the highest estimated cost per
DALY averted (a uniform strategy at a 20% coverage level,
US$1,126–US$1,780 [uncertainty due to PrEP conditional effica-
cy: US$1,036–US$4,254) is below the WHO-CHOICE threshold
for a cost-effective intervention for Peru (,US$5,401/DALY
averted) [34], while only prioritisation scenarios (some prioritisa-
tion and high prioritisation) at low coverage, and the low bound of
a high prioritisation scenario at high coverage, are likely to be cost-
effective using the more conservative threshold suggested by the
World Bank (,US$745/DALY averted) [43]. None of the
scenarios appear to be cost-effective when the lower bound of
PrEP conditional effectiveness is included in the analysis, nor are
the scenarios considered very cost-effective using the World Bank
threshold of ,US$149/DALY averted. However, the cost per
DALY averted is substantially reduced with a high degree of
prioritisation. It could be higher in larger PrEP programmes (with
20% rather than 5% coverage). In Table 3, we present the cost-
effectiveness results for our six main scenarios, together with the
total cost over 10 y for each scenario. For the same total
investment, prioritisation improves cost-effectiveness. In Table
S1, we include the downstream ARV costs averted. PrEP
interventions could potentially be cost-effective in most scenarios,
and cost-saving in some, if the treatment costs of infections averted
are included (see Figures S5, S6, S7). Figure 5 (bottom panel)
compares the cost-effectiveness of PrEP to that estimated for other
prevention interventions in Peru [38]—the estimates for other
interventions were derived from Aldridge et al. [38], specific to
Peru. Figure 5 shows that, depending on the implementation
strategy, PrEP could be as cost-effective as treatment for sexually
transmitted infections, MSM outreach, or highly active ART. It
also suggests that PrEP should be considered as an additional
intervention available as part of a comprehensive combination
HIV prevention approach. An alternative representation of the
information in Figure 5 can be found in Figures S4, S5, S6.
Behaviour Change Associated with PrEP Use
A major issue in considering the impact of PrEP interventions is
whether individuals using PrEP will reduce how often they use
condoms. We estimated the impact of PrEP programmes making
different assumptions about condom use changes by individuals on
PrEP, ranging from complete cessation of use (2100% condom
use), to a small increase in use (+20% condom use). In Figure 6, we
show how number of infections averted and the cost per DALY
averted are affected by these changes, in the context of a low or
high coverage intervention with a high degree of prioritisation
(plots for a high prioritisation strategy including downstream ARV
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costs are given in Figure S8; results for other prioritisation
strategies including and excluding downstream ARV costs are
given in Figures S9, S10, S11, S12). Compared with no change in
behaviour, a complete cessation of condom use among those on
PrEP reduces the number of infections averted over 10 y by
between 1,500 (32%) and 2,250 (45%), and increases the cost per
DALY averted by US$200–US$315 for a high coverage
programme (blue bars). The effect is greater for a low coverage
programme (green bars). This is because only those at highest risk
of acquiring and transmitting infection are receiving PrEP, such
that each breakthrough infection has greater potential to cause
onward epidemic spread. The potential for a PrEP intervention to
have the net effect of generating more new infections is
theoretically possible but highly unlikely, requiring that the lowest
empirical estimate of intrinsic efficacy of PrEP be true (40% is the
lower bound of the confidence interval of effectiveness among
participants with drug levels in their blood [95% CI 40–99]) and
that all users reduce their condom use by at least 50% (results not
shown). We further explored two different scenarios where
behaviour change was correlated with adherence and found that
the effect on HIV incidence of behavioural change in those with
high adherence is only modest (because if individuals do
consistently take the PreP pills, then the degree of protection is
very high). The effect of behaviour change on incidence is greater
if those with bad adherence are found to change their behaviour
(Figure S12). Nevertheless, communication programmes to limit
risk compensation may be a cost-effective complement to PrEP
interventions.
Averting One-Third of New Infections Using PrEP
Finally, we identify alternative strategies that would be expected
to reduce the number of infections over 10 y by one-third
(Table 4). With a rapid scale-up of 2 y and a highly prioritised
strategy, a minimum of 435,000 PrEP person-years would be
required, at an estimated cost of US$196 million to US$310
million over 10 y. The same impact would be generated with a
slower scale-up and a uniform distribution, but at a higher cost:
US$277million to US$439 million over 10 y. With all strategies,
modelling a longer period to reach an intended coverage level
increases the amount of person-years on PrEP needed. The total
cost and cost-effectiveness of different PrEP strategies to avert one-
third of infections, including downstream ARV costs averted, are
shown in Table S1. While the resources needed are still important
in these scenarios, the cost-effectiveness is greatly improved.
Discussion
We estimated the potential impact of PrEP under different
intervention scenarios, examining the relative importance of
implementation strategies and individual adherence. Our model
shows an important epidemiological impact of PrEP use, largely
driven by the characteristics of the implementation programme—
PrEP conditional efficacy, coverage, prioritisation strategy, and
time to scale up—and risk compensation behaviour.
Overall, if downstream ARV costs averted are not included,
PrEP is predicted to be cost-effective in this population by the
WHO-CHOICE guidelines, and borderline cost-effective by the
more conservative World Bank guidelines, if the intervention is
prioritised to those most vulnerable to infection. If downstream
ARV costs are included, most PrEP scenarios are found to be cost-
effective. This argues for PrEP to be considered among the set of
efficacious and cost-effective interventions that could be included
in a comprehensive combination of HIV prevention interventions
for MSM in this setting. Consistent with the significant heteroge-
neity in risk behaviours among MSM and transwomen at higher
risk, our results show that prioritising people in higher risk groups
Figure 3. Proportion of total new infections averted over 10 y by giving 25,000 PrEP person-years to each subgroup in isolation.
The error bars reflect the iPrEx efficacy estimate of 92% (95% CI 40–99).
doi:10.1371/journal.pmed.1001323.g003
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(e.g., transwomen at higher risk) when implementing PrEP would
have the largest impact. While risk compensation could reduce the
impact of PrEP, our results suggest that, under a range of
assumptions, PrEP is still likely to be cost-effective.
A higher coverage strengthens the impact on incidence over
10 y, as does a rapid scale-up of the intervention. However,
implementation of PrEP in isolation to a scale that it would arrest
the epidemic would require more resources than have been
available. To reduce new infections by one-third, the total cost of
introducing PrEP will amount to at least US$20 million on average
per year (over US$200 million over 10 years). As a comparison,
total HIV spending (prevention, treatment, and care) in Peru for
the year 2009 was reported to be just over US$40 million [44].
Furthermore, while Peru has been an important aid recipient from
The Global Fund to Fight AIDS, Tuberculosis and Malaria in
Latin America, the total approved HIV grant amount to date has
been just over US$85 million [45].
The modelling results presented here are one of the first to
quantify the potential population impact of PrEP incorporating
data from the only clinical trial carried out in an MSM population.
We highlighted the need to represent heterogeneity in adherence
behaviour together with a high intrinsic efficacy of PrEP (when
adherence is high). It is also to our knowledge the first model to
examine the impact among MSM and transwomen in a low- or
middle-income country.
Our results are broadly consistent with previous modelling work
on the impact of PrEP among MSM in the US, where most
authors have found that while PrEP might be cost-effective under
certain assumptions, the investment needed remains very high. For
instance, Desai et al. [46] found that a PrEP program was cost-
effective under most variations in efficacy and adherence—a high
impact was possible for an efficacy of 70% and program adherence
of 50%. Paltiel et al. [47] also found that PrEP could have a
substantial effect on lifetime HIV infection risk, especially among
younger populations, and that it could be a cost-saving interven-
tion with drug efficacy levels over 70% and an annual PrEP cost of
US$2,500 or less. Recently, Koppenhaver et al. [48] found that
although reductions in new HIV cases following PrEP introduc-
tion among MSM in New York City led to substantial reductions
in treatment costs, these savings were largely offset by increases in
PrEP costs. The authors assumed both high costs for PrEP—
including costs for implementing PrEP and for tenofovir/
emtricitabine (valued at $22/d)—and a coverage of 100% of all
susceptible. Juusola et al. [49] varied the coverage of susceptible
Figure 4. Estimated impact of PrEP with respect to coverage, adherence, and prioritisation of key populations. The error bars reflect
the uncertainty in the iPrEx efficacy estimate of 92% (95% CI 40–99). In this comparison, we show two scenarios (low coverage in green [A]; high
coverage in blue [B]) including three prioritisation strategies—uniform, where the coverage is the same in each subgroup; some prioritisation, where
higher coverage is achieved in the transwomen at higher risk and sex worker populations (but no more than 50% covered) than in MMSM and
MMSW; and high prioritisation, where 90% of transwomen at higher risk and 11% of sex workers receive PrEP in the low coverage scenario, or 90% of
transwomen at higher risk, 90% of sex workers, 3.9% of MMSM, and 21.5% of MMSW receive PrEP in the high coverage scenario.
doi:10.1371/journal.pmed.1001323.g004
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MSM and also included high costs of PrEP consistent with US
costs. Juusola et al. [49] concluded that ‘‘PrEP in the general
MSM population could prevent a substantial number of HIV
infections, but it is expensive’’.
Results from modelling studies of PrEP use in generalised
epidemics have been conflicting. Abbas et al. [50] found that with
high effectiveness, PrEP could have a beneficial impact when
targeted to those at highest risk, if it did not lead to an increase in
risk behaviours. Recently, Pretorius et al. [39] found a PrEP
intervention to be cost-effective according to the WHO-CHOICE
threshold, but concluded that it did not provide value for money
when compared to the scale-up of ART. Hallett et al. [51] found
the use of PrEP in serodiscordant couples to be a cost-effective
alternative, especially in couples with increased risk behaviours.
Although our findings cannot be directly compared with these, as
the settings differ greatly, one explanation for the different results
obtained could be the difference in incidence assumptions (higher
incidence rates among MSM lead to prevention interventions
having a greater value).
Our study balances heterogeneity considerations with data
availability and the programmatic relevance of distinguishing
particular subgroups, but it has limitations. The model is limited
by the need to capture important variation and complexity in
sexual behaviour in this population into a simplified framework.
To account for this, we applied a Bayesian model calibration
procedure. Because of the large amount of consistent prevalence
data available for MSM and transwomen in Lima, the best fit was
used in our analysis. However, we explored the potential effect of
uncertainty around the best fit epidemiological scenario on our
main outputs (i.e., the cost-effectiveness of PrEP across all
programmatic scenarios) and observed that although the range is
broad, it does not change the main conclusions from this analysis.
The model does not capture the possibility of evolution of drug
resistance generated by individuals using PrEP after breakthrough
Figure 5. Cost-effectiveness of PrEP, estimated as cost per DALY averted. The top panel shows PrEP cost per DALY averted with regard to
coverage levels and strategies. The bottom panel shows a comparison of PrEP cost per DALY averted with other HIV prevention strategies. The error
bars reflect the uncertainty in the iPrEx efficacy estimate of 92% (95% CI 40–99). The height of the bars shows the variation due only to the cost
assumptions of one person-year on PrEP. In the top panel, the iPrEx adherence profile is used for the scenarios. In green: low coverage scenario: 5%;
in blue: high coverage scenario: 20%. In the bottom panel, the variation in cost for the interventions reflects different coverage strategies assumed
and the uncertainty in the costing. Values from Aldridge et al. [38] presented in this paper were calculated using assumptions from the GOALS model
on coverage and intervention design (see also Stover et al. [54]). PrEP estimated cost/DALY was calculated for both uniform and high prioritisation
strategies (including 5% and 20% coverage scenarios). The red lines correspond to (1) the World Bank threshold for a cost-effective intervention,
,US$745/DALY averted, and (2) the World Bank threshold for a highly cost-effective intervention, ,US$149/DALY averted. FSW, female sex worker;
HAART, highly active ART; STI, sexually transmitted infection; VCT, voluntary counselling and testing.
doi:10.1371/journal.pmed.1001323.g005
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Table 3. Cost-effectiveness and total cost of PrEP over 10 y.
Distribution Coveragea (Proportion)
Total
Person-
Yearsb
Cost/DALY: Cost
Assumptions Onlyc (US
Dollars)
Cost/DALY: Total
Uncertaintyd (US
Dollars) Total Coste (US Dollars)
Uniform 0.05 45,325 1,076–1,702 419–4,182 23,795,696–37,619,863
Uniform 0.20 182,596 1,125–1,779 428–4,254 95,863,381–151,555,440
Some prioritisation 0.05 (0, 0, 0.26, 0.5) 44,925 447–707 159–1,596 23,852,467–37,709,615
Some prioritisation 0.20 (0.04, 0.08, 0.5, 0.5) 187,116 886–1,400 397–3,133 96,398,735–152,401,810
High prioritisation 0.05 (0, 0, 0.11, 0.9) 44,002 403–637 163–1,553 23,877,220–37,748,747
High prioritisation 0.20 (0.21, 0.03, 0.9, 0.9) 183,851 665–1,052 310–2,258 96,071,585–151,884,601
Downstream ARV costs averted not included.
aCoverage in the uniform distribution strategy is equal in all subgroups (MMSW, MMSM, sex workers, and transwomen at higher risk). The coverage showed in both
strategies involving prioritisation (some and high) are given as overall population coverage and, in parentheses, the coverage in each subpopulation (MMSW, MMSM,
sex workers, transwomen at higher risk).
bTotal number of person-years on PrEP over 10 ys.
cVariation in the cost/DALY due to cost assumptions only (corresponding to the height of the coloured bars in the top panel of Figure 5).
dVariation due to total uncertainty, including both cost and PrEP efficacy assumptions as well as epidemiological assumptions.
eTotal cost of PrEP intervention over 10 y; the range reflects the uncertainty of PrEP programme costs only.
doi:10.1371/journal.pmed.1001323.t003
Figure 6. Population impact and cost of PrEP with respect to changes in condom use for a high prioritisation strategy. The top panel
shows behaviour change and population impact of PrEP. The bottom panel shows behaviour change and PrEP cost per infection averted. This figure
assumes there is no correlation between adherence and risk compensation. We explore this issue separately in Figure S12. The iPrEx adherence
profile was used for these scenarios. In green: low coverage scenario: 5%; in blue: high coverage scenario: 20%. The red lines correspond to (1) the
World Bank threshold for a cost-effective intervention, ,US$745/DALY averted, and (2) the World Bank threshold for a highly cost-effective
intervention, ,US$149/DALY averted. The height of the bars shows the variation due only to the cost assumptions of one person-year on PrEP.
doi:10.1371/journal.pmed.1001323.g006
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infection, which has been a concern. However, several models
suggest that the amount of resistance generated by individuals
using PrEP after breakthrough infection will be small compared
to that generated by ART itself [52], provided individuals on
PrEP are tested frequently. Our results suggest that only four of
every 1,000 PrEP person-years would be wrongly allocated to
infected individuals (in a low coverage, high prioritisation
scenario) if individuals on PrEP are tested every 3 mo. This
increases to eight of every 1,000 PrEP person-years if the delay
between tests is set to every 6 mo (results not shown). Moreover,
Supervie et al. [53] recently used a mathematical model to
explore resistance in the context of PrEP use in the MSM
community of San Francisco, California, showing that if risk
behaviours did not increase, then transmitted resistance would
decline with PrEP.
Furthermore, the validity of DALYs as an aggregate measure
of effectiveness depends on assumptions made for disability
weighting, discounting, age weighting, and life expectancy. We
followed standard practices regarding these assumptions, aiming
to increase the comparability of our analysis while providing
meaningful results for policy-makers. However, we recognise that
standard assumptions about DALYs averted by averting HIV
transmission do not fully consider strong preferences to remain
HIV-uninfected, given the burden of lifelong daily therapy and
stigma associated with HIV infection. In addition, we limited the
calculation of the total DALYs averted to a function of the
number of infections averted during the 10-y intervention period,
assuming 80% of these would have received treatment otherwise.
By doing this, we provide a conservative estimate of the cost-
effectiveness of PrEP (i.e., not including the savings due to
treatment costs averted). However, this could also represent an
optimistic approximation of potential benefits, as we assume that
those infections averted during the intervention will not happen
afterwards. We tested this by running the model for an additional
60 y after the end of the intervention and found that the number
of infections averted overall is greater than that observed during
the intervention period (results available in Text S1). The spread
of infection is a dynamic process; stopping infections during one
period protects others from being infected further down the line
in a similar way that vaccines do. We did not use this information
to produce results, to ensure comparability with other cost-
effectiveness analyses using mathematical models of HIV
transmission. Additionally, recognising that we made a large
number of assumptions to estimate the effect of PrEP during the
10 y of the intervention, we preferred not to extrapolate beha-
vioural assumptions afterwards.
Another limitation of this study is that interactions between
PrEP and earlier treatment for prevention of onward transmission
are not fully considered. How PrEP and treatment programs will
interact in practice remains to be learned. Although capacity for
manufacturing ARV drugs, including generic formulations of the
most popular agents, has not been limiting, the funding available
to purchase these drugs has. Theoretically, PrEP could compete
with treatment scale-up by using limited funding or limited clinic
capacity, and this should be avoided. Alternatively, PrEP could
enable treatment programs, by allowing greater volume discounts
on drug prices and costs, by increasing testing coverage, by
fostering retention in treatment by destigmatizing ARV drugs and
the people who use them, or by fostering popular and political
support for attracting more funding to HIV/AIDS initiatives. In
the absence of information about how these various possibilities
will play out, this paper has aimed to evaluate the potential impact
of PrEP as a prevention strategy among a population with
relatively high risk of infection and to explore the effect of different
programmatic factors such as prioritisation and coverage. While
widespread treatment is assumed in this model in the context of
universal ART access along current guidelines, a detailed analysis
of how PrEP could affect treatment coverage is beyond the scope
of available information at this time.
In conclusion, we have shown that if it is prioritised to key
groups and has a rapid scale-up, PrEP could be a cost-effective
intervention for MSM populations and transwomen in Lima,
Peru. Despite cost-effectiveness at apparently feasible levels of
coverage and uptake, considerable expenditures and human
resources will be required to generate a significant reduction in
incidence. These expenditures should not be considered unless
well-performing ART services are already in place, which is not
the case everywhere in Peru, and even less so across the region. If
such conditions are assured, however, a strategically implemented
PrEP programme could make a significant contribution as part of
a combination package of priority, well-implemented interventions
for MSM/transwomen populations in concentrated epidemics
after a scale-up of ART.
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Table 4. Scenarios to achieve one third of new infections averted over 10 y.
Distribution Scale-Up Coveragea (Proportion)
Total Person-
Yearsb
Cost/DALYc (US
Dollars) Total Costd (US Dollars)
Uniform Two years 0.46 597,165 1,189–1,880 269,888,000–426,680,500
Uniform Five years 0.57 625,155 1,263–1,996 277,445,500–438,628,500
Some prioritisation Two years 0.40 (0.26/0.38/0.63/0.63) 521,040 1,046–1,654 235,447,000–372,232,000
Some prioritisation Five years 0.54 (0.51/0.51/0.7/0.7) 591,730 997–1,879 262,597,000–415,153,500
High prioritisation Two years 0.34 (0.27/0.22/0.9/0.9) 433,810 870–1,375 195,959,000–309,802,000
High prioritisation Five years 0.49 (0.42/0.41/0.9/0.9) 535,155 1,073–1,696 237,555,000–375,563,000
aCoverage in the uniform distribution strategy is equal in all subgroups (MMSW, MMSM, sex workers, and transwomen at higher risk). The coverage showed in both
strategies involving prioritisation (some and high) are given as overall population coverage and, in parentheses, the coverage in each subpopulation (MMSW/MMSM/
sex workers/transwomen at higher risk).
bTotal number of person-years on PrEP over 10 y.
cThe range represents the variation observed in the estimated costs per PrEP person-year.
dTotal cost of PrEP intervention over 10 y; the range represents the variation observed in the estimated costs per PrEP person-year.
doi:10.1371/journal.pmed.1001323.t004
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Figure S1 Estimated impact of PrEP with respect to
coverage, adherence, and prioritisation of key popula-
tions: number of infections averted/1,000 PrEP person-
years. Impact is shown as infections averted for every 1,000 PrEP
person-years (PY). The error bars reflect the uncertainty in the
iPrEx efficacy estimate of 92% (95% CI 40–99). In this
comparison, we show two scenarios ([A]: low coverage, in green;
[B]: high coverage, in blue) for three adherence profiles including
three prioritisation strategies—uniform, where the coverage is the
same in each subgroup; some prioritisation, where there is higher
coverage achieved in the transwomen at higher risk and sex
worker populations (but no more than 50% covered) than in
MMSW and MMSM; and high prioritisation, where 90% of
transwomen at higher risk and 11% of sex workers receive PrEP in
the low coverage scenario, or 90% of transwomen at higher risk,
90% of sex workers, 3.9% of MMSM, and 21.5% of MMSW
receive PrEP in the high coverage scenario.
(TIFF)
Figure S2 Estimated impact of PrEP with respect to
coverage, adherence, and prioritisation of key popula-
tions: proportion of infections averted over 10 y. Impact is
shown as percentage of total infections that are averted with PrEP.
The error bars reflect the uncertainty in the iPrEx efficacy estimate
of 92% (95% CI 40–99). In this comparison, we show two
scenarios ([A]: low coverage, in green; [B]: high coverage, in blue)
for three adherence profiles including three prioritisation strate-
gies—uniform, where the coverage is the same in each subgroup;
some prioritisation, where there is higher coverage achieved in the
transwomen at higher risk and sex worker populations (but no
more than 50% covered) than in MMSW and MMSM; and high
prioritisation, where 90% of transwomen at higher risk and 11%
of sex workers receive PrEP in the low coverage scenario, or 90%
of transwomen at higher risk, 90% of sex workers, 3.9% of
MMSM, and 21.5% of MMSW receive PrEP in the high coverage
scenario.
(TIFF)
Figure S3 Cost-effectiveness of PrEP, estimated as cost
per DALY averted: downstream ARV costs included. (A)
Downstream ARV costs averted included at US$1,000/person-
year on ARV drugs. (B) Downstream ARV costs averted included
at US$3,500/person-year on ARV drugs. iPrEx adherence profile
used for these scenarios. In green: low coverage scenario: 5%; in
blue: high coverage scenario: 20%. The variation in costs reflects
the uncertainty in the costing of one person-year on PrEP. The red
lines correspond to (1) the World Bank threshold for a cost-
effective intervention, ,US$745/DALY averted, and (2) the
World Bank threshold for a highly cost-effective intervention,
,US$149/DALY averted.
(TIFF)
Figure S4 Cost-effectiveness and total cost of PrEP over
10 y: downstream ARV costs not included. iPrEx adher-
ence profile used for all scenarios. In green: low coverage scenario:
5%; in blue: high coverage scenario: 20%. Lines are plotted
against the y-axis of cost/DALY averted in US dollars and against
the x-axis—total number of DALYs averted over 10 y. The
numbers over the lines indicate the data points as follows: 1, low
coverage, uniform scenario; 2, low coverage, some prioritisation
scenario; 3, low coverage, high prioritisation scenario; 4, high
coverage, uniform scenario; 5, high coverage, some prioritisation
scenario; 6, high coverage, high prioritisation scenario. These data
points have uncertainty bars representing the variation in the
costing of one person-year on PrEP. The boxes are plotted against
the right-hand axis only. They represent the total cost of scenarios.
The variation in costs (height of boxes) reflects the uncertainty in
the costing of one person-year on PrEP.
(TIFF)
Figure S5 Cost-effectiveness and total cost of PrEP over
10 y: downstream ARV costs averted included at
US$1,000/person-year on ARV drugs. iPrEx adherence
profile used for all scenarios. In green: low coverage scenario:
5%; in blue: high coverage scenario: 20%. Lines are plotted
against the y-axis of cost/DALY averted in US dollars and against
the x-axis—total number of DALYs averted over 10 y. The
numbers over the lines indicate the data points as follows: 1, low
coverage, uniform scenario; 2, low coverage, some prioritisation
scenario; 3, low coverage, high prioritisation scenario; 4, high
coverage, uniform scenario; 5, high coverage, some prioritisation
scenario; 6, high coverage, high prioritisation scenario. These data
points have uncertainty bars representing the variation in the
costing of one person-year on PrEP. The boxes are plotted against
the righthand axis only. They represent the total cost of scenarios.
The variation in costs (height of boxes) reflects the uncertainty in
the costing of one person-year on PrEP.
(TIFF)
Figure S6 Cost-effectiveness and total cost of PrEP over
10 y: downstream ARV costs averted included at
US$3,500/person-year on ARV drugs. iPrEx adherence
profile used for all scenarios. In green: low coverage scenario:
5%; in blue: high coverage scenario: 20%. Lines are plotted
against the y-axis of cost/DALY averted in US dollars and against
the x-axis—total number of DALYs averted over 10 y. The
numbers over the lines indicate the data points as follows: 1, low
coverage, uniform scenario; 2, low coverage, some prioritisation
scenario; 3, low coverage, high prioritisation scenario; 4, high
coverage, uniform scenario; 5, high coverage, some prioritisation
scenario; 6, high coverage, high prioritisation scenario. These data
points have uncertainty bars representing the variation in the
costing of one person-year on PrEP. The boxes are plotted against
the righthand axis only. They represent the total cost of scenarios.
The variation in costs (height of boxes) reflects the uncertainty in
the costing of one person-year on PrEP.
(TIFF)
Figure S7 Cost of PrEP with respect to changes in
condom use for a high prioritisation strategy. (A)
Downstream ARV costs averted included at US$1,000/person-
year on ARV drugs. (B) Downstream ARV costs averted included
at US$3,500/person-year on ARV drugs. This figure assumes
there is no correlation between adherence and risk compensation.
We explore this issue separately in Figure S12. iPrEx adherence
profile used for these scenarios. In green: low coverage scenario:
5%; in blue: high coverage scenario: 20%. The red lines
correspond to (1) the World Bank threshold for a cost-effective
intervention, ,US$745/DALY averted, and (2) the World Bank
threshold for a highly cost-effective intervention, ,US$149/
DALY averted.
(TIFF)
Figure S8 Population impact of PrEP with respect to
changes in condom use. (A) ‘‘Uniform’’ scenario. (B) ‘‘Some
prioritisation’’ scenario. This figure assumes there is no correlation
between adherence and risk compensation. We explore this issue
separately in Figure S12. In green: low coverage scenario: 5%; in
blue: high coverage scenario: 20%. Reference is no change in
condom use.
(TIFF)
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Figure S9 Cost-effectiveness of PrEP with respect to
changes in condom use: downstream ARV costs averted
not included. (A) ‘‘Uniform’’ scenario. (B) ‘‘Some prioritisation’’
scenario. This figure assumes there is no correlation between
adherence and risk compensation. We explore this issue separately
in Figure S12. iPrEx adherence profile used for these scenarios. In
green: low coverage scenario: 5%; in blue: high coverage scenario:
20%. The red lines correspond to (1) the World Bank threshold for
a cost-effective intervention, ,US$745/DALY averted, and (2)
the World Bank threshold for a highly cost-effective intervention,
,US$149/DALY averted.
(TIFF)
Figure S10 Cost-effectiveness of PrEP with respect to
changes in condom use: downstream ARV costs averted
included at US$1,000/person-years on ARV drugs. (A)
‘‘Uniform’’ scenario. (B) ‘‘Some prioritisation’’ scenario. This
figure assumes there is no correlation between adherence and risk
compensation. We explore this issue separately in Figure S12.
iPrEx adherence profile used for these scenarios. In green: low
coverage scenario: 5%; in blue: high coverage scenario: 20%. The
red lines correspond to (1) the World Bank threshold for a cost-
effective intervention, ,US$745/DALY averted, and (2) the
World Bank threshold for a highly cost-effective intervention,
,US$149/DALY averted.
(TIFF)
Figure S11 Cost-effectiveness of PrEP with respect to
changes in condom use: downstream ARV costs averted
included at US$3,500/person-year on ARV drugs. (A)
‘‘Uniform’’ scenario. (B) ‘‘Some prioritisation’’ scenario. This
figure assumes there is no correlation between adherence and risk
compensation. We explore this issue separately in Figure S12.
iPrEx adherence profile used for these scenarios. In green: low
coverage scenario: 5%; in blue: high coverage scenario: 20%. The
red lines correspond to (1) the World Bank threshold for a cost-
effective intervention, ,US$745/DALY averted, and (2) the
World Bank threshold for a highly cost-effective intervention,
,US$149/DALY averted.
(TIFF)
Figure S12 Population impact of PrEP with respect to
differential changes in condom use. (A) Only good adherers
change their behaviour. (B) Only bad adherers change their
behaviour. This figure assumes there is a correlation between
adherence and risk compensation. iPrEx adherence profile used
for these scenarios. In green: low coverage scenario: 5%; in blue:
high coverage scenario: 20%. Reference is no change in condom
use.
(TIFF)
Table S1 Scenarios to achieve one-third of new infec-
tions averted over 10 y: downstream ARV costs averted
included at US$1,000 and 3,500/person-year on ARV
drugs. Total PY: total number of person-years on PrEP over
10 y. Cost/DALY: cost in US dollars/DALY. Total cost: total cost
of PrEP intervention over 10 y. (1) Includes downstream ARV
costs averted included at US$1,000/person-year on ARV drugs.
(2) Includes downstream ARV costs averted included at
US$3,500/person-year on ARV drugs. The range observed in
this column and in the Total cost column represents the variation
observed in the costs per PrEP person-year. Coverage in the
uniform distribution strategy is equal in all subgroups (MMSW,
MMSM, sex workers, and transwomen at higher risk). The
coverage showed in both strategies involving prioritisation (some
and high) are given as overall population coverage and, in
brackets, the coverage in each subpopulation (MMSW/MMSM/
sex workers/transwomen at higher risk).
(DOC)
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Editors’ Summary
Background Without a vaccine, the only ways to halt the
global HIV epidemic are prevention strategies that reduce
transmission of the HIV virus. Up until recently, behavioral
strategies such as condom use and reduction of sexual
partners have been at the center of HIV prevention. In the
past few years, several biological prevention measures have
also been shown to be effective in reducing (though not
completely preventing) HIV transmission. These include male
circumcision, treatment for prevention (giving antiretroviral
drugs to HIV-infected people, before they need it for their
own health, to reduce their infectiousness) and pre-exposure
prophylaxis (or PrEP), in which HIV-negative people use
antiretroviral drugs to protect themselves from infection.
One PrEP regimen (a daily pill containing two different
antiretrovirals) has been shown in a clinical trial to reduce
new infections by 44% in of men who have sex with men
(MSM). In July 2012, the US Food and Drug Administration
approved this PrEP regimen to reduce the risk of HIV
infection in uninfected men and women who are at high risk
of HIV infection and who may engage in sexual activity with
HIV-infected partners. The approval makes it clear that PrEP
needs to be used in combination with safe sex practices.
WhyWas This Study Done? Clinical trials have shown that
PrEP can reduce HIV infections among participants, but they
have not examined the consequences PrEP could have at the
population level. Before decision-makers can decide whether
to invest in PrEP programs, they need to know about the
costs and benefits at the population level. Besides the price
of the drug itself, the costs include HIV testing before
starting PrEP, as well as regular tests thereafter. The health
benefits of reducing new HIV infections are calculated in
‘‘disability-adjusted life years’’ (or DALYs) averted. One DALY
is equal to one year of healthy life lost. Other benefits include
future savings in lifelong HIV/AIDS treatment for every
person whose infection is prevented by PrEP.
This study estimates the potential costs and health benefits
of several hypothetical PrEP roll-out scenarios among the
community of MSM in Lima, Peru. The scientists chose this
community because many of the participants in the clinical
trial that showed that PrEP can reduce infections came from
this community, and they therefore have some knowledge
on how PrEP affects HIV infection rates and behavior in this
population. Because the HIV epidemic in Lima is concentrat-
ed among MSM, similar to most of Latin America and several
other developed countries, the results might also be relevant
for the evaluation of PrEP in other places.
What Did the Researchers Do and Find? For their
scenarios, the researchers looked at ‘‘high coverage’’ and
‘‘low coverage’’ scenarios, in which 20% and 5% of
uninfected individuals use PrEP, respectively. They also
divided the MSM community into those at lower risk of
becoming infected and those at higher risk. The latter group
consisted of transwomen at higher risk (transsexuals and
transvestites with many sexual partners) and male sex
workers. In a ‘‘uniform coverage’’ scenario, PrEP is equally
distributed among all MSM. ‘‘Prioritized scenarios’’ cover
transwomen at higher risk and sex workers preferentially.
Two additional important factors for the estimated benefits
are treatment adherence (i.e., whether people take the pills
they have been prescribed faithfully over long periods of
time even though they are not sick) and changes in risk
behavior (i.e., whether the perceived protection provided by
PrEP leads to more unprotected sex).
The cost estimates for PrEP included the costs of the drug
itself and HIV tests prior to PrEP prescription and at three-
month intervals thereafter, as well as outreach and counsel-
ing services and condom and lubricant promotion and
provision.
To judge whether under the various scenarios PrEP is cost-
effective, the researchers applied two commonly used but
different cost-effectiveness thresholds. The World Health
Organization’s WHO-CHOICE initiative considers an interven-
tion cost-effective if its cost is less than three times the gross
domestic product (GDP) per capita per DALY averted. For
Peru, this means an intervention should cost less than
US$16,302 per DALY. The World Bank has more stringent
criteria: it considers an intervention cost-effective for a
middle-income country like Peru if it costs less than US$500
per DALY averted.
The researchers estimate that PrEP is cost-effective in Lima’s
MSM population for most scenarios by WHO-CHOICE
guidelines. Only scenarios that prioritize PrEP to those most
likely to become infected (i.e., transwomen at higher risk and
sex workers) are cost-effective (and only barely) by the more
stringent World Bank criteria. If the savings on antiretroviral
drugs to treat people with HIV (those who would have
become infected without PrEP) are included in the calcula-
tion, most scenarios become cost-effective, even under
World Bank criteria.
The most cost-effective scenario, namely, having a modest
coverage of 5%, prioritizing PrEP to transwomen at higher
risk and sex workers, and assuming fairly high adherence
levels among PrEP recipients, is estimated to avert about 8%
of new infections among this community over ten years.
What Do these Findings Mean? These findings suggest
that under some circumstances, PrEP could be a cost-
effective tool to reduce new HIV infections. However, as the
researchers discuss, PrEP is expensive and only partly
effective. Moreover, its effectiveness depends on two
behavioral factors—adherence to a strict drug regimen and
continued practicing of safe sex—both of which remain hard
to predict. As a consequence, PrEP alone is not a valid
strategy to prevent new HIV infections. It needs instead to be
considered as one of several available tools. If and when PrEP
is chosen as part of an integrated prevention strategy will
depend on the specific target population, the overall funds
available, and how well its cost-effectiveness compares with
other prevention measures.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001323.
N Information is available from the US National Institute of
Allergy and Infectious Diseases on HIV infection and AIDS
N NAM/aidsmap provides basic information about HIV/AIDS,
summaries of recent research findings on HIV care and
treatment, and a section on PrEP
N Information is available from Avert, an international AIDS
charity, on many aspects of HIV/AIDS, including HIV
prevention
N AVAC Global Advocacy for HIV Prevention provides up-to-
date information on HIV prevention, including PrEP
N The US Centers for Disease Control and Prevention also has
information on PrEP
N The World Health Organization has a page on its WHO-
CHOICE criteria for cost-effectiveness
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HIV/Syphilis sentinel surveillance questionnaire applied to prison inmates in Peru 
Interviewer: ______________ Date of interview: _____________ 
 
Establishment: _________________________________________ 
 
1. Initials: __ __ __ __ 
      PL     ML   1F   2F 
2. DOB 
3. Date of entry for current 
incarceration:__/__/__ 
4. Previous place of residence: District: _____ 
  Province: _____ 
5. Have you ever been in a penitentiary 
establishment before? 
No ( ) Yes ( ) How many times? __ 
6. Have you had a tattoo done in the past 5 
years? 
No ( ) Yes ( ) 
7. Have you received a blood transfusion in 
the past 5 years? 
No ( ) Yes ( ) 
8. Civil status 
(a) Married  (b) Cohabiting (c) Single (d) 
Separated or divorced (e) Widower 
9. How many sexual partners have you had in 
the past 12 months? ____ 
10. In the past 3 months have you had sexual 
relationships with: 
a) Wife or cohabiting partner?   No ( ) 
Yes ( ) 
b)  Female sex workers?    No ( ) 
Yes ( ) 
c) Female friends?    No ( ) Yes ( ) 
d) A same sex partner?    No ( ) Yes ( ) 
11. Did you use a condom in you last sex act 
with your stable partner? 
No ( )  Yes ( ) 
Does not have a stable sexual partner ( ) 
12. Did you use a condom in you last sex act 
with another partner? 
No ( )  Yes ( ) 
Does not have sex with another partner ( ) 
13. What kind of drugs have you used in the 
past 12 months? 
None    ( ) 
Alcohol   No ( ) Yes ( ) 
Cocaine paste   No ( ) Yes ( ) 
Cocaine   No ( ) Yes ( ) 
Marihuana  No ( ) Yes ( ) 
Injected drugs  No ( ) Yes ( ) 
Others: __________ 
14. How often did you have sex under the 
influence of alcohol in the past 12 months? 
a) Never 
b) A small number of times 
c) Half the time 
d) Most times 
e) Always 
15. How often did you have sex under the 
influence of drugs in the past 12 months? 
a) Never 
b) A small number of times 
c) Half the time 
d) Most times 
e) Always 
16. Have you had an STI in the last 12 months? 
17. Have you had secretion or pus from your 
penis in the last 12 months? 
18. Have you a burning pain while urinating or 
itching on the penis in the past 12 months? 
19. Have you had a wound or ulcer on the 
penis in the last 12 months? 
Many thanks for your participation. 
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Univariable analyses for having had sex with FSW, MSM in the past 3 months, reporting 0 
partners in the past 12 months and reporting non-condom use at last sex with casual 
partner in 2000 (Part 1). 
 Sex with FSW Sex with men No partners 
w..casual partner 
Unprotected sex 
last casual 
 
OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
Socio-demographic 
2000 
        
Marital status     
 
  
Married     
Cohabiting 1.2 [0.8-1.8] 2.4 [1.2-4.7]* 0.4 [0.1-1.8] 1.1 [0.7-1.8] 
Single 1.8 [1.2-2.7]** 6.2 [3.2-12.1]*** 3.8 [1.1-12.8]* 1.1 [0.7-1.8] 
Divorced  2.2 [1.3-3.5]** 3.0 [1.4-6.6]** 1.7 [0.3-8.4] 0.7 [0.4-1.2] 
Widower 0.5 [0.1-4.3] 7.0 [1.7-29.5]** 0.0 [NA] 1.4 [0.3-7.7] 
Age      
 
  
18 to 30    
31 to 40 1.1 [0.8-1.4] 0.5 [0.4-0.8]*** 1.6 [0.7-3.7] 0.8 [0.6-1.0] 
41 to 50 1.0 [0.7-1.4] 0.3 [0.2-0.5]*** 1.3 [0.4-4.3] 1.0 [0.6-1.5] 
Over 50 0.9 [0.5-1.8] 0.3 [0.1-0.9]* 4.0 [1.1-14.7]* 0.6 [0.3-1.4] 
Incarceration history         
Time in prison     
 
  
under 1 year    
1 to 4 years 1.6 [1.2-2.0]*** 1.8 [1.3-2.5]*** 1.3 [0.6-2.9] 0.5 [0.4-0.7]*** 
over 4 years 2.2 [1.3-3.6]** 3.2 [1.8-5.6]*** 1.3 [0.3-5.9] 0.9 [0.5-1.6] 
Previous incarcerations     
 
  
0    
1 to 3 0.9 [0.7-1.2] 1.2 [0.9-1.6] 5.8 [1.8-18.1]** 1.6 [1.2-2.2]** 
4 and more 1.0 [0.6-1.6] 1.6 [0.9-2.6] 1.5 [0.6-3.5] 2.1 [1.2-2.2]* 
Drug use         
Alcohol 1.5 [1.1-1.9]** 2.4 [1.7-3.3]*** 0.5 [0.2-1.1] 1.6 [1.2-2.2]*** 
Marihuana 1.7 [1.3-2.2]*** 2.5 [1.8-3.5]*** 0.3 [0.1-1.5] 1.0 [0.7-1.5] 
Cocaine paste 1.4 [1.0-1.8]* 3.8 [2.8-5.2]*** 3.2 [1.5-6.9]** 2.0 [1.4-2.9]*** 
Cocaine 1.7 [1.3-2.2]*** 2.6 [1.9-3.5]*** 1.1 [0.4-2.5] 1.1 [0.8-1.6] 
IDU 1.7 [0.5-5.5] 4.8 [1.5-14.7]** 
 
1.5 [0.4-5.7] 
Exposure to HIV         
Tattoo  1.3 [1.0-1.7] 1.6 [1.2-2.2]** 0.7 [0.3-1.7] 1.1 [0.8-1.4] 
Blood transfusion 1.8 [1.1-3.0]* 1.6 [0.9-2.8] 2.6 [0.8-8.7] 0.8 [0.4-1.5] 
Sexual behaviour         
Partners in past 12 
months  
    
 
  
1    
0 NA NA NA NA 
2 10.0 [6.2-
16.3]*** 
4.8 [2.7-8.5]*** NA 0.6 [0.4-0.9]* 
3 and more 25.0 [15.8-
39.4]*** 
12.6 [7.6-20.8]*** NA 0.6 [0.4-0.9]** 
Partners in the past 3 
months 
    
 
  
Sex with men  5.4 [3.9-7.3]*** NA NA 1.2 [0.8-1.6] 
Sex with wife  0.6 [0.4-0.7]*** 0.4 [0.3-0.5]*** NA 1.0 [0.8-1.3] 
Sex with FSW  NA 5.4 [3.9-7.3]*** NA 0.3 [0.2-0.4]*** 
Sex with female 
friends 
2.6 [2.0-3.3]*** 1.7 [1.3-2.3]*** NA 1.4 [1.1-1.9]* 
Condom use last sex 
casual partner 
    
 
  
No    
Yes 4.1 [3.1-5.5]*** 0.8 [0.6-1.2] 0.2 [0.0-1.5] NA 
Does not have a 
casual partner 0.0 [0.0-0.1]*** 0.1 [0.0-0.1]*** 1.4 [0.6-3.2] NA 
Condom use last sex 
stable partner  
    
 
  
No    
Yes 2.7 [1.8-4.1]*** 1.1 [0.6-1.9] 1.3 [0.2-11.4] 0.1 [0.1-0.2]*** 
Does not have a 
stable partner 2.2 [1.7-2.9]*** 2.3 [1.7-3.1]*** 11.1 [4.2-29.7]*** 0.6 [0.4-0.8]*** 
Sex under influence of 
alcohol 
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Sex with FSW Sex with men No partners 
Unprotected sex 
casual 
 
OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
Sex under influence of alcohol 
 
  
 
  
Never 
 
  
 
  
almost never 1.1 [0.8-1.6] 2.0 [1.3-2.9]*** 0.6 [0.2-2.2] 1.7 [1.2-2.5]** 
Sometimes 2.4 [1.3-4.2]** 6.1 [3.5-10.7]*** 0.9 [0.1-6.5] 4.7 [2.0-11.1]*** 
nearly always 3.0 [1.8-5.1]*** 2.7 [1.5-5.1]** 0.0 [NA] 1.1 [0.6-2.0] 
Always 1.5 [0.3-7.4] 15.0 [3.6-63.7]*** 0.0 [NA] 2.2 [0.5-10.8] 
Sex under influence of drugs 
 
  
 
  
Never 
 
  
 
  
almost never 1.5 [0.9-2.6] 4.8 [2.9-7.8]*** 1.5 [0.3-6.4] 2.0 [1.1-3.6]* 
Sometimes 3.9 [2.2-7.2]*** 8.7 [4.7-16.1]*** 1.4 [0.2-10.7] 2.3 [1.0-5.0]* 
nearly always 1.9 [0.8-4.5] 3.2 [1.3-7.8]** 0.0 [NA] 1.8 [0.7-5.0] 
Always 0.9 [0.1-7.4] 8.7 [1.7-43.6]** 0.0 [NA] 1.2 [0.2-6.6] 
STI symptoms in past 12 months         
STI  3.0 [1.9-4.6]*** 2.3 [2.0-6.2]** 0.6 [0.1-4.6] 0.5 [0.3-0.9]* 
Pus  3.6 [2.1-6.1]*** 3.5 [1.5-3.0]*** 1.0 [0.1-7.1] 0.9 [0.5-1.7] 
Itching/burning  2.1 [1.5-2.8]*** 2.2 [1.5-3.0]*** 0.8 [0.3-2.4] 1.0 [0.7-1.3] 
Ulcers  1.7 [1.1-2.5]* 1.8 [1.1-2.9]* 0.4 [0.1-3.1] 0.9 [0.6-1.4] 
Biological outcomes         
Syphilis antibodies 1.5 [0.8-2.7] 3.8 [2.1-6.9]*** 2.2 [0.5-9.6] 1.0 [0.5-2.0] 
 
Univariable analyses for having had sex with FSW, MSM in the past 3 months, reporting 0 
partners in the past 12 months and reporting non-condom use at last sex with casual 
partner in 2000 (continued). 
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 Sex with FSW Sex with men No partners 
Unprotected 
sex casual 
 
OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
Socio-demographic 2005         
Province (Lima) 0.5 [0.4-0.8]** 3.0 [0.9-9.5]˜ 1.4 [0.9-2.0] 1.6 [1.0-2.3]* 
Marital status         
Married Reference   
Cohabiting 0.7 [0.4-1.1] 1.3 [0.4-3.8] 0.6 [0.4-0.9]* 1.8 [1.1-2.9]* 
Single 1.3 [0.8-2.0] 3.7 [1.3-10.5]* 2.9 [1.9-4.5]*** 1.7 [1.0-2.7]* 
Divorced  1.6 [0.9-2.8] 1.5 [0.4-5.9] 3.2 [1.9-5.3]*** 1.9 [1.1-3.3]* 
Widower 1.3 [0.4-4.9] 2.7 [0.3-25.9] 7.7 [3.2-18.4]*** 1.8 [0.5-6.7] 
Age          
18 to 30         
31 to 40 1.6 [1.1-2.1]** 0.5 [0.3-0.9]* 1.0 [0.8-1.3] 0.5 [0.4-0.7]*** 
41 to 50 1.7 [1.2-2.5]** 0.5 [0.3-1.1] 1.1 [0.8-1.6] 0.5 [0.4-0.7]*** 
Over 50 1.3 [0.7-2.3] 0.1 [0.0-1.0] 2.4 [1.7-3.6]*** 0.7 [0.4-1.2] 
Incarceration history         
Time in prison         
under 1 year Reference   
1 to 4 years 1.8 [1.2-2.6]** 1.0 [1.0-1.1] 1.8 [1.4-2.3]*** 0.8 [0.6-1.1] 
over 4 years 3.7 [2.4-5.5]*** 1.9 [1.0-3.5]* 1.8 [1.3-2.5]** 0.6 [0.4-0.8]** 
Previous incarcerations         
0 Reference   
1 to 3 1.7 [1.3-2.2]*** 1.2 [0.7-2.0] 0.9 [0.7-1.2] 0.9 [0.7-1.2] 
4 and more 2.1 [1.3-3.4]** 3.8 [2.1-6.9]*** 0.7 [0.4-1.1] 1.2 [0.7-1.8] 
Drug use         
Alcohol 1.3 [1.0-1.7]˜ 2.9 [1.8-4.6]*** 0.7 [0.5-0.9]** 0.9 [0.7-1.2] 
Marihuana 1.3 [0.9-1.8] 4.6 [2.9-7.3]*** 1.0 [0.7-1.3] 1.0 [0.8-1.3] 
Cocaine paste 1.4 [1.0-2.0]˜ 4.1 [2.5-6.6]*** 1.5 [1.1-2.0]** 1.4 [1.0-1.9] 
Cocaine 1.5 [1.0-2.1]* 4.3 [2.6-7.0]*** 0.8 [0.6-1.2] 1.2 [0.9-1.6] 
IDU 
1.3 [0.3-6.1] 
16.0 [5.6-
45.3]*** 1.4 [0.5-4.2] 2.0 [0.6-6.7] 
Exposure to HIV         
Tattoo  1.0 [0.8-1.3] 1.7 [1.1-2.6]* 0.6 [0.5-0.8]*** 1.1 [0.9-1.4] 
Blood transfusion 1.1 [0.4-2.5] 1.7 [0.5-5.5] 0.7 [0.3-1.7] 0.7 [0.3-1.4] 
Sexual behaviour         
Partners in past 12 months          
1 Reference   
0 NA NA NA 1.6 [1.0-2.6] 
2 6.9 [4.3-11.0]*** 3.4 [1.7-7.1]*** NA 0.7 [0.5-1.0] 
3 and more 
25.4 [16.6-
38.8]*** 
11.7 [6.5-
21.0]*** NA 0.5 [0.3-0.6]*** 
Partners in the past 3 
months         
Sex with men  6.5 [3.8-11.0]*** NA NA 0.8 [0.5-1.3] 
Sex with wife  0.3 [0.2-0.4]*** 0.4 [0.2-0.7]*** NA 1.2 [0.9-1.6] 
Sex with FSW  NA 6.5 [3.8-11.0]*** NA 0.2 [0.1-0.2]*** 
Sex with female 
friends 1.7 [1.3-2.4]*** 1.6 [0.9-2.7] NA 1.3 [1.0-1.6]* 
Univariable analyses for having had sex with FSW, MSM in the past 3 months, reporting 0 
partners in the past 12 months and reporting non-condom use at last sex with casual 
partner in 2005 (Part 1). 
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Sex with FSW Sex with men No partners 
Unprotected 
sex casual 
 
OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
Condom use last sex casual partner     
 
  
No Reference   
 
Yes 6.1 [4.2-8.7]*** 1.3 [0.8-2.1] 0.5 [0.3-0.7]*** NA 
Does not have a casual partner 0.0 [0.0-0.1]*** 0.1 [0.0-0.2]*** 1.7 [1.3-2.3]*** NA 
Condom use last sex stable partner      
 
  
No Reference   
 
Yes 1.7 [1.1-2.7]* 1.1 [0.5-2.5] 0.7 [0.4-1.2] 0.2 [0.1-0.3]*** 
Does not have a stable partner 2.6 [1.9-3.5]*** 2.2 [1.4-3.6]*** 4.5 [3.5-5.8]*** 0.6 [0.5-0.8]*** 
Sex under influence of alcohol     
 
  
Never Reference   
 
almost never 1.6 [1.1-2.4]* 3.7 [2.2-6.4]*** 0.2 [0.1-0.4]*** 1.2 [0.9-1.8] 
Sometimes 3.7 [1.5-9.1]** 3.4 [0.8-14.8] NA 1.8 [0.7-4.8] 
nearly always 2.5 [1.3-5.0]** 5.8 [2.6-12.9]*** 0.1 [0.0-0.6]* 2.4 [1.2-4.8]* 
Always 5.2 [0.9-31.6]˜ 7.5 [0.8-68.7] NA 1.2 [0.2-8.3] 
Sex under influence of drugs     
 
  
Never Reference   
 
almost never 1.8 [1.1-3.0]* 9.4 [5.4-16.3]*** 0.5 [0.3-1.0]* 0.9 [0.6-1.3] 
Sometimes 6.3 [1.7-23.7]** 15.0 [2.8-79.5]** NA 0.6 [0.2-2.7] 
nearly always 3.1 [1.7-5.8]*** 11.0 [5.4-22.3]*** 0.1 [0.0-0.6]* 1.5 [0.8-2.9] 
Always 5.3 [0.9-31.6]˜ 18.8 [3.3-105.2]*** 0.7 [0.1-6.1] 0.7 [0.1-4.3] 
STI symptoms in past 12 months         
STI  1.7 [0.8-3.5] 6.4 [3.2-12.9]*** 0.9 [0.4-1.8] 1.7 [0.9-3.2] 
Pus  1.9 [0.6-5.7] 13.7 [5.2-35.8]*** 0.6 [0.1-2.5] 1.6 [0.6-4.7] 
Itching/burning  1.3 [0.7-2.3] 2.9 [1.5-5.9]** 1.4 [0.8-2.3] 1.2 [0.7-2.1] 
Ulcers  1.3 [0.7-2.3] 3.2 [1.6-6.5]** 0.9 [0.5-1.6] 1.3 [0.8-2.2] 
Biological outcomes         
Syphilis antibodies 1.1 [0.5-2.4] 2.2 [0.8-5.6] 1.8 [1.0-3.2]* 1.3 [0.6-2.7] 
HIV antibodies 1.0 [0.3-3.4] 1.9 [0.4-8.3] 1.9 [0.8-4.4] 0.3 [0.1-1.1] 
Univariable analyses for having had sex with FSW, MSM in the past 3 months, reporting 0 
partners in the past 12 months and reporting non-condom use at last sex with casual 
partner in 2005 (continued). 
 
 
 
 
 
 
 
 
  
387 Appendix Chapter 4 
Causal pathways analysis 2000 looking at modified variables to differentiate effects of 
condom use and partnership type 
P values are reported as follows:  . = borderline significant, *<0.05, **<0.01, ***<0.001 
*Adjusted OR are adjusted for all proximate determinants in the table 
Percentage distributions of proximate determinants and their association with HIV serostatus for 2000 
survey 
 
 
 
 
 
Proximate determinants 
Percentage 
distribution 
Unadjusted OR           
(95%CI) 
Adjusted OR          
(95% CI) 
Blood transfusion 4.7 0.83 (0.21-3.35) 0.0 (0.00-inf) 
Tattoo 26.5 1.40 (0.76-2.58) 1.78 (0.78-4.04)  
IDU 0.8 2.69 (0.34-20.97) 2.30 (0.22-23.79) 
     
Number of partners in past 12 months     
0 1.9 1.00 1.00  
1  52.4 0.02 (0.01-0.05) *** 0.02 (0.00-0.08) *** 
2 to 4  36.5 0.03 (0.01-0.07) *** 0.03 (0.01-0.12) *** 
5 to 9  6.4 0.02 (0.00-0.11) *** 0.01 (0.00-0.09) *** 
10 and more  2.9 0.02 (0.00-0.20) *** 0.02 (0.00-0.21) ** 
Sex with FSW 19.9 1.20 (0.61-2.38) 1.04 (0.40-2.69) 
Sex with men 12.8 0.97 (0.41-2.31) 0.75 (0.24-2.38) 
Sex with female friends 39.2 0.93 (0.52-1.67) 0.85 (0.33-2.14) 
Sex with wife/cohabiting partner  57 0.33 (0.18-0.62)*** 0.71 (0.28-1.81) 
Partner type      
Stable only 28.1 1.00  
Stable and casual 37.8 0.73 (0.27-1.99)  
Casual only  22.1 2.88 (1.35-6.16) **  
None 12.0 3.89 (1.72-8.81) **  
Condom use with stable partner     
No 87.4 1.00  
Yes 12.6 6.45 (2.45-16.98) ***  
Condom use with casual partner     
No 64.4 1.00   
Yes 35.6 1.84 (0.82-4.14)  
Condom use (Yes) 18.1 3.98 (2.02-7.83)*** 
4.48 (1.84-
10.90)*** 
STI in past 12 months 5.3 1.02 (0.48-2.18) 1.29 (0.42-3.96) 
Secretion or pus from penis in past 12 
months 3.6 0.57 (0.08-4.18) 0.73 (0.07-7.91) 
Burning or itching while urinating in 
past 12 months 15.3 0.94 (0.42-2.12) 0.86 (0.25-2.94) 
Ulcer or wound on penis in past 12 
months 7.3 1.15 (0.41-3.25) 0.72 (0.08-6.08) 
Syphilis AB  3.4 4.27 (1.77-10.32) ** 
8.00 (2.04-31.33) 
** 
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Causal pathways analysis for the 2005 survey 
Proximate determinants for HIV infection  
Univariable analyses were carried out for all potential proximate determinants and two variables 
were significantly associated with HIV status: having had sex with a wife or cohabiting partner in the 
past 3 months was found to be protective against HIV, and reporting not having a stable partner to 
the question “did you use a condom at last sex with your stable partner?” was positively associated 
with being HIV positive. Answering “yes” to the previous question was also positively associated with 
HIV infection but the relationship was borderline significant. When looking at the “condom only” 
and “partner type only” variables, using condoms consistently and not having a partner (as opposed 
to having a stable partner) were positively and significantly associated with HIV infection. Those who 
reported having a casual partner or having both a casual and a stable partner were not significantly 
more or less likely to be HIV positive than those who only reported having a stable partner.  
A number of associations were borderline significant and as the number of HIV cases was small it is 
worth mentioning them: reporting condom use at last sex with a casual partner was positively 
associated with being HIV positive, number of partners in the past 12 months, specifically having had 
1 partner as opposed to no partners in the past 12 months was protective against HIV, having 
received a blood transfusion in the last 5 years was positively associated with the outcome. Again, 
none of the behaviours that would traditionally be considered as carrying risk: sex with FSW, MSM, 
casual partners, having multiple partners, unprotected sex or history of STIs were associated with 
HIV status. Only protective behaviours stood out as important factors.  
Variables that were significant or borderline significant in the univariable analysis were included in 
the multivariable analysis to adjust for potential confounding.  The modified condom use variable 
was included instead of the original variables to minimise the number of categories. However, those 
who reported no partner were included as an extra categories (instead of coded as missing) to avoid 
losing cases. The partner type variable was not included as it was highly correlated with the other 
variables informing on partner type (sex with wife, FSW, men, friends). When adjusting for all 
identified proximate determinants, sex with wife and number of partners lost significance, blood 
transfusion remained borderline significant and condom use remained significant but the strength 
and significance level of the association decreased. This is because condom use was correlated with 
sex with wife and number of partners.   
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 Unadjusted OR 
[95% CI] p value 
Adjusted OR 
[95% CI] p value 
Exposure to HIV         
Tattoo  0.7 [0.3-1.7] >0.05 
 
  
Blood transfusion 3.7 [0.9-16.1] >0.05* 4.0 [0.9-17.9] >0.05* 
IDU 4.8 [0.6-37.4] >0.05 
 
  
Sexual behaviour         
Partners in past 12 months   
  
  
0 Reference 
1 0.4 [0.1-1.1] >0.05 * 1.0 [0.2-4.7] >0.05 
2 1.0 [0.3-2.9] >0.05 2.0 [0.4-10.0] >0.05 
3 and more 0.8 [0.3-2.5] >0.05 1.4 [0.3-7.4] >0.05 
Sex with men 1.9 [0.4-8.3] >0.05 
 
  
Sex with wife 0.4 [0.2-0.9] <0.05 0.7 [0.8-1.8] >0.05 
Sex with FSW  1.0 [0.3-3.4] >0.05 
 
  
Sex with female friends  0.9 [0.4-2.3] >0.05 
 
  
Condom use last sex casual partner    
  
  
No Reference 
Yes 3.4 [0.9-12.3] >0.05* 
 
  
Does not have a casual partner 2.0 [0.6-6.9]] >0.05 
 
  
Condom use last sex stable partner    
  
  
No Reference 
Yes 2.9 [1.0-9.0] >0.05* 
 
  
Does not have a stable partner 3.2 [1.4-7.6] <0.01 
 
  
Condom use (yes) 3.4 [1.4-7.8] <0.01 3.0 [1.2-7.7] <0.05 
Type of partner   
  
  
Stable Reference 
Casual 2.1 [0.8-5.4] >0.05 
 
  
Both  1.2 [0.4-3.6] >0.05 
 
  
None 4.1 [1.4-12.0] <0.01 
 
  
STI symptoms in past 12 months         
STI  1.3 [0.2-10.0] >0.05 
 
  
Pus  4.5 [0.6-34.7] >0.05 
 
  
Itching/burning 1.8 [0.4-7.7] >0.05 
 
  
Ulcers  0.8 [0.1-6.1] >0.05 
 
  
Biological outcomes         
Syphilis antibodies 1.3 [0.2-9.6] >0.05     
*Adjusted for significant proximate determinants in the univariable analysis only. 
Association of proximate determinants with HIV infection for 2005 survey 
 
Underlying determinants of HIV infection 
Regarding underlying determinants, 4 variables were significant in the univariable analysis: civil 
status, with single, divorced or widowers being more likely to be HIV positive than married or 
cohabiting men. Reporting to sometimes, nearly always or always have sex under the influence of 
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alcohol (as opposed to never or almost never) was positively associated with HIV. The same was 
observed for reporting sex under the influence of drugs but the association was stronger and highly 
significant. Cocaine use was also positively associated with HIV. Being 31 or more was protective 
against HIV infection and using cocaine paste was positively associated with HIV but the associations 
were borderline significant. The prison history variables were not significantly associated with HIV 
which differs from what was observed in 2000. When adjusting for all significant underlying 
determinants, only frequency of sex under the influence of drugs remained significant. The strength 
and significance level of the association decreased (OR=8.1, p<0.001 in crude model OR=5.8, p<0.05 
after adjustment) when adjusting for frequency of sex under the influence of alcohol. Over 80% of 
HIV positive inmates who reported having sex under the influence of drugs also reported having sex 
under the influence of alcohol. When including an interaction term between these two variables in 
the model it was highly significant. Reporting both of these behaviours probably reflects riskier 
conditions for meeting partners and for sex itself. All HIV positive inmates who reported sex under 
the influence of drugs reported using cocaine, over 65% reported using cocaine paste, half reported 
using marihuana and 15% reported injecting drugs. These are inmates who are heavily involved in 
drug use which is common in prison settings and is the root of many of the problems confronted by 
this population. In order to capture the effect of the interaction between sex under the influence of 
alcohol and drugs, an aggregated variable was created with the following categories: sex under the 
influence of alcohol only, drugs only, both and none. In the univariable analysis having sex under the 
influence of both alcohol and drugs was positively and significantly associated with HIV (OR=11.3 
(CI=4.1-31.1), p<0.0001). The multivariable analysis was redone replacing the variables on sex under 
the influence by the aggregated variable. The latter remained significantly associated with HIV with 
little variation in the OR but a drop in significance.  
When adjusted for the proximate determinants that were most strongly associated with HIV 
(condom use and blood transfusion), the magnitude and level of significance of sex under the 
influence of alcohol and drugs increased (OR=11.5 (CI=3.1-42.2) p<0.001 to OR=15.0 (CI=3.9-58.3) 
p<0.0001). This is not surprising as condom use is a preventive behaviour and it cannot explain HIV 
infection. In fact it is probably a consequence of infection rather than a predictor. Also, sex under 
the influence of alcohol and drugs was negatively associated with condom use even when adjusted 
for HIV status. The information available on proximate determinants did not allow determining the 
causal pathways through which sex under the influence acts. 
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 Unadjusted OR 
[95% CI] 
Partly adjusted OR 
[95% CI] 
Fully adjusted OR 
[95% CI] 
Socio-demographic       
Province (Lima) 0.7 [0.2-1.9] 
 
  
Marital status   
 
  
Married/cohabiting Reference 
Single/divorced/widower 2.5 [1.1-5.5]* 2.2 [0.9-5.3]~ 1.5 [0.6-4.0] 
Age    
 
  
18 to 30 Reference 
31 and more 0.5 [0.2-1.1]~ 0.5 [0.2-1.3] 0.5 [0.2-1.2] 
Incarceration history       
Time in prison   
 
  
under 1 year Reference 
1 to 4 years 1.5 [0.7-3.3] 
 
  
over 4 years 0.6 [0.1-4.5] 
 
  
Previous incarcerations   
 
  
0 Reference 
1 to 3 0.6 [0.3-1.5] 
 
  
4 and more 1.5 [0.6-3.8] 
 
  
Drug use       
Alcohol 1.4 [0.7-3.1] 
 
  
Marihuana 1.7 [0.7-4.1] 
 
  
Cocaine paste 2.1 [0.9-5.0]~ 0.7 [0.2-2.3] 0.6 [0.2-2.0] 
Cocaine 3.2 [1.4-7.5]** 2.1 [0.7-5.9] 2.5 [0.9-7.2]~ 
Sexual behaviour       
Sex under influence of alcohol    
 
  
Never/almost never Reference 
Sometimes/nearly 
always/always 
5.4 [2.0-14.6]*** 
   
Sex under influence of drugs    
 
  
Never/almost never Reference 
Sometimes/nearly 
always/always 
8.1 [3.2-20.4]*** 
   
Sex under the influence   
 
  
None Reference 
alcohol only 0.0 [0-+inf] 0.0 [0-+inf] 0.0 [0-+inf] 
drugs only 3.2 [0.4-24.2] 3.2 [0.4-25.7] 3.6 [0.4-30.0] 
Both 11.3 [4.1-31.1]*** 11.5 [3.1-42.2]*** 15.0 [3.9-58.3]*** 
The partially adjusted OR were adjusted for other significant underlying determinants.  
The fully adjusted OR were adjusted for other significant underlying determinants and proximate determinants 
most strongly associated with HIV. p values borderline significant at the 0.05 level, *<0.05, **<0.01, ***<0.001 
Association of underlying determinants with HIV infection 
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Discussion  
Some proximate determinants were identified in the crude analysis. However, all could be attributed 
to protective behaviours against transmission. Having sex with a stable partner is generally safer as it 
often implies monogamy, in this case having had sex with a wife or cohabiting partner was strongly 
associated with having 1 partner as opposed to none or more than 1. In fact, once controlled for 
number of partners, sex with wife lost significance. Condom use is also a protective behaviour. 
Receiving a blood transfusion in the past 5 years became significant once controlled for the 
underlying determinants. This is surprising as Peru’s system to screen blood donors has been in 
place since the 1980’a. It is likely that receiving a blood transfusion is associated with other 
determinants of infection such as drug use.  
The association between having sex under the influence of alcohol and drugs and HIV infection was 
not explained by the proximate determinants. It is possible that we are observing two sets of people, 
those who are unaware of their status and are having unprotected sex under the influence with 
riskier partners and those who are aware of their status and change their behaviour. Unfortunately, 
because the number of cases is small it is not possible to formally identify these. Another 
explanation, already proposed in the 2000 analysis, is that we might be looking at past and present 
behaviours: the question on condom use refers to last sex, which is likely to be a recent event, the 
question on partner types (sex with wife, men, FSW, friends) refers to the past 3 months. In contrast, 
the question on sex under the influence refers to the past 12 months and asks about frequency, 
which characterises behaviours in a more general way. HIV positive inmates who report sex under 
the influence might have had behaviours that put them at risk of HIV previous to knowing their 
status and changed them thereafter. In fact, inmates who report sex under the influence of drugs 
are significantly more likely to report sex with men, sex with FSW, sex with friends, non-condom use 
with last casual partner, to have had an STI and experienced secretion/pus in the past 12 months as 
well as to have a positive RPR test. The causal pathways analysis for reporting an STI in the past 12 
months was carried out (analysis not shown here) and having sex under the influence of alcohol or 
drugs were significantly associated with the outcome. Once adjusted for the other significant 
underlying determinants (alcohol, marihuana, cocaine paste and cocaine use) and for the significant 
proximate determinants (sex with men and number of partners) sex under the influence lost 
significance. It suggests having sex under the influence might act through having sex with men and 
having multiple partners to cause STIs. A similar pathway might be causing HIV infection among 
inmates.
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Appendix Chapter 5  
 
Mathematical modelling of HIV transmission in Lurigancho 
Model 1 
Model structure 
Summary 
Model 1 simulated HIV transmission in a population stratified by sexual behaviour. HIV was 
transmitted through sex between inmates or between inmates and female visitors. Infected 
individuals were assumed to progress through 3 stages: acute infection, chronic infection and pre-
AIDS. The population was divided into 5 groups of inmates and 4 groups of female visitors including 
FSW. Inmates could either only have sex with their wife (MOSW), have heterosexual casual sex 
(MCHS), have sex with men and women (Bisexual), be transwomen and sell sex to men (TSW) or 
have no sexual activity (No sex). Visitors were categorised as wives of MOSW, MCHS, Bisexual men 
or as FSW. These groups were characterised by their mixing patterns, the total number of 
partnerships per year, the number of sex acts per partnership, and the use of condoms with each 
type of partner. The size of each group was assumed to remain constant through time. Inmates and 
their visitors were assumed to exit prison at a certain rate and to be replaced by new inmates and 
visitors, keeping the total population size constant. At entry a proportion of individuals was assumed 
to be infected and entered the latent stage of infection. The basic model structure is presented 
below in figure 1. Two main structures were considered for the representation of sexual behaviour 
and the bottom one was applied for reasons detailed further in this section.  
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Figure 1: diagrams representing model 1 structure for the progression through infectious stages, the movement through the prison system and the 
mixing patterns between groups with specific sexual behaviours 
 
HIV Natural History Prison population dynamics Sexual behaviour 
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Full definition 
 
The model is represented by the set of differential equations (1) to (4). The state variables are given 
by )(tX
s
i . t is the time elapsed in the simulation; s is the infection-status (1= susceptible; 2= acute 
infection; 3= latent infection; 4= pre-AIDS), i designates the  ‘sexual behaviour group’ (1=No sex; 
2=Men who only have sex with their wife; 3=Men who have casual heterosexual sex; 4=Bisexual 
men; 5=Transgender Sex Workers ; 6=Wives of men who only have sex with their wife; 7=Wives of 
men who have casual heterosexual sex; 8=Wives of bisexual men; 9= Female Sex Workers).  
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σ is the rate of progression from each disease stage to the next. )(ti  is the rate of infection of 
group i at time t. Ϛ is the rate at which individuals exit the prison. Ω is the HIV prevalence at entry. 
Natural history of infection 
HIV natural history was described as a progression through four stages: susceptible, acute infection 
(3 months duration and high transmission probability), latent infection (8 years duration, low 
transmission probability) and pre-AIDS (1 year, high transmission). People were assumed to stop 
having sex when they acquired AIDS due to the debilitating nature of the disease so this stage was 
not considered in the model.  Parameter values were taken from the literature and given in table 1.  
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Parameters Symbol Estimate Reference  
Average transmission rate of HIV per sex act  β
3
 0.001 
 
HIV prevalence at entry Ω 0.013 
HIV 
programme 
Relative transmission rate per receptive vaginal sex act  βi,i' 1 - 
Relative transmission rate per insertive vaginal sex act  βi,i' 0.5 [7] 
Relative transmission rate per insertive anal sex act  βi,i' 3 [7,431] 
Relative transmission rate per insertive or receptive anal 
sex act  
βi,i' 10 [7,319,431] 
Relative transmission rate per receptive anal sex act  βi,i' 15 [319] 
Relative infectiousness in acute phase infection  β
2
 27 [11] 
Relative infectiousness in latent phase infection  β
3
 1 - 
Relative infectiousness in pre-AIDS phase infection  β4 7·2 [11] 
Mean duration of acute phase infection  1/σ2 
3 
months 
[11,320] 
Mean duration of latent phase  1/σ3 8 years [11,320] 
Mean interval with elevated viral load, pre-AIDS  1/σ4 
10 
months 
[11,320] 
Table 1. Parameter values for the natural history of infection 
 
Sexual behaviour 
Mixing between groups 
The mixing matrix, defined by ρi,i’, is the probability that a person in group i forms a partnership with 
a person in group i’. By definition, among men who only have sex with their wife (MOSW) all their 
partnerships are formed with their wife, so ',ii  is set at 1 for i’ corresponding to wives of MOSW 
and 0 for all other groups. It was assumed that stable partners of inmates were monogamous so 
',ii  was set at 1 for i’ corresponding to their partner and 0 for all other groups. TSW were assumed 
to only have sex with bisexual men, as given the nature of their identity they very rarely have sex 
with women or between them. Men who have casual sex with women shared their partnership 
between their stable partner and FSW. The proportion of partnerships shared with their wife was 
calculated so that men who have CHS would have one wife and the rest was shared with FSW. 
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Bisexual men were assumed to have sex with their stable partners, FSW, TSW and between each 
other.  
It was assumed that the demand for sex was driven by men playing the insertive role during vaginal 
or anal sex. To balance the number of partnerships formed between the groups, the total number 
and proportion of partners that receptive individuals had in each group Ci and ρi,i’  respectively was 
inferred from the number of partners they had in group i’. The number of partners for female 
visitors (wives and FSW) was therefore calculated based on the number of partners reported by men 
and on men’s sexual mixing matrices. In the same way, the number of partners of TSW was 
calculated based on the demand from Bisexual men. 
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Force of infection 
The per capita force of infection of an individual of group i at time t, λi(t) depends on the rate of 
partner acquisition Ci, the proportion of partnerships that are formed in group i’ ρi,i’, the “effective 
prevalence” Pi’(t) among individuals in group i’ at time t which depends on the proportion of infected 
individuals and the transmission probability by stage of infection βs, the transmission factor 
associated to the type of sex act practiced with group i’  Bisexual men were assumed to be versatile 
when they had sex with other bisexual men and to be exclusively insertive when they had sex with 
TSW. TSW were assumed to be exclusively receptive. Mi,i’, the number of sex acts per week with 
partners from group i’ ωi,i’ and the frequency of condom use with partners from group i’ φi,I’.  
Parameter values describing sexual behaviour in the model are given in table 2. 
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Parameter Symbol Estimate Reference 
Fraction of the population who:    
do not have sex κ1 0.018 SS 2000  
are MOSW κ2 0.25 SS 2000 
are MCHS κ3 0.27 SS 2000 
are Bisexual κ4 0.06 SS 2000 
are Trans Sex Workers κ5 0.006 HIV programme/MSF report 
are wives of MOSW κ6 0.24 By definition 
are wives of MCHS κ7 0.12 Assumption 
are wives of Bisexual men κ8 0.02 Assumption 
are FSW κ9 0.02 HIV programme/MSF report 
Number of partners among:    
men who do not have sex C1 0 By definition 
MOSW C2 1.3 SS 2000 
MCHS C3 3 SS 2000 
bisexual men C4 3.4 SS 2000 
Number of sex acts with    
sex workers ω5,i and 
ω9,i 
2 Assumption 
stable partner ω6to8,i 52 Assumption 
casual partners ω4,4 10 Assumption 
Proportion of partnerships among:    
MOSW formed w/their wife ρ2,6 1 By definition 
MCHS formed w/ MCHS wives ρ3,7 0.34 Assumption 
MCHS formed w/ FSW ρ3,9 0.66 Assumption 
Bisexual men formed w/ their wife ρ4,8 0.125 Assumption 
Bisexual men formed w/ FSW ρ4,9 0.375 Assumption 
Bisexual men formed w/ other Bisexual men ρ4,4 0.125 Assumption 
Bisexual men formed w/ TSW ρ4,5 0.375 Assumption 
TSW partnerships w/ Bisexual men ρ5,4 1 Assumption 
MOSW wives formed w/ MOSW  ρ6,2 1 By definition 
MCHS wives formed w/ MCHS ρ7,3 1 By definition 
Bisexual men wives formed w/ Bisexual men ρ8,4 1 By definition 
Condom use with    
stable partner  θ6to8,2to4 0.12 SS 2000 
TSW θ5,4 0.3* SS 2000 
FSW θ9,3to4 0.7 SS 2000 
between bisexual men θ4,4 0.22 SS 2000 
 
Table 2. Baseline parameterisation of the model according to 2000 Sentinel Surveillance survey 
*Condom use was not available from data for this group so it was assumed to be about one third higher than between 
bisexual men as levels of protection are higher in commercial sex.  
 
Prison demographics 
Regarding the demographics of the prison population, inmates and their partners entered and exited 
prison at the same rate to approximate the fact that women are only present in the prison system 
while their partners are incarcerated. Average time spent in prison during the current incarceration 
at the moment of the survey (1.8 years) was used as a proxy for average sentence length.  The entry 
rate was set to be equal to the exit rate to keep population size constant. New inmates and their 
female partners were distributed in groups according to the distribution described previously and a 
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fixed proportion, independent of sexual behaviour, was assumed to be HIV positive at entry. Values 
for demographic parameters are given in table 3. 
Initial conditions 
The total population including prison inmates and visitors ΣXi(t) was set at 6500 individuals, which 
corresponds to the current population size in Lurigancho, and was kept constant throughout the 
simulation. The number of individuals in each group was determined by the proportion of individuals 
in each group κi times the total population. This also remained constant throughout the simulation. 
The HIV epidemic was assumed to start in 1975. 
Parameter Symbol Estimate Reference 
Start of simulation   1964 MSF report 
Population size: Total/inmate Nt=0 10900/6500 INPE 2011 
Average sentence length S1 1.8 SS2000 
Table 3. Parameter values for prison demographics 
Model’s outputs 
The total HIV prevalence among inmates obtained with model 1 is shown in figure 2. Equilibrium was 
reached in the early 80’s and prevalence remained stable at 1.3% thereafter. This approximates the 
estimate from the 2005 sentinel surveillance survey and from the HIV programme within the prison 
in later years. Despite being parameterised using 2000 data, the model does not reproduce the 
prevalence obtained in that survey as closely. 
Once equilibrium was reached, incidence was constant at 0.09%, suggesting low levels of 
transmission. 
 
Figure 2. Prevalence (A) and incidence (B) among prison inmates in Lurigancho 
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The distribution per sexual behaviour group was calculated to reproduce the data from the 2000 
survey as illustrated in figure 3A. Prevalence in each group in 2000 is shown in figure 3B. There was 
little variation between groups with TSW having a slightly higher prevalence than the rest and in 
general the model underestimated prevalence in each group, which is expected as it underestimated 
total prevalence in 2000.  
   
Figure 3. Distribution (A) and HIV prevalence among inmates by sexual behaviour group 
Critique 
Model 1 represented the prison setting in the most simplistic way. This structure is often used when 
modelling disease transmission in prison and might be sufficient to accurately represent the 
epidemic.  However, heterogeneity in sentence length and recidivism might have an effect on the 
epidemic and although this is partially addressed by adjusting prevalence at entry it does not offer 
any possibility to investigate the potential effect of prison exposure on HIV prevalence. As 
mentioned in the introduction, being in a community where HIV prevalence is higher will increase 
the risk of infection if partners are chosen from within the community. This along with other 
fundamental questions regarding the potential impact of changes in characteristics of the prison 
system on prevalence cannot be explored with this model. 
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Model 2 
Model structure 
Summary 
Model 2 simulated HIV transmission in a population stratified by sexual behaviour, offender type 
and prison status, allowing movement from prison to the community and back. Offender type refers 
to the frequency of reoffending and to sentence length. Heterogeneities regarding these patterns 
were represented by dividing inmates into 4 groups: one time offenders, regular offenders, frequent 
offenders and offenders serving a long sentence. Individuals entered the 1st incarceration stage, 
were released to the community and reoffenders entered a separate compartment in order to 
differentiate first offenders from reoffenders.  All sentences apart from long sentences were 
assumed to have the same duration and the time spent outside prison in between incarcerations 
was tailored to the delinquency types, with frequent offenders spending less time outside. All exits 
from the system were replaced resulting in a stable prison population size of 6500, corresponding to 
the current number of inmates in Lurigancho. The natural history of infection and sexual behaviour 
remained unchanged from the previous model. The basic model structure is represented in figure 4. 
Two structures were considered for the representation of the prison demographics and the bottom 
one was applied for reasons detailed further in this section. 
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Figure 4. diagrams representing model 2 structure for the progression through infectious stages, the movement through the prison system and the 
mixing patterns between groups with specific sexual behaviours
HIV natural history Sexual behaviour Prison population dynamics 
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Full definition 
Model 2 simulates HIV spread over time in prison and assumed there is no transmission in the 
“outside stage”. The state variables are given by )(
,
, tX
sM
ri . t is the time elapsed in the simulation; s is 
the infection-status (1= susceptible; 2= acute infection; 3= latent infection; 4= pre-AIDS), i designates 
the  ‘sexual behaviour group’ (1=Men who do not have sex; 2=Men who only have sex with their 
wife; 3=Men who have casual heterosexual sex; 4=Bisexual men; 5=Transgender Sex Workers ; 
6=Wives of men who only have sex with their wife; 7=Wives of men who have casual heterosexual 
sex; 8=Wives of bisexual men; 9= Female Sex Workers), r  is the offender type (1=One time offender; 
2=Regular offender; 3=Long sentence, 4=Frequent offender), M corresponds to the prison status 
(F=First time in prison, O=Outside, R=Subsequent incarcerations). The equations determining both 
the infection process and the demographic movement are presented below:  
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κr and γr designate the distribution of individuals by sexual behaviour i and offender type r 
respectively. σ is the rate of progression from each disease stage to the next. )(ti  is the rate of 
infection of group i at time t. τ is the population turnover which is equal to 1 over the duration of 
time in delinquency. Ϛr and φr represent the rate at which individuals in each offender group exit 
prison and the outside stage, respectively.  αr is the proportion of long sentences who only offend 
once and therefore are moved to the one time offenders outside stage , gr is the proportion of long 
sentences who reoffend (=1-α). lr is the proportion of reoffenders who remain in the same category 
when entering prison after a period outside. mr and nr represent the proportion of long sentences 
who become regular and frequent offenders respectively at their subsequent incarcerations. hr and 
qr represents the proportion of regular and frequent offenders who get a long sentence at a 
subsequent incarceration respectively.  
Natural history of infection and sexual behaviour 
The description of sexual behaviour and of the natural history of infection is available from model 1. 
Prison demographics 
The population was stratified into 4 “offender types”: One time, regular, frequent and long sentence 
offenders, who progress along 3 main states: “first incarceration”, “out” and “subsequent 
incarcerations” to differentiate 1st time offenders from re-offenders. The structure is presented in 
figure 4. 
The proportion of first time offenders entering each group ϓ was adjusted so that the proportion of 
first offenders was constant at 62% and so that the distribution of offender types in the reoffending 
category corresponded to the observed patterns (see table 4). In 2000, about 50% of reoffenders 
had been in prison once before. The model was calibrated so that 45% of reoffenders were regular 
offenders, 45% were frequent offenders and 10% were long sentences. 
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By definition, one time offenders enter prison one time and never go back in. Regular and frequent 
offenders were assumed to be incarcerated 2 and 4 times on average respectively. For parsimony all 
sentences except long sentences were assumed to last 1.8 years. Long sentences were assumed to 
last 10 years on average. The duration in the outside period in between incarcerations was 
calculated based as a residual of the total duration in delinquency and the total time spent in prison. 
The total duration in delinquency corresponds to the total population turnover and it was calculated 
so that the number of new entries per month was of approximately 150 per month, which is the 
current average entry rate in Lurigancho.  Entries and exits are equivalent in this model as the 
population size is kept constant with time. The average duration of criminal career was of 12 years, 
which would be consistent with the age patterns observed in Lurigancho, where the average age at 
entry is approximately 28 and the majority of inmates are under 40 years old. As an example the 
time spent outside between incarcerations for frequent offenders was of 1.2 years ((12-(4*1.8))/4). 
All values are given in table 4.  
A proportion of long sentences α are assumed to never come back to prison and are directed to the 
outside stage of one time offenders, of the remainder, a proportion m become regular offenders, a 
proportion n become frequent offenders and the rest get another long sentence. Both regular and 
frequent offenders had a probability h and q respectively of getting a long sentence after their first 
sentence and the remainder entered their original category according to l. Values are provided in 
table 4. 
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Offender type 
 
 
Symbol 
One time Regular 
Long 
sentence 
Frequent 
Reference 
Basic prison demography 
 
          
Total population at start Nt=o 37,000   
Inmate population at equilibrium 
 
6,500   
Distribution by offender type at entry ϓ 0.45 0.40 0.05 0.10 
SS 2000                 
/calibration 
Rate of exit from delinquency τ 1/12 1/12 1/12 1/12 
Assumption              
/calibration 
Rate of exit from prison Ϛ 1/1.8 1/1.8 1/10 1/1.8 SS 2000 
Rate of exit from the outside stage φ 0 1/8.4 1/15 1/1.2 
Assumption             
/calibration 
Movement between offender categories   
Proportion of long sentences who 
never reoffend α 0 0 0.5 0 
Assumption 
Proportion of long sentences who  
reoffend g 0 0 1-α 0 
Assumption 
Proportion who remain in the same 
offender category on return to prison l 0 1-h 1-m-n 1-q 
Assumption 
Proportion of regular offenders who 
get a long sentence on return to prison m 0 0.5 0 0 
Assumption 
Proportion of frequent offenders who 
get a long sentence on return to prison n 0 0 0 0.4 
Assumption 
Proportion of long sentences who 
become regular offenders on return to 
prison h 0 0 0.05 0 
Assumption 
Proportion of long sentences who 
become frequent offenders on return 
to prison q 0 0 0.02 0 
Assumption 
Table 4. Parameterisation of prison demography 
At the start of the simulation, all individuals enter the 1st incarceration stage and as time progresses 
the “outside” and “subsequent incarceration” compartments fill in until equilibrium is reached. The 
total population at start was calculated to have a total population size at equilibrium (ie.1st offenders 
and reoffenders) equal to 6500: Lurigancho’s current population size. 
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Model outputs 
The resulting HIV prevalence and incidence curves are shown in figure 5A and 5B. Prevalence 
reached equilibrium in the late 80’s and remained stable at just over 1% thereafter. Incidence was 
constant at 0.08% from 2000 onwards. This is slightly lower than the estimate obtained from model 
one because individuals spend time in the outside boxes where no transmission is assumed. The 
modelled prevalence in 2000 is lower than the estimate from the sentinel surveillance survey. It is 
possible that prevalence at entry or transmission in prison was higher at the time.  
 
Figure 6. Total prevalence (A) and incidence (B) among prison inmates 
The model was calibrated to fit data from the 2000 surveillance data in terms of distribution by 
sexual behaviour, reoffending and length of stay. The threshold for long and short sentences was 
arbitrarily defined as less and more than 3 years. The distribution and prevalence in each of these 
groups is shown in figure 7. There was little variation between groups, which is expected taken into 
account the low incidence obtained from simulating transmission based on the reported sexual 
behaviours from 2000. Prevalence among reoffenders is lower than among 1st offenders which is 
inconsistent with the data. By definition reoffenders spend some time outside where there is no 
transmission and since new entries do not directly enter these compartments there is no direct 
replenishment of infected individuals. Prevalence is slightly higher among long sentences reflecting 
longer exposure to transmission in prison.  
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Figure 7.  Distribution and HIV prevalence among inmates in 2000 by incarceration stage, sentence length and sexual risk behaviour 
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Critique 
Model 2 represented heterogeneity in incarceration patterns based on an interpretation of 
delinquents’ characteristics. It therefore assumes that delinquent behaviour is predetermined. 
Inmates who enter the “frequent offender” category are bound to reoffend many times which might 
actually correspond to reality. It is likely that inmates who come from a neighbourhood or 
environment where crime is the main form of making a living will repeatedly be in contact with the 
prison system. This type of construction would allow assigning different sexual behaviours 
depending on offenders’ characteristics if it was found that frequent offenders lead riskier sexual 
lives as compared to one time offenders for instance. This would simply involve attributing a specific 
distribution per sexual behaviour to each of the offender categories. The disadvantage of this 
conceptualisation is that sexual behaviour would be somehow independent of exposure to prison as 
inmates would have the same behaviour on the 1st or 4th incarceration and on the 1st or 10th year of 
their sentence.  
Behaviour change as a result of prison exposure is an issue prone to speculation as there is a variety 
of reasons and ways in which this artificially created environment could modify behaviours. 
Although associations between exposure to prison and risk behaviours are often found in studies, 
the direction of the relationship is unclear. Inmates that have had more contact with the system 
might have changed their behaviour as a result of prolonged or frequent exposure. On the other 
hand inmates with prolonged and frequent exposure might simply lead riskier life styles. Measuring 
this is difficult as there is often no information on inmates’ behaviour outside of prison and even less 
of delinquents who have not been in contact with the prison system. Longitudinal studies collecting 
behavioural information from the same inmates at different periods in time would allow shedding 
light on this issue.  
This hypothetical categorisation implies a subjective processing of the data. Thresholds need to be 
determined in order to define regular and frequent offenders as well as long sentences, making it 
difficult to interpret results as they do not directly match the information available from data. Model 
outputs are likely to be influenced by these assumptions and adding this layer of complexity might 
be unnecessary. 
In addition, the structure lacks flexibility and precision. It does not allow differentiating between 
inmates that have been in prison 2, 3, 4 or 5 times or differentiating those that have been in for 3 
years from those who have been in for 7 years for instance. This would be important if prison 
context was found to have an important effect on HIV risk. One of the assumptions that might be 
worth reconsidering is the assumption that all inmates spend the same time in delinquency. Here, 
  
410 Appendix Chapter 5 
regular offenders spend over 8 years outside before entering prison again. A more realistic 
assumption might be that regular offenders spend less time in delinquency and have their two 
incarcerations closer together. The age patterns by incarceration stage observed in the sentinel 
surveillance data seem to correspond better to the latter scenario as age increases with the number 
of incarceration 
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Structured questionnaire to identify determinants and pathways of HIV risk among prison inmates 
Number Questions and filters Codes Instruction
s to 
programme
r 
Socio-economic indicators and living conditions 
101 How old are you? 
  
  
  
AGE     [__|__] 
Does not remember     88 
Did not answer    99 
  
  
    
    
    
102 What is your D.O.B.? 
  
  
  
DATE [DAY|MONTH|YEAR] 
Does not remember     88 
Did not answer    99 
  
  
    
    
    
103 What is you civil status? 
  
  
  
  
  
  
Married 1 
Cohabiting 2 
Single 3 
Divorced 4 
Widower 5 
Did not answer      99 
  
  
    
    
    
    
    
    
104 How many children do you have? 
  
  
Number of children [_|_] 
Did not answer     99 
  
  
    
    
105 Have you been to school? 
  
  
  
YES 1 
NO 2 
Did not answer      99 
  
  
  =>P107 
    
    
106 What level did you reach? 
  
  
  
  
  
  
None 1 
Primary 2 
Secundary 3 
High School 4 
Higher 5 
Did not answer    99 
  
  
    
    
    
    
    
    
107 What type of accommodation did you live in 
before this incarceration? 
Family home 1 
Hostel/unstable housing 2 
Street 3 
Did not answer     99 
  
  
    
  => P109 
    
    
108 Have you ever had to live in the streets? 
  
  
  
YES 1 
NO 2 
Did not answer      99 
  
  
  => P110 
    
    
109 For how long have you been living/did you live 
in the street? 
days 1 
weeks 2 
Months 3 
years 4 
Did not answer      99 
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110 What was your job before coming to prison? 
  
I had my own business 1 
I was a skilled-man 
(plumber/carpenter/taxi 
driver etc) 2 
I worked in the government 
3 
I worked for a private 
company 4 
I did not have a job 5 
Did not answer      99 
  
  
    
      
      
      
      
      
111 How much per month did you earn on average 
before coming to prison? 
Less than 1,000 pesos 1 
Between 1,000 and 2,000 2 
Between 2,000 and 5,000 3 
Between 5,000 and 10,000 4 
More than 10,000 5 
Did not answer     99 
  
  
    
    
    
    
    
    
112 Have you ever migrated to the U.S.? 
  
  
  
YES 1 
NO 2 
Did not answer      99 
  
  
    
    
    
Childhood and schooling 
201 For most of your childhood who did you live 
with? 
  
  
  
  
  
  
My mother and father 1 
Only with my mother 2 
Only with my father 3 
Other family members 4 
With none of these 5 
Did not answer      99 
  
  
    
    
    
    
    
    
202 How many brothers and sisters do you have? 
  
  
Number of siblings [_|_] 
Did not answer      99 
  
  
    
    
203 How many people lived in the house at most 
times? 
One to four 1 
Five to ten 2 
More than ten 3 
Did not answer      99 
  
  
    
    
    
    
204 For most of your childhood where did you live? 
  
  
Drop menu 
Did not answer      99 
  
  
    
    
205 Did your family have financial difficulties? 
  
  
  
YES 1 
NO 2 
Did not answer      99 
  
  
    
    
    
206 Did any of your parents had alcohol or 
substance abuse problems? 
Mother 1 
Father 2 
Both 3 
None 4 
Did not answer      99 
  
  
    
    
    
    
    
207     
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  Did you ever suffer from any of these types of 
violence at home? (multiple answers possible) 
Psychological 1 
Physical 2 
Sexual abuse 3 
None 4 
Did not answer      99 
  
  
    
    
    
    
208 How old were you when you left the family 
home? 
  
  
AGE     [__|__] 
Did not answer      99 
  
  
    
    
209 How old were you when you left school? 
  
  
AGE     [__|__] 
Did not answer      99 
  
  
    
    
210 How old were you when you started your first 
job? 
  
  
AGE     [__|__] 
Did not answer      99 
  
  
    
    
211 Where you part of a gang when you were 
young? 
  
  
  
YES 1 
NO 2 
Did not answer      99 
  
  
    
    
   
212 How many tattoos do you have? 
  
  
Number of tattoos [_|_] 
Did not answer      99 
  
  
    
    
213 Where any of these not done with a 
professional machine? 
YES 1 
NO 2 
Did not answer      99 
  
  
    
    
    
Drug use outside prison 
301 Have you ever taken any drugs? 
  
  
  
  
Yes 1   
  No 2 →401  
      
  Did not answer    99   
      
302 How old were you when you first tried drugs? 
  
  
AGE     [__|__]   
  Did not answer      99   
      
303 What drugs have you tried? 
(multiple answers possible) 
  
  
  
  
  
  
Marihuana 1   
  Tiner 2   
  Cocaine paste 3   
  Cocaine 4   
  Methamphetamines 5   
  Heroin 6   
  Did not answer    99   
      
304 In the last 6 months outside prison, what drugs 
did you use? 
(multiple answers possible) 
  
  
  
  
Marihuana 1   
  Tiner 2   
  Cocaine paste 3   
  Cocaine 4   
  Methamphetamines 5   
  Heroin 6   
   
 
 
Did not answer    99 
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305 In the last month outside prison, how often did 
you use drugs? 
At least once a day 1   
  Several times a week 2   
  Less than once a week 3   
  Did not answer    99   
      
306 When you took cocaine paste, did you 
sometimes share the inhaler? 
Yes 1   
  No 2   
  Did not answer    99   
      
307 Have you ever injected drugs? 
  
  
  
Yes 1   
  No 2 →701 and 
skip IDU in 
prison 
(1102a-
1102e) 
  Did not answer     99   
      
308 How old were you when you first injected 
drugs? 
  
  
Number [_|_]   
  Did not answer     99   
      
309 Have you injected drugs whilst you’ve been 
outside prison? 
Yes 1   
  No 2 →701 
  Did not answer     99   
      
310 In the last month outside prison, how many 
times did you inject drugs? 
At least once a day 1   
  Several times a week 2   
  Less than once a week 3   
  Did not answer     99   
      
606c On the last occasion, did you use CLEAN 
injecting equipment? by this we mean either 
new or cleaned with bleach and that nobody 
used before you injected 
Yes 1   
  No 2   
  Did not answer    99   
      
606d On the last occasion when you did not use 
clean injecting equipment: By (approximately) 
how many people had the equipment had 
been used for injecting drugs previously?  
None 0   
  One 1   
  Two to five 2   
  Six to twenty 3   
  More than 20 4   
  I don't know 5   
  Did not answer    99   
      
606e Speaking only about the person with who 
injected IMMEDIATELY before you: 
Had you shared injecting equipment with this 
person before this occasion? 
  
  
  
Si 1   
  No 2   
  Did not answer   99   
      
  Have you ever contracted a debt or taken a 
credit to pay for drugs? 
Yes 1   
  No 2   
  Did not answer     99   
      
      
      Sexual behaviour outside prison 
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401 Have you ever had sex? (defined as vaginal or 
anal) 
  
  
  
YES 1   
  NO 2 => 501 
  Did not answer      99   
      
402 How old were you when you first had sex? 
  
  
AGE     [__|__]   
  Did not answer      99   
      
403 How many different sexual partners have you 
had in your lifetime? 
Number of partners [_|_]   
 Did not answer     99   
    
404 Have you ever paid for sex outside prison? 
  
  
  
YES 1   
  NO 2   
  Did not answer      99   
      
405 Have you ever sold sex outside prison? YES 1   
   NO 2   
   Did not answer      99   
      
406 Have you ever had sex with a man outside 
prison? 
  
  
  
YES 1   
  NO 2   
  Did not answer      99   
      
407 How old were you the first time you had sex 
with a man? 
AGE     [__|__]   
 Did not answer      99   
    
408 The first time you had sex with a man it was 
  
  
  
in prison 1   
  outside prison 2   
  did not answer    99   
      
409 When you have sex with men you are 
  
  
  
always active/insertive 1   
  always passive/receptive 2   
  both 3   
  did not answer    99   
      
410 You would say you are 
  
  
  
  
  
heterosexual 1   
  bisexual 2   
  homosexual 3   
  trans 4   
  other 5   
  did not answer    99   
     
411 Have you ever been coerced to have sex or 
raped outside prison? 
YES 1   
  NO 2   
  Did not answer      99   
      
412 How many different sexual partners did you 
have in the last 6 months outside prison? 
Number of partners [_|_]   
  Did not answer     99   
  
 
 
     
413 
  
 
Wife/cohabiting partner 1 
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  In the last 6 months outside prison with whom 
of these partners did you have sex? 
  
(multiple options possible) 
  
  
  
Girlfriend 2   
  Boyfriend/casual male 
partner 3 
  
  FSW 4   
  MSW 5   
  Transwoman 6   
  Did not answer     99   
      
414 Did you use a condom with your last stable 
sexual partner outside prison? 
  
YES 1   
  NO 2   
  Did not answer      99   
     
415 Did you use a condom with your last casual 
sexual partner outside prison? 
  
YES 1   
  NO 2   
  Did not answer      99   
      
416 How often did you have sex under the 
influence of alcohol in the last 6 months? 
  
  
  
Never 1   
  Sometimes 2   
  Often 3   
  Always 4   
  Did not answer     99   
      
417 How often did you have sex under the 
influence of drugs in the last 6 months? 
Never 1   
  Sometimes 2   
  Often 3   
  Always 4   
  Did not answer     99   
      
Access to health care outside prison 
501 How long did it take you to reach the closest 
health centre from your house? 
Less than 30 mins 1   
  30 mins-1h 2   
  1-2 hours 3   
  Over 2 hours 4   
  Did not answer   99   
      
502 How often did you go to the health centre or 
to see a doctor? 
Several times per year 1   
  Once per year 2   
  Less than once per year 3   
  Did not answer   99   
      
503 Remember the last time you had to stay home 
because you felt ill, what did you do? 
  
  
  
  
  
I went to see the doctor 1   
  I took something they gave 
me at the pharmacy 2 
  
  I took something I had at 
home or that a friend/family 
gave me 3 
  
  nothing 4   
  Did not answer   99   
      
504 In the last year/period before this 
incarceration, did you ever have any pain while 
urinating, ulcers or abnormal genital 
discharge? 
Yes 1   
  No 2 →801 
  Did not answer    99   
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505 What did you do? 
  
  
  
  
  
I went to see the doctor 1   
  I took something they gave 
me at the pharmacy 2 
  
  I took something I had at 
home or that a friend/family 
gave me 3 
  
  nothing 4   
  Did not answer   99   
      
506 Have you ever had an HIV test done outside 
prison? 
Yes 1   
  No 2   
  Did not answer   99   
      
507 A healthy looking person can have the AIDS 
virus 
true 1   
  false 2   
  Did not answer    99   
      
508 A person cannot be infected by sharing food 
with someone with AIDS 
true 1   
  false 2   
  Did not answer    99   
      
509 For a man, which of these is the riskiest form 
of sex for HIV infection 
oral 1   
  anal insertive (active) 2   
  vaginal 3   
  anal receptive (passive) 4   
  Did not answer    99   
      
Mental health 
Apply 
instrument  
      
Time in prison and recidivism/ criminal history 
701 What is your date of entry into prison in this 
current sentence? 
DATE [DAY|MONTH|YEAR]   
      
  Did not answer      99   
      
702 What type of crime were you accused of? 
(multiple options possible) 
  
  
  
  
stealing 1   
  sexual violence 2   
  Crime against life 3   
  Drug related offence 4   
  Did not answer      99   
      
703 Have you been sentenced? 
  
  
  
Yes 1   
  No 2 →705 
  Did not answer      99   
      
704 How long do you have left? 
  
  
  
  
Number of years [_|_]   
  Number of months [_|_]   
  Number of days [_|_]   
  Did not answer      99   
      
705 How many times have you been in prison 
before this time? 
Number of times [_|_] If 0 →801 
  Did not answer      99   
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706 How old were you the first time you got into 
prison? 
  
  
[_|_]   
  Did not answer      99   
      
707 How long in total have you spent in prison in 
your life? 
Number of years [_|_]   
  Number of months [_|_]   
  did not answer    99   
      
708 Before this time, when was the last time you 
were in prison? What is the date you went 
out? 
DATE [DAY|MONTH|YEAR]   
      
  Did not answer     99   
      
709 What type of crime were you accused of that 
time? 
  
(multiple options possible) 
  
  
  
Stealing 1 
sexual violence 2 
Crime against life 3 
Drug related offence 4 
Did not answer      99 
  
  
    
    
    
    
    
710 How long did you spend in prison that time? 
  
  
Number of years [_|_] 
Number of months [_|_] 
did not answer   99 
  
    
    
    
711 In which prison were you then? 
  
  
  
List of prisons in country  
outside country 
did not answer   99 
 
    
   
    
712 Before that last time, when was the second 
most recent time you were in prison? What is 
the date you went out? 
DATE [DAY|MONTH|YEAR] 
Did not answer     99 
  
if the 
answer in 
206 is 2 or 
more then 
go to 210a 
and repeat 
questions 
209b to d  
    
    
 Social Network 
801 Did you know someone in this prison from 
before you were incarcerated? 
(multiple answers possible) 
  
  
Family members 1   
  Friends 2   
  Acquaintances 3   
  None 4   
  Did not answer     99   
      
802 Who do you get on with? 
 (multiple options possible) 
  
  
  
  
No one 1 
With people I knew outside 
2 
with people I met in prison 
in a previous incarceration 3 
With people I met in prison 
during this sentence 4 
Did not answer   99 
  
has to be 
able to 
choose 
several 
options 
    
  this option 
should be 
eliminated 
if this is the 
first time 
they are in 
prison 
    
    
    
803 Are you part of a gang? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
   
   
   
804 Are you actively involved in a religious group in Yes 1   
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  prison? 
  
No 2 
Did not answer   99 
  
  
    
    
805 Do you belong to a sports team? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
806 How often do you have visits? 
  
  
  
  
  
At least one a week  1 
At least once a month 2 
Less than once a month 3 
Never 4 
Did not answer   99 
  
  
    
    
  →810 
    
    
807 Who visits you? 
  
  
  
  
  
  
  
Mother 1 
Father 2 
Other family members 3 
Wife or cohabiting partner 4 
Girlfriend 5 
Friends 6 
Did not answer   99 
  
  
    
    
    
    
    
    
    
808 Do you have access to the official conjugal 
visit? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
809 Do you have sexual partners visiting you 
outside the official conjugal visit?  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
810 Have you separated from your main partner 
since you entered prison? 
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
811 Have you lost the support of family members 
since you entered prison? 
Yes 1 
No 2 
Did not answer   99 
  
    
    
    
812 Have you lost the support of friends since you 
entered prison? 
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
Position in hierarchy 
901 Do you have a job in prison? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
902 Do you attend any workshop? 
  
  
Yes 1 
No 2 
Did not answer   99 
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903 Do you have responsibilities in the prison? 
  
  
  
  
  
Delegado (drop down 
menu) 1 
Housekeeping 2 
Maintain order in ward 3 
Church 4 
Did not answer   99 
  
  
    
    
    
    
    
904 Do you feel respected by other inmates? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
905 Do you sleep in a cell? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
  =>907 and 
then   910 
    
906 How many other inmates are in the same cell 
as you? 
Number [_|_] 
Did not answer    99 
  
  
    
    
907 Where do you sleep? 
  
  
  
On a bed 1 
On the floor 2 
Did not answer    99 
  
  
    
    
    
908 Is your sleeping spot 
  
  
  
Close to the toilet 1 
Far from the toilet 2 
Did not answer    99 
  
  
    
    
    
909 Have you been in the same cell since your 
arrival? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
910 How many cells have you been in? 
  
  
  
Yes 1 
No 2 
Did not answer   99 
  
=>1001 
    
    
    
911 What have your reasons for moving been? 
(multiple options possible) 
  
  
  
  
Abuse from others 1 
Evicted by others  2 
Found a better/ more 
comfortable cell 3 
Needed protection 4 
Did not answer   99 
  
  
    
    
    
    
    
Drug use in prison 
1001 Have you ever used drugs in prison? 
  
  
  
Yes 1 
No 2 
Did not answer    99 
  
  
  →1100 
    
    
1002 In the last 6 months in prison, what drugs have 
you used? 
(multiple answers possible) 
  
Marihuana 1 
Tiner 2 
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Cocaine paste 3 
Cocaine 4 
Methamphetamines 5 
Heroin 6 
Did not answer    99 
  
  
    
    
    
1003 In the last month in prison, how often times 
did you use drugs? 
At least once a day 1 
Several times a week 2 
Less than once a week 3 
Did not answer    99 
  
  
    
    
   
    
1004 When you take cocaine paste in prison, do you 
sometimes share the inhaler? 
Yes 1 
No 2 
Did not answer    99 
  
  
    
    
    
1005 Have you injected drugs in prison?  
  
  
  
Yes 1 
No 2 
Did not answer    99 
  
  
  →1201 
    
    
1006 In the last month in prison, how many times 
did you inject drugs? 
At least once a day 1 
Several times a week 2 
Less than once a week 3 
Did not answer     99 
  
  
    
    
    
    
1007 On the last occasion, did you use clean 
injecting equipment? Meaning new or cleaned 
with bleach just before you injected 
Yes 1 
No 2 
Did not answer    99 
  
  
    
    
    
1008 On the last occasion when you did not use 
clean injecting equipment: By (approximately) 
how many people had the equipment had 
been used for injecting drugs previously?  
None 0   
  One 1   
  Two to five 2   
  Six to twenty 3   
  More than 20 4   
  I don't know 5   
  Did not answer    99   
      
1009 Speaking only about the person who used the 
equipment IMMEDIATELY before you: 
Had you shared injecting equipment with this 
person before this occasion? 
Si 1   
  No 2   
  Did not answer   99   
      
1010 Have you ever contracted a debt or taken a 
credit to pay for drugs in prison? 
Yes 1   
  No 2   
  Did not answer     99   
      
Sexual behaviour IN prison 
1101 Have you ever had sex with a FSW in prison? 
  
  
  
Yes 1 
No 2 
Did not answer     99 
  
  
    
    
    
1102 Have you ever had sex with a man in prison? 
  
Yes 1 
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No 2 
Did not answer     99 
  
  
    
1103 Have you ever been coerced to have sex or 
raped in prison? 
Yes 1 
No 2 
Did not answer     99 
  
  
    
    
    
1104 In this last 6 months in prison, how many 
different sexual partners have you had? 
(including anal and vaginal sex) 
Number of women [_|_] 
Did not answer    99 
  
if 0→903 
  and skip 
905-906     
1105 In the last 6 months in prison with whom of 
these partners did you have sex? 
Wife/cohabiting partner 1 
Girlfriend 2 
Boyfriend 3 
FSW 4 
MSW 5 
Transwoman 6 
Did not answer    99 
  
  
    
    
    
    
    
    
    
1106 Did you use a condom with your last stable 
sexual partner in prison? 
YES 1 
NO 2 
Did not answer      99 
  
  
    
    
    
1107 Did you use a condom with your last casual 
sexual partner in prison? 
YES 1 
NO 2 
  
  
    
    
1108 How often did you have sex under the 
influence of alcohol in the last 6 months? 
Never 1 
Sometimes 2 
Often 3 
Always 4 
Did not answer     99 
  
  
    
    
    
    
    
1109 How often did you have sex under the 
influence of drugs in the last 6 months? 
Never 1 
Sometimes 2 
Often 3 
Always 4 
Did not answer     99 
  
  
    
    
    
    
    
1110 During this incarceration, have you sold or 
exchanged sexual services for protection, food 
or favours? (including anal, oral sex and other 
sexual contacts) 
Yes 1 
No 2 
Did not answer      99 
  
  →1113 
    
    
1111 How many times in the last month? 
  
  
Number of times [_|_] 
did not answer    99 
  
    
    
1112 Last time you gave sexual services in exchange 
of money food of favours, what did you do? 
Performed oral sex 1 
Received oral sex 2 
Received anal sex 3 
Performed anal sex 4 
Other 5 
Did not answer      99 
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1113 Was a condom used in that last occasion you 
provided sexual services? 
Yes 1 
No 2 
Did not answer     99 
  
  
    
    
    
1114 Thinking about your current period of time in 
this prison, have you ever experienced a 
situation in which another person coerced you 
to have sex when you were not willing? 
Yes 1   
  No 2 →1120 
  Did not answer  99   
      
1115 How many times during your current stay in 
this prison has someone coerced you to have 
sex when you were not willing? 
Number of times [_|_] 
did not answer    99 
  
  
    
    
1116 Last time you were coerced into having sex, 
what did you do? 
Performed oral sex 1 
Received oral sex 2 
Received anal sex 3 
Performed anal sex 4 
Other 5 
Did not answer      99 
  
    
    
    
    
    
    
1117 How many people perpetrated this coerced 
sexual experience against you? 
Number of people [_|_] 
did not answer    99 
  
    
    
1118 Had this same person/ people ever coerced 
you into sex before? 
Yes 1 
No 2 
Did not answer     99 
  
  
    
    
    
1119 Did the perpetrators use a condom when 
performing the sexual acts? 
Yes 1 
No 2 
Did not answer     99 
  
  
    
    
    
1120 Thinking about your current period of time in 
this prison, have you ever coerced another 
person to have sex with you when they were 
not willing? 
Yes 1 
No 2 
Did not answer  99 
  
repeat 
questions 
1115 to 
1119 but 
with the 
participant 
being the 
perpetrator 
of the 
violent act 
  →1201 
    
    
Access to health care in prison 
1201 During this incarceration, the last time you felt 
very ill, what did you do? 
I went to see the doctor 1   
  I took something a 
friend/family gave me 2 
  
  nothing 3   
  Did not answer   99   
      
1202 In the last month you have spent in prison: 
have you had any pain while urinating, ulcers 
or abnormal genital discharge? 
  
  
  
Yes 1 
No 2 
Did not answer    99 
  
  
  →end 
    
    
1203 What did you do? 
  
  
  
I went to see the doctor 1 
I took something that a 
friend/family gave me 2 
nothing 3 
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    Did not answer   99 
  
  
1205 Have you ever had an HIV test done in prison? Yes 1 
No 2 
Did not answer   99 
  
  
    
    
    
Mental health/Current emotional state 
Apply instrument     
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